slide_ID,class,MC_score
2675EFF6-5DDF-475D-BFE4-EF39693E746A,Pituitary adenoma,1
A761B999-2C7F-4889-A042-42BDF6F5458E,Diffuse paediatric-type high grade glioma,1
0E3825CF-3B64-43C6-A8F3-B4551A0368F2,papillary tumour of the pineal region,1
00327711-313A-4CA9-A349-A043646259CD,Pituitary adenoma,1
CA6CACCD-1D46-444F-BEA5-C2A163BCC52A,Diffuse paediatric-type high grade glioma,1
D279523B-CA10-4820-A287-BBA8DAB1E605,Diffuse paediatric-type high grade glioma,1
FB9D40BB-DED5-4979-B902-A9BE20DA2F50,normal pineal gland and pineocytoma,1
3D498F28-CA44-4654-8C0E-8A3CFE086A6C,papillary tumour of the pineal region,1
275FB5DC-CA17-4319-8A70-AA428C0B8759,Pituitary adenoma,1
1772659F-3D57-417F-9284-E148AD415930,Malignant melanotic nerve sheath tumour,1
8B666FB1-7872-401C-A1A3-79C866D6F870,Pituitary adenoma,1
F8087264-C2B2-4CD7-9612-89A13F7084A0,Diffuse paediatric-type high grade glioma,1
44B960B1-1D1C-4C74-8AF7-7431C212E42F,"Neuroepithelial tumour, PLAGL1-fused",1
017EA634-336F-429A-9F34-67BEE9AC73A2,"Adult-type diffuse high grade glioma, IDH-wildtype",1
4E17E07E-24A0-4D45-A009-86CE6B8EA7E9,"Adult-type diffuse high grade glioma, IDH-wildtype",1
34FBF5EC-D79D-451C-89C6-59C278D5C736,Malignant melanotic nerve sheath tumour,1
B4C4055F-B3BC-4058-8697-7A2F3A0A2824,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,1
35D8D7EB-B09D-40B8-AAB4-44ECDA0226AD,Pituitary adenoma,1
2516FFD1-9833-45BD-ABC5-7E41B8BBF057,Diffuse leptomeningeal glioneuronal tumour,1
A5CADE4C-EC24-4B0F-A75E-78F71DD43B02,Pituitary adenoma,1
B141F254-C2FD-4066-9604-308F54E73E14,Malignant melanotic nerve sheath tumour,1
BE2FCC18-996E-44D3-A7AB-DE337D60FB71,choroid plexus papilloma,1
A3B206DC-C01C-431D-B988-2F45D1B29838,Pituitary adenoma,1
7B23229D-39BB-49A4-A3F0-C7CB3637794B,Malignant melanotic nerve sheath tumour,1
B656BC17-FCA9-4B36-A71E-F796A536FD40,Diffuse leptomeningeal glioneuronal tumour,1
61681EEB-B258-4441-9EFA-EFD0E32ADB27,"supratentorial ependymoma, ZFTA fusion-positive",1
98364881-BEA3-46DB-B5BF-2032ACD38A3F,Malignant melanotic nerve sheath tumour,1
FCD0D5B5-73A5-4548-AFCC-4D268D98F6F5,"Adult-type diffuse high grade glioma, IDH-wildtype",1
E97950CF-D83F-43A0-9B38-FEA323FC8879,Pituitary adenoma,1
C4F720F6-ED63-44B6-AC4F-9E4B64C72245,"Diffuse midline glioma, H3 K27-altered",1
D482C9B0-6E77-48C0-918D-02F3E79A55E6,"supratentorial ependymoma, ZFTA fusion-positive",1
C05D32B8-1B98-4E41-BDB3-E09A415D26F0,Pituitary adenoma,1
29E3CB98-E0AC-44BB-95AA-135E4644775C,"Neuroepithelial tumour, PLAGL1-fused",1
AF265E86-4268-4B8A-9201-D213292F8141,Pituitary adenoma,1
6F957697-DF3B-43D1-B3C4-1942E940C026,"Diffuse midline glioma, H3 K27-altered",1
79361AA2-7EAD-44BF-B12A-5953C017F38B,choroid plexus carcinoma,1
34996DC3-A6C6-4FDC-B9FD-177EE3CDFF44,Pituitary adenoma,1
269904CD-B61F-4F6D-85FE-AD92FEC22433,choroid plexus papilloma,1
ECE0B774-7C1D-4441-9FE9-A18C596A549C,Pituitary adenoma,1
51748D17-FD55-4AFE-ADEF-9FCE3FC0EA9B,"supratentorial ependymoma, ZFTA fusion-positive",1
BF32EC5F-9559-4F8F-B0B2-6B6315BC95E7,"Diffuse midline glioma, H3 K27-altered",1
67F67121-E720-4E0D-8C99-6393E2028AC3,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,1
BFC63948-DF8B-4F79-B27C-5D6BE0EEB585,Diffuse paediatric-type high grade glioma,1
AA86B5A2-68CA-479A-B8ED-8C33B138E84D,Pituitary adenoma,1
78DFC101-6067-4942-9704-E37A0DE43944,"Diffuse midline glioma, H3 K27-altered",1
E1AAC928-4CBA-4F27-A17C-BF3A608B2E89,Pituitary adenoma,1
42BA87CA-5180-4F7A-8D15-C190BEC4B28C,Diffuse paediatric-type high grade glioma,1
ABA1A958-6C0A-4B11-A355-3637B93C4946,Pituitary adenoma,1
1B0E1827-FECB-48F6-A967-C8933DDB77EF,Diffuse paediatric-type high grade glioma,1
8C51C856-470B-4595-AC33-445497EC2F0B,papillary tumour of the pineal region,1
832BA6AD-2D65-45D2-B30E-075CBFFC0124,Diffuse paediatric-type high grade glioma,1
3521D15F-F54E-4739-B4A0-650006F18BD4,Diffuse paediatric-type high grade glioma,1
28C3DBF2-4F9E-444D-BAA5-1DE63075EBD1,Diffuse paediatric-type high grade glioma,1
BC8A55AA-0FBD-4E0B-961F-FF92C75FDB53,Diffuse paediatric-type high grade glioma,1
7D018839-CD41-4D77-8B4B-08B85AB416C8,Malignant melanotic nerve sheath tumour,1
BEB5A776-4023-449B-B7C7-BFA6E0CEAF0A,Anaplastic neuroepithelial tumour with condensed nuclei,1
A5FA1DB2-DDB5-48D8-A390-9F92F2BFDFC5,normal pineal gland and pineocytoma,1
2AB821CB-BD45-4A01-BD2B-0039EECD222E,"supratentorial ependymoma, ZFTA fusion-positive",1
FA94BD8E-2465-4676-9C02-13B02A9BDB86,Pituitary adenoma,1
696EB3D7-2B76-4864-B16C-04DC03022579,Pituitary adenoma,1
89092F4C-223D-4637-9EB1-7D1884CE102F,Anaplastic neuroepithelial tumour with condensed nuclei,1
B1416B6D-D6C4-4306-951E-15EE4ECC4286,Anaplastic neuroepithelial tumour with condensed nuclei,1
22BC85E2-52B9-4720-85FE-8F4466F0575D,Anaplastic neuroepithelial tumour with condensed nuclei,1
3285A410-27AC-41C4-A46B-FC27E6ABB4A6,Anaplastic neuroepithelial tumour with condensed nuclei,1
08ADD291-C79C-4633-A4F9-C1E107C31782,Anaplastic neuroepithelial tumour with condensed nuclei,1
5BE86600-A899-4572-8FE0-3FE37328496C,pilocytic astrocytoma,0.999999999
833C2A01-B953-4275-AB2D-0FF5E5CD1E81,Pituitary adenoma,0.999999999
8EBFCE02-4D84-4D23-AFE1-CA9EF39931F3,Pituitary adenoma,0.999999999
BE7E4BBF-7715-4064-BA8B-63C02D4CF243,Diffuse leptomeningeal glioneuronal tumour,0.999999999
859D627C-D903-44C5-96BA-5741F71D8A3B,choroid plexus papilloma,0.999999999
11FF3265-C6AF-4222-8436-CCC60E6BC70C,pilocytic astrocytoma,0.999999999
A4CFE09F-E610-41D6-996A-1D9BA9A882D7,Malignant melanotic nerve sheath tumour,0.999999999
75D9C569-3BB7-452B-A8CD-01D22B45EFE3,Pituitary adenoma,0.999999999
3B0B55F9-A53A-4DC5-98E0-3C3FF751133A,"Neuroepithelial tumour, PLAGL1-fused",0.999999999
0F36F550-59FC-44D2-8C00-1DA012168E5A,"Neuroepithelial tumour, MN1:CXXC5-fused",0.999999999
DC26624E-F189-4CC7-958F-8FD187B4A2C1,"Neuroepithelial tumour, MN1:CXXC5-fused",0.999999999
D7F554BF-FD01-412F-9B96-BC43A4963C62,Malignant melanotic nerve sheath tumour,0.999999999
8D0C1706-E45D-4B76-8A76-06398FB70D01,"CNS Schwannoma, VGLL-fused",0.999999999
7D4EA41E-E561-4996-ADE5-76FDBE0A945E,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.999999999
6AE73A57-E7F8-4FFE-8AB8-8D9DEF6A0D82,Pituitary adenoma,0.999999999
4A09B5D4-E786-4FD3-93E1-4A8BF41FA809,"supratentorial ependymoma, ZFTA fusion-positive",0.999999999
77866280-0F9D-4568-ADC9-444CD808CC6F,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999999999
B3FC7BFA-29C7-48A8-A714-CE05C5FFFDD1,normal pineal gland and pineocytoma,0.999999999
A57516C0-EA17-44AE-B04A-B1637D905057,Extraventricular neurocytoma,0.999999999
78E7666D-DF47-43FF-8ABD-AE480A3286CD,choroid plexus papilloma,0.999999998
40159D0D-2882-4E9D-96A4-98CB7096DF7A,"supratentorial ependymoma, ZFTA fusion-positive",0.999999998
C9DAC24C-3D97-4525-9E7B-C0BEB9089FE3,choroid plexus papilloma,0.999999998
9142278D-A78C-41EE-89C7-3CD004FF3596,Atypical teratoid rhabdoid tumour,0.999999998
1CA29A7C-1904-434A-A4AC-A9F17B3B91B1,choroid plexus papilloma,0.999999998
ADFE9711-2028-4498-91A1-BFEF36F26D3D,control tissue,0.999999998
001D2A6C-57D9-4A6A-AD3F-B651F6A22C4B,Pituitary adenoma,0.999999998
3CA760CF-4948-4760-A866-F46A39D2989F,"Diffuse midline glioma, H3 K27-altered",0.999999998
D7D4C27E-63B6-4F2B-A591-990FAAF75B50,Pituitary adenoma,0.999999997
476BA909-2D8D-4FF1-AF24-00A1A6CE7824,"supratentorial ependymoma, ZFTA fusion-positive",0.999999997
FD2F9D4B-445A-421A-BDB8-B3766A362C24,"Neuroepithelial tumour, PLAGL1-fused",0.999999997
841CEDD2-A26F-41E5-9659-4ADB49B56C01,Pituitary adenoma,0.999999997
5EC9E96E-9CA6-4990-B0E5-A828C678483D,"glioblastoma, IDH-wildtype",0.999999997
349BCB72-03C9-4CB9-BE78-1AC7D4814949,"Angiocentric glioma, MYB/MYBL1-altered",0.999999997
2C5CE2E0-8FB9-4179-B292-0FF111893CD5,choroid plexus papilloma,0.999999997
CDF53623-4CD4-468B-BEC8-60199AA687D8,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999997
51791892-8C54-4472-898A-B965C97BC7B2,Pituitary adenoma,0.999999997
9F67244C-560D-4708-8DCF-65F58EB4B69B,Diffuse paediatric-type high grade glioma,0.999999996
8C2A876C-4851-44DA-8C2A-CE306D48292D,normal pineal gland and pineocytoma,0.999999996
5F1806EA-DDC4-4D1D-9B89-AEE35B94FF01,choroid plexus papilloma,0.999999995
B3266D95-E028-4786-8CBA-630975719784,"glioblastoma, IDH-wildtype",0.999999995
DA67376B-DAB8-4EAF-B8D7-D83D5F992A47,Atypical teratoid rhabdoid tumour,0.999999995
B8CB889F-E5EC-4F62-916B-D804352C7AFA,"supratentorial ependymoma, ZFTA fusion-positive",0.999999995
E156C08E-0906-4EE9-BA0F-1C0E38CF410C,pilocytic astrocytoma,0.999999995
E13A029F-01C0-4A13-824A-56058D2F4E3B,control tissue,0.999999995
978929AF-15F9-4DF0-873C-40417D9C6D40,Pituitary adenoma,0.999999995
61FF8865-09DF-4BAA-BAE1-5AE173F3088C,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999995
03749486-99A4-4610-AC98-AA4A7B57A8B1,papillary tumour of the pineal region,0.999999994
FAE8C6C0-D693-434A-8365-18565605DB74,Atypical teratoid rhabdoid tumour,0.999999994
2F155FF5-0C14-4522-97E9-6AE73B350899,Infant-type hemispheric glioma,0.999999994
F13B10EB-F982-4215-85B4-7946B1F8D40C,Diffuse leptomeningeal glioneuronal tumour,0.999999994
33B66729-3F26-4BAB-9379-243353081927,Infant-type hemispheric glioma,0.999999994
80AC0004-1ED0-41AD-BF0D-8F64B0D632D2,Diffuse paediatric-type high grade glioma,0.999999994
91702260-612B-42FA-B8BC-D49FBA65E5E8,"Angiocentric glioma, MYB/MYBL1-altered",0.999999994
E19437A6-082B-4B44-9D78-639285164E96,"supratentorial ependymoma, ZFTA fusion-positive",0.999999993
055625E2-3A9A-4002-92E8-8B8DB4599D4C,"supratentorial ependymoma, ZFTA fusion-positive",0.999999992
96D5AE32-4FC0-4753-99F1-D369760031FB,Teratoma,0.999999992
3826745F-01A4-41A3-856D-C8F68B536F8F,spinal subependymoma,0.999999992
61362366-841F-4CCF-9718-B79D721CB0EE,"diffuse glioma, MYB- or MYBL1-altered",0.999999992
13D39DFB-BD81-4FF5-B1F9-34ADEB059B24,"glioblastoma, IDH-wildtype",0.999999992
5B9ED41F-3400-43DC-B677-DB9C87A3C970,"glioblastoma, IDH-wildtype",0.999999991
57C5699D-1604-4F40-BE1D-2659546B06B7,"glioblastoma, IDH-wildtype",0.999999991
37D3E7EF-B3F3-4E1C-9E0C-62015AB6712E,"glioblastoma, IDH-wildtype",0.999999991
0F97BDCF-7225-4AA4-99B0-FC9FD6380F93,"supratentorial ependymoma, ZFTA fusion-positive",0.999999991
585F7CE6-91E1-434C-B521-206F38BC0FA0,Ganglioglioma,0.999999989
E9AC64AB-E29E-4514-9D84-3B11714A6DF4,papillary tumour of the pineal region,0.999999989
36E3C83D-0A45-462C-A506-8015FDB5FB15,spinal subependymoma,0.999999988
D167A682-48A1-4AEB-8AB3-33BC930FCC20,papillary tumour of the pineal region,0.999999988
CE96A3FE-6F4F-4E35-8C2E-2107ECB45998,Pituitary adenoma,0.999999988
D3B2725B-8033-40C8-9716-1503134F6083,"supratentorial ependymoma, ZFTA fusion-positive",0.999999988
072EF5F5-6735-4804-8DA9-546674AC2794,Pituitary adenoma,0.999999987
039A4C2F-06DC-49E4-A370-82284B668904,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999987
F9C3DD47-E17D-4539-BEC9-EB2772389BDF,CIC-rearranged sarcoma,0.999999986
A4474BE8-0CE8-4FAB-9D0B-18DA68C03F0A,posterior fossa ependymoma group A,0.999999985
415DBAA4-A7BC-427D-94F8-2F1604FFCA80,pilocytic astrocytoma,0.999999985
5C1F95EF-33FC-406D-83DA-7E499BF531BE,Pituitary adenoma,0.999999984
FA8695A6-4FF2-4B00-8CE4-261A654679BC,"supratentorial ependymoma, ZFTA fusion-positive",0.999999984
3F06C0D8-32DB-4350-A227-03EAE93AA7EF,"glioblastoma, IDH-wildtype",0.999999984
314E1158-A037-401A-A250-846C204CA239,CIC-rearranged sarcoma,0.999999984
F71C48DD-87EB-40F1-9274-A62B49DF54F9,Pleomorphic xanthoastrocytoma,0.999999983
FFA7147E-F1E8-45A9-8D28-8A6116F21EA8,Pleomorphic xanthoastrocytoma,0.999999983
09AF4146-BA5C-4FC3-9596-3DE3F6A003CB,Pleomorphic xanthoastrocytoma,0.999999983
11D3E124-2EFE-4CBC-91EA-3D31DAA7A4F8,"supratentorial ependymoma, ZFTA fusion-positive",0.999999983
438BDA66-A867-4C5C-BD40-D84F7B8EB086,"supratentorial ependymoma, ZFTA fusion-positive",0.999999983
7BD98B94-28CD-470F-9211-CCE80E0F3068,"supratentorial ependymoma, ZFTA fusion-positive",0.999999983
98A9A138-1E7D-4F5E-BBD1-320DDD40B87F,Diffuse paediatric-type high grade glioma,0.999999981
EA16F44B-C4A2-4A00-BA86-D2BE64284187,control tissue,0.999999981
9A6D4EC9-E8E1-4C99-BEB3-B871ECF29456,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.999999981
7AF74439-5D7F-46A6-9C02-4F69B6BC602F,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.999999981
23987939-EA83-4C08-9DAF-277EFCCC1F8D,Pituitary adenoma,0.99999998
B20E1EC8-F8D3-4C97-970A-2E537BAF2CCF,pilocytic astrocytoma,0.99999998
8677D658-3141-415A-9FAF-06C4B3D779B9,"glioblastoma, IDH-wildtype",0.999999979
E8F3D34B-457C-48AB-91D5-EB4482CF5A20,Atypical teratoid rhabdoid tumour,0.999999978
DB0C22F7-BBB4-42E6-A4AB-476A9D9EEB97,Atypical teratoid rhabdoid tumour,0.999999978
987D6DEA-2314-48E4-8031-D7AEA0B11009,"CNS Schwannoma, VGLL-fused",0.999999976
D9220973-7158-4D3D-A163-9BF0C3D03A17,Pituitary adenoma,0.999999976
7FEE62CD-C33C-4C33-B6FD-2497C1211254,posterior fossa ependymoma group A,0.999999975
8BCC7E88-9437-41E3-BB38-6F392C40716C,Pleomorphic xanthoastrocytoma,0.999999975
B0233361-C537-4E13-A338-C63C903772AA,"supratentorial ependymoma, ZFTA fusion-positive",0.999999975
D8327474-CA7D-40BC-8037-2F3C0E1DF018,"supratentorial ependymoma, ZFTA fusion-positive",0.999999974
020E3AE9-AB4A-4FC5-8304-7B309D41CCDB,Malignant melanotic nerve sheath tumour,0.999999974
072A5A60-33C9-4BC4-84CC-1869EDBDE0D4,pilocytic astrocytoma,0.999999973
51E185F0-E0F7-48ED-A423-1F42A5C48465,control tissue,0.999999972
A9F6E92A-B559-42FA-932B-02D4B9323329,posterior fossa ependymoma group A,0.999999971
C2BC1300-13F6-4CAD-97CD-9CC844C2A041,"glioblastoma, IDH-wildtype",0.99999997
92DAB708-7323-4E1E-BE4E-07D65E4A73BE,control tissue,0.99999997
9CB3218F-D1A5-4C48-A4E6-E41711D7F95E,Malignant melanotic nerve sheath tumour,0.99999997
AA650E25-4AFB-4622-BC39-0802F1BA14A0,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.99999997
FA4C3834-9260-4595-8290-F5D2A961D217,Pituitary adenoma,0.999999968
3D1597B3-2839-4EF9-BA7F-80704A7B9FE2,Atypical teratoid rhabdoid tumour,0.999999968
5450951D-2744-43E4-B527-44CA32E85211,Pituitary adenoma,0.999999967
77DD938E-CF67-47FF-B85E-3A4B3FC11024,Pituitary adenoma,0.999999967
CAB2B472-5617-45CC-8C72-091FA047FE5C,Rhabdomyosarcoma,0.999999967
604CE91B-A675-438E-9CFD-677299FF6DE5,Diffuse paediatric-type high grade glioma,0.999999966
EC70DE22-D9F8-40F7-88FA-63C6CC960BC1,Diffuse paediatric-type high grade glioma,0.999999966
3497B52F-9D7D-45C8-98CB-48BB7D7038BE,control tissue,0.999999965
E1C323E6-AD51-4A2E-A826-BEACFFCDC576,"glioblastoma, IDH-wildtype",0.999999965
E3F6CF9A-581C-40FB-BC5D-6E313EB344F5,"glioblastoma, IDH-wildtype",0.999999964
ACF8E186-638B-4491-BD0A-2CC7647889D9,control tissue,0.999999964
1C8955E8-4173-46F1-927C-3550EDBD6FF6,Pituitary adenoma,0.999999963
2DEFA19E-307A-4CF8-AC9A-C3EE54BA3977,posterior fossa ependymoma group B,0.999999963
96DCEFD2-0FF9-4642-B491-EC1D7C643632,Teratoma,0.999999962
8D1ECFB1-2ED2-4FAB-A6F7-E4C301EFE0CB,Pleomorphic xanthoastrocytoma,0.999999962
D800EE63-17D9-4990-8D29-04D3C26AD72F,Malignant melanotic nerve sheath tumour,0.999999958
569998B8-B1CE-4DB6-85AA-E83EC42431A6,CIC-rearranged sarcoma,0.999999958
CE25B702-48CB-4C7F-B9CD-5C448630FA60,"glioblastoma, IDH-wildtype",0.999999957
8C1BE7FE-3D80-468A-ACD2-059772B8FDEA,"Angiocentric glioma, MYB/MYBL1-altered",0.999999956
0FAE076A-3859-4F80-8B80-3291EDE7FFB9,"glioblastoma, IDH-wildtype",0.999999955
1EA5346B-96EB-43EE-992C-5AC1A93E3F18,"glioblastoma, IDH-wildtype",0.999999952
1F7543F3-8416-49FF-8276-E78CD44CC89C,Pituitary adenoma,0.999999952
2965958C-5D25-448F-AFF7-9257F1A7FF38,choroid plexus papilloma,0.999999949
607F91CE-47A3-43B0-8A1E-051E41D3126A,"Diffuse midline glioma, H3 K27-altered",0.999999949
5560F83D-5444-4C6C-B34A-CDBD2C7DF6C9,"glioblastoma, IDH-wildtype",0.999999949
5678FB7D-CB59-48A5-812D-915EE5BF0456,Pleomorphic xanthoastrocytoma,0.999999949
2479EF07-10B3-46B5-B012-6C8372705D9F,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999948
E042C716-1D19-4B90-A968-703CA44C12A6,Diffuse paediatric-type high grade glioma,0.999999947
9B040770-0C92-43C9-98F7-A17C4FBCE354,"glioblastoma, IDH-wildtype",0.999999946
BA82E253-6111-4DF2-BC09-065310609F4E,"supratentorial ependymoma, ZFTA fusion-positive",0.999999944
3392F3E5-2656-4B3E-AD26-E16DCC757818,"supratentorial ependymoma, ZFTA fusion-positive",0.999999943
BBB86E1D-2A06-43DE-A706-3F66A5E60572,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999999943
CDB37E56-AE62-4602-BCFA-CA079374A37A,CIC-rearranged sarcoma,0.999999943
6F92FB9A-863B-4F43-B74E-AC07B2675D8C,Pituitary adenoma,0.999999942
43420C0C-FA91-4094-8339-9A21E522882F,Atypical teratoid rhabdoid tumour,0.99999994
BC04AD20-21DF-45C3-B5B9-68A524102751,posterior fossa ependymoma group A,0.999999938
4FBF4BBE-2C42-41A3-956E-8F69C1E3BF61,"supratentorial ependymoma, ZFTA fusion-positive",0.999999934
AC1119B7-0719-4225-A94F-59360B0222A3,"supratentorial ependymoma, ZFTA fusion-positive",0.999999933
32D0A9C1-8CA3-4568-949C-CACCD049D280,"glioblastoma, IDH-wildtype",0.999999933
506D1CE6-69DB-49E2-9C4D-1EA2F5B7D3CA,"supratentorial ependymoma, ZFTA fusion-positive",0.999999932
0106AFFA-91C3-4E30-B6A1-490E0B8A7547,Pituitary adenoma,0.999999932
CEEDFE2C-3AD3-4AF0-BE27-AF2726196B97,pilocytic astrocytoma,0.999999932
F82C9B42-44C7-47B1-90C9-439F17C0157E,"glioblastoma, IDH-wildtype",0.999999929
6AB41749-549D-493A-8EBE-0CA2B71A2D06,Diffuse paediatric-type high grade glioma,0.999999929
664619FB-D969-400C-A951-39ED00D3077F,Diffuse paediatric-type high grade glioma,0.999999927
DCE64031-2DFA-454E-A69E-35B8D7005D1B,posterior fossa ependymoma group A,0.999999926
E30BE2B5-CDCB-4BEE-A4C6-ED34896767FF,Pituitary adenoma,0.999999925
9D650369-7C68-4116-941C-CB6427D60254,Pituitary adenoma,0.999999924
C0ECE14E-1187-4383-ADBF-3E8013B77831,"supratentorial ependymoma, ZFTA fusion-positive",0.999999923
25F446AE-20D2-4EAD-9AE8-C1AF842D57AC,Pituitary adenoma,0.999999921
4CD9AB37-8DCF-4166-8294-D1690BB9D8CB,"glioblastoma, IDH-wildtype",0.999999917
047BC149-942F-4328-A0B7-0311F46E5955,Pituitary adenoma,0.999999916
FB1343E9-84A1-4E8C-BD0A-FD713272545E,Pituitary adenoma,0.999999916
B3FEBD7F-F5C4-4CE8-9F7A-FE108DC6F005,control tissue,0.999999915
6F38AE27-E61A-4C4A-B228-406132AA0AD1,"glioblastoma, IDH-wildtype",0.999999913
EB2C126E-2431-4A19-9826-02ABE054B5C4,"glioblastoma, IDH-wildtype",0.999999913
DD9D05D5-A41C-4142-AC1D-B0008B9265C5,"glioblastoma, IDH-wildtype",0.999999913
67C0E424-7FB8-4224-B91D-6BDDCFD4AB2F,pilocytic astrocytoma,0.999999912
F06C9535-BD26-48C9-BE93-09E510B98BCD,choroid plexus papilloma,0.999999911
C4D20B22-E113-4F49-B743-F1F059545F47,"supratentorial ependymoma, ZFTA fusion-positive",0.99999991
FF379B69-E31D-420B-ABB5-474AEB69CD79,Atypical teratoid rhabdoid tumour,0.999999908
4C2F0014-4EC8-4FD7-A764-0108077E3084,"supratentorial ependymoma, ZFTA fusion-positive",0.999999908
7FB78646-00AB-4543-ACF5-36F6DEEBC718,"Pineoblastoma, miRNA pathway altered, group 1",0.999999907
C49861D8-77E3-4A46-8733-00D8EE7BB3F9,Pituitary adenoma,0.999999906
6F33D564-967D-4A2E-8B69-920B6F8D207B,posterior fossa ependymoma group A,0.999999906
6BB977AD-135C-46DA-8116-24B802F10A94,Yolk sac tumour,0.999999898
918494B8-D706-4981-A612-7A745AE44910,Yolk sac tumour,0.999999898
D394D815-B406-4308-8395-DC69F5EA54F4,"supratentorial ependymoma, ZFTA fusion-positive",0.999999898
DDE12C7D-0868-4895-B65D-9853A6C5AC78,posterior fossa ependymoma group B,0.999999898
3EE5C6FB-CF82-4686-B499-5E747F8F2767,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999892
442CE7F5-F896-4C7C-919A-933439624AAE,Pituitary adenoma,0.999999891
0DC64E7B-9530-4A94-A8D8-78B0FCE0AA20,"glioblastoma, IDH-wildtype",0.99999989
369097FB-CB1A-4AB6-9679-C653C9ACC957,Intraocular medulloepithelioma,0.999999889
64A9245B-00B3-4544-956F-E1EF2AE5B452,"glioblastoma, IDH-wildtype",0.999999886
54BF899C-1CE5-4D49-8F1C-0FAF8EE8A73F,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999884
745A7681-9D85-445F-98FE-03D9DBC0FEB6,choroid plexus papilloma,0.999999883
9E953E1F-A3E9-4260-82EE-36A055151FFB,Pituitary adenoma,0.999999883
D31338ED-36DB-4830-AE66-90B86235578E,"supratentorial ependymoma, ZFTA fusion-positive",0.999999882
4396C39E-74B9-4327-B76D-9661FBFE3921,Atypical teratoid rhabdoid tumour,0.999999881
F31E30A5-4CD5-44C9-AA02-67FE2954E027,Ganglioglioma,0.999999876
1CD8BFB8-F524-47CB-A4AB-17603634F8CE,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999874
C958C43B-19FC-4E34-A108-CD461B80AEFF,choroid plexus papilloma,0.999999871
2BF84D7C-3D6D-4F83-B7F9-0E663EE33E49,Pituitary adenoma,0.999999868
3987D85C-B2F5-435D-AF2C-7EB7C3B1691F,posterior fossa ependymoma group A,0.999999867
2857D76C-F592-43F2-B3FA-3B1A8E62DB93,control tissue,0.999999866
B3274D18-B375-4145-9721-122C2F2B43C9,Plasmacytoma of the CNS,0.999999865
250B38DD-3208-49B4-BF55-42692618472E,control tissue,0.999999864
53EDD284-9A62-42C2-8F7F-12D89F6CE873,Pituitary adenoma,0.999999863
30338F46-92E5-442E-A6ED-503ABA582A8C,choroid plexus papilloma,0.999999861
CCB81D57-F382-4210-BAAF-6C1189B8E019,Pituitary adenoma,0.99999986
C612785B-2CEE-4DC3-A457-33CC12087806,Pituitary adenoma,0.999999859
F5DF495F-4C17-4E66-B917-9413B3E5F410,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999999857
FBC5E0E7-510E-4919-9906-C42258EAD0AD,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999999857
461D1A22-37B5-471D-B840-C68640FCDB7A,"supratentorial ependymoma, ZFTA fusion-positive",0.999999857
6EBCB2B8-FC3B-48C3-B4C6-3906B10EB8F5,posterior fossa ependymoma group A,0.999999855
E07BF420-0852-4249-8A76-A4BF9A4442FD,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999851
000F6719-39FE-4A7C-A5ED-EB3D4938E6A3,Malignant melanotic nerve sheath tumour,0.999999847
EABA9A03-2AC6-41F9-A8BC-1703DC098089,Malignant melanotic nerve sheath tumour,0.999999847
63991B25-94E1-4A7E-AE25-179B26B6B229,CNS Embryonal tumour with PLAG-family amplification,0.999999846
6506F797-29A2-4A12-BCD9-003EDA19FFB8,medulloblastoma Group 3,0.999999844
C092C142-0D74-4B3F-B223-EB8D8AD8C1C3,"glioblastoma, IDH-wildtype",0.99999984
6A5C05DA-351B-4412-BE57-E8F46C414787,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999839
5DB41115-56B5-4BA9-B8B4-0E1CF11710F1,"Sinonasal undifferentiated carcinoma, IDH2-mutant",0.999999836
1D75000C-6C34-42E4-942D-31E1055886FE,"Sinonasal undifferentiated carcinoma, IDH2-mutant",0.999999836
27F94C7A-1751-4689-9715-3A01B12DE5A6,medulloblastoma Group 3,0.999999835
E4D0930F-FD65-4E33-8981-CB68E5D2139E,Pituitary adenoma,0.999999834
F35F5C88-04FF-4C2D-893A-3BC77529FA63,"supratentorial ependymoma, ZFTA fusion-positive",0.99999983
DCBD799A-D399-4AED-94ED-BADD9600AC29,Atypical teratoid rhabdoid tumour,0.99999983
F724B879-6EEE-4941-95EB-379ED0B5F9B0,Infant-type hemispheric glioma,0.999999827
CE4FDC48-ED90-444E-A1D0-E1EEFC26520F,Infant-type hemispheric glioma,0.999999827
3EED8CEB-0FCE-4831-8107-46CD1CEFD748,posterior fossa ependymoma group A,0.999999825
49099240-1B9C-40E8-A677-0E5F1C56EA05,Pituitary adenoma,0.999999823
EF976A0D-2E2A-4881-B651-6649FB26AED9,pilocytic astrocytoma,0.999999821
0233BE26-BFDB-4563-B38F-FB5709D277B5,pilocytic astrocytoma,0.999999821
1FED0EF1-C871-4371-AE88-651DE745F598,Haemangioblastoma,0.999999815
A9B06098-7F79-4311-BABC-977CB1022C61,control tissue,0.999999814
1AB9E8D7-FD1D-478D-A2BC-B9728F3452E9,control tissue,0.999999814
96592C9F-5CA8-4A83-9CE5-6E432180BC95,control tissue,0.999999812
4A3D8423-151B-4301-8CE2-67ABE2FBF772,"glioblastoma, IDH-wildtype",0.999999811
C5DF083B-2C7A-480F-AD4F-F8413A8D4350,"Angiocentric glioma, MYB/MYBL1-altered",0.999999808
57B925C0-42C8-4910-89BE-0959397A1E38,"Pineoblastoma, miRNA pathway altered, group 1",0.999999806
54162253-DC4D-40A9-80F3-130CE93690BB,"Astrocytoma, IDH-mutant",0.999999806
1B731E9A-4692-4754-8E92-DC096A22E255,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.9999998
6AFC1D71-41D3-4281-BC02-53CF3E894FD1,control tissue,0.999999794
49F79536-5F1D-405F-A477-2EC7BDD54753,control tissue,0.999999794
F33E3962-E8A0-4C7F-919B-976C34CF81AC,pilocytic astrocytoma,0.999999789
7398372F-7EBD-4654-9E21-C9413832F13D,"Astrocytoma, IDH-mutant",0.999999789
25D5CA72-45BE-4A76-A551-8B0EF21AB756,"supratentorial ependymoma, ZFTA fusion-positive",0.999999778
936EF376-BCCD-47B8-B44A-80958B79FDC5,"Sinonasal undifferentiated carcinoma, IDH2-mutant",0.999999773
E93E3100-2A7D-4AB0-AD65-9AB26A30AB1A,"glioblastoma, IDH-wildtype",0.999999771
67E8D3C4-AEE3-4D62-9799-F4863FD65F14,Pleomorphic xanthoastrocytoma,0.999999769
BF37285F-15BD-4BED-8E51-F174BF756533,Malignant melanotic nerve sheath tumour,0.999999768
0FC95502-37C1-4445-9375-FE204DC04210,Pituitary adenoma,0.999999768
04987113-444A-443B-BAE7-B6D847B5CF61,"supratentorial ependymoma, ZFTA fusion-positive",0.999999767
C1A7C21A-68AA-4626-ABA8-0A6A67F7F67E,"Supratentorial ependymoma, YAP1-fused",0.999999764
E90F1305-CC1C-4275-862F-1C1E04FA4850,Pleomorphic xanthoastrocytoma,0.999999763
4F51A7FA-97B8-43CA-B6E0-03CB120D5599,Pituitary adenoma,0.999999761
B34F531D-35B4-40E9-A8FE-01160D1C05AE,medulloblastoma Group 3,0.999999761
B80E1D73-30A9-44FC-8464-0927701AFA7D,Atypical teratoid rhabdoid tumour,0.999999761
F5B6579A-6814-448C-8146-2C38FCF3B2DB,Pituitary adenoma,0.99999976
D8F444E9-5BE2-4D20-B8A1-89D6DF7CA1E4,Plasmacytoma of the CNS,0.999999751
0F224158-801E-4E50-9C64-44ADB6174530,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.99999975
2E239E6A-E561-4B19-8203-2556B833F47C,"Spinal ependymoma, MYCN-amplified",0.999999746
4FB8846C-A8C9-4A1F-A6B5-4455931FFB57,control tissue,0.999999741
327F83BE-3752-4FE5-B54C-50A9BD7B5110,Rhabdomyosarcoma,0.999999741
FD78CE3D-A856-436D-A2DF-F4313FC63FED,Pituitary adenoma,0.999999734
FA0D7BCB-5C63-48FE-8696-4DBF3FBA27B6,pilocytic astrocytoma,0.999999733
4378F898-0DD0-4053-BBC2-4FA4FB38AFB3,posterior fossa ependymoma group A,0.999999732
6D74BB67-D484-419F-8726-47B75AC09EC4,"supratentorial ependymoma, ZFTA fusion-positive",0.999999726
3D414373-3815-46BF-9670-DACF2E48CA1F,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999722
3B5A28C6-2474-4442-9F44-B4E6F6E697D4,"Pineoblastoma, miRNA pathway altered, group 1",0.999999721
AA03E89C-4793-498E-B1AD-69F8AF2D2158,"glioblastoma, IDH-wildtype",0.999999719
8C2CC0EB-B174-4AFD-AFCD-85B607CEFBF4,CNS tumour with EP300:BCOR(L1) fusion,0.999999706
42520998-E6DB-479A-AD12-81A12D0CBADA,Pleomorphic xanthoastrocytoma,0.999999705
32A6A72F-8B04-43A9-8DA2-30F31F7F2FCE,Diffuse paediatric-type high grade glioma,0.999999703
0658AFB9-B085-4564-A885-95411295AB7B,"supratentorial ependymoma, ZFTA fusion-positive",0.999999699
3B2DCBB1-B146-4402-97EC-D477446B2A5A,pilocytic astrocytoma,0.999999694
4E173DC8-F742-4935-82BE-9679ED124DEE,Atypical teratoid rhabdoid tumour,0.99999969
370FDBFF-DAEF-4E68-85AF-B71402258DB6,Plasmacytoma of the CNS,0.99999968
37E4A4E5-6182-44FD-80A7-C97E7A594F31,"glioblastoma, IDH-wildtype",0.999999679
0A8A5D7E-ED47-4C5A-B244-A1F8C6544162,"Pineoblastoma, miRNA pathway altered, group 1",0.999999669
7FA37E43-D86D-4BAA-8DE4-1551E91BA21C,"Angiocentric glioma, MYB/MYBL1-altered",0.999999666
C60F05E0-CCB2-4A13-967F-55469645195B,"supratentorial ependymoma, ZFTA fusion-positive",0.999999661
CDF6A4A3-4446-449A-A267-CDAFF98BE6FE,Plasmacytoma of the CNS,0.999999652
AEFF1BC6-74F2-40E8-8340-E1B277B0ACFA,"glioblastoma, IDH-wildtype",0.999999648
FFB10490-19D5-4409-8475-CEEED623EB22,"glioblastoma, IDH-wildtype",0.999999647
9DC2CF66-B0D4-4CFD-A239-31B32376AAD3,"glioblastoma, IDH-wildtype",0.999999647
B5A38D8B-A98D-48B9-A75B-BE01604B0956,"glioblastoma, IDH-wildtype",0.999999646
D9D6AEE5-85E0-47E8-804C-06F0BE675330,posterior fossa ependymoma group B,0.999999642
13724BB6-E582-414B-B6CA-89E902986F4D,Pituitary adenoma,0.999999631
DE849882-A987-4660-B7F7-4004D807D2B6,"glioblastoma, IDH-wildtype",0.999999623
B3512500-461F-4152-99FD-11093DB82C43,pilocytic astrocytoma,0.999999606
8CB692C9-CDB3-4EE8-8BCB-87A7BAEDF6CA,Pleomorphic xanthoastrocytoma,0.999999605
4E44AE16-C6FC-4EAB-BA64-5499D9E6D982,Pituitary adenoma,0.9999996
C55D5371-5A6B-4110-8890-6221D769A469,posterior fossa ependymoma group A,0.999999597
A069C088-63E0-4B05-B96E-0CE51658463C,"supratentorial ependymoma, ZFTA fusion-positive",0.999999595
DC7C0E2B-046B-41A8-BD77-A0FD3A5C8091,"Astrocytoma, IDH-mutant",0.999999593
21B974A2-2AFD-4B5C-AAAC-A2A8E1ABAF57,"Neuroepithelial tumour, PLAGL1-fused",0.999999585
E2D82C97-154F-4C39-92BC-899A46465EFE,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999583
5228CC6E-E70B-4F8F-B128-63F01E10831F,Atypical teratoid rhabdoid tumour,0.999999582
351C331E-84D8-432B-B526-40C971CF6AD6,Pleomorphic xanthoastrocytoma,0.999999574
286B68F0-17D9-47C6-8418-FB63551C6379,Spinal ependymoma,0.999999556
E699A0D8-7833-40D1-A8E0-DD7D99CCA3AC,Spinal ependymoma,0.999999556
B31F8942-0388-44AA-A5AA-B22A33BFD29F,Pleomorphic xanthoastrocytoma,0.999999542
B75A43E4-A8F8-483F-B9EB-BE3D76AB21B0,Pleomorphic xanthoastrocytoma,0.999999542
FD2DFD88-557C-41D6-A762-B2DD2CE6560A,Pleomorphic xanthoastrocytoma,0.999999542
AEE1137D-7CDA-41F1-B4A2-7C9D9A15FC1A,"glioblastoma, IDH-wildtype",0.999999538
EA92411A-CD73-46C3-B3BE-CD89111F72D2,pilocytic astrocytoma,0.999999534
2FB603D8-77F1-4D34-98F2-D2667FB57FA8,medulloblastoma Group 3,0.999999532
7BD36A70-7A77-4211-89CE-933D9B77D450,"supratentorial ependymoma, ZFTA fusion-positive",0.999999524
168FD078-3E39-4C9D-ABEE-38D35B3FE2B0,Atypical teratoid rhabdoid tumour,0.999999521
BE229313-2B81-438E-BB7B-5847F744D11B,Pituitary adenoma,0.999999519
F409A418-FEA3-47D5-8B51-9CBF3C22DB54,spinal subependymoma,0.999999512
5D504EDF-41A9-423E-A640-B23BFBD7A852,"meningioma, intermediate",0.999999481
DE812FB6-07C9-4A03-87AA-D57004A822FB,"meningioma, intermediate",0.999999481
FC49DEA9-5D81-400D-AAC7-EE5EB63CFD70,"meningioma, intermediate",0.999999481
E0F9CB9E-7CE3-4999-846E-DA9D29C54EF9,"meningioma, intermediate",0.999999481
C36D3536-C3D4-4E52-BAA3-3F570F2F305D,"meningioma, intermediate",0.999999481
D17A7746-A052-49C2-86FD-781882E24D3D,"meningioma, intermediate",0.999999481
14E9BB65-BF66-4A12-9AC6-2A23BEA7EDB9,"meningioma, intermediate",0.999999481
F017BEA2-443E-4EEF-970E-DCC9C687861F,"meningioma, intermediate",0.999999481
EC93DA2A-349E-4792-8512-41CF20FE24C5,"meningioma, intermediate",0.999999481
C8F97218-70D3-4B62-A4B4-8D473013F4B0,"meningioma, intermediate",0.999999481
A576934C-FF2A-40B6-923C-B5FD696B353B,"supratentorial ependymoma, ZFTA fusion-positive",0.999999471
67B7B251-4160-43B7-AC10-C2482224E1FB,control tissue,0.999999466
037E6047-A9C8-4FBB-A737-A0704BB2BF57,"supratentorial ependymoma, ZFTA fusion-positive",0.999999466
DDE8414D-F9EC-426A-A08B-93F2FC14CD90,"glioblastoma, IDH-wildtype",0.999999464
CE32F0D2-1C91-4FA1-B90F-31619F49612D,pilocytic astrocytoma,0.99999946
7C7735F2-B254-4CF4-B45A-87971E9EDCCD,pilocytic astrocytoma,0.999999459
351997A6-BCE4-4C47-83A3-5E623A00F9C1,Plasmacytoma of the CNS,0.999999455
451A2AFE-0EA0-499F-866B-C828FB015E69,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999999453
0945BC5D-2098-49EF-928D-916EEEAFE218,"Pineoblastoma, miRNA pathway altered, group 1",0.999999453
A255B05F-A489-478F-92D9-F4C1F78E2F57,"supratentorial ependymoma, ZFTA fusion-positive",0.999999447
86829E4A-22F0-4B89-8122-3A4281888983,Pituitary adenoma,0.999999444
C1809AC6-2152-4857-81C3-80A5E43D0F62,Olfactory neuroblastoma,0.999999434
2EAA664D-DA95-42A9-999E-34A6C284008A,Spinal ependymoma,0.999999433
51003C3C-AF05-4D64-83C5-0ED401495BD2,"supratentorial ependymoma, ZFTA fusion-positive",0.999999424
030D9B10-BB30-444F-B1D3-CF541891DA52,Germinoma,0.999999416
2E7730F9-E5F5-4CB5-A5C8-710152371735,"Astrocytoma, IDH-mutant",0.999999413
CC4119EC-B017-46DB-BF40-01CC3A7B91AB,Pituitary adenoma,0.999999383
EBD796DB-5F23-4E88-BCA5-5B3A05AFCC90,"glioblastoma, IDH-wildtype",0.999999377
3392ECBA-413C-456E-9420-0A74E427171D,pilocytic astrocytoma,0.999999377
A9FE0A41-1486-4413-9790-CD6DC79569DA,Pineal parenchymal tumour of intermediate differentiation,0.999999367
17B0F4DA-39D4-4CB9-8C1F-AF262C34F03E,Rosette-forming glioneuronal tumour,0.999999354
D219B1EA-9651-4958-AB8B-A0C77710F995,"Pineoblastoma, miRNA pathway altered, group 1",0.999999342
96E52333-8DFC-4EB2-A00A-D721C1D679A8,"Diffuse midline glioma, H3 K27-altered",0.999999337
435F972E-4E59-4B9B-960B-1C58FFCE56FB,Infant-type hemispheric glioma,0.999999331
9476C4F0-2671-4845-BE8C-2B30D546CCDC,Pituitary adenoma,0.999999328
D8BA4F89-ECDB-4010-9346-F2EB4764048A,pilocytic astrocytoma,0.999999318
2324A019-24C8-4BB0-90B1-FD4D5A00B3D1,Pituitary adenoma,0.999999302
46B25591-21D4-499F-BD13-205A0794ECA0,pilocytic astrocytoma,0.999999291
14BB1F38-A92F-47BF-81B3-CDCD4047FF95,"diffuse glioma, MYB- or MYBL1-altered",0.999999288
3290D7DE-71E6-493F-8693-40B0D4411C69,"Oligosarcoma, IDH-mutant",0.999999284
A663ABB7-39C4-422A-BA82-052CC5DAC3CE,"Astrocytoma, IDH-mutant",0.999999275
E607E153-4513-498B-8AFD-8B4571EE1543,"supratentorial ependymoma, ZFTA fusion-positive",0.99999927
2D89282C-F7C0-415C-A9A8-565F73225218,posterior fossa ependymoma group A,0.99999926
B34C0234-EBA2-4E66-90EF-79383FECA2A8,Olfactory neuroblastoma,0.999999259
6D6B3538-0D23-4235-8729-6D97CDAACAE6,Pituitary adenoma,0.999999259
B893480B-1A9D-4228-8788-850C3EF1546B,"medulloblastoma, SHH-activated",0.999999245
96A83934-30C8-4A54-B298-0DC57CFD0705,posterior fossa ependymoma group A,0.999999244
AB96212F-B789-414D-9F29-E46B750B3B4F,papillary tumour of the pineal region,0.999999225
70A24EBD-7FB5-4A3B-89D8-B504EE757116,Haemangioblastoma,0.999999213
48D5274C-F5AD-4DF2-A94C-5E5F5A28D7F6,"supratentorial ependymoma, ZFTA fusion-positive",0.999999206
B3DD1CBB-980D-4E79-AFB8-677479B24E91,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999999206
3D69BAC8-FCD4-4096-A662-A0C03B141544,Diffuse paediatric-type high grade glioma,0.999999197
6AF5E139-17C4-4B30-978A-CAB59C788AC7,papillary tumour of the pineal region,0.999999179
F4B6D1FC-C2F8-4846-A640-002BAF41B10C,"supratentorial ependymoma, ZFTA fusion-positive",0.999999179
8330473B-A39F-4CF1-B6B2-EB419CF2EB54,"Diffuse midline glioma, H3 K27-altered",0.999999177
D6000E77-87B2-4076-8C80-68A23E7FD793,Pituitary adenoma,0.999999173
15496FBE-77AB-4DF5-A149-BB8AC6A5C7C0,pilocytic astrocytoma,0.999999165
5954FAC3-025F-479A-A31B-7392576FD46F,Pleomorphic xanthoastrocytoma,0.999999147
A8749484-C1F7-4476-ADEB-73B5EEE2CB10,"Pineoblastoma, miRNA pathway altered, group 1",0.999999144
15C73877-3674-4BE8-827B-527CB59EE9A6,choroid plexus papilloma,0.999999137
13D3D7B4-09FE-4697-9C71-F856D082A740,choroid plexus papilloma,0.999999137
1D02E333-D047-4EB9-9483-CCE6EEB80AAF,choroid plexus papilloma,0.999999137
E7565640-6B0A-460A-AD6C-F8A3DCA81D24,choroid plexus papilloma,0.999999137
E2EB8A2A-38C9-407D-90CD-736254D8E513,choroid plexus papilloma,0.999999137
BC6786D3-43D5-4E97-AC02-42AFE17CD410,choroid plexus papilloma,0.999999137
835C7F15-987E-4AD7-B9FA-1559B618B581,"Astrocytoma, IDH-mutant",0.999999125
C39433B4-0E3F-4261-95E1-B085012EFA79,"Astrocytoma, IDH-mutant",0.999999125
352A2E58-00E1-419E-8CEF-6E904F75BB1F,"Astrocytoma, IDH-mutant",0.999999104
820FA3AA-C372-4711-AA72-0E59584B097A,"Astrocytoma, IDH-mutant",0.999999104
C38A3AE0-F891-45B8-98E8-E0AF3CF2AB9A,choroid plexus papilloma,0.9999991
B162A41C-BE5E-4150-9587-12330DA4B2C1,Myxopapillary ependymoma,0.999999094
EE374609-B7DB-43AD-B780-E9211694A44F,posterior fossa ependymoma group A,0.999999094
9810CD96-660B-47E7-B60A-D67C8126C676,Haemangioblastoma,0.999999091
ECA8CF37-23BD-4195-8B59-C80436E61B27,posterior fossa ependymoma group A,0.999999064
9EE7FAA2-7B9A-4A27-BE0E-072771A7D813,"supratentorial ependymoma, ZFTA fusion-positive",0.999999046
56D21A34-74D1-4504-A714-6DD8B3742ED2,CIC-rearranged sarcoma,0.99999903
019DC826-7F4F-470B-92AA-02010E4E3093,Pituitary adenoma,0.999999027
FF5CFB7C-88D0-4158-B025-C87F592A205D,pilocytic astrocytoma,0.999999022
150DC494-75AA-4FBD-8089-B23749A4D49D,"meningioma, benign",0.999999008
C96A5130-A0AC-4ED4-A701-04864F45AB70,"meningioma, benign",0.999999008
30C7088B-3402-4CE7-88CB-B79EA3413358,"glioblastoma, IDH-wildtype",0.999999007
1C60A405-95A0-4638-BB3E-5D9D2D6333FD,"diffuse glioma, MYB- or MYBL1-altered",0.999999005
ECBFED07-3A9A-4DF5-B4F5-DBC8BAEB07AF,Pituitary adenoma,0.999998991
C9405F0E-11F6-4A29-9F56-7E901C1CAFA6,"Pineoblastoma, miRNA pathway altered, group 1",0.999998981
8231B513-DD2B-4895-8280-C549F655EC1B,posterior fossa ependymoma group A,0.999998967
CAC13762-57A0-4EFE-8DFE-17F2E5374610,"glioblastoma, IDH-wildtype",0.999998957
49544FF6-94D6-4CB4-B725-770B0D641524,Pituitary adenoma,0.999998942
3091A426-3020-4EF9-8733-EFB706870516,Rhabdomyosarcoma,0.999998935
83AB2E8A-49C9-41A5-8973-3790C1F8530E,medulloblastoma Group 3,0.999998908
56D63823-0FD0-451C-845D-D1A87A5EC70C,"supratentorial ependymoma, ZFTA fusion-positive",0.999998879
66589969-E642-4F39-A82C-50A04A00D63F,CNS tumour with BCOR internal tandem duplication,0.999998844
C669E0ED-C674-4499-B225-564AF5E919B7,"glioblastoma, IDH-wildtype",0.999998837
36F1E9BF-D257-4B47-A715-F13DF02AE64B,Pituitary adenoma,0.999998824
FF5914A9-F6C3-46EE-9E59-9B7C6025AA6E,"supratentorial ependymoma, ZFTA fusion-positive",0.99999882
4A4F8A65-B7C4-47B6-8E36-3F335E64D3FE,Pituitary adenoma,0.999998809
2796C07D-0B95-4B9C-BB31-B9715DEDA4E5,"diffuse glioma, MYB- or MYBL1-altered",0.999998808
98A7010F-34CE-4039-9DEF-0F1C3B6717FB,"meningioma, benign",0.999998802
30964A0F-3709-4209-946E-8C09A1E06754,Germinoma,0.999998796
1351837F-384E-484A-B735-91266CB3618E,Pituitary adenoma,0.999998789
C0538F63-5F78-4769-970B-5CB0BB79E507,"Astrocytoma, IDH-mutant",0.999998786
0476814D-D355-457A-8489-454361C03911,Ewing sarcoma,0.999998785
D7765239-7879-42DB-BC1C-DE60051B8AD0,"glioblastoma, IDH-wildtype",0.999998756
898F5832-F12B-44F1-813E-D9B4B190AE66,Haemangioblastoma,0.999998755
5C60E176-CFC5-4B7A-9292-FA3E1BE667CB,CNS tumour with BCOR internal tandem duplication,0.999998743
BC75CD58-4FFD-49FC-914E-01713F2EA9D6,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999998726
56803783-4B9C-4342-8CFD-03885ECF49FA,"Angiocentric glioma, MYB/MYBL1-altered",0.999998708
905C11F9-C232-4518-BA4A-D11AF47BDBA9,posterior fossa ependymoma group A,0.999998699
DBB0876C-85FC-44A5-A668-C4B30ACDB2F4,Pleomorphic xanthoastrocytoma,0.999998687
DF24503A-F083-4906-BFC5-27157DCF191A,"glioblastoma, IDH-wildtype",0.999998679
72B82C82-5E18-45BB-BE66-895B9998BEC7,Pituitary adenoma,0.999998678
8224D100-1734-4015-8CB4-13B8289BB19B,"Oligosarcoma, IDH-mutant",0.999998654
F9FFF846-664D-465B-ABCE-955BBD5947A6,"Oligosarcoma, IDH-mutant",0.999998654
8EB59DCE-46B4-483F-B6EF-A4172BD46A4E,Myxopapillary ependymoma,0.999998646
1ABEF5CD-C369-4D63-86B1-662EEC7863CD,Spinal ependymoma,0.999998633
6CFE3307-D321-4B44-BD03-8B3E3F01F928,"Diffuse midline glioma, H3 K27-altered",0.999998621
161DD5BB-3359-44C2-A140-E828A2BCC325,"glioblastoma, IDH-wildtype",0.999998605
B706EA37-CFF4-4231-9CE3-19F6594EAD57,embryonal tumour with multilayered rosettes,0.999998567
2B542DFB-873F-4134-8FED-ABB9210C1B4F,embryonal tumour with multilayered rosettes,0.999998567
AE952E9D-7028-4D89-83DB-390D7A46F195,"Medulloblastoma, WNT activated",0.999998547
9708C34F-F2B3-4013-AE3C-EB769C3ED011,"Diffuse midline glioma, H3 K27-altered",0.999998544
46B6EC48-219A-4E39-976B-AAF767EEB845,Diffuse paediatric-type high grade glioma,0.999998533
FD8D0BD5-CD39-4272-A13B-BDDA840E0175,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999998525
928EF0B6-6541-4AF6-8C2D-705E9A3AF822,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999998525
36B2FD86-BDAF-4396-A316-A58650724786,choroid plexus papilloma,0.999998524
C0055E08-C27B-42F0-AE56-B7869D5C8C1A,embryonal tumour with multilayered rosettes,0.999998523
55649CFC-58DE-4D85-BD92-BF935F8E3636,Solitary fibrous tumour / haemangiopericytoma,0.99999852
16A042D6-4AAF-41D4-984D-7823CAF29689,medulloblastoma Group 3,0.9999985
A141F5EA-19CC-4BE2-A544-6B098503CABF,"Astrocytoma, IDH-mutant",0.999998493
DDC90668-BA85-4247-889A-CC69355A5CF1,Pituitary adenoma,0.999998482
C80702AE-3B70-48CA-B147-999AF2833BD3,"supratentorial ependymoma, ZFTA fusion-positive",0.99999846
4D6FA7B9-36AF-4E96-A065-97B1EE7B740C,High-grade astrocytoma with piloid features,0.999998435
65B341CE-98F2-45DA-9A52-CA5EC0FA0A88,Pineal parenchymal tumour of intermediate differentiation,0.999998434
261E4AB0-2341-47AC-9143-74EB55EA8270,medulloblastoma Group 3,0.999998428
CDF4C783-08CA-4210-8CFE-F7ACF8D02FF0,spinal subependymoma,0.999998422
13CEB8B4-DDE9-4224-B271-3CB250406147,"Oligosarcoma, IDH-mutant",0.999998417
AB84F911-8F61-454E-9CA1-E031993185AB,"Oligosarcoma, IDH-mutant",0.999998417
7569E38F-1C4A-4F5B-BCF3-364C694B61C3,normal pineal gland and pineocytoma,0.999998414
949906A0-2193-4849-90C6-8EA447D185D6,normal pineal gland and pineocytoma,0.999998414
C4EE1A27-BA85-4B95-841E-7CFF98843E39,"supratentorial ependymoma, ZFTA fusion-positive",0.999998371
85823450-E74A-4960-975D-B00C41A3BFD0,"medulloblastoma, SHH-activated",0.999998363
076D6345-0941-4993-9AB4-3E27DAD2D7B4,Pituitary adenoma,0.999998346
CB4B321F-D948-48A2-89BD-936C136E4305,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999998342
F0FC493C-3090-4D72-9520-A05EC5E573E7,Germinoma,0.999998317
E4D55F6E-279E-4A45-BFDA-29444912970B,High-grade astrocytoma with piloid features,0.999998304
8F789F33-2D1E-41D6-9EA0-9F60745DBF7B,"glioblastoma, IDH-wildtype",0.9999983
E736F4EE-6B20-4313-96BE-BD873546E85D,Teratoma,0.999998296
115996F6-693E-4DD7-86C3-38B8C3DAAEFF,Pineal parenchymal tumour of intermediate differentiation,0.999998271
288634D5-9955-4829-8BA9-656DADF9FEEB,"glioblastoma, IDH-wildtype",0.999998263
AD17D500-F244-4631-81FD-99AD0C9DE13A,"Diffuse midline glioma, H3 K27-altered",0.999998223
68E3C14D-8C51-4BF3-BA76-BE4A9E9057A8,"glioblastoma, IDH-wildtype",0.999998223
D2EFFE59-DA5C-4BAE-B61A-B1A5DB2ED998,Myxopapillary ependymoma,0.999998207
9A6DE582-22C7-4B80-929E-8FA12899DB74,"Astrocytoma, IDH-mutant",0.999998183
4DC80C03-A226-4237-ADEA-B7522D8672E3,Pituitary adenoma,0.999998159
133CC5F6-005C-4031-B5E8-27BB808A53CB,Diffuse paediatric-type high grade glioma,0.999998128
32D8D894-32B9-4896-B115-9F74A46705C1,"meningioma, benign",0.999998124
140AB532-5AEA-4499-88D2-4C78AF609F3F,"glioblastoma, IDH-wildtype",0.999998115
38034CC6-4608-408C-8724-DDBE2D353DBA,High-grade astrocytoma with piloid features,0.999998107
4D398A7F-7C27-4924-8B56-AF875872D061,"glioblastoma, IDH-wildtype",0.999998077
7DA2EE5A-910F-490B-B5BB-C1C79A6A122E,"glioblastoma, IDH-wildtype",0.999998077
3F8FD855-E99C-4644-B02C-27828E861BD9,Olfactory neuroblastoma,0.999998061
AE0AFA3E-4E8F-4556-A238-CEBAE7D53142,medulloblastoma Group 3,0.999998033
72CB1F24-DE89-4BDB-BC2E-225B8FA64480,"supratentorial ependymoma, ZFTA fusion-positive",0.999997991
5C712315-700F-4945-9914-62E0139A2C70,Malignant melanotic nerve sheath tumour,0.999997981
AEE4C1CE-F5D9-4C6B-A062-64621EBC90F7,Myxopapillary ependymoma,0.999997979
A45ECD23-9259-4677-B010-7EC8EBB4EB9D,"supratentorial ependymoma, ZFTA fusion-positive",0.999997928
D940FD66-18CC-4B5A-ADCC-ABDC0D9D9F2B,"Astrocytoma, IDH-mutant",0.999997912
3D45DB5C-0E15-4488-A4CB-C7839F6F2FD0,"Diffuse midline glioma, H3 K27-altered",0.999997905
284E5E29-0A9D-4B3A-AE3A-47F086A87564,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999997899
A94A11C5-E8E2-4DE0-81F9-E48CACB635DF,Diffuse paediatric-type high grade glioma,0.999997884
EDB7EF07-40EC-4765-9632-80576B25C8B9,Infant-type hemispheric glioma,0.999997878
B1FF1BC7-4AD7-4A12-ADE9-F3623ECECC81,"glioblastoma, IDH-wildtype",0.999997859
C563BED5-6496-4935-9C49-869E96E97170,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999997842
4FF1D968-B907-4EAD-A96B-5FD06F226B28,normal pineal gland and pineocytoma,0.999997815
2C5A8743-3388-4B0C-B2A0-246900D8B291,Pituitary adenoma,0.999997815
920EE492-FEFC-42EA-B42D-E94432797CBD,"glioblastoma, IDH-wildtype",0.999997807
21CD7F80-9520-494C-A55C-66F7AD3A37C9,"glioblastoma, IDH-wildtype",0.999997807
B68D17A2-4414-4203-A4BC-4A821750B5A1,pilocytic astrocytoma,0.999997805
4D2EA67A-1F86-4043-903C-55F5BBFDEB34,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999997796
25E0F0AC-8B13-44BA-AF7A-38693EA93EBB,Spinal ependymoma,0.999997778
EF7B40AF-5188-484B-B172-299A066E0565,"glioblastoma, IDH-wildtype",0.999997745
A1818258-7510-4745-8BAF-A9904939B71B,"Astrocytoma, IDH-mutant",0.99999771
82B1A684-CD6E-4F3D-8344-F2533A239600,Spinal ependymoma,0.999997688
7C2437FA-1257-4B4B-A83B-7666D3DF61A2,embryonal tumour with multilayered rosettes,0.999997644
4B3EE2EB-1BED-46CA-8EED-6FAC6527F820,pilocytic astrocytoma,0.999997628
AEE86667-DE9E-48FA-9E9A-BBA07EA05532,pilocytic astrocytoma,0.999997628
4A600F02-E7FB-418F-96F6-D6BCBF3AF5C4,Olfactory neuroblastoma,0.999997616
10A22EFE-C60A-475C-960C-4A4E22723F03,Spinal ependymoma,0.999997601
3FB8A4A1-3ED1-4EDA-A522-C14E1C74D842,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999997591
6D7DDFF7-FD69-475F-B8F7-EC256440B2DA,Malignant melanotic nerve sheath tumour,0.99999759
807F8897-92B5-4B59-9DC3-F57551558B32,"supratentorial ependymoma, ZFTA fusion-positive",0.999997579
F318B436-B033-43F3-AD70-AC5897F1686E,"glioblastoma, IDH-wildtype",0.999997568
785C54C3-BB2A-4591-AC7A-2CE7993337AE,"glioblastoma, IDH-wildtype",0.999997568
3A507957-DE49-4BBC-A63E-199F7AD301AC,Myxopapillary ependymoma,0.999997506
BDC42004-9346-4AFF-9005-B17652F4D055,pilocytic astrocytoma,0.999997497
23C4BF74-B922-461A-BC86-348B4B64EF45,"meningioma, benign",0.999997474
29CEB669-E867-484F-B1D4-E8009F2EF017,Spinal ependymoma,0.999997466
3AF45404-5C51-4245-8A55-097C75BAD5A6,Pituitary adenoma,0.999997453
0A634BDB-B529-4428-8E0B-39D87EC5B388,pilocytic astrocytoma,0.999997452
01E40029-8057-4D72-BECE-B2B1945F1363,"Pineoblastoma, miRNA pathway altered, group 1",0.999997439
3118BF6E-42C0-4BFD-9957-FB6AD0996B9B,"glioblastoma, IDH-wildtype",0.999997435
38CDF871-7274-438F-97C8-316E220870C8,Haemangioblastoma,0.999997409
F3DF7A3F-64D4-4FF9-9EEA-381C9144EA9B,Pineal parenchymal tumour of intermediate differentiation,0.999997394
13B48B78-30C7-4CC0-BC4A-5B38FE012380,posterior fossa ependymoma group A,0.999997388
B2352381-9C09-41FC-92C7-72311038CCC5,Haemangioblastoma,0.999997388
DA7260DE-0D1D-47DC-AAE6-794FEA1D4668,"Chordoid glioma, PRKCA-mutant",0.999997375
3CCA3B1F-7053-4180-A54F-2B82614039A3,"CNS Schwannoma, VGLL-fused",0.99999737
E7228B83-420B-4CFF-AF60-5CE6D864CBA0,Pineoblastoma,0.999997367
22DA479F-47BE-4FC3-9976-D15620DA8293,embryonal tumour with multilayered rosettes,0.999997354
A0F97715-0809-4436-848D-F5EA29EF3C1B,Atypical teratoid rhabdoid tumour,0.999997351
FF17F1F7-AE59-44CA-84AA-F03389E8CF2E,pilocytic astrocytoma,0.999997346
6BF42052-C9DE-4C62-8AD2-67B4F7CC56A7,medulloblastoma Group 3,0.999997339
1922DADC-BDFF-412F-B643-035C7022AB75,posterior fossa ependymoma group B,0.999997338
3EC8D9AD-8A73-4E79-B0EB-574D3E580EDC,"supratentorial ependymoma, ZFTA fusion-positive",0.999997303
FBA2F09E-3878-49CB-A044-94313438242A,Pineal parenchymal tumour of intermediate differentiation,0.999997295
742EAB6A-1252-48A5-BFF0-CCD9A3DCFA1B,"glioblastoma, IDH-wildtype",0.999997289
A1EAFACA-FD38-4527-8A42-5918F6D3674B,"Pineoblastoma, miRNA pathway altered, group 1",0.99999727
F4DC4577-65C7-4F6B-B184-0A82889FA187,choroid plexus papilloma,0.999997261
1EAD5F7E-DCCF-4210-920F-1FBF88BED40F,"glioblastoma, IDH-wildtype",0.999997253
F85630F0-0948-499C-9088-72BAE98C325D,"glioblastoma, IDH-wildtype",0.999997253
AD4EC229-DF85-4A34-98DE-892656B6C307,"glioblastoma, IDH-wildtype",0.999997253
E0835AA9-91C5-499B-8DB1-1D2CE18B0B02,"glioblastoma, IDH-wildtype",0.999997253
BBA9233E-1DA5-4ABA-9993-02A3A9E4B993,pilocytic astrocytoma,0.999997251
7E3918C8-3909-410D-9534-A8CA76B55658,Melanoma [metastatic],0.999997228
3CA48CD9-B043-4AC7-9DA0-7A7C2550CC83,medulloblastoma Group 3,0.999997221
846E6EE8-064D-4527-A126-A7B8BD53FECF,Olfactory neuroblastoma,0.999997179
88882748-12F6-400A-BF71-B1721A0D7A3E,pilocytic astrocytoma,0.999997172
67906E50-B0C0-4061-9DDA-1ABF7E1AE5C6,"Medulloblastoma, WNT activated",0.999997172
B785039D-559D-4471-B136-666CA077F5D8,pilocytic astrocytoma,0.999997122
F8AF5DFE-9C55-4C3E-B1EA-630D35CCA181,Myxopapillary ependymoma,0.999997117
D76647BD-7174-41CA-9F73-EF09732E7DC0,Spinal ependymoma,0.999997108
B7F84602-1C60-44BA-891D-EB29C24D6535,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999997091
D1C7D289-6EC1-4B17-9838-567AA35F95A9,Myxopapillary ependymoma,0.999997048
DADE45EA-D27D-4667-8F8E-EEBD0C934F39,Spinal ependymoma,0.999997037
D1FC8500-C617-457A-A89D-0A0D42235282,"glioblastoma, IDH-wildtype",0.999997037
820537FD-A354-4EEB-833C-A42D20DF9F92,"Diffuse hemispheric glioma, H3 G34-mutant",0.999997001
A59391F9-C092-47BB-955A-146AFFAD7770,"Diffuse hemispheric glioma, H3 G34-mutant",0.999997001
07C4B1C6-0ABE-4D34-80C9-FE816B789573,"glioblastoma, IDH-wildtype",0.999996997
4E895D82-C464-4897-B202-168F6031AFE3,"supratentorial ependymoma, ZFTA fusion-positive",0.999996974
0F808537-6492-4C50-AEA3-E895A7740709,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999996972
8D5942FA-87E3-41E0-82A2-02C9ABB0B52F,Myxopapillary ependymoma,0.999996946
4D0131B1-D530-4E69-90FB-D7EB012FB99B,Myxopapillary ependymoma,0.999996946
2B0BE60C-F717-4B71-8B66-FCDC7E04FDDA,posterior fossa ependymoma group A,0.999996943
6CC56047-2E11-4AF4-96C9-E98A2175C3DB,"meningioma, benign",0.999996906
BA3EAAA1-2469-418F-90EC-BEEC364A0569,posterior fossa ependymoma group A,0.999996876
ED95C23B-7DAB-4DE2-AA58-A1E1F71EE5CF,"medulloblastoma, SHH-activated",0.999996871
ADC45789-111F-4E49-AD34-F0DAE748B1F6,"Diffuse midline glioma, H3 K27-altered",0.999996865
1BF706F9-E2B1-436A-B602-EF7B5F59BB50,"Oligosarcoma, IDH-mutant",0.999996862
7DB81A64-6D90-4A4F-8920-50054213219C,"Oligosarcoma, IDH-mutant",0.999996862
865AB809-1483-4033-9687-00F89E2AFD7B,"meningioma, benign",0.999996859
508952CA-9EDF-4BD9-B103-71DB012464FE,"glioblastoma, IDH-wildtype",0.999996855
18C68CA7-78FF-4469-8C46-0FD137757A92,"Diffuse midline glioma, H3 K27-altered",0.999996842
FDCE03A2-0CC2-4657-8D74-27A249F6A7B8,posterior fossa ependymoma group A,0.999996839
C1327ED9-D5C0-4B48-88B0-1090FC5F2C3A,spinal subependymoma,0.999996834
39B7DE4C-D6E3-4143-9ACA-23EE7580F883,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999996823
22A94724-9815-4EF9-A479-37C6A708B495,"meningioma, benign",0.999996822
6F58CCE8-0049-4EB5-A215-E9CF21B71CA8,"supratentorial ependymoma, ZFTA fusion-positive",0.999996809
B28D7E97-9484-4A91-8D41-3F64DFF97A6D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999996803
5B72CF42-1254-401F-AE1A-44EBD2A88A71,Myxopapillary ependymoma,0.999996771
5E260C76-A55C-4A36-AF75-667B1E6C84EF,"glioblastoma, IDH-wildtype",0.999996769
8E6855FF-217D-48EC-9674-3CACA21C9A63,"glioblastoma, IDH-wildtype",0.999996769
6D9EB131-BF73-449F-8E72-6FC0B96617D1,"glioblastoma, IDH-wildtype",0.999996769
47A07B16-05CE-4F9B-B4A8-12EFBBDBB80D,"glioblastoma, IDH-wildtype",0.999996769
F74C2836-03E6-4E9C-B669-37F652CE63DC,"glioblastoma, IDH-wildtype",0.999996769
72B183D8-8417-41A8-BA07-9A7AB4C22071,"glioblastoma, IDH-wildtype",0.999996769
BF96B994-D161-42C1-84B2-638397D3AF7C,"glioblastoma, IDH-wildtype",0.999996769
068FF051-7F66-4517-9C61-C1FE0D168899,"glioblastoma, IDH-wildtype",0.999996769
B853202E-123C-483B-B803-FCA576BE9C47,"glioblastoma, IDH-wildtype",0.999996769
77D32314-6A9F-43FB-A572-72F55C827554,"glioblastoma, IDH-wildtype",0.999996769
86B3E39F-C723-430B-AAE6-131D7379938C,"glioblastoma, IDH-wildtype",0.999996763
75A29358-C3F1-41E1-8D4C-A27188968357,embryonal tumour with multilayered rosettes,0.99999674
9D6718DB-8F99-40CA-947B-820E7D8AA738,posterior fossa ependymoma group B,0.999996728
85F8798E-B45F-4E49-9E85-47D3B6E7025B,pilocytic astrocytoma,0.999996668
EF26CF85-72EF-47C9-8FED-4FC2D2CDA2E2,Pituitary adenoma,0.999996664
D5573996-602D-4CA6-820A-58377C3F1B6A,embryonal tumour with multilayered rosettes,0.999996656
462C240C-5790-4F85-8843-F4F593A37200,"glioblastoma, IDH-wildtype",0.999996628
5CCCF1F8-B0BF-4F50-A327-3AD1868C6DC5,choroid plexus papilloma,0.999996618
6CA06ECE-9DE4-4634-B5ED-7874538DF6DF,CIC-rearranged sarcoma,0.99999661
AC3E8177-F2E2-402B-85E8-62F9294544CA,Haemangioblastoma,0.99999659
DF4F3DC9-3C3F-4A63-B1ED-1B2679027C21,"glioblastoma, IDH-wildtype",0.999996577
26FE2FC6-DFEB-4D18-9BC2-5A1F58529B38,"glioblastoma, IDH-wildtype",0.999996532
2171773D-7719-463F-98E0-6B0714181CC6,"glioblastoma, IDH-wildtype",0.999996532
2D61C39B-98D8-4EB0-96AD-4CAD71928138,Pleomorphic xanthoastrocytoma,0.999996521
6CA1E47B-64CB-45AA-B6A0-8AA5C78AC5D9,Pleomorphic xanthoastrocytoma,0.999996521
0419C0EB-AF19-4C41-84B6-F5C6D9A09AF0,choroid plexus papilloma,0.999996452
7B5DCC63-4FA0-48AB-BA4B-1B6787F59C57,Atypical teratoid rhabdoid tumour,0.999996447
B92091B5-AA00-438F-A92D-68923781EEE0,choroid plexus papilloma,0.99999641
42F14022-D2B0-4449-8380-64C63784A4A4,"Spinal ependymoma, MYCN-amplified",0.999996399
B3E770C1-2B30-4741-B353-0D77EF7CFB40,"Spinal ependymoma, MYCN-amplified",0.999996399
093D629E-C957-4694-A2CD-06369B3B4C0B,pilocytic astrocytoma,0.999996386
EB48ECC8-AA67-408D-AF47-D779AB0E3C73,"Astrocytoma, IDH-mutant",0.999996381
7EB6ACB3-D1B7-4DA7-A9BC-D5F39D770B15,Pituitary adenoma,0.999996379
336C4507-E6A0-4DF5-980B-2C6EE387AA3F,"supratentorial ependymoma, ZFTA fusion-positive",0.999996352
2EF1DD8B-AF40-412B-A602-83778113F200,"Medulloblastoma, WNT activated",0.999996335
3EA38E58-B4DB-4438-9049-17C62728FC88,embryonal tumour with multilayered rosettes,0.999996332
15F03F3B-C09C-4EB2-9C93-732D53E5FCD1,Ewing sarcoma,0.999996315
F8EA72DF-44B8-42C9-9B45-74294BE8424B,Myxopapillary ependymoma,0.999996298
41DF6015-FEBE-4C13-94F2-223E3BE49817,Spinal ependymoma,0.999996294
ACF39446-9D50-4520-AFCE-DBDBC8549BD0,"glioblastoma, IDH-wildtype",0.999996261
3C791D96-A38E-410A-9875-F93C77310A8D,Myxopapillary ependymoma,0.999996219
FE9F8452-E3C7-4515-B71A-58E8572C8715,Myxopapillary ependymoma,0.999996217
4FBBAB8F-5FA5-4CBA-8303-5443DC1572D6,Spinal ependymoma,0.9999962
5D4E8066-5A6D-4816-8AE5-04F857940816,posterior fossa ependymoma group A,0.999996191
323C1A25-A505-46B5-A2CF-C468CC677371,embryonal tumour with multilayered rosettes,0.999996172
84C553E8-165C-4733-8F43-5D86DB7CDE60,"meningioma, benign",0.999996122
E63312C4-A15C-48A9-AD7E-49251FDA4479,embryonal tumour with multilayered rosettes,0.999996095
299368F5-FA27-4DD1-887C-EF1EB274F03B,"Medulloblastoma, WNT activated",0.999996052
87282A6A-071A-4C09-AB54-16D6810C1C6D,Pituitary adenoma,0.999996025
568A6C86-DC84-472E-862E-D7F3C5A18E69,"Diffuse midline glioma, H3 K27-altered",0.999996024
9FB91610-57B9-4A25-A609-F528BB194225,posterior fossa ependymoma group B,0.99999602
990A2627-AD50-41D2-A042-65F4B7301DF9,posterior fossa ependymoma group B,0.99999602
F3946EA3-D7AB-49BC-8591-3B13FD5D1478,"supratentorial ependymoma, ZFTA fusion-positive",0.999996018
80184741-0F21-4673-96E9-20EBCC479498,"meningioma, benign",0.999996011
ED950887-C639-418C-852F-9CFC767FEC6F,posterior fossa ependymoma group A,0.999995999
A9E05097-8920-45F9-AD4D-E767B4F3B557,embryonal tumour with multilayered rosettes,0.999995986
DEDB8867-6103-431D-A031-5A89C3538025,"supratentorial ependymoma, ZFTA fusion-positive",0.999995972
2FC48D69-C9F9-439B-9AEA-37F2BDC513A3,Pituitary adenoma,0.999995967
2D00DFDC-1A7C-482F-BE9A-3AFB6DAAFB65,pilocytic astrocytoma,0.999995947
DCBFB0F3-E698-422E-B234-8A0F090D6522,pilocytic astrocytoma,0.999995921
1801555A-568B-47A1-B474-42A1A8A0A5FF,"glioblastoma, IDH-wildtype",0.999995864
883721F4-27D1-4860-A2AF-3E14EA3C9F71,Spinal ependymoma,0.99999585
CDB4B5BE-E55B-485F-ACE6-9C2A2BC07C15,embryonal tumour with multilayered rosettes,0.999995847
5C421A7A-2D07-4C63-AB98-B29F2C4A7F91,posterior fossa ependymoma group A,0.999995823
16C8325D-7BAC-4C33-B506-FA12B7D290F6,Malignant melanotic nerve sheath tumour,0.999995816
4BD37701-739A-458B-BB90-158DD619914C,Pleomorphic xanthoastrocytoma,0.999995796
7F17A1BE-F7A7-4645-86A6-451058D32B29,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99999578
A082A888-6A8B-4173-8212-D496D99748A7,"Medulloblastoma, WNT activated",0.99999576
CA3C8BBF-89B3-42A6-96C6-240121E55C59,"meningioma, benign",0.999995746
B40E393C-192D-4521-9B10-7DADD4A207C9,"meningioma, benign",0.999995746
262F7139-40BC-4C2E-93D8-6239DB9A7434,Pituitary adenoma,0.999995737
7FD7BA4A-06B0-4C65-B9F7-B13ACA5785A3,embryonal tumour with multilayered rosettes,0.999995735
ABC55476-3C3B-44F1-86DD-FC9A447B2844,Spinal ependymoma,0.999995718
592F0014-943D-45A9-A4C8-89F8511A51B1,"Diffuse midline glioma, H3 K27-altered",0.999995707
D0E98E31-0367-4304-976F-033C58242990,"glioblastoma, IDH-wildtype",0.999995701
1753C016-4CE3-464F-BBBB-5B44BA9E9F4B,Pituitary adenoma,0.999995661
BB132289-474E-4C2C-9BC6-323A9310D50B,medulloblastoma Group 3,0.999995615
177756A4-B008-4C84-9302-8CD2E611A23C,Spinal ependymoma,0.999995588
3307C794-2126-44E1-ABCF-272D327C862B,"Astrocytoma, IDH-mutant",0.999995587
599BC461-97D9-4D7B-A4AF-23D53F277B6E,"Astrocytoma, IDH-mutant",0.999995587
D7D2914B-D88A-43EB-BDF8-0D6CA32C2AA0,"Astrocytoma, IDH-mutant",0.999995587
05B67ADA-AB3E-4798-8343-1B29B60F6BE1,Pituitary adenoma,0.99999558
41E7421C-3A18-4A2F-BECB-38A02179D8DF,papillary tumour of the pineal region,0.999995577
086EDAF1-A786-4D70-8197-2D0E12ACC265,"glioblastoma, IDH-wildtype",0.999995577
09CEF454-8917-4C7B-955C-8DA5A5888BE3,posterior fossa ependymoma group B,0.999995556
5A7FA1E5-7E98-4F8F-BB54-4A296850750E,control tissue,0.999995543
E71F74CB-8053-4918-88CD-03E096896AB6,"supratentorial ependymoma, ZFTA fusion-positive",0.999995531
B6C3E150-C0F3-46D8-BCD6-0141D6FFEF4E,"glioblastoma, IDH-wildtype",0.999995515
FE127DBB-5E7E-4381-A32E-78D1808AE11B,"glioblastoma, IDH-wildtype",0.999995515
14D8D186-04D9-4CE1-949C-DD3B3529BC17,normal pineal gland and pineocytoma,0.999995495
ADE2A595-0123-4849-BE17-6E40FD4722C3,papillary tumour of the pineal region,0.999995465
2F89D5BE-625F-4142-B9BA-27051CBF5DB0,"supratentorial ependymoma, ZFTA fusion-positive",0.999995452
4D3FB3B8-FA63-496D-8373-A3191B40D06B,"supratentorial ependymoma, ZFTA fusion-positive",0.999995452
700BD6BB-697C-400D-8F95-A1722A17183D,embryonal tumour with multilayered rosettes,0.999995406
45F542C2-518B-4C34-B516-E5AD0E24EC4F,pilocytic astrocytoma,0.999995368
2F0B9E59-1848-40D8-82FA-959638731C63,"Angiocentric glioma, MYB/MYBL1-altered",0.999995309
A4288975-8F8C-4203-8947-B0875E84638D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999995302
B939E36E-5FFF-4F67-8B70-8EF1FDB29212,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999995302
C690E680-EA28-46E2-97EB-09C7C64A1FD5,"Astrocytoma, IDH-mutant",0.999995302
97F346F2-4E17-4C82-862B-21145A5DF83F,"Astrocytoma, IDH-mutant",0.999995302
FA41C11A-E862-42A3-BAC5-B2686BF40A60,Atypical teratoid rhabdoid tumour,0.99999528
F4131589-AF55-42CC-AD79-FF1E29484116,posterior fossa ependymoma group A,0.999995273
A9B95C95-82CE-4C1F-97E3-DF315E1F0115,"Diffuse midline glioma, H3 K27-altered",0.999995259
6FFC9480-4352-41F4-BD7F-17B11C8664FC,posterior fossa ependymoma group A,0.99999523
7AD469EB-8616-4F48-AD82-378F1D83939E,Atypical teratoid rhabdoid tumour,0.999995214
998110EA-3AA5-416B-82C6-3E6D08FB0CEF,Spinal ependymoma,0.999995184
53FB353D-8B79-4091-8ADC-BF11A80F5B31,Spinal ependymoma,0.999995184
8373A041-4608-43A1-9645-04BB8EDC912C,"glioblastoma, IDH-wildtype",0.999995176
88F58D94-ECCC-4F9A-BEA5-2489711EDCDB,Haemangioblastoma,0.999995168
FA4AF8AF-80E0-42DC-A6AE-4F5AD8D4C8ED,Pituitary adenoma,0.999995159
55C6C362-A9D2-44F9-B97A-DB180226E2A9,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.99999514
D845C2ED-13C7-458C-BEBA-EB6FD6E76C1D,Myxopapillary ependymoma,0.999995083
718A3C21-3BE3-4CE4-B375-2E81E3D87968,"meningioma, benign",0.999995082
6F15527D-CF3F-4D14-B809-2021269C80C3,"meningioma, benign",0.999995082
DB18ABD2-0F43-46E8-BF8A-5C5C89426FA7,"meningioma, benign",0.999995082
519046C0-DCFD-40B6-A95E-F1D90C918A09,pilocytic astrocytoma,0.99999508
619F026C-EB81-4B73-9B4A-26E9A2EEAEAF,"glioblastoma, IDH-wildtype",0.999995066
3DC4C222-35EB-45B4-B540-63B5625D60D1,Pituitary adenoma,0.999995058
4363A8DC-4B60-46C2-8429-E70C3FDC5C41,Pituitary adenoma,0.999995052
2C36FA84-F439-4D87-88A2-1ACFBB8816B0,posterior fossa ependymoma group A,0.999995034
1A4D5E67-F277-439C-B254-D56B202E2C36,pilocytic astrocytoma,0.999995007
03190133-2E74-4628-9DDC-F9B2D87E1D0D,"medulloblastoma, SHH-activated",0.999994996
296A43D4-0F88-4763-AFB8-F07D28A72702,Spinal ependymoma,0.999994974
503C5CC9-009E-4EAE-A584-BFE78A72BFED,Pleomorphic xanthoastrocytoma,0.999994942
1CD7E1D8-D246-475D-9105-40BA21369DF2,"Oligosarcoma, IDH-mutant",0.999994933
D32EE6F2-E29D-405F-8CA7-9CD712B240D0,embryonal tumour with multilayered rosettes,0.999994926
5FCC1ADC-4866-40E1-B5DD-5A3BD4A6521D,"glioblastoma, IDH-wildtype",0.999994871
14D63737-B2E0-422B-AE1C-7C69D3F79010,"glioblastoma, IDH-wildtype",0.999994871
51D3E56F-E7BB-4BC5-A19F-722DC885059F,Diffuse paediatric-type high grade glioma,0.999994869
9B77A4D0-5D08-4A6F-8889-F4F9DA9920AA,posterior fossa ependymoma group B,0.999994821
452F58B4-0884-4E9E-9B7F-9E92CC996ABD,"glioblastoma, IDH-wildtype",0.999994744
D75D2BB4-9BD7-4887-9DB7-394CCF307EBF,"glioblastoma, IDH-wildtype",0.999994744
2C117FBC-A3C1-4EBF-AE18-3A4109291759,"Astrocytoma, IDH-mutant",0.999994725
4F673C93-08F8-4BE5-9DE3-8344215543D7,"Astrocytoma, IDH-mutant",0.999994725
109C09DD-0317-4CEF-A558-8F10BBBC2BCB,Spinal ependymoma,0.999994721
C5E7A5C8-63DD-4BE6-AFC0-5643401544BA,"glioblastoma, IDH-wildtype",0.999994666
2A7015F5-3F2C-43CB-8E5F-6D7F60A0128B,posterior fossa ependymoma group B,0.99999466
348769A8-5F8B-428A-AB08-3A118B51E06F,posterior fossa ependymoma group B,0.999994633
71389ED2-5389-4C16-8679-B2EB3E55859F,Myxopapillary ependymoma,0.999994626
4739B066-C854-4C8B-868E-875D46BAF074,"Pineoblastoma, miRNA pathway altered, group 1",0.999994588
B25F997B-A81F-4217-B360-31FD3A9C83E0,Pituitary adenoma,0.99999457
E508AE5C-D88A-4799-A336-63D9042C3DD3,Haemangioblastoma,0.999994513
4C6657E0-E934-4F68-9766-ECE16F926F3D,Myxopapillary ependymoma,0.999994446
7EA91691-0494-44F9-A63B-AE26A6868BCE,Diffuse paediatric-type high grade glioma,0.999994401
27390FDC-3C02-465A-9B29-8FD746AAC2B4,Diffuse paediatric-type high grade glioma,0.999994401
E308CD0F-64D5-4BC8-B972-C84511DB40F6,CNS tumour with BCOR internal tandem duplication,0.999994393
00AC141E-3C7A-4B41-B562-240933A40922,Spinal ependymoma,0.999994277
170F650C-1610-4B90-89DB-18AA3A72F12F,choroid plexus papilloma,0.999994266
03FF95CF-189B-406B-9ECE-962F3C39FEDA,Ganglioglioma,0.99999425
58E67CFE-88A4-4CE9-B393-1D5DCE86E47C,"glioblastoma, IDH-wildtype",0.999994238
ACF9ECC3-A4C6-4658-B7CA-8B840D6A6DB7,control tissue,0.999994226
CFA360A1-FC21-4DFC-B64B-BE20593B3B70,"Diffuse midline glioma, H3 K27-altered",0.999994121
6EEA58E8-7AA6-48FE-982B-9E8820ED5096,embryonal tumour with multilayered rosettes,0.999994119
DC99E97B-6BFB-4098-BC1E-6BE10873E717,Spinal ependymoma,0.999994063
BA010722-44E3-4FB7-A32E-0D164923C762,Pituitary adenoma,0.999994053
7B92816E-B39B-4929-B445-9F7829C02158,Myxopapillary ependymoma,0.999994051
7167EE63-3E4D-49FF-803D-D720B2F8F2A7,embryonal tumour with multilayered rosettes,0.999993983
ADEBB801-CC15-4F21-8338-389E8FF5C8FA,Melanoma [metastatic],0.999993958
CF3E64DE-A618-4C77-99BE-EEC5CE6F3DEF,Spinal ependymoma,0.999993949
9A2C380E-1AA7-47AA-A06A-A76C8EAEF874,Myxopapillary ependymoma,0.999993936
B6CBE8E6-A704-4E9B-97DC-143ABDCA0065,Myxopapillary ependymoma,0.999993926
DB24B926-0DBE-4954-9CF9-C24997A00921,normal pineal gland and pineocytoma,0.999993925
7668972B-529D-4EBC-9506-908D82FF06FB,High-grade astrocytoma with piloid features,0.999993916
6804E361-923E-479F-A384-E1B0B45BDA6D,"Pineoblastoma, miRNA pathway altered, group 1",0.999993911
78BC0346-A671-452B-85A6-5C58E0C48BFF,Pineoblastoma,0.99999389
7F554313-4C89-4DCC-9689-AF62CB129643,Pituitary adenoma,0.999993875
007AF43E-49D3-4D1C-A8A9-D05DE48F3176,Diffuse paediatric-type high grade glioma,0.999993808
9FEEA037-A489-487B-B784-EFB24CF4AE70,Diffuse paediatric-type high grade glioma,0.999993805
252ADB37-B250-435B-8406-DBD0E57EE87F,"glioblastoma, IDH-wildtype",0.999993798
9F7AED7C-554C-4D15-A3E6-4BDB5CEF3ACE,embryonal tumour with multilayered rosettes,0.999993758
6204DD75-B062-482A-A4D6-7BE53A9B0577,"Astrocytoma, IDH-mutant",0.999993747
4206771F-C265-42FA-87C5-FA3A92FDF593,"glioblastoma, IDH-wildtype",0.999993739
5C1093C4-509B-43AF-A618-3AC9F053910D,"glioblastoma, IDH-wildtype",0.999993739
AA06F6EA-3C0A-4930-B28B-F161CFCE810D,"glioblastoma, IDH-wildtype",0.999993739
229C6576-F8A3-46F0-B4C8-01AF121A6256,"Astrocytoma, IDH-mutant",0.999993706
90A096F7-78FE-4532-8E7D-B56C30F40753,Pituitary adenoma,0.999993691
2577C958-D869-48BC-AB70-F9B971928283,"glioblastoma, IDH-wildtype",0.999993679
7930B613-C7E2-4E63-8256-35D8222ED6F5,"glioblastoma, IDH-wildtype",0.999993679
1814BB51-2656-48E9-8246-C187F1E8278A,pilocytic astrocytoma,0.999993671
9215A2D7-E714-476C-B04A-FC1C68E585AA,"Angiocentric glioma, MYB/MYBL1-altered",0.999993638
78D4810A-9446-44D6-A530-B14F5FAEF2DC,Pituitary adenoma,0.999993632
716C7F5C-90AD-4444-AB42-FD3C7F3A7F9E,"glioblastoma, IDH-wildtype",0.999993607
1C915A9B-DA07-49BF-8FC0-7572E5C258B8,"glioblastoma, IDH-wildtype",0.999993607
CC6372C8-917E-46E1-AC06-0C9CB756DBD1,"glioblastoma, IDH-wildtype",0.999993573
6D160A8C-8B9A-498B-9C76-4A677ABC5370,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999993557
39FEAF38-B546-4611-8055-DCFDC4D0FBD2,Spinal ependymoma,0.999993542
04A84D99-08FB-4E81-AEA4-FE3D622A2448,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999993505
E7A95AEA-B3CA-485A-B57F-22DF23A4F763,"meningioma, intermediate",0.999993497
2E99D867-0DE0-4E98-B01B-10D0B3247CAD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999993486
C9953FF7-0830-4ECD-90FC-977E905DF33E,Pineal parenchymal tumour of intermediate differentiation,0.999993479
ACE707F6-5A8F-476C-B679-3FE8E86D75B8,posterior fossa ependymoma group A,0.999993429
2F7D5E1A-F9D0-4EFD-8AD5-E757144E25E8,"Chordoid glioma, PRKCA-mutant",0.999993426
B6881FC9-230F-4535-9834-6347C007AE5D,"Primary intracranial sarcoma, DICER1-mutant",0.999993416
245225E3-FD1E-4795-A817-1442F9DC1AFF,Atypical teratoid rhabdoid tumour,0.999993399
B58D6BE6-3C04-4D64-A088-75234F96B8C5,Pineoblastoma,0.999993361
9FE30431-E1F7-4CD2-BBB1-6A6026757AAB,embryonal tumour with multilayered rosettes,0.999993327
F332757B-B2B8-4E95-ACCA-ACEB4BCD910A,Pineal parenchymal tumour of intermediate differentiation,0.999993299
26B83592-F585-4CE1-816B-B793FBD6EC65,Myxopapillary ependymoma,0.999993254
4D8A5CBE-0242-4007-A0B4-23188BC372C3,Myxopapillary ependymoma,0.999993254
939FD6D1-01FD-4F12-85B1-7F69FBE2BDAB,Myxopapillary ependymoma,0.999993254
390220BD-9300-480B-9297-70ECE601E6B9,"glioblastoma, IDH-wildtype",0.99999319
7007D70D-4EC5-402E-9812-85F3ECF2636D,posterior fossa ependymoma group A,0.999993161
714F0F26-5D30-485E-9E30-363F75D556A0,"supratentorial ependymoma, ZFTA fusion-positive",0.99999316
180DAEE2-38C5-4DC6-98EE-5A072CE77492,posterior fossa ependymoma group A,0.999993141
1EC81609-447A-4C86-BF37-A34C544E37DC,posterior fossa ependymoma group A,0.999993085
E8834332-2137-48E0-8DFC-1B276CAA1775,"medulloblastoma, SHH-activated",0.999993066
1E036DBF-1E18-4C21-A820-738CEB2FE87A,Pituitary adenoma,0.999993034
090183DB-8D6F-45E4-9382-4D5318DE14C0,embryonal tumour with multilayered rosettes,0.99999292
7FD2698C-36E4-4263-856E-B9F54E0C54AF,"glioblastoma, IDH-wildtype",0.999992892
CF1C29B9-7D9A-4E71-85CE-F5E83CD66CBA,Melanoma [metastatic],0.999992869
4B91992E-A77C-43EA-B47E-E4F626A20E40,"glioblastoma, IDH-wildtype",0.999992827
D6324890-AC7D-4584-956C-CFF3298D6BFD,"Medulloblastoma, WNT activated",0.999992747
404FA845-E5E8-494E-94F3-9849862AFE4A,Haemangioblastoma,0.999992691
E705C0D6-72BE-4CF9-B427-6FD99D25FBC7,Spinal ependymoma,0.999992653
A4AA30D5-CEB1-41C2-A1F8-D694BB0A848D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999992612
C5E4E7BA-8CD1-4488-BA84-80C839EFDBF2,"meningioma, benign",0.999992558
B59A1D3F-0D05-4A4C-A323-A85339FFF247,Pituitary adenoma,0.999992557
6AA4EBB1-3B0C-467C-8E1B-00460F3CF3FB,Pituitary adenoma,0.999992557
0E1DF3AA-1B51-43EE-8E00-CB7B178EA251,"glioblastoma, IDH-wildtype",0.999992487
FB2C3A32-2381-4A55-8643-20FE6B5A2FC7,"Diffuse midline glioma, H3 K27-altered",0.999992479
B357439B-7B7B-497B-A4C2-A0AF6D6C5F42,"Diffuse midline glioma, H3 K27-altered",0.999992479
A9FA3BF6-2413-43AE-A655-83792ACD422E,"Medulloblastoma, WNT activated",0.999992477
2F89861C-772C-4A5B-8930-C6C961831DCD,"glioblastoma, IDH-wildtype",0.999992435
6BC79FF8-D762-40C5-94C7-F859849D8360,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999992396
1679EB52-C7F3-4F61-948C-430DF3B107F3,Plasmacytoma of the CNS,0.999992384
D6B22869-EA55-4DC6-BF0E-2C9513D677F1,Myxopapillary ependymoma,0.999992303
D7D89E6C-C8BC-4DED-9ED7-8637B6EE9019,"meningioma, benign",0.999992281
6CD6BCE2-DAA0-45AF-A4E7-3D14005061A3,choroid plexus carcinoma,0.999992261
80E92E70-72B0-4AD1-9E83-E08DBFF20977,Pineal parenchymal tumour of intermediate differentiation,0.999992259
4B414EBE-E581-49D8-B051-570542F195FC,Pituitary adenoma,0.999992188
64050213-E8A6-4A6E-8A7B-C3D825E78825,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999992184
146637A8-5FFA-498C-97B4-6C3A4D803BD3,Pituitary adenoma,0.999992142
59FC8824-A99E-45F6-9E47-B1F92DED9A05,Myxopapillary ependymoma,0.999992121
F3C52C9B-49EC-4E52-9C6E-58104ADE0E84,"glioblastoma, IDH-wildtype",0.99999211
DFA9E8E8-A542-493B-8B23-4FC040A8D7EC,"Pineoblastoma, miRNA pathway altered, group 1",0.999992097
D55E56B8-F437-44B5-850E-394D7DAAEC4D,Diffuse paediatric-type high grade glioma,0.999992064
1966AAEE-2096-4986-86AC-2FEACBF80DCD,"glioblastoma, IDH-wildtype",0.999991934
C9725EC4-6D0B-47BD-8D55-0A410D3D2CD0,Olfactory neuroblastoma,0.999991898
1ED7A9D5-19FB-436D-8943-8F206E924809,Myxopapillary ependymoma,0.999991889
67282A8B-38F9-4099-B281-58C781DC225D,Atypical teratoid rhabdoid tumour,0.999991859
114F9934-5586-426C-BDFB-30C951358859,posterior fossa ependymoma group B,0.999991838
09F3762A-BA79-48EC-8D90-54CA906FD44E,pilocytic astrocytoma,0.999991786
E5596C62-88EA-4178-94B1-B66F22EBF228,"glioblastoma, IDH-wildtype",0.999991782
5D8A3E2E-FCBE-493C-8B35-2DADC48521FF,Myxopapillary ependymoma,0.99999178
5DA1D0F8-7A26-4C5A-B943-DAD391C6C7F8,"meningioma, benign",0.999991738
162CA9D7-F350-4BCD-836A-2FF07D4FF0B6,"meningioma, intermediate",0.999991712
17B88355-79DB-4C02-987A-8B97D0D8949D,embryonal tumour with multilayered rosettes,0.999991658
5150CF7D-F0DD-46E1-8E69-6B55DDA002CB,Pituitary adenoma,0.999991588
8947E2EC-B357-44B5-9278-0D1EE50D70D4,posterior fossa ependymoma group A,0.999991569
10401467-50E9-48C0-A5F4-FAD11045C3E2,Pineal parenchymal tumour of intermediate differentiation,0.999991559
2D50C0C9-ACB3-4B6A-9B66-C1257A5C0D51,embryonal tumour with multilayered rosettes,0.999991541
04DF183B-8FCA-4E8B-A56B-F5D2F5F34543,Spinal ependymoma,0.999991461
AB3D1A52-4132-4F57-AAF4-E8BE4C954A78,Ganglioglioma,0.99999146
5600579F-F860-4527-B94D-644803F58133,embryonal tumour with multilayered rosettes,0.999991444
351B8FBC-2BCC-476C-8747-77E9F92F07EC,choroid plexus papilloma,0.999991418
ECDF6206-3B34-4F35-B117-76B2DDBD5437,embryonal tumour with multilayered rosettes,0.999991395
619CE9AE-B205-4E4D-8D2D-CB62399E9987,Spinal ependymoma,0.999991307
26502D70-A79E-45C0-8F9C-667A534A67BD,Spinal ependymoma,0.999991307
BC231D32-6A49-486E-93AA-C84ECDA2C199,Pleomorphic xanthoastrocytoma,0.999991301
2C7288E6-2094-4786-9F5A-D3AF4892C27B,Pineal parenchymal tumour of intermediate differentiation,0.999991274
34DF7418-E405-4F16-A285-19D9C4BA6D92,"glioblastoma, IDH-wildtype",0.999991211
B996FA64-E5C9-4699-B55C-5B1AF1C0F479,"glioblastoma, IDH-wildtype",0.999991211
BB298335-CEC0-433F-9300-D3157A840312,Myxopapillary ependymoma,0.999991145
E8A13BA9-26A9-4370-94D0-5F322FFA9F3F,"glioblastoma, IDH-wildtype",0.999991136
CE4D0962-E7D9-43FB-941C-EA54583DFE0F,"glioblastoma, IDH-wildtype",0.999991136
C462B384-A2AC-4B05-974D-940A856BAC2A,"glioblastoma, IDH-wildtype",0.999991136
3938BF15-96A3-4987-8C65-DAE336B2F2FE,Pituitary adenoma,0.999991129
8606801A-5213-4251-9AB2-C10151903751,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999991073
D8B348B1-0F44-4C92-90A1-41B1E9936FAB,Myxopapillary ependymoma,0.999991071
4B17DE7A-4307-4E62-95F0-69B292840F5E,Pituitary adenoma,0.999991025
0B0D2278-6BA0-4137-B86C-89A564482C45,posterior fossa ependymoma group A,0.99999097
5621650C-AB60-4998-A784-7B3B4A8413B0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999990931
BB8C79F3-47B4-4724-81E2-B4CF890E27F2,"Chordoid glioma, PRKCA-mutant",0.999990924
AB3B75FC-2D8A-432F-80BD-12A739C387CC,"Diffuse midline glioma, H3 K27-altered",0.999990891
C2B299C8-E416-435D-8AED-DA575621BE7A,"Chordoid glioma, PRKCA-mutant",0.999990855
4703E1A5-366E-412D-A003-F432F2FC8DDA,Spinal ependymoma,0.999990843
29F38471-7F32-4724-9637-2E3A2EA4E348,pilocytic astrocytoma,0.999990839
48C6373C-B391-4838-9CDB-561E9F2A3BF3,"meningioma, benign",0.999990797
37F74ADD-8E4C-4015-9D1B-62917AE59E47,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999990765
CECD53B3-8D3B-4A88-850F-45008A824F71,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999990662
9FBCA76C-B1BD-4EDF-B1E8-26C43B65123E,Pineal parenchymal tumour of intermediate differentiation,0.999990576
10DAB0DD-1DAC-4753-AF12-04EB86BC8EF4,Atypical teratoid rhabdoid tumour,0.999990558
71E47816-3633-450E-A870-F9BE25EF9D4C,Haemangioblastoma,0.999990454
7DC11D9D-3600-48AE-B00D-C35DF5BDD55B,Pituitary adenoma,0.999990411
29283CB1-7C5E-451A-B015-B8CBEE1D70D4,Spinal ependymoma,0.999990405
7E8CE463-D074-4E34-BB00-D0F040D59D32,"Sinonasal undifferentiated carcinoma, IDH2-mutant",0.999990365
792EC4B8-831B-4544-9EF3-596C06810056,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999990329
52A45C4D-9B45-4122-A2B4-79278447AE7B,posterior fossa ependymoma group A,0.999990281
BB53705C-1CF8-456C-848D-5B4E372511B9,"glioblastoma, IDH-wildtype",0.999990259
B5428475-B315-468E-A6E6-2695C2801DA8,pilocytic astrocytoma,0.999990236
4ADFD2E0-1040-4590-93F9-855CEE6C020B,Pituitary adenoma,0.999990225
34B66A22-907F-438E-AB8D-A23553020DE3,Pituitary adenoma,0.999990126
45D50D93-2D9B-4369-81E7-BF0C2FEAF622,Ewing sarcoma,0.999990116
D267AE8D-3D6A-4BF6-97ED-671F3CCFC8B9,"Astrocytoma, IDH-mutant",0.999990071
43CB970C-42FF-417E-A7A6-63DE10537652,pilocytic astrocytoma,0.999990058
44261E69-86A9-49EC-A0FE-4BFDBBE6F4FC,"Diffuse midline glioma, H3 K27-altered",0.999990015
C5D88B82-7F96-4FA1-8809-C5109F5A73BC,"meningioma, benign",0.999990013
A36C9481-5265-43E4-8AF4-1506C1B062ED,Olfactory neuroblastoma,0.999989996
C78A62C5-4F59-49C4-822C-F738E19C031C,"meningioma, intermediate",0.999989974
1DC5CBC5-F10E-4ABB-B301-5DE0D0D1068C,"glioblastoma, IDH-wildtype",0.999989837
BC71243D-E383-4F60-B0DA-8201351F7594,"glioblastoma, IDH-wildtype",0.999989837
98073B6A-D17B-463D-8D21-E9A44D412A8A,Spinal ependymoma,0.999989831
0741F2E0-ABFF-4B1F-BBBC-55E43B384132,"Astrocytoma, IDH-mutant",0.999989814
61523992-32E7-4736-92F8-F7900536E691,Atypical teratoid rhabdoid tumour,0.999989812
06C8D668-56EE-4293-9C02-546178A5C2E4,"Diffuse midline glioma, H3 K27-altered",0.999989799
7049551D-C7A3-4986-8390-6EDCD5BA3D3B,Myxopapillary ependymoma,0.999989785
287DAD9F-EAB1-4095-B5F8-6B6108CF36F4,posterior fossa ependymoma group B,0.999989723
3E589112-1F18-4F1D-8AC6-D51C756C77B7,"Diffuse midline glioma, H3 K27-altered",0.999989603
36649045-8413-49CC-8FFA-E21ABC648B08,"meningioma, malignant",0.999989573
5D5EB47C-B9F5-455C-9494-C80E7217C428,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999989552
4F239B79-9A7A-47BE-A1CF-A1837E6E1076,"meningioma, intermediate",0.999989346
8891FCD0-0AFF-4833-B187-F8CEA38D6471,"meningioma, intermediate",0.999989346
518F5EFA-0CB1-478B-B21C-E375497781E9,Spinal ependymoma,0.999989343
E3FECEC8-46A2-483A-B6E6-45FAFD4B981C,"Astrocytoma, IDH-mutant",0.999989291
199ADA39-D7C5-4C91-9785-AE70F8EB6FB7,Pituitary adenoma,0.99998929
BF74FA43-0FE0-4B40-A2F6-32D5E8CF3AFB,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999989168
3D68570E-F9EB-4D45-B593-2F4BCB5B50DB,Pituitary adenoma,0.99998906
40AE90CD-1767-4599-99E9-644CD9E8814B,"glioblastoma, IDH-wildtype",0.999988927
2416E06A-E799-44A7-9F98-C6FBDC18C202,"Diffuse midline glioma, H3 K27-altered",0.999988846
EE48F88C-9A9F-4C86-9FAA-4FE4A2EB9FA3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999988722
00A544AD-2BFF-4203-870C-A597CED7E4D3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99998861
810B1D8C-74F3-47A1-A1A2-02FC1EB17F2C,Myxopapillary ependymoma,0.999988604
E31FFB8E-963C-4390-87DA-2177A5A3D605,Pineal parenchymal tumour of intermediate differentiation,0.999988567
254D85E8-9615-425A-81F0-76ED556FC3CB,Ewing sarcoma,0.999988536
70B992AB-D5D4-4A41-8F66-FC90D23F2567,Pleomorphic xanthoastrocytoma,0.999988536
A36ACA95-C524-40B5-B1D0-280C14F34B2B,Pleomorphic xanthoastrocytoma,0.999988536
30932891-2E73-46DC-906B-CC87DDAE72A8,Pleomorphic xanthoastrocytoma,0.999988536
3202548C-24D6-44F3-8EA0-73F83DBE57D6,Pleomorphic xanthoastrocytoma,0.999988536
F1B90676-35DA-48DF-A0F4-182B1B390DC2,Olfactory neuroblastoma,0.999988472
4316A90A-9473-4901-91A0-36E38F841035,"meningioma, intermediate",0.999988466
B25D2D1E-EA74-4EA0-B4C9-167B65BD59A7,"glioblastoma, IDH-wildtype",0.999988448
B75ED4DA-714C-42AB-B455-083331292722,Melanocytoma,0.999988444
4AEB84A8-9F81-4B0F-8FE9-082D2F2AC470,"supratentorial ependymoma, ZFTA fusion-positive",0.9999883
38F6C1DD-460E-4F2E-A055-DBC3361C7BD6,Rosette-forming glioneuronal tumour,0.999988298
1E5E74BF-6110-4DBD-A99E-3652862F2F77,Rosette-forming glioneuronal tumour,0.999988298
9B5E9ED9-F47C-4452-93A0-9152D3BA96A3,"meningioma, benign",0.999988216
18D6F8E7-A375-419F-B6C1-8D8541CA2274,pilocytic astrocytoma,0.999988152
72F55C71-8BD0-42DC-A924-13DC4048BB44,Spinal ependymoma,0.999988149
A50D3B84-39A4-4CBB-9DF6-3E29D58D15CC,papillary tumour of the pineal region,0.999988079
80D8CD72-9670-443B-8528-33E809F8C583,Pleomorphic xanthoastrocytoma,0.999987903
6BCD2B4F-E57E-49BD-BCAE-46FC9C4EED99,Ewing sarcoma,0.9999879
90CD2A89-1010-4187-9732-DFBD78ECF168,posterior fossa ependymoma group A,0.999987884
75C8CA92-6C5A-4AF3-BD24-72E5C1E058BE,Pituitary adenoma,0.999987847
7BF0996B-2953-4DB0-AD69-1D43BBB045AC,pilocytic astrocytoma,0.999987725
4D976A5D-118D-49A1-B54B-89B25E523ED0,"glioblastoma, IDH-wildtype",0.999987638
5ECE342E-E4D8-48F9-AA07-235279295BA2,"Supratentorial ependymoma, YAP1-fused",0.999987559
8378D0A3-EA30-4F7D-9C51-888B8A6FCE60,"meningioma, benign",0.999987519
F255D49F-D955-41FF-B90C-6B6D7BA7064D,"glioblastoma, IDH-wildtype",0.999987464
D0AF6CE4-6E0D-42CB-9A6F-461D80A533F6,pilocytic astrocytoma,0.999987462
8777A3F5-C22D-4D81-8431-9949CD41A897,"Astrocytoma, IDH-mutant",0.999987445
3CFDBB42-1EB4-402E-B135-15908451FEC0,"Astrocytoma, IDH-mutant",0.999987437
7157BCB5-139B-45A9-A296-B833BA07C56C,"glioblastoma, IDH-wildtype",0.999987406
2F2CA548-282A-45C0-8680-8872AC369874,"Diffuse midline glioma, H3 K27-altered",0.999987386
1B586D10-BC62-43C9-85C1-0FBBA9A87AE0,"Diffuse midline glioma, H3 K27-altered",0.999987373
84CE9EED-06E8-4EDA-867F-7C1A53745767,"meningioma, benign",0.999987259
B3CDEC87-159E-4946-9D0B-1A8FB90ECB54,Pituitary adenoma,0.999987251
983C3F10-8222-4236-8ADC-9DDEE6196B1E,posterior fossa ependymoma group A,0.999987196
FDD8FD83-C5C5-45E3-AA0D-C7359B753DC9,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999987195
85325CD3-7747-447A-A6D1-6D34577AF3E2,Myxopapillary ependymoma,0.999987139
16C9FE10-C1A1-4CF9-B926-1B6BDDD44A57,"glioblastoma, IDH-wildtype",0.999987137
701A9BB2-C8C5-4924-A6C8-10F10942A663,"Astrocytoma, IDH-mutant",0.999987095
D08E4D2D-7CE7-428D-ADB0-43BC4DEE8007,posterior fossa ependymoma group A,0.999987051
065F0D4E-0CED-405E-83F7-94315A358A0B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999986982
B5A635CB-6276-47A9-8515-FC6D053D2F8A,Myxopapillary ependymoma,0.999986928
C6E0C3FA-69D1-41CF-8ABF-C49168DC9420,posterior fossa ependymoma group A,0.999986925
400798CC-5E58-416A-BA58-2F3B6FE56837,Myxopapillary ependymoma,0.999986897
414DF260-5992-45BD-A2F6-AB571B19C79F,"glioblastoma, IDH-wildtype",0.999986739
83145560-0FE0-4CEA-BDBF-A0C10D268AC8,Pituitary adenoma,0.999986638
5484697D-FCDF-47F4-8CBF-D1CA79BA1B1E,Spinal ependymoma,0.999986585
454078AF-1611-486B-8B25-8370C2A94369,"Pineoblastoma, miRNA pathway altered, group 1",0.999986545
DC9BEC4A-BDB8-4ECA-B842-9B95D40CB7DC,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999986298
5C5858A6-C30F-4EA0-97DA-B68D63D3B964,"Medulloblastoma, WNT activated",0.999986284
D1BC73EB-4339-4EA9-98D5-3C7EB8426226,Spinal ependymoma,0.999986255
46E9C805-70CF-47CC-BB00-A524D3384B1F,Pineal parenchymal tumour of intermediate differentiation,0.999986214
71182B8D-09BD-4686-8B57-5EE08CBBC040,"supratentorial ependymoma, ZFTA fusion-positive",0.999986107
D27428D7-F639-4049-8CBC-E6ED79B4B1D8,medulloblastoma Group 4,0.99998609
5699BF74-504A-480A-92D5-6FF270F6139A,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999986083
789B808B-BBA1-4091-9023-F0BAC18D7598,medulloblastoma Group 4,0.999985936
52BE2238-6732-4073-B093-B08DB794EFF2,medulloblastoma Group 4,0.999985918
9334C8DD-CE38-409F-91E0-4E575FEC01D6,"supratentorial ependymoma, ZFTA fusion-positive",0.999985817
CDA1F1B3-DA4C-4713-A285-F2892715038F,posterior fossa ependymoma group A,0.999985815
64EC1B59-C231-4CFE-8935-D83D6B20EDBB,Spinal ependymoma,0.999985739
30A0EB10-F16D-4715-8399-E60ADEC02F0B,Atypical teratoid rhabdoid tumour,0.999985677
CBB4E198-257D-49C9-B0DA-A8A27A2D6D21,Pleomorphic xanthoastrocytoma,0.999985662
E692CB21-B7A9-47D1-81F5-1CB6E9B93022,"supratentorial ependymoma, ZFTA fusion-positive",0.999985571
24856E46-EE78-4F9F-8BC8-B1E581B85970,Malignant melanotic nerve sheath tumour,0.99998557
4312347A-B1F2-4865-81E8-1BB40301D138,Olfactory neuroblastoma,0.999985529
95B5A1C2-053D-4955-B290-CA8392DEA406,medulloblastoma Group 3,0.999985528
4662CB80-6254-458D-BB7D-13FFC864F753,"Chordoid glioma, PRKCA-mutant",0.999985429
E7E9C8B1-6F25-428E-9379-E375AE01F218,"Chordoid glioma, PRKCA-mutant",0.999985429
8ACCFA2D-778D-48C5-99A4-0B2BF7B0D5C5,Spinal ependymoma,0.999985411
282282A6-28A2-4E0B-AEB9-2E92520D3317,"Astrocytoma, IDH-mutant",0.9999854
C8E57E61-2024-43DC-AA94-8878971A61F1,choroid plexus papilloma,0.999985193
59674D32-4648-4C18-AFA1-02AF85457D6C,"glioblastoma, IDH-wildtype",0.999985157
32A8E151-1917-465D-884F-98824F7A34AF,posterior fossa ependymoma group A,0.999985097
44EE9A7B-8C07-408A-9534-170BC9EC8CC4,Myxopapillary ependymoma,0.999985092
0B86F403-C968-43C8-A6C7-FB22826978AD,"meningioma, benign",0.999984953
5F56CF74-9206-449B-914B-D877BA00CF2F,Pituitary adenoma,0.999984913
21F824FB-30F6-43F5-AFA6-EBACA897A553,"Astrocytoma, IDH-mutant",0.999984906
24AEF1C6-C33F-4395-8C81-6B4425731158,"Astrocytoma, IDH-mutant",0.999984906
A179A477-754D-4CF9-8BDA-29996F808F78,"Astrocytoma, IDH-mutant",0.999984906
57812DCE-045E-4087-ABA4-25B4F3537266,"Astrocytoma, IDH-mutant",0.999984906
54E2CF40-4BBF-4AED-B56E-57790075CF86,"Astrocytoma, IDH-mutant",0.999984906
2875AF87-6D1D-44A3-A580-56DD3582A036,Myxopapillary ependymoma,0.999984871
BFC31FB1-35DB-421F-B0A3-BCDCE3E09193,Myxopapillary ependymoma,0.999984783
4ED5FB88-9370-435D-A39A-FF839C4E5D2A,Pituitary adenoma,0.999984709
FAFAE496-564E-4C9A-8E1A-1B8A1A823223,"Neuroblastoma, MYCN subtype",0.999984617
B228F6D2-0B03-405C-853D-6CB53AA05D3B,medulloblastoma Group 4,0.99998459
63564717-EA42-40E1-85AB-27E4D8F4E5D1,pilocytic astrocytoma,0.999984584
13C8C9B6-4057-4EE8-914D-B0793DC79413,medulloblastoma Group 4,0.999984582
A9850AA3-C0E5-4FC7-9E33-4583B33F8FB9,"glioblastoma, IDH-wildtype",0.999984467
4127CAA2-98DE-4F49-B5FC-6DE2E4DFAE8A,"glioblastoma, IDH-wildtype",0.999984467
234CE7A6-0AE1-4B57-999F-B8C2127DFF35,"glioblastoma, IDH-wildtype",0.999984467
81622346-F424-4E34-9197-65918C74E0C2,posterior fossa ependymoma group A,0.999984405
792E8DC0-1350-4B9A-BC07-CCE95C5F0560,Pituitary adenoma,0.999984356
EB8717C8-3DB6-400B-AD47-20D6DCC59802,"Diffuse hemispheric glioma, H3 G34-mutant",0.999984319
2BC8D9EE-EEC8-487C-9B08-B26270F7D9BE,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999984308
C71815E8-F950-401B-B305-BB50FF1D32FA,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999984295
51E399E7-38DB-40FB-8E27-E49F8D2C40A3,posterior fossa ependymoma group A,0.999984151
23B626AF-51D4-4C4F-A2EB-17671C2BF454,pilocytic astrocytoma,0.999984139
570817F8-DCAA-4900-B238-C2E8DD323969,Pituitary adenoma,0.999984097
339DB957-5748-4499-AB7C-F103FFCFF216,"glioblastoma, IDH-wildtype",0.999984096
911C2E62-A0C3-4229-910C-DDC43BC7DF9F,"glioblastoma, IDH-wildtype",0.999984007
B93F639D-3E34-4C93-9BB1-5D74A54C6175,Pleomorphic xanthoastrocytoma,0.999983946
9DC7BE79-C914-44C4-B89A-5C8442D45C86,pilocytic astrocytoma,0.999983902
21A6B0B2-DCDB-4781-81B6-2FCC3D29F4D0,"glioblastoma, IDH-wildtype",0.999983853
4CA57D11-951D-48C0-AF45-8696F806E021,Myxopapillary ependymoma,0.99998383
1AB4A352-0396-4FB0-9C9E-4EB2BD06DF48,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999983824
963368AB-C593-4F7A-B9BF-BFF6FD12FB61,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999983824
4F4D7742-47D0-4E1D-9207-BA30D0E8BE25,Pituitary adenoma,0.999983804
7FF43CFE-5602-4735-8CBF-A506F4B7C55D,Pituitary adenoma,0.999983772
BB05406B-FD69-4B40-8B2B-4897443BDBE3,posterior fossa ependymoma group A,0.999983752
1106A823-0DC0-43D4-BBE3-334E7A8A5A94,pilocytic astrocytoma,0.999983563
5B56B0FB-307B-4409-A6D1-26A42FD7041B,"Astrocytoma, IDH-mutant",0.999983526
7EFD8308-7DF0-4766-83F4-E21EA7C74DA5,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999983518
78C6C63B-A7AB-4ECB-AC47-90F0DA6B5905,medulloblastoma Group 3,0.999983429
8623A0CA-B8E7-4645-BC22-FC34C12497DC,embryonal tumour with multilayered rosettes,0.999983404
61482F85-F98A-47E4-B916-F5FE324F1D6D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999983385
46E88F9E-588E-40C3-BEBD-97AE793C8060,pilocytic astrocytoma,0.999983374
EC86FD08-C3D4-48B2-950E-11D5F8CBB298,"glioblastoma, IDH-wildtype",0.999983357
188086E0-2640-4B39-A217-B02D198C7974,Pineoblastoma,0.999983351
32229C92-E821-4EA9-99FC-061BEACCB899,Pituitary adenoma,0.999983321
8ECE04F7-2365-4156-A158-0D4E9106AE41,"glioblastoma, IDH-wildtype",0.999983266
EB7CEF35-CCC8-4EA1-BD19-D19DAEC0F1F7,Atypical teratoid rhabdoid tumour,0.999983172
1350BB40-7DCE-4132-ADAD-A6093A69DF66,"glioblastoma, IDH-wildtype",0.999983043
BEE6F2B2-2950-4A13-9BC5-26FCEEB86280,Supratentorial subependymoma,0.999982918
6250B130-E2ED-47EF-8B25-FEBABB87B9D7,High-grade astrocytoma with piloid features,0.999982779
3309ACF9-06A8-40B9-94C9-A8F4E811795B,Rhabdomyosarcoma,0.999982745
B477244B-1540-47AC-85D2-BF304A1E3169,"meningioma, benign",0.999982683
18B0920A-46AF-4171-986E-91528F8F3DF9,Myxopapillary ependymoma,0.999982615
46F014FF-A550-4BDB-AF61-ED1F5B8036C2,pilocytic astrocytoma,0.99998253
F33821D2-78C5-4253-94C6-12F25C088517,"glioblastoma, IDH-wildtype",0.999982455
47C1272C-BF48-4603-9FFD-99F2D0981A9D,"glioblastoma, IDH-wildtype",0.999982455
BB6E2DA8-CB40-451D-9FE0-F6D012264C53,"glioblastoma, IDH-wildtype",0.999982455
66389B38-594C-4091-80D8-24A2192A229F,"Astrocytoma, IDH-mutant",0.999982452
1161E9EE-67DF-43D4-A174-C7BC77F8D07F,"Astrocytoma, IDH-mutant",0.999982373
5FB88916-A42B-4D28-B9E4-6768BDAE9C4F,"Medulloblastoma, WNT activated",0.999982293
D03DE24E-07A8-4189-8720-E76B7C7CC32A,pilocytic astrocytoma,0.99998228
E47E0C80-EF9E-4AD9-A606-A240F5160D5A,Malignant melanotic nerve sheath tumour,0.99998215
358C54E7-0D78-46E6-A583-D7DF459D007F,embryonal tumour with multilayered rosettes,0.999981938
47EE368F-BA66-4113-9B0A-836486C3A8EB,Pituitary adenoma,0.999981729
F5363CC4-50FC-44A5-BB2F-34A0C1E27E78,Pituitary adenoma,0.999981635
663DBB1F-FA75-40B4-8028-E9BC55491571,"glioblastoma, IDH-wildtype",0.999981627
2824D1EF-337A-442F-A32F-1C9030C808B3,"glioblastoma, IDH-wildtype",0.99998161
EFF09F2E-9BE3-448F-9EE4-399D456D3AB9,"glioblastoma, IDH-wildtype",0.99998161
BEAC71ED-35BF-43AA-A532-8754CDCD5078,Chordoma,0.999981601
F60A77A8-0229-4678-BD6C-5053E03A26BE,Myxopapillary ependymoma,0.9999816
C9F5C836-BBB8-4F0F-9E6C-B5783559E304,Myxopapillary ependymoma,0.999981558
602B2D49-A5C1-41BF-9406-05DBF5A4B5E9,Myxopapillary ependymoma,0.999981551
BC05F203-40CF-4BED-9887-5DD059AD4AD9,Pituitary adenoma,0.999981493
F79023D5-BAD3-48F0-93DD-FE70E75D6599,"glioblastoma, IDH-wildtype",0.999981397
DCA44390-62B2-4770-A294-AB93F3EDE613,"meningioma, intermediate",0.999981363
5B2E7D73-C552-4DC2-96EA-B2188AD28816,"glioblastoma, IDH-wildtype",0.999981313
3F4FB292-61E9-4A10-B7C6-8594809FD403,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
4C65272E-17FA-4B9C-89C9-97F1BDF37319,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
2E4FE25B-7D2C-44A0-A680-3192C7785E16,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
3FF4690D-F101-48CE-B37A-A19019692631,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
CE52906C-F6A6-428E-A646-B3B3EE5311F0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
65132557-2F3E-4C48-9AEA-5AFAF1288781,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
BF6CB35E-100A-4D1C-808D-E900EC19470D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
B046D443-6E90-4F7D-9C07-021238156DE4,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999981265
7E3139E2-F8A2-413E-A82B-03E5B6B469B9,posterior fossa ependymoma group A,0.999981125
9A9A61E1-B78B-426F-A704-B917B4C7476B,posterior fossa ependymoma group A,0.999981125
4FD6593F-3AAA-42A9-AD98-367749EBE5C2,Diffuse paediatric-type high grade glioma,0.999981118
340CE85E-D871-4148-93CF-58AD146A0F8D,"glioblastoma, IDH-wildtype",0.999981112
6E8EFFE0-ECF4-4ED2-8B99-52CC163D5DFD,"glioblastoma, IDH-wildtype",0.999981112
3518A7A3-E1C4-43BE-930A-2BB5F641BF24,"Chordoid glioma, PRKCA-mutant",0.9999811
9860DE2E-94AE-4427-BD29-CEB4CFC43A02,"supratentorial ependymoma, ZFTA fusion-positive",0.999980992
F17764F3-14E4-4007-83F1-D27B4EF2E918,medulloblastoma Group 4,0.999980907
A6FBF328-693D-4439-8196-FE994F291BAC,control tissue,0.999980845
60C31FB5-DC2D-4134-AC0B-F6BBDBDC13FC,"glioblastoma, IDH-wildtype",0.999980754
85F97970-5F9D-4CD2-B1BF-64FD4D1A877E,pilocytic astrocytoma,0.99998072
219A2243-A98B-478F-B527-AA2EBA24DD90,"supratentorial ependymoma, ZFTA fusion-positive",0.999980719
BB95169A-878B-404A-A67E-A76E1B471757,"supratentorial ependymoma, ZFTA fusion-positive",0.999980719
C9115353-288A-4F8D-9D86-7B905FCBDD38,"supratentorial ependymoma, ZFTA fusion-positive",0.999980719
3A922DD1-2D18-455F-9317-FAF573A565E2,Myxopapillary ependymoma,0.999980681
BBADC845-809F-4982-BD76-D1F8135AA282,"glioblastoma, IDH-wildtype",0.999980643
FF9F2193-AE72-4167-92EC-D968D2969EF2,"Diffuse midline glioma, H3 K27-altered",0.999980625
24B499A9-530A-4E05-8173-F57DA2C368A3,"Astrocytoma, IDH-mutant",0.999980559
07794C1B-11CD-48A8-9BAE-61FD9FDA6197,Posterior fossa subependymoma,0.999980552
1AB545AA-3B12-4BD5-B64E-ADF75279EE5E,"Diffuse midline glioma, H3 K27-altered",0.999980543
F27F52D1-D327-4D2E-8101-AF58C2D4AE84,Atypical teratoid rhabdoid tumour,0.999980498
6CB27FBD-CE29-4B6C-9FD4-5B45E9574757,medulloblastoma Group 4,0.999980459
DC0A8F66-A5DF-4023-B233-9B8644F9A418,"glioblastoma, IDH-wildtype",0.999980394
20A199A7-2FB3-4175-8FCB-6A43B7985F43,Infant-type hemispheric glioma,0.999980253
1357808C-A62B-40B1-83ED-F1EB5BBC7359,embryonal tumour with multilayered rosettes,0.999980106
2777A8DC-74A5-4A41-A9F6-D50D08540D2F,embryonal tumour with multilayered rosettes,0.999980025
343A3E14-9B8F-4BA1-857E-E6B558D9F974,embryonal tumour with multilayered rosettes,0.999980025
23D087F8-9036-4402-9711-6274BF3D8F91,embryonal tumour with multilayered rosettes,0.999980025
85EE2850-39ED-4B68-9158-BD29349473CF,"glioblastoma, IDH-wildtype",0.999979995
3948B6D2-F188-4987-A66D-FE15AC22CD56,"Chordoid glioma, PRKCA-mutant",0.999979947
E6BE4CBC-A467-467A-A6D9-DE08C9CE20FD,"glioblastoma, IDH-wildtype",0.999979864
CE7E966E-187D-4E77-9EE5-02B9592113BB,"glioblastoma, IDH-wildtype",0.999979715
6B68BD7F-0D78-4335-8637-A473952B804B,Myxopapillary ependymoma,0.999979708
EDA20B63-214D-48AF-86EB-CFCFEF8704D9,"Pineoblastoma, miRNA pathway altered, group 1",0.999979684
8D11420F-6166-4CAF-9D8E-504A1280F12F,"Pineoblastoma, miRNA pathway altered, group 1",0.999979684
8DBDA831-126F-44E3-9343-0C9F54029EB8,Atypical teratoid rhabdoid tumour,0.999979684
40CB58D8-F22A-4E1E-A471-463E0BF09AF6,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999979497
23F7CACD-8ABF-4474-9CC2-DAAA9C7D0864,Myxopapillary ependymoma,0.999979467
1E7BD017-2457-40CE-B149-777539E4D391,"glioblastoma, IDH-wildtype",0.999979366
21FA7CE5-90FA-4CF4-B570-7D1A0DDF867B,Pineoblastoma,0.999979189
8B768925-6F1B-42D8-9C9E-2138690FCD33,"Supratentorial ependymoma, YAP1-fused",0.999979181
7FFA5AC2-F30C-4F7E-B3F6-1246C4FB9412,"glioblastoma, IDH-wildtype",0.999979179
F9D16A41-9672-4745-8B2E-6234A48760B8,"meningioma, benign",0.99997911
7E1F9139-641A-4636-8A7B-71AA61025FAD,Melanocytoma,0.999979098
530C87D0-6896-41C8-AD68-9A1C18EF0DAA,Diffuse paediatric-type high grade glioma,0.999979064
027B3044-7CCD-470E-88F6-0E009115261A,Myxopapillary ependymoma,0.999979064
02F952E2-BF8E-4525-A98F-9E36B05F683D,Germinoma,0.999978858
A9F696B3-935D-4188-96A5-0C20AD756BE6,"Astrocytoma, IDH-mutant",0.999978825
48AA2EEA-881F-4E3B-B5EC-DEBB6F4051AF,Pituitary adenoma,0.999978819
B56DEA7A-9865-4F58-8D52-B8EA22F4D6A2,"glioblastoma, IDH-wildtype",0.999978784
56FDD02D-F14A-46C5-8420-477CB341B77C,"Astrocytoma, IDH-mutant",0.999978756
12F08E47-A2DC-4C89-9F59-B2050B5AD98C,"glioblastoma, IDH-wildtype",0.999978666
107F2689-9489-476C-B2FE-C320090B17FC,"glioblastoma, IDH-wildtype",0.999978666
ED8AE306-03AF-4195-8E21-E06E16EBAF7A,Spinal ependymoma,0.999978556
65C446BB-413A-480F-AA79-8254CD67104A,"glioblastoma, IDH-wildtype",0.999978359
4BFE03EF-976C-4325-A496-3A9951E72A41,"Medulloblastoma, WNT activated",0.999978317
471C5633-487F-488C-ACFE-1EF6CD8235D0,Diffuse paediatric-type high grade glioma,0.999978296
77407B1F-0095-4478-B2EF-921DA770871D,"glioblastoma, IDH-wildtype",0.999978187
EC3FCB15-8849-4C90-B1AE-28F351BD13F4,"glioblastoma, IDH-wildtype",0.999978008
5C4186D0-B741-406E-9875-EFB6B6CACDA7,medulloblastoma Group 3,0.999978003
337E875A-3F83-416A-8E1A-EA1479EA273A,posterior fossa ependymoma group A,0.999977926
AB3D4FFD-C253-42F5-BA1B-50459087C4C1,pilocytic astrocytoma,0.999977915
0428CD22-8AA5-4C42-B5BA-2911614DB65A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999977836
BCEBE5E3-E482-4E27-82FD-A2FFF12F5C84,"Medulloblastoma, WNT activated",0.999977816
23A0EC0F-9AFD-460A-AA26-08EECB334BC5,Pituitary adenoma,0.999977774
701B10B0-C937-4CD7-9E38-12E2EA2821BC,posterior fossa ependymoma group A,0.999977767
C62004C2-14FA-417F-8990-808F49594561,control tissue,0.999977733
8C7AA95E-5FD2-437C-9337-16B7D78516C0,Diffuse paediatric-type high grade glioma,0.999977667
9B3BD741-37C3-4C4C-82D4-8609E99E8A2C,"meningioma, benign",0.99997761
E0DDE613-9A44-4661-A03A-CF5CD8376858,"meningioma, benign",0.99997761
F34A5768-6B05-4D04-923C-38E841DD0723,"meningioma, benign",0.99997761
D7A3FCA3-3C6F-4016-B2B5-7AF44921FB11,Ganglioglioma,0.99997748
0C45E74C-4A08-45A4-B544-84B1D96FC43B,"glioblastoma, IDH-wildtype",0.999977458
B8767551-4119-4EE0-AB64-3B9768B9E400,"meningioma, benign",0.999977432
4038AF9C-537A-4B52-8149-F37BCC218556,High-grade astrocytoma with piloid features,0.999977351
794CFC85-6AB7-4C69-90EF-5EFE080460DE,High-grade astrocytoma with piloid features,0.999977351
BE31416A-E7F2-4BAD-9E19-E0314F3B438B,High-grade astrocytoma with piloid features,0.999977351
8C75344D-577A-4121-87CA-1E0F4F53D333,Diffuse leptomeningeal glioneuronal tumour,0.999977319
AC8D4EA4-B84A-4D48-A858-EBD25D283E5C,"Chordoid glioma, PRKCA-mutant",0.999977308
B90F9481-5770-4B18-B73F-4172E5685B59,"glioblastoma, IDH-wildtype",0.999977293
C5F5FCF0-5057-4E3A-BA2C-23DE6C82EDB2,"Astrocytoma, IDH-mutant",0.999977229
DCAFB273-E959-49CE-BA5C-B8850EB820F5,"meningioma, benign",0.999977174
7B8AD5AF-CD15-481D-A505-C2DF3A56DF84,Solitary fibrous tumour / haemangiopericytoma,0.999977171
BA127E48-E4C9-46F1-8439-7DB0A7CC7806,"meningioma, benign",0.999977153
440203FC-57E1-46E4-A866-897884F5A71D,"Diffuse midline glioma, H3 K27-altered",0.999976888
C8C2CB66-BD20-4AFD-8019-F1D15D15C922,Rosette-forming glioneuronal tumour,0.999976808
FB5B320A-3E40-4697-A305-8FCA2AA292EF,Spinal ependymoma,0.999976713
7DEA9967-6099-4C8A-86A6-669B85D778DE,Pineal parenchymal tumour of intermediate differentiation,0.999976693
8084DB7E-B2CC-40EE-B82D-96BAC0432174,"Astrocytoma, IDH-mutant",0.99997666
787EAF74-7897-478D-90C5-ECBA9EDA330B,Rhabdomyosarcoma,0.999976635
D3A408A1-69B3-4C3F-86C1-ED8825073DDD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999976533
D067D36B-6AB3-454D-8519-795368BFAD0A,Haemangioblastoma,0.999976181
F3513078-CAAB-458A-BCC1-18D74D3E1489,Myxopapillary ependymoma,0.999975819
83FE69F8-505B-4A61-8D81-EEE62C6EEB60,"supratentorial ependymoma, ZFTA fusion-positive",0.999975666
E2FF1370-342C-4DC9-9EB2-1C6325A10D61,"glioblastoma, IDH-wildtype",0.999975541
5EBA0CA1-F1E4-4296-B9B3-7B5FA6B10690,"supratentorial ependymoma, ZFTA fusion-positive",0.999975517
25AADCE7-8E02-4695-8328-AF3D6F22BB58,Pituitary adenoma,0.999975479
4CF17FB8-8CC7-49FB-A695-4958B64FBAB3,"Astrocytoma, IDH-mutant",0.999975403
6A226F2C-E514-4344-ABB6-1DC40FF297BA,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999975397
4E704E8A-14BB-498C-A40D-9E7FC35DA974,Myxopapillary ependymoma,0.999975338
B99FBA27-0B35-45DF-84E5-83E289E47A26,Myxopapillary ependymoma,0.999975291
20E5A649-B4CD-468F-B15C-7361C933EEA7,Subependymal giant cell astrocytoma,0.99997524
D85BC099-32F2-415E-9BB3-B0D8C19F55BB,medulloblastoma Group 4,0.999975079
6E77C2E9-8B53-4FBB-B160-A2DCC0CE57BD,"glioblastoma, IDH-wildtype",0.999975032
179391AA-F0D6-41D2-966A-280217A7548D,"meningioma, intermediate",0.999974938
99DFB419-BD9A-4EEC-A39C-4199E29688FD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99997455
03EAD9F5-5EBA-4E61-949A-81E74D2C6573,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99997455
6378530D-379A-4CD8-B114-C5DE64549C61,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999974407
6DF1F0DD-79A0-48A1-85FD-6D73DEBF8851,Melanoma [metastatic],0.999974318
297583D9-95F1-471F-9DC7-E068EE41044E,pilocytic astrocytoma,0.999974279
006FB650-68AF-4725-B8B6-C37F117D81D9,Chordoma,0.999974181
D5B3A0E1-4FC8-4E45-9924-1063CF21AD2D,Pituitary adenoma,0.999974034
0C403BAC-2FAF-4379-8D69-DDD8B0C2BF43,"meningioma, benign",0.999973892
63224506-23C1-4940-AAC2-634CD137C0D9,"glioblastoma, IDH-wildtype",0.99997382
20AEA744-DBC2-45A3-8875-071158B3C3CC,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999973723
D2416289-7A96-480F-83A7-36F3F8E2DE04,medulloblastoma Group 4,0.999973669
23A0F7A6-0778-46AF-A7D2-6D932A7A747D,pilocytic astrocytoma,0.99997365
0F6995DD-9D6D-4950-927A-6C025A1742C3,Pineoblastoma,0.999973571
6B62FE67-C584-40FC-B10B-5281E7FEC3CB,Pineoblastoma,0.999973571
B75616E0-8C3D-42EF-922D-1B1E52DAD033,Pineoblastoma,0.999973571
39312116-F988-4019-9E19-8DC777C8292A,Pineoblastoma,0.999973571
863FFDFA-001A-46ED-90AB-890B238AAE9A,Pituitary adenoma,0.99997354
FDCB13F4-7779-4AD8-86D6-7D40083E9953,Myxopapillary ependymoma,0.999973492
83CC75C7-4A5D-4740-9E5F-07FE806A4A42,Ganglioglioma,0.999973197
AC5395D3-AD97-4A41-BA89-6323559283A1,medulloblastoma Group 4,0.999973174
092EDC6E-B431-4029-B633-A841527A2C53,"glioblastoma, IDH-wildtype",0.999973067
6D3E4F40-7724-47D1-9525-0AF2A25805D0,"glioblastoma, IDH-wildtype",0.999973067
405E6808-E606-4E98-B80B-2F5E64EAFD41,"glioblastoma, IDH-wildtype",0.999973067
C4264B87-BE66-4B7C-A596-F45F962E6ED4,"glioblastoma, IDH-wildtype",0.999973067
1993251C-C8CA-4F22-B2F1-709BCC2EB86E,Melanocytoma,0.999972908
F370B380-320B-487B-8DD7-5B983AE8F774,Melanocytoma,0.999972908
58C7F724-651E-48FA-B50C-EE03DF529306,"Medulloblastoma, WNT activated",0.999972842
8662E871-5C25-4777-8145-521C6BB10FA1,"Diffuse midline glioma, H3 K27-altered",0.999972778
33166787-098C-467C-AB18-15B21D004949,"glioblastoma, IDH-wildtype",0.9999727
F9734DE7-D752-40A7-86D4-3E838BDC2753,medulloblastoma Group 4,0.999972518
A9A5C792-C94E-4CFD-ABE9-81FAC256415D,Haemangioblastoma,0.999972416
BF12EDA6-8CB1-465A-9A4B-33251FEE20CC,Pituitary adenoma,0.999972409
D4EAA20B-21E2-4EAE-9A98-EE97C9F9BAE0,"glioblastoma, IDH-wildtype",0.999972385
7B4417B5-CDD3-4BC0-9D82-3EF633182CBB,"meningioma, benign",0.999972346
78DEFCBA-5AE2-496C-B078-3C73D69A14C7,Pituitary adenoma,0.99997234
76EFE88A-0865-48BD-83A4-77539B4F9193,"glioblastoma, IDH-wildtype",0.999972302
0683C0B0-95EB-4A17-954C-890A73B06DB0,medulloblastoma Group 3,0.999972293
27D52756-ACA3-4F25-88FB-0C429781ABB0,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.999972211
A3E84CB2-04B8-4B45-A3C4-871223E4D0B2,"Chordoid glioma, PRKCA-mutant",0.99997213
32E7E02A-7DB7-417F-AC9C-1A49D2C1E72A,"meningioma, benign",0.999972108
544920E4-FD69-4991-B072-AC8D18941BA5,Diffuse paediatric-type high grade glioma,0.999971863
99326F43-F482-440F-AF35-EB89C46A5628,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999971695
AC11A0CB-DDAA-471F-AB56-EC1C18733D33,Atypical teratoid rhabdoid tumour,0.999971675
5C26A472-3145-40CE-AAEA-8E5D3195D5EA,medulloblastoma Group 4,0.999971628
F41EA68D-3334-4259-995A-50A9B7306289,"Diffuse midline glioma, H3 K27-altered",0.999971607
48F4DA09-C8DA-43D2-8A85-82DF65E36048,"glioblastoma, IDH-wildtype",0.999971566
74628E0C-F89B-4FEE-817D-0519A5304238,Myxopapillary ependymoma,0.999971312
AE2229BD-93A9-4DAE-90C9-09343404DBE1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999971167
B69C1475-5B7B-4351-ACC2-5B87FCB31497,embryonal tumour with multilayered rosettes,0.999971014
EC6E9BAB-18F8-466D-B81E-B16FE60D8BCA,Myxopapillary ependymoma,0.999970962
3786FC26-A0C2-4E19-AB54-0E62A92C0FD7,"Astrocytoma, IDH-mutant",0.999970345
4C0A1984-0791-4D93-AAA0-01E02CDF0ED6,Pituitary adenoma,0.999970163
961C47C0-776B-4684-A4C3-6BDD3F9E187C,posterior fossa ependymoma group A,0.999969919
5D83A6B3-4307-4EFF-B6F3-7A56641EDAB6,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999969811
4B3ABA6E-76F6-450B-AE8D-37D0E29A727F,posterior fossa ependymoma group A,0.99996975
6E2C5044-7939-4AA2-8156-6497BCCEEE08,Myxopapillary ependymoma,0.999969678
8199F1A8-E24F-4211-B80E-EEF9DABFB28F,"meningioma, intermediate",0.99996964
5CAD99FA-1692-4A72-978B-DD6F68854339,"Diffuse midline glioma, H3 K27-altered",0.999969582
CC4A1A65-77FA-47B5-9D78-8FDA9A72650A,Olfactory neuroblastoma,0.999969415
AC421646-06E8-405F-AAE4-6E0BD4807320,"glioblastoma, IDH-wildtype",0.999969377
36FCD148-A405-4310-B172-63071710187B,embryonal tumour with multilayered rosettes,0.999969209
8CC05448-1E59-4D5B-B0EB-2FDB5EB42FB5,"glioblastoma, IDH-wildtype",0.999969037
BED2AA3B-1ADB-4F25-978E-5A29169076EC,"glioblastoma, IDH-wildtype",0.999969037
9CF77FEC-E345-4BDC-8C31-8925BA86DF81,"glioblastoma, IDH-wildtype",0.999969037
6A1B2705-DAC5-4C4F-94AC-261BEAD9A53B,choroid plexus papilloma,0.999969008
F89CA6F2-B40A-40BB-819C-B1509FC87895,Posterior fossa subependymoma,0.999968979
884762F9-10F7-481A-8E1A-6767EB23C450,Pituitary adenoma,0.999968919
232531B8-9177-43DE-80BA-3D0262124A72,Myxopapillary ependymoma,0.999968837
90735061-3E4E-4CEB-8A04-CE50C1940E18,Myxopapillary ependymoma,0.999968837
60373171-5F8F-44AD-ABDA-A18F61C95559,pilocytic astrocytoma,0.999968831
C98AA59E-AA34-433A-9DF7-1480F3227E0F,pilocytic astrocytoma,0.9999688
BC7D8B19-6C38-48DE-B110-0F47FB8F12F0,pilocytic astrocytoma,0.9999688
CC3E9F32-48C3-4D92-8582-FBD581966273,pilocytic astrocytoma,0.9999688
73AD2844-C8A2-4905-B087-17A3ECC8AB3B,pilocytic astrocytoma,0.9999688
DAAB6541-00DC-446B-91CC-80F38452686E,pilocytic astrocytoma,0.9999688
4366FE19-6CB2-44CC-8216-4D0FCF4B6A7F,spinal subependymoma,0.99996879
5BE6BC33-5310-4A98-BA91-12EB8AA0890D,Pituitary adenoma,0.999968415
9F027DE3-198D-4796-A034-01DA8A97446B,Haemangioblastoma,0.999968303
90857C8A-DBA1-441A-A062-88957AA2BFA2,"supratentorial ependymoma, ZFTA fusion-positive",0.999968285
66892F6F-49FD-4DB2-A0D8-B8D96994F435,Pleomorphic xanthoastrocytoma,0.999968211
CE692FB7-B84C-4CCC-B521-06FE4E41D3F5,Pleomorphic xanthoastrocytoma,0.999968211
D5F15F81-3C9F-4EC7-B0C4-D24CE2E34840,"Astrocytoma, IDH-mutant",0.999967897
23F55634-96A4-4326-9DCC-B51F8195C6AE,"meningioma, benign",0.99996787
53D112EE-937E-4AA4-A091-B15728767D27,"meningioma, benign",0.99996787
3311D821-DE30-4E2B-9FE8-87187AC0B5F5,control tissue,0.999967757
7E8A54A1-F6CA-4C38-8937-22689D7DFF2F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999967719
7F2876C3-57A6-49B7-9C2C-E8C8890BFEA1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999967719
DA9B1965-22BC-405A-8D8E-7959C7807CCC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999967719
50CA7F17-3EC4-4D5E-ACD3-C1422920D84C,"glioblastoma, IDH-wildtype",0.999967527
8A458906-4035-4B1F-BC89-C9E7206B464A,Olfactory neuroblastoma,0.999967506
1CCFCBA8-F4B4-4952-8EB2-D53DF5105B38,"meningioma, benign",0.999966889
FFC68E4A-6119-4048-A687-8F87643BA7B5,embryonal tumour with multilayered rosettes,0.999966876
2664C983-9403-43FF-89DC-E9177C723A5F,"glioblastoma, IDH-wildtype",0.999966856
0071913C-062F-4DF6-8EBA-39A5E8250430,Atypical teratoid rhabdoid tumour,0.999966819
B7138E55-E875-45C1-9941-32958CC87ABE,Atypical teratoid rhabdoid tumour,0.999966634
C8AEC43A-B90E-4C18-A01D-5042E8C39C3F,medulloblastoma Group 4,0.999966418
4B3D7406-09CD-4C18-A66B-D33267E97339,medulloblastoma Group 3,0.999966402
0338F7F5-9315-4FE0-88AD-BAFE8DBC98DA,"medulloblastoma, SHH-activated",0.999966301
F4E2EABE-E401-41F3-8CC6-D7194B139707,"Spinal ependymoma, MYCN-amplified",0.999966255
DFE24D7C-67C2-426D-984E-11D87ADF8DAA,Diffuse paediatric-type high grade glioma,0.999966104
0ECE75BE-DA66-477B-A7FD-C43A56F21EF3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999966089
DA034F17-C4DB-462D-ABF8-076F500C93FA,"meningioma, intermediate",0.999966071
43132217-5BCC-486C-AFA0-7B08EB582066,"Diffuse midline glioma, H3 K27-altered",0.999965957
735084B2-4E3E-411C-AB3B-86AD0FB5DAD6,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999965673
607C6943-9AEB-4DFB-B029-7AEA822D9C21,"supratentorial ependymoma, ZFTA fusion-positive",0.999965617
29AF536F-B983-41F5-AE07-D2DA66A6C2B2,posterior fossa ependymoma group A,0.999965493
84B84D8A-3900-4EEE-954D-3215DCDC86F0,pilocytic astrocytoma,0.99996546
4F1D8A19-DB26-406E-A61B-2D481B7380DB,"meningioma, intermediate",0.999965458
11697BDA-63E2-4E91-988D-799EE2EEE55C,Posterior fossa subependymoma,0.999965188
638293F3-D109-458E-9873-9859CA49A426,Posterior fossa subependymoma,0.999965188
1EF68F2B-2FEB-499F-A609-327AA63A574A,pilocytic astrocytoma,0.999965096
79FBBCDF-061B-414F-B8B3-A3D7270AF5BA,Myxopapillary ependymoma,0.999965051
049207AA-0F55-41B0-83B7-08A693C2913D,"medulloblastoma, SHH-activated",0.999965006
9907FC9C-3ED8-4741-B0DC-CC64A88DAF8D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999964928
L9,Liponeurocytoma,0.999964344
250D92C9-5F64-4FA7-8107-9B9173C80F2D,"glioblastoma, IDH-wildtype",0.999964286
D9FDD78E-BD53-4D41-8716-B028D7FE195E,"supratentorial ependymoma, ZFTA fusion-positive",0.999964222
L8,Liponeurocytoma,0.999964041
54DFF877-FC01-4421-B076-09BA5DDD2F81,Olfactory neuroblastoma,0.999964015
5F01C194-C8F2-4AAE-A079-73170FE6100C,Pleomorphic xanthoastrocytoma,0.999963955
990A58BD-A81A-4BBC-8152-581780B03BDC,"meningioma, benign",0.999963851
EB9760FB-6CE7-42C1-82D3-7AF243821979,posterior fossa ependymoma group B,0.999963724
F1C8AF73-1AE9-4A48-873C-BE6CCF2CDC20,papillary tumour of the pineal region,0.999963626
71997F78-80B4-4A25-9D47-BA7D8E636CE3,Myxopapillary ependymoma,0.999963595
D207A814-6B78-426E-ADAD-7A836A995E79,posterior fossa ependymoma group A,0.999963142
DD2E5844-8C76-437E-8AF4-CD2913DB3F5E,Spinal ependymoma,0.999963135
E4D9311A-29C2-4924-8B27-2D033D1892CC,Pituitary adenoma,0.999963075
5D93AD24-66AE-43D8-865D-3BC11400543C,embryonal tumour with multilayered rosettes,0.999962989
E300126F-6892-4DCF-BC96-0BE4153D24F0,embryonal tumour with multilayered rosettes,0.999962957
A6553430-4B47-4E55-B298-B8B8F0E1DA42,Pituitary adenoma,0.999962942
A4A4C730-F86F-4F71-A666-2C841743B6B5,"Astrocytoma, IDH-mutant",0.999962608
83140647-1B55-4192-9BFB-D18762B5B2B8,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999962311
3607F2DA-B54C-4B08-A79E-BFAE406FC8BF,"supratentorial ependymoma, ZFTA fusion-positive",0.999962241
56887EB7-97FB-45E3-A72C-8A536541395D,medulloblastoma Group 3,0.999962235
4EF92503-501C-49FF-B4EF-51FD5ADEDBCE,Pineoblastoma,0.999962216
6062B591-1CD1-4519-8503-B00AC43ADB74,papillary tumour of the pineal region,0.999962201
EBA58000-2BBE-4393-A8A0-21AF52832B50,"medulloblastoma, SHH-activated",0.999961922
E32E89DF-4B72-4A5A-8F25-F4B5BAFB1418,"Astrocytoma, IDH-mutant",0.999961697
A97B88E6-AAB1-48FB-A730-0A1E0F488A62,pilocytic astrocytoma,0.999961588
570D07E2-03E2-4CF6-AD7E-F0479FF1EC4F,"medulloblastoma, SHH-activated",0.999961332
4C9B8256-0B3D-4B34-9490-BE633EA7C931,Melanocytoma,0.999961161
3F82877C-EE55-4014-8F73-ACD5A92C4A92,"glioblastoma, IDH-wildtype",0.999961071
AF606271-9688-431B-9BF6-BC59F8737E25,"glioblastoma, IDH-wildtype",0.999960962
D5A1B4D1-B526-477E-BEBA-D0CFC396DC41,"glioblastoma, IDH-wildtype",0.999960962
69726962-5295-49B8-9085-188C02FEAB49,"Astrocytoma, IDH-mutant",0.999960822
9878DED5-AB43-4EA0-B18F-A5BA42F1FC28,"Astrocytoma, IDH-mutant",0.999960822
6BB79111-7A54-4B7F-BA73-0BEF94511059,"Astrocytoma, IDH-mutant",0.999960822
C957599B-4144-4113-BC02-63D950C19FAE,"Astrocytoma, IDH-mutant",0.999960822
F1E60F23-7C15-4FEE-8975-B68043EC50F9,"Astrocytoma, IDH-mutant",0.999960822
EC49846F-9B75-4F70-A74B-E09DEA59A112,"Astrocytoma, IDH-mutant",0.999960822
96A199E8-908A-41CC-90B9-9B78C173AF2A,"Astrocytoma, IDH-mutant",0.999960822
8EF5D8D0-3A8B-4697-896D-5736D80F4DB4,"Astrocytoma, IDH-mutant",0.999960822
312E5443-EE7C-4359-BC14-5D6E32FBE6D4,medulloblastoma Group 4,0.999960692
E21527DE-AFC7-4B57-8C5B-770C2352E583,"glioblastoma, IDH-wildtype",0.999960476
22C9DED8-E224-4895-A02D-128FAB6F630E,Subependymal giant cell astrocytoma,0.999960475
4FC8EDC0-AD67-4D17-A699-E498693CBEE8,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9999603
13984537-C2DE-4652-828D-0E1D84AA33D3,Melanocytoma,0.999960096
5E3F9D04-237D-4433-B88F-400E680F4C0F,Haemangioblastoma,0.999960083
9CE4085E-9FD7-471A-9928-986584D249B4,Myxopapillary ependymoma,0.999960051
24DDCED2-B823-4E14-8F3A-4B2A0BCE9108,"Medulloblastoma, WNT activated",0.999959925
766DFED7-8A33-48FF-A3A1-550FA05638B3,Pituitary adenoma,0.999959807
EB16D080-B321-4274-865D-E13105F0848A,embryonal tumour with multilayered rosettes,0.999959792
546EDFB4-FACE-417D-9FB1-AFA9C8677F19,"meningioma, benign",0.999959582
08EF0F2B-5C9C-4A8F-8605-E9FCE4AB3BAE,"meningioma, benign",0.999959582
669A7385-0F39-4FA0-A056-53799FDDF7DA,Myxopapillary ependymoma,0.999959494
A6D8B515-61C9-486C-9E2B-62A41DE0BE6B,Pituitary adenoma,0.999959302
95834AB2-DBBC-461C-9DD4-880A311E7AD1,medulloblastoma Group 3,0.999959169
CB72FAD3-B0F7-4373-884C-051CE6410D7E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999958792
D134AB2C-32B0-4CB5-BAA2-D8D0E899D70F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999958792
93116D01-FF23-406D-9715-E650A4C555A6,Pleomorphic xanthoastrocytoma,0.999958294
0D76A77A-FED7-41F5-AA23-7AF26CFB3DFE,posterior fossa ependymoma group A,0.99995826
7DDC2317-29D2-42C0-9ECD-8625343B8C6E,"glioblastoma, IDH-wildtype",0.999958144
2EB868D6-62B0-4C85-B2A9-DBEAA6333DAD,"glioblastoma, IDH-wildtype",0.999958103
42E73F80-0D7A-4619-A21A-DE802828D8D5,Ewing sarcoma,0.999957796
855640BA-29F3-4785-9AA8-2090E9C8902E,"glioblastoma, IDH-wildtype",0.999957761
9EA9528F-4509-4EC0-A6F9-0C16D7AA7DB4,"glioblastoma, IDH-wildtype",0.999957567
9FB1EA2E-654D-44A3-8306-392E67EFAD4D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999957457
457A4528-0E43-4979-B7AA-A4458A531316,"Astrocytoma, IDH-mutant",0.999957366
D73A8825-BAB5-415B-847D-5CC1EDC7649D,"medulloblastoma, SHH-activated",0.999957354
675E6FFD-5DCC-42DB-9DB3-D72207F3AE92,"meningioma, intermediate",0.999957268
DFF72AC6-5932-43BD-9E27-46A7C74454D7,"Astrocytoma, IDH-mutant",0.999957235
BB6F930C-DDE0-45A9-9A05-24668F6FFA91,Myxopapillary ependymoma,0.999957118
0C529B41-3AFE-412C-9EF9-8248D45C81A2,"glioblastoma, IDH-wildtype",0.999957079
695F0E3E-7922-42F6-9F29-FA19FADD81BE,"glioblastoma, IDH-wildtype",0.999957064
EEB4BCB7-ED4B-4969-8555-86BE6400AC13,Pituitary adenoma,0.999956963
F3748C7B-E0C7-43D2-8E9B-0B41AD6BCBBB,pilocytic astrocytoma,0.999956922
FE7314B7-0108-4C48-B19F-E6DA7A07B02B,"Astrocytoma, IDH-mutant",0.999956907
83E068B9-D08B-49B8-AB8C-1A2FE7641E76,"Diffuse midline glioma, H3 K27-altered",0.999956783
2FC7A5D6-B1D4-436C-8ADC-0A7D9F29907C,"Astrocytoma, IDH-mutant",0.999956751
DD187AA0-7D4B-40B9-9AD6-68974F6005E1,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999956378
F0E326B6-1C73-4268-B8F6-13FFC64B9148,Ewing sarcoma,0.99995628
2C558192-64A3-4DD3-AF17-4EFD71B6CCB9,Spinal ependymoma,0.999956202
894D1A40-9129-4FBE-AE91-E7C0F9F0A81A,"glioblastoma, IDH-wildtype",0.999955782
C024EF4C-2262-45D7-939E-40A9F08FB138,"glioblastoma, IDH-wildtype",0.999955748
28E25814-EA6C-46F3-8F3B-56E25CBE2724,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999955692
19496933-6F8C-4D27-9666-9DD1D526EABD,posterior fossa ependymoma group B,0.999955522
53B4061B-9180-4D9B-A15A-C8CFBC99592A,posterior fossa ependymoma group B,0.999955522
C0B1E78C-6AF2-49D6-936D-2C8744ED8658,embryonal tumour with multilayered rosettes,0.999955371
3F635E42-8818-42F0-97CD-BDFF6E8185D1,embryonal tumour with multilayered rosettes,0.999955371
2AABC8A0-C919-4AF9-9331-1C5599D85420,Myxopapillary ependymoma,0.999955327
BDE69B67-B360-4C33-B241-47D1A36238E8,medulloblastoma Group 4,0.999955162
212DC0F2-0386-4A0C-A860-449F1576F4E3,Solitary fibrous tumour / haemangiopericytoma,0.99995507
46AFD0B2-A75B-40D3-B840-05237CA2CF19,medulloblastoma Group 3,0.999954984
BB336B77-1833-4945-9A0F-F75D7425038D,medulloblastoma Group 3,0.999954984
54D2C2FE-99FB-47D2-8503-A7EA83377AA9,"glioblastoma, IDH-wildtype",0.999954971
405FDC07-19E7-413E-9525-6944D87EA40B,medulloblastoma Group 3,0.999954835
1A08FF18-A15C-4C96-B726-0D384308E18D,"glioblastoma, IDH-wildtype",0.999954547
B1FF6651-5B14-4D0B-B812-B1668561A398,Myxopapillary ependymoma,0.999954377
3BC967A7-29F1-4AC9-A2F3-171E1E8D6894,Myxopapillary ependymoma,0.999954259
B17F63EC-9589-4E0A-A186-9B8DEA407D1D,posterior fossa ependymoma group B,0.999954014
D1826E01-AA0A-483D-BB92-EABBE22630E3,"meningioma, benign",0.999953915
DC117B48-93C2-4B0D-8823-A557EAF4D515,"meningioma, benign",0.999953763
C75A7BF3-BBC0-4F20-AF2E-A176E895F821,"supratentorial ependymoma, ZFTA fusion-positive",0.999953635
1C352BAD-EE21-492B-BBAB-38986F2232E2,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999953311
FA616DD8-A32B-4F72-A557-924FBEA28851,"glioblastoma, IDH-wildtype",0.99995331
5B766A7C-8889-4523-8D9D-70E2551CA4DB,papillary tumour of the pineal region,0.999953251
F8E5FDA3-2058-4E9D-9822-8C207F8F835C,pilocytic astrocytoma,0.999953164
B3AA991E-FE16-4616-BFC7-1AE6519594B7,"Diffuse hemispheric glioma, H3 G34-mutant",0.999953153
23D0D70C-9D3B-4DBD-ABEA-87A330E6F8A7,pilocytic astrocytoma,0.999953118
1AC7256B-89E7-4037-9AE4-24D7151F31F1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999953061
3972E9A9-2FED-42EE-9C5D-6549D5C0BCEA,Pituitary adenoma,0.999952917
34105756-CE44-4607-BBCF-EB831C057FE0,Atypical teratoid rhabdoid tumour,0.999952771
18E08A0E-6692-41AA-BF8C-2BFFD70650F5,"Diffuse midline glioma, H3 K27-altered",0.999952716
470CB000-7251-4FBB-8BB9-57BA3552A3B0,"Diffuse midline glioma, H3 K27-altered",0.999952716
AA6D56FC-C6DB-4CE7-AB29-FEB8AD4AD813,Atypical teratoid rhabdoid tumour,0.999952362
B403C1BA-7366-4D1A-AF8C-5FAC1B6B1942,medulloblastoma Group 4,0.99995236
78CF361F-6BD4-4E5E-83E8-9EA3B17F0EC8,"glioblastoma, IDH-wildtype",0.999952344
B5B4E977-10A5-4E63-AA0F-4CE1E792FC98,"medulloblastoma, SHH-activated",0.999952335
E83EE0F9-FF25-47A8-B209-9FF4D2EFE36C,"glioblastoma, IDH-wildtype",0.999952274
L7,Liponeurocytoma,0.999951855
D31000D8-2C1C-4101-B896-9F359511AC00,embryonal tumour with multilayered rosettes,0.999951761
B515C3A1-7ABC-460F-9779-C3D72E763AD9,Ganglioglioma,0.999951554
6DE4695E-CC5E-4CA1-BDB2-D5484638F35D,"medulloblastoma, SHH-activated",0.999951348
D46A1587-02ED-43AD-B83C-547F51ACC2F7,"Diffuse hemispheric glioma, H3 G34-mutant",0.9999512
16F2466B-0AD6-443E-991F-7E3CE8798331,"Diffuse hemispheric glioma, H3 G34-mutant",0.9999512
05FFB7CA-AFC1-4587-998F-DD4A91FE9B01,"glioblastoma, IDH-wildtype",0.99995102
D98B3730-6B40-4AD7-90A1-741A4AD0C776,"glioblastoma, IDH-wildtype",0.99995102
CE9299EA-43CD-4C66-A60D-28957A3F1029,"glioblastoma, IDH-wildtype",0.99995102
DD982A76-7743-40A4-AA2D-C5646BA3AA77,"glioblastoma, IDH-wildtype",0.99995102
01D29628-017C-46C1-AE30-C5E2F0C5A05C,"Astrocytoma, IDH-mutant",0.999951007
995547BE-DDFA-4BF4-9C00-08686A30C459,CIC-rearranged sarcoma,0.999950936
751943D6-CE4B-4E67-83BD-34749BD760EA,"glioblastoma, IDH-wildtype",0.999950694
B3C4AED8-3322-4532-967B-82F3D68AB2E8,Pituitary adenoma,0.999950522
555A81F1-485C-43DC-95B3-DE6A334F51BA,"supratentorial ependymoma, ZFTA fusion-positive",0.999950509
4E715B67-318C-4A71-B8F7-765C79A9B014,"medulloblastoma, SHH-activated",0.999950509
4B343DFD-A11E-4D80-96AA-4C158072D2C2,"Medulloblastoma, WNT activated",0.999950462
44AFE45E-BC36-4C23-8450-BB7A25BA2B3E,"Diffuse midline glioma, H3 K27-altered",0.999950298
50F128A5-6292-4C07-9972-89D7659E0FD5,Spinal ependymoma,0.999950189
279A4EC5-A34B-4369-9195-F5790D648D86,"Astrocytoma, IDH-mutant",0.999949942
1A20CCE4-3C9D-4180-AA82-576DD8BC24AB,choroid plexus papilloma,0.999949909
4151DB63-6CBD-43A2-A8B3-E657AABD54B5,"glioblastoma, IDH-wildtype",0.999949529
03DAAC15-C8E0-4B21-B596-20ACE0C9E018,pilocytic astrocytoma,0.999949252
8FF1F41D-9441-4A3C-AD19-7283CBD76ACD,"Diffuse midline glioma, H3 K27-altered",0.999948878
69057229-BB57-4197-8F82-C5DE2D646321,"Diffuse midline glioma, H3 K27-altered",0.999948749
D19DF925-7C78-44A2-AC05-9EA215E7C450,"meningioma, benign",0.999948748
E07B1599-972D-4377-8B7C-53F87D1DBE9B,Pleomorphic xanthoastrocytoma,0.999948724
1194DF1F-5D56-4FBE-B793-B8A7B4EF6A08,"meningioma, benign",0.999948612
5CB9706C-1C0E-40F1-874A-919ED636D8AD,"meningioma, benign",0.999948612
5F74DBF9-F848-40D9-AEE3-ADC637FF8A76,"meningioma, benign",0.999948612
A8FCC7E8-079E-4221-99E9-FF69D677B811,"meningioma, benign",0.999948612
F6A86235-24BF-4530-A82A-CF7C22B47657,"meningioma, benign",0.999948612
B09D46EA-5DBF-44BC-AB08-DE3D05E163EF,"glioblastoma, IDH-wildtype",0.999948326
66DC2121-B68D-494F-9F3D-9ED5FDBF77CE,choroid plexus papilloma,0.999948193
A8CABCD5-93B5-4ABC-B313-F624DCC952A1,Spinal ependymoma,0.999948183
05DD37E2-46C7-4C6E-9C18-2CEC216BD1FB,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999947973
5F67A209-95E3-4AA0-846A-CF2CD145EC5A,embryonal tumour with multilayered rosettes,0.999947903
2D467904-A1AA-492F-89D9-CBCA8F459CF5,medulloblastoma Group 3,0.999947717
F7EF663B-D59B-4856-BB0C-6134417AC3F3,"Astrocytoma, IDH-mutant",0.999947705
3BA5AC15-3D8B-4490-BB50-EE3EE8EFD76B,Atypical teratoid rhabdoid tumour,0.999947543
11474FE5-F804-46CF-8CCC-F56D15E3EDD3,"meningioma, benign",0.999947521
68199B3D-0C05-4087-8347-ED89067C17BE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999947147
73E366FB-ABD1-45C5-AB1D-81087728BE86,Spinal ependymoma,0.99994703
85395089-C4BF-4CF2-BD36-4C2905E1D4E2,pilocytic astrocytoma,0.999946829
35409815-A570-4AF7-867E-0B447B528122,"Astrocytoma, IDH-mutant",0.999946777
470B2317-D1BB-4F5E-AAEE-4F94BF610460,"Diffuse midline glioma, H3 K27-altered",0.999946508
675762E4-7ACE-40D1-9776-AF8C207C9290,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99994613
23E7A3EE-299B-4977-A4DA-A4C3A1281AB9,Rosette-forming glioneuronal tumour,0.999946099
532F7E5E-4B0C-4497-9C0D-B4FDCE07DD06,"glioblastoma, IDH-wildtype",0.999946071
0A6976B6-A380-45EB-A90C-92B21D7C6ED5,Ganglioglioma,0.999946041
5142EBBC-3CEC-43FE-8250-9204979EB195,"glioblastoma, IDH-wildtype",0.999945995
6BA00CB1-8373-4CBE-A512-B21FE43F121E,medulloblastoma Group 3,0.999945978
ED1D3F01-16F8-4E61-9495-6D71C64C8310,"Astrocytoma, IDH-mutant",0.999945806
33D57B82-5790-4C51-973A-0EACE8F0D0B6,Rhabdomyosarcoma,0.999945748
9F933ED4-059C-4B69-9ED4-C41580A23331,Schwannoma,0.999945657
8D4BA3AE-35A3-48F5-8FC1-5D3C0D103DDB,"meningioma, benign",0.999945127
3CEAA0D1-86B3-423C-A1A4-4F3D4A0A5B51,posterior fossa ependymoma group A,0.999945075
90F83D57-82D8-417B-83B9-A7484FACFF86,Solitary fibrous tumour / haemangiopericytoma,0.999945007
AFD66A32-72F0-4358-AA7F-514D20029C94,Atypical teratoid rhabdoid tumour,0.999944953
65DBB255-7068-462B-AA38-7CFAF09B3C7F,"meningioma, benign",0.99994485
FFA0A2DC-13EB-4082-901F-3795585A33F4,"Astrocytoma, IDH-mutant",0.999944171
2D3D5D8D-7F3C-42FA-A39A-33C06A5E3A51,medulloblastoma Group 4,0.999944053
D295C543-F865-41E6-AB25-8F7C23CD6473,Diffuse paediatric-type high grade glioma,0.999943932
39A1CAFF-5BB7-42EF-9784-854307400E4C,"glioblastoma, IDH-wildtype",0.9999435
20CC9413-D33B-4408-80FE-5CEB4B33B757,"glioblastoma, IDH-wildtype",0.9999435
BC798EB9-1F75-4DAD-AC75-8F61B16AF4B6,"Astrocytoma, IDH-mutant",0.999943484
A20520FC-5CAC-4506-B03E-71D6AE69404C,"glioblastoma, IDH-wildtype",0.999943295
0FA91581-D1D3-4153-8F22-73355884C5FC,"Astrocytoma, IDH-mutant",0.999942967
747655A8-73D0-46A5-8EF0-56608F063261,"Diffuse midline glioma, H3 K27-altered",0.999942903
E3C16BF4-F40E-4365-8BAA-D2191ADB0A4C,spinal subependymoma,0.999942683
A165D5DC-323A-4EDB-A08C-6F8E2EA6F8A8,"medulloblastoma, SHH-activated",0.999942666
AE2BFE7F-6F03-4DAF-B1B1-2EF13553222C,"Astrocytoma, IDH-mutant",0.999942535
BA9C1AA9-684E-4C8F-8E1B-8CD0F91B6E64,Pleomorphic xanthoastrocytoma,0.999942509
1F32A80F-7D15-4472-AE4E-AD94DA176B81,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999942315
6F2AF0E8-692E-4343-90E4-5D6503C26210,pilocytic astrocytoma,0.99994191
0E0426D2-DC65-4C65-B66F-B704FA098691,Atypical teratoid rhabdoid tumour,0.99994188
5354289E-0956-4B26-9315-79CD6CD4A4AC,medulloblastoma Group 4,0.999941879
6ED0667B-7CA8-4B87-801B-D8B3F5C47C63,"glioblastoma, IDH-wildtype",0.999941841
60A39563-18D4-4A56-8BEB-B36B877485A7,medulloblastoma Group 4,0.999941729
554A278E-6513-4E8D-8500-F5C777902290,Pituitary adenoma,0.999941688
32D6C810-9DB8-4FD0-8B7D-CCAB54C34793,Spinal ependymoma,0.999941662
CAB2C3C6-FB78-4194-AD32-33791DBBAF4D,"glioblastoma, IDH-wildtype",0.999941638
41978448-F4A4-4297-8193-28A993B8D3BC,Myxopapillary ependymoma,0.999941352
AD761B99-472B-4A41-9013-5A830EB7CBE4,medulloblastoma Group 4,0.999941173
DB0E3A56-61CE-4A3D-A7BA-F4416BA5C1C6,Posterior fossa subependymoma,0.999941131
7A89FFA6-F022-409A-B419-FA1404B961F4,Posterior fossa subependymoma,0.999941131
2BF20C75-AF50-45B8-A1A7-0C77E42D5960,"Diffuse midline glioma, H3 K27-altered",0.999940946
C254DB99-11FB-4FF1-A436-6F11D46CC15A,Myxopapillary ependymoma,0.999940695
94D47D44-77C0-4944-AB80-2A57F502EA18,"meningioma, benign",0.99994068
5A2C52DF-E6E0-4F2C-874F-173D4519556A,"meningioma, benign",0.99994068
C48DEF46-7703-4618-935D-8A0D6F2237AA,Pituitary adenoma,0.999940266
25FB6213-05EA-490E-BE5F-544E1AD26545,"Diffuse hemispheric glioma, H3 G34-mutant",0.999940261
277476F7-502F-4E26-8F34-A8795F835A1D,"medulloblastoma, SHH-activated",0.999939887
35FD797E-44C4-40BA-B1A4-B9A08AD546E7,medulloblastoma Group 3,0.999939767
0350D10E-215B-4A35-813A-1A99D2564D69,medulloblastoma Group 3,0.999939259
5548F371-9D3E-4A24-A662-FBB141A51541,"glioblastoma, IDH-wildtype",0.999939178
13FD0162-9387-4B98-B1E1-ADA0D433E9CF,pilocytic astrocytoma,0.999939032
C15EACB2-FAF2-4F27-A62F-208E7319A6B9,Pituitary adenoma,0.999938428
3E7C6BCA-148D-454D-9DAB-208384599E2B,Malignant melanotic nerve sheath tumour,0.999938205
ACA77D92-EF27-423B-A861-09508FCD86CE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999937795
AD5B4B58-2DBE-48A5-9270-62557D2A9D89,"meningioma, benign",0.999937733
77B1BC4A-4A01-4CA2-A982-8815CC922AB7,"medulloblastoma, SHH-activated",0.999937522
1C10752F-1913-4264-BD2A-06A0E655A059,Pituitary adenoma,0.999937519
0E3460CD-6687-4F7F-8EB7-EC4574531968,"Diffuse midline glioma, H3 K27-altered",0.999937218
E903CDA8-68D9-4CCB-B687-9AA99BED7534,Diffuse paediatric-type high grade glioma,0.99993681
1D574D80-A4AE-427E-8CE5-E0013625A174,Spinal ependymoma,0.999936767
30110227-C803-45CA-B9EF-AAC1087363BE,Spinal ependymoma,0.999936767
47D8EB63-6C35-4068-9063-E958F01DFB93,"medulloblastoma, SHH-activated",0.999936399
FDEBD919-ACCA-4A69-BFA5-914EA3487821,Atypical teratoid rhabdoid tumour,0.999936325
943EED0A-8ACE-4C7C-A588-61AC9AD5AB1A,"glioblastoma, IDH-wildtype",0.999935753
62D50C3A-9CEC-4595-A74C-43D16400C68D,"glioblastoma, IDH-wildtype",0.999935753
9435F47D-20A0-4BA7-BFA8-A3ADE841BCEF,Pituitary adenoma,0.999935743
8C25952B-5ECD-48EE-ADDA-643B66CD3888,Atypical teratoid rhabdoid tumour,0.999935646
B8131941-1CCF-4041-A1B5-29EC34C2F9B1,"Astrocytoma, IDH-mutant",0.999935324
10D2B83B-5EE7-4637-8CEE-28D04749A439,"glioblastoma, IDH-wildtype",0.999935233
EC84739C-1FEA-44F8-84A0-1B01D9105CBD,Ganglioglioma,0.99993431
55157472-9552-464E-88AD-F16F1ABA8CC4,posterior fossa ependymoma group A,0.999933997
A53D6F09-8FF4-4137-81E8-4354D97E59CE,Melanocytoma,0.999933754
44EF7307-3134-4215-BAF7-73001A8670E2,"glioblastoma, IDH-wildtype",0.999933551
AB2DF356-AE8D-4D35-BBE9-1ECDA37A9314,pilocytic astrocytoma,0.999933501
A121A0B3-8BDE-45DF-A20D-8D6CE1936664,Posterior fossa subependymoma,0.999933412
B8B29CFD-012A-45C5-AFAB-5383A1863D73,Posterior fossa subependymoma,0.999933389
76C2A3BC-9437-4C18-AA76-750D4F0C1EE8,"meningioma, benign",0.999933388
E6CD3041-9F5D-410F-974D-C799D441DB49,"medulloblastoma, SHH-activated",0.99993279
9BC87F7F-7E0D-4BEE-B496-F5DC468D009D,CNS tumour with BCOR internal tandem duplication,0.999932771
7263A882-9591-41AB-8174-2E777C5AB0F5,"supratentorial ependymoma, ZFTA fusion-positive",0.999932543
B0BFA0CC-7802-413A-B582-0D1EC36AA37D,"glioblastoma, IDH-wildtype",0.999932424
FF8855BA-DB82-4341-91AC-72D2016E8C96,Myxopapillary ependymoma,0.99993238
B365F2FE-4D2F-4DEA-B96A-E1E262C2AF09,Myxopapillary ependymoma,0.99993238
B9560483-C21C-45DD-9FAA-B3A70A43D168,posterior fossa ependymoma group A,0.999932162
156220F5-C6F6-4446-AFC6-290B79B86D86,posterior fossa ependymoma group A,0.999932035
534F990C-5041-4094-B102-6213AFF09CEE,posterior fossa ependymoma group A,0.999932035
5430E845-0977-4D29-AF48-F7B88B2FE243,Subependymal giant cell astrocytoma,0.999931982
C40473C2-7B57-49E9-9A36-767E15645325,Subependymal giant cell astrocytoma,0.999931982
9A0CCBC2-FA78-4E5F-82EC-2AEE12C3CAAD,pilocytic astrocytoma,0.999931906
39E6690A-C442-4C98-916A-B36DFD3CF81F,medulloblastoma Group 4,0.999931863
D667113E-9B43-42A4-B40F-4E0AF5230BCE,"Chordoid glioma, PRKCA-mutant",0.999931681
42EC672B-972F-4D2F-9462-FA68756A9EA2,normal pineal gland and pineocytoma,0.999931676
07FDADB9-ADB2-43E3-8DCE-7FF86B474040,Pleomorphic xanthoastrocytoma,0.999931113
844DBCDA-F85E-460D-9DB0-A45D0FE2E3DB,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999931069
B29DC406-6603-491C-A59F-77E0C07FB172,medulloblastoma Group 4,0.999930996
76E24F10-9677-49D1-9D42-A5342BCA47FB,"meningioma, benign",0.999930935
A987E163-169F-4BA1-B29E-C7C91E3D0FCF,"medulloblastoma, SHH-activated",0.999930783
6CED6133-FC91-4442-9D55-54530591170E,Pituitary adenoma,0.999930649
87411529-AEBC-4A01-9AAD-E1122AE6E435,Pituitary adenoma,0.999930613
6DFD32FA-773D-4C60-9E50-3EFF513D3234,"medulloblastoma, SHH-activated",0.999930188
EE6DDEA2-3612-4C6A-BED3-0965E58F7131,"glioblastoma, IDH-wildtype",0.999930173
0A82E73E-8073-4639-93B2-F6B18E126FEB,"glioblastoma, IDH-wildtype",0.999930173
D8E3B42D-472E-465A-9646-6B2B6BE1D832,Infant-type hemispheric glioma,0.999930051
25D63274-FD89-4221-9D61-ABB390BC7547,Infant-type hemispheric glioma,0.999930051
4CD33C4A-120D-442E-8953-6B28D1DF3727,Spinal ependymoma,0.999929933
E760F71C-447B-4E15-A1B8-A714E141FCD0,Pleomorphic xanthoastrocytoma,0.999929737
8D635E3C-8B1C-4ACA-B6F2-C31BCF5A5404,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999929626
62E2CC30-DFEF-40EF-8544-B24F2B07DC51,pilocytic astrocytoma,0.999929464
A25FA488-9A63-4F55-80CD-D7C62B866472,medulloblastoma Group 4,0.999929454
DC1C6BF7-C346-4100-AE10-17D2CB5787BC,"glioblastoma, IDH-wildtype",0.999929404
B897DD4C-4C63-496E-850F-86E6F7BF9A2F,Rhabdomyosarcoma,0.999929162
60CF03B0-9D33-42C8-A926-9811304AFCBE,Pituitary adenoma,0.999928424
5AB1149F-D628-414B-9223-95222EEF0696,Pleomorphic xanthoastrocytoma,0.99992802
DC745C49-02ED-48C1-80D3-3226FC5FB5F4,posterior fossa ependymoma group B,0.999926994
42AD3AED-5902-410F-B546-FD39F7E25976,"glioblastoma, IDH-wildtype",0.999926988
CB21DF92-9E3C-4E21-8026-DB2555A4620A,"meningioma, benign",0.99992691
99C1D052-DDDF-4882-89D5-8E5763B25D87,Chordoma,0.999926906
AC339E11-0445-4F2A-9957-9A230DB99FE0,"glioblastoma, IDH-wildtype",0.999926731
F11B6760-5727-4AAE-890A-B254B67BF726,"glioblastoma, IDH-wildtype",0.999926424
BCD872F0-455B-4243-A249-7CDA04640E2F,"meningioma, benign",0.999926231
3F3ABC5A-7545-4C51-9A4D-FF6CAA6B4AD8,"glioblastoma, IDH-wildtype",0.999926099
C8AA2085-4B99-44E3-BEFB-B053B05C29FC,"supratentorial ependymoma, ZFTA fusion-positive",0.999925985
7E789EC3-AC9F-41B2-9BEF-CB3B6A99B8AD,"meningioma, benign",0.999925435
BC34360D-1AE3-40F7-AA9E-8C27E60689E9,control tissue,0.999925372
5A3FB0AA-E661-4D58-B115-E5D9DA52B002,Rhabdomyosarcoma,0.999925354
7FA3B0B8-45F4-4F7E-AB32-9ACFCB11BD06,Pleomorphic xanthoastrocytoma,0.999924927
E227A4AF-2C1A-45FE-894D-2C9E0AE24501,"meningioma, benign",0.999924398
3FDA5F4F-E497-4743-AA4A-48E56D72B54B,posterior fossa ependymoma group A,0.999924289
0CD344C5-AEAA-4B30-B808-4F7C3C0212F0,pilocytic astrocytoma,0.999924012
DA4EEBE7-5399-44F4-B2B5-14BDAE89A79E,medulloblastoma Group 4,0.999923964
C1D438D4-2B73-4C50-B1D3-920E1F184CE9,Subependymal giant cell astrocytoma,0.999923868
D9F0410D-53F0-4AE0-A2B1-E51C572E28B7,"meningioma, benign",0.999923819
50743D24-85D9-4938-AF6F-FCB9A2139F68,Pituitary adenoma,0.999923516
E6A80773-6C75-43A8-B7BD-F12EF69BE061,medulloblastoma Group 4,0.999923411
830FDBDE-4450-4D1B-89EE-57A3808CF923,"glioblastoma, IDH-wildtype",0.999923255
A69F1C52-47EB-4011-AB73-A5F8ABEE9BAC,"glioblastoma, IDH-wildtype",0.999923255
BF3FE518-3E79-4972-8F90-45D7BB3AB9D1,medulloblastoma Group 3,0.999923246
EF66D7F4-C629-48D6-9FDC-3D4BF00FF71D,papillary tumour of the pineal region,0.999922832
DA4CF2E0-B3A7-4F30-9904-D485BCF811FD,"meningioma, benign",0.999922729
6106E876-752B-40AD-AC25-0FAA0529CF1D,"glioblastoma, IDH-wildtype",0.999922689
A845065D-5CCB-4996-8B0D-A84F5435809E,Myxopapillary ependymoma,0.999922631
BA2B7E14-9646-46BA-9D65-588328A6C0C7,embryonal tumour with multilayered rosettes,0.999922448
70B1B267-6D97-44E2-89E2-2EA39C122E9B,Myxopapillary ependymoma,0.999922398
CFDBEC24-A351-4855-80E7-8B1E5095AC3B,Atypical teratoid rhabdoid tumour,0.999922275
3A2C2EE9-D5ED-4F26-A974-BC89C888F5D6,control tissue,0.999922109
71E4589D-824B-498D-AE03-95CBD63AB69D,medulloblastoma Group 4,0.999922066
F26B4043-C309-4EED-A03D-AED126BFD850,"glioblastoma, IDH-wildtype",0.999921993
C3669E41-B594-457C-8F2A-BA8D8B347C5C,"meningioma, intermediate",0.999921778
5A653A5A-DAF6-4031-BC77-4F9239934BF1,"CNS neuroblastoma, FOXR2-altered",0.999921563
75414391-09F7-4F15-BF19-F94E81F3EE4A,"glioblastoma, IDH-wildtype",0.999921437
7128A84E-12A8-460A-9D0B-6C837C48BEA2,"glioblastoma, IDH-wildtype",0.999920836
95138AAA-FD92-4B61-84F3-69AA1D114392,Posterior fossa subependymoma,0.999920637
8A52E264-6270-4AFA-81CF-6AA4214B0A7E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999920418
F758F129-1803-4AD3-A86B-88BDE67295E0,"meningioma, benign",0.999920392
CAEC5514-2556-4742-B19B-41D76C63049A,Myxopapillary ependymoma,0.999920222
95779480-D933-4587-B893-C25F2471C080,"meningioma, benign",0.999919928
L5,Liponeurocytoma,0.999919912
32C70A8C-3748-4D64-B727-393755BBDE2C,Spinal ependymoma,0.999919846
AA06327E-41D0-48FD-97FB-32B98A095478,"glioblastoma, IDH-wildtype",0.999919717
18D71683-C68D-40E8-8625-40ADFA5A2CD5,Pituitary adenoma,0.999919594
730DFC96-1864-4F2F-95FD-F7E7607C7B36,medulloblastoma Group 4,0.999918986
6FE5774A-2E28-4C6E-BD5F-ADFC713DFC0B,"medulloblastoma, SHH-activated",0.999918801
E3732DE4-DB29-4B49-AF8D-D0D6DE19BCF4,pilocytic astrocytoma,0.999918775
672FC945-6AEF-4392-A07B-ED343EA35300,medulloblastoma Group 4,0.999918731
1839A3FB-895B-477C-BA69-D83038DA3B45,medulloblastoma Group 4,0.999918731
D8A8D925-F201-4839-A930-511BC75EA254,Pituitary adenoma,0.999918612
55A569DC-A477-44AA-8C06-175CA129E5F7,"Astrocytoma, IDH-mutant",0.999918468
0A9D1886-DE5A-4A3F-A2C7-E59AB9CA589B,Posterior fossa subependymoma,0.999918286
66E0AFF8-1E80-43F7-ACFA-C6E70D2DDE3B,"glioblastoma, IDH-wildtype",0.999918224
EBF0DEE7-7E15-4F32-A940-9C2C0282226C,"CNS neuroblastoma, FOXR2-altered",0.999918087
B5B95E63-0333-4702-BAEA-DA74B754926B,"CNS neuroblastoma, FOXR2-altered",0.999918087
2F40657C-CC90-4E43-8C28-A4228E94FC27,"Astrocytoma, IDH-mutant",0.999917981
C447A1B8-856B-46E3-BC42-34EB8240BB7F,"glioblastoma, IDH-wildtype",0.99991773
F9CDE046-EA68-4255-88D7-549C65276267,Myxopapillary ependymoma,0.999917675
05C3BFBB-DC0C-4198-8ABD-216EB0B95086,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999917503
8DE225DE-F8E6-4AD4-B653-1C976C4332E8,embryonal tumour with multilayered rosettes,0.999917347
04C43CC0-0316-4121-B28A-1ECCAEADE761,Pituitary adenoma,0.999917346
3585DF9C-6C9E-4559-9E44-2AA9893CCD34,"Astrocytoma, IDH-mutant",0.999917291
D5873471-45CD-4728-91A7-D2039C7B6CB5,medulloblastoma Group 4,0.999917083
DA1F47E9-307C-4E26-B76F-BD163E834364,Myxopapillary ependymoma,0.999916871
0FF52D86-57C1-4034-A720-FFB9ED1C2C20,"meningioma, benign",0.999916694
90CC2951-2C30-4708-BF74-78895635CF07,embryonal tumour with multilayered rosettes,0.999916662
EDB919C3-E71B-48C8-B66B-79D9F48B26DA,"Spinal ependymoma, MYCN-amplified",0.999916403
33F31110-4810-4F3A-8025-1A771CF93A2A,"meningioma, benign",0.999916211
98AEF411-C6BA-44C6-A1E6-53256C5F4BCB,"glioblastoma, IDH-wildtype",0.999915798
BF90FFBA-2519-44C3-8AA8-369BD6D3495A,Posterior fossa subependymoma,0.999915313
3AC8F597-4156-4B44-A4DD-32199B289207,Spinal ependymoma,0.999915054
6F932864-B041-4DC3-A64B-7BBAD1100BE1,Spinal ependymoma,0.999915054
DF0A45DA-F621-45A2-A9E9-068227EE6DB2,Liponeurocytoma,0.999914794
BE6B81AC-B6CE-4CD4-9CAE-B28E58E7A530,Chordoma,0.99991453
E5F733A2-0D2B-470B-AA2F-1EEF0BEBF5CC,Pituitary adenoma,0.999914323
E0D9348F-C86F-43A6-AE65-CD1024BE252B,"meningioma, benign",0.999913727
DF8034EE-2951-4412-B561-0C71EC7FC54A,"glioblastoma, IDH-wildtype",0.999913303
0F724ADD-6A5D-4668-95C3-ADCC03228BDA,"medulloblastoma, SHH-activated",0.999913054
9AB1CAFB-2956-479D-A95F-CA3E5AA4292B,Ganglioglioma,0.999912619
3B1B1BD9-8F4D-4DE4-B86C-CF583609359B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999912602
4C83D422-9DC5-4E3A-A120-6E2DEB47D553,"medulloblastoma, SHH-activated",0.999912537
AB4B3203-08D6-4097-A000-5A6BCC8A53FB,"medulloblastoma, SHH-activated",0.999912319
A774D3B3-AE20-4531-B1DA-BFE9982DD86F,"glioblastoma, IDH-wildtype",0.999912073
ADD9E302-C814-4E3F-92CB-C5E3AECECC14,Diffuse paediatric-type high grade glioma,0.999911632
78FD55F6-0474-47D2-A955-8CFF92C26A28,"supratentorial ependymoma, ZFTA fusion-positive",0.999911612
B8AA7BD9-EF7B-4404-BAA0-219D2A82CD61,"Diffuse hemispheric glioma, H3 G34-mutant",0.999911042
B23E5016-1047-42E4-BBDF-8106C821EDA1,posterior fossa ependymoma group A,0.999910992
270E1BD1-529C-4BB9-9978-0A4E922B1754,"medulloblastoma, SHH-activated",0.999910784
FBFF9221-18B8-4BF8-BA44-7548558F236D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999910356
5662A89A-1F1F-4A69-AA86-B06FD9D122A8,"Diffuse hemispheric glioma, H3 G34-mutant",0.999910223
AB153331-9936-4A9E-B63A-81E8C6944E17,"meningioma, benign",0.999909502
905BDB5A-6DC3-47B8-B6F5-D67205113D7B,Posterior fossa subependymoma,0.99990949
A9415F7C-3629-4EF6-9253-B17BC4D2D947,"glioblastoma, IDH-wildtype",0.999909232
88E4EDAD-5CF2-4EF3-9C04-97FDF98588A9,Pleomorphic xanthoastrocytoma,0.999908752
A1C1C5E5-104C-4F38-8311-954CA235D26B,"Astrocytoma, IDH-mutant",0.999908677
3E2AFE40-9D74-4614-8C49-DEE4D66FE9C3,"glioblastoma, IDH-wildtype",0.999908445
04BEC7A7-1FCB-4864-B7EC-3898BB2FAF0D,"glioblastoma, IDH-wildtype",0.999908445
0405C6F5-1286-4FFB-B86D-BE96207AC533,"meningioma, benign",0.999908367
3D28CD43-0874-40AE-944F-15E765B4D833,posterior fossa ependymoma group A,0.999907962
8883324B-3225-4332-B033-940FDE69B8E4,Myxopapillary ependymoma,0.999907827
132FA5AE-8856-4885-A4F1-DB8C392E4693,posterior fossa ependymoma group A,0.999907784
9ACA8847-674B-4A9D-B986-E3E73496FD90,medulloblastoma Group 3,0.999907742
681E816D-C59D-4219-9021-B2142EF0A029,Pituitary adenoma,0.999907708
475CA943-1751-47AF-8415-3DC1A98A9243,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999907543
9790C593-CCFC-4669-8827-07C057DE6055,Pituitary adenoma,0.999907536
4BF606D0-C909-4C84-9C3B-90E9CEFB6341,pilocytic astrocytoma,0.999907461
EFD06C7B-D5F1-4341-A557-0D5C5B1F238D,Adamantinomatous craniopharyngioma,0.99990744
E75AE85E-7012-4590-A357-4435CF859B30,"meningioma, benign",0.999907263
3D358F78-C617-44FE-AD3C-BE235D8DB22B,medulloblastoma Group 4,0.999907057
C4000721-17BD-4EBD-9EFC-ABA7C395FA52,"Astrocytoma, IDH-mutant",0.999906942
D37705CA-07A7-420E-9E0E-23A034E64297,"medulloblastoma, SHH-activated",0.99990624
C40BBDE0-C7EC-4CF8-A389-A9B796BC6C42,Myxopapillary ependymoma,0.999905612
EDA11A46-8944-4488-B491-5A20A937BC92,Olfactory neuroblastoma,0.999905454
B98BD459-100E-42F7-8FD0-C10272FB8117,"Diffuse midline glioma, H3 K27-altered",0.999905434
0F085B8A-CC3E-437F-8C72-469C1F403CE2,Ewing sarcoma,0.999905409
FF841C72-4EF8-4A3B-ACA9-DA0B77381AAB,Ewing sarcoma,0.999905409
D0BFC43D-639E-4EF1-BB88-3ECAE7FFC548,Olfactory neuroblastoma,0.999905369
7C2DDB19-15FB-4AD8-94EC-1E6FB5FE0C52,Pituitary adenoma,0.999905015
2C924A65-DA37-4964-9470-AAC226F2D1F3,medulloblastoma Group 3,0.999904993
8FFC7956-9823-43CC-A599-59A228AB6E50,medulloblastoma Group 3,0.999904567
B0C06E97-5B8D-4B92-9F92-7C623B96F879,"supratentorial ependymoma, ZFTA fusion-positive",0.999904432
3F45F4DE-AB97-4899-9001-277BB06767E3,Dysembryoplastic neuroepithelial tumour,0.999904097
2F867856-C7A3-43BA-8A68-8934EB8AD5EA,"Astrocytoma, IDH-mutant",0.99990287
AC6DAFE6-2B68-4FF3-8141-E6251A4769FC,"Astrocytoma, IDH-mutant",0.99990287
A4737805-A858-4F22-9711-389D8FC5AED2,Pineal retinoblastoma,0.999902421
01071A6A-A0F2-47B7-95BE-1BBF40518A13,Myxopapillary ependymoma,0.999902101
36616DC5-0B96-403E-B95E-B6E41D17502F,Pineoblastoma,0.99990203
00DA694B-BA9C-47CF-9000-537A9CDF2504,"meningioma, benign",0.999901908
3C77E162-566C-4FAF-99CE-D3BD7786CCE6,"meningioma, intermediate",0.999901403
DABCC202-8A32-4242-8810-22FA4F8E78DC,"meningioma, intermediate",0.999901403
90DDE4B7-068A-4B40-AA62-86B302C72C6D,"meningioma, intermediate",0.999901403
29618C7A-3D92-4D10-83C5-CF22B555E7CB,medulloblastoma Group 4,0.999901225
843B0235-C53D-4934-AD3E-CDAD395E318C,"glioblastoma, IDH-wildtype",0.99990119
9B6EDE20-874F-4F2E-B2D2-314FCDE78FE9,"Astrocytoma, IDH-mutant",0.999900343
3ABA2B19-6EEF-4274-8522-D20AC13BC763,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999900046
AF0001AD-AB47-4019-B324-1CE3C37EB51C,Atypical teratoid rhabdoid tumour,0.999900011
C99BE3A9-8BBF-4B79-B653-28F79A9FD370,"glioblastoma, IDH-wildtype",0.999899812
D808FE9F-E7E5-4F7A-B15D-3E72371A48E5,Posterior fossa subependymoma,0.999899424
3B79F122-C264-411F-9264-F37DC6E83E9E,Posterior fossa subependymoma,0.999899424
C92F9A33-CBF8-4053-8BC5-AE7ADA616D27,"medulloblastoma, SHH-activated",0.999898731
F60659C5-1F8E-42FA-8C37-538AA6672580,control tissue,0.999898173
E3048A4F-C51C-4F6B-A666-3B342DB93408,"Diffuse hemispheric glioma, H3 G34-mutant",0.999897868
12AB891E-B8DC-48EB-9ADA-60FFF321309E,"Diffuse midline glioma, H3 K27-altered",0.999897116
03125090-D418-489F-B81F-C105CFE8E775,"glioblastoma, IDH-wildtype",0.999896839
EDA06D05-7617-4E25-876E-0B5633D13ACA,"meningioma, benign",0.999896593
E878F310-BB33-449D-887D-F554727DC89F,medulloblastoma Group 4,0.999896444
471ED840-444D-4EEF-9C99-C9B8B6DE8271,Pituitary adenoma,0.999896005
4E2034C5-73E2-4C6F-ACE7-AC1013AC76A3,Central neurocytoma,0.999895791
F302CB7F-C66D-44AD-B3A3-69AAD0B3FDD4,"Diffuse midline glioma, H3 K27-altered",0.999895484
82E297A7-43B4-47A5-B893-0A2EC8501634,Spinal ependymoma,0.999895338
67C62552-BF0E-4357-A829-39F74B97F112,medulloblastoma Group 3,0.999894833
BC9BE830-4E44-441F-958D-AD0562B590E1,posterior fossa ependymoma group A,0.999894649
28FF5CB0-4232-42DC-8EC5-2E04C21821A9,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.999894311
BA50D2EC-D26C-48EE-B908-46315DB73D2E,posterior fossa ependymoma group A,0.999894152
06E89C0A-1E4A-4DB4-87A3-37AD1EAC701A,posterior fossa ependymoma group A,0.999893826
24181691-249E-4544-BC63-C12F00AD1200,Myxopapillary ependymoma,0.999893644
14CAF1AC-A87D-46FC-8A9E-78A3D1C6328D,"Astrocytoma, IDH-mutant",0.999893376
1DBA935D-FA5B-4B21-BA0F-87168BCEEC3F,"Astrocytoma, IDH-mutant",0.999893376
E334B3A9-1295-4327-9C2A-48AAB1173C9C,"Astrocytoma, IDH-mutant",0.999893376
A021A962-B018-4160-9F77-A140355ABD85,"Astrocytoma, IDH-mutant",0.999893376
C35BD2D9-B32B-4171-AE6C-64F1306A3400,"Astrocytoma, IDH-mutant",0.999893376
6FE5196D-D3DB-48AF-A3F2-4A61C3FCC36F,"Astrocytoma, IDH-mutant",0.999893376
A2A92408-BEE8-4AFB-89D0-72574717D111,"Astrocytoma, IDH-mutant",0.999893376
0967BB09-A93A-4912-A8E6-A2D11DC15A6A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999893372
2BA72C2E-0232-4B81-9C22-2A8222C67ED0,choroid plexus papilloma,0.999893289
9A5DE053-D631-469B-A527-45DE793092A0,choroid plexus papilloma,0.999893289
5EFB74DA-6F5E-47C5-B167-0B0C7FD2E2EA,choroid plexus papilloma,0.999893289
9854597A-CC4E-4BE1-810E-B37E7362CE19,choroid plexus papilloma,0.999893289
D424E1E5-58C4-42B1-90DF-4D04970C8E7E,choroid plexus papilloma,0.999893289
3AF93700-DCF6-41A0-8FB0-07C13FA3A368,"meningioma, benign",0.999893277
86FE4448-5A14-4A3E-9F6B-DC45227DF04F,"glioblastoma, IDH-wildtype",0.999892371
E5D12760-008D-4F62-8CDA-D338D8DB37DA,Myxopapillary ependymoma,0.99989202
3A90B2D0-8CA0-444D-A8DA-048B1499D4AB,"medulloblastoma, SHH-activated",0.999891968
BBE9EA74-3485-431A-BFB1-B24C722D0D1F,posterior fossa ependymoma group B,0.999891893
FB6AEB30-E765-449E-8F40-67FBB7679312,Anaplastic neuroepithelial tumour with condensed nuclei,0.999891653
568DC77C-84A6-452C-A7B3-A80B4A432767,Myxopapillary ependymoma,0.999891338
6166C994-D14A-4A6A-BB3B-C367CF1070C5,"glioblastoma, IDH-wildtype",0.999891079
E3EE0279-1BA6-47E7-A501-E84C04C52927,"glioblastoma, IDH-wildtype",0.99989107
7082BA34-C86C-41C4-B8D6-D5FADDECEFB4,Dysembryoplastic neuroepithelial tumour,0.999891057
2D779F38-4B0F-4960-B180-93408EDB845A,"meningioma, benign",0.999890996
DC238B5C-F9F9-4F3A-A7E2-6611B9960E3A,posterior fossa ependymoma group A,0.999890786
629DFC24-1322-440A-A09A-972EC3BFB494,posterior fossa ependymoma group A,0.999890786
583B68AB-8C23-49FF-A0C4-FFE7B3FE8189,"glioblastoma, IDH-wildtype",0.999890558
B25156C9-4520-4D1B-BCD0-001F3FE2A6AA,"glioblastoma, IDH-wildtype",0.999890558
7DA28731-F46B-4EFA-9BC6-62767E3ECF54,"glioblastoma, IDH-wildtype",0.999890558
61EAE13D-B12C-4CD0-9D1D-1A6A14608839,"glioblastoma, IDH-wildtype",0.999890558
A2C28365-B547-4BC9-AB22-EAA8484C2801,"glioblastoma, IDH-wildtype",0.999890558
BA976DB8-7106-4562-A5A1-B76FE6977397,"CNS neuroblastoma, FOXR2-altered",0.999890548
284F7C9F-78CD-4D1F-A538-19006FC46927,"glioblastoma, IDH-wildtype",0.999890471
26800CDE-1563-4E64-85E4-A58F5AA844C6,"meningioma, benign",0.999890378
CAB9535D-D299-4CF7-A1EC-9F493F95F075,"meningioma, benign",0.999890378
F2510EF2-5652-4A94-A607-1A827384B81D,"meningioma, benign",0.999890378
E080BB30-A61D-402F-A381-D94C1E0CADE6,medulloblastoma Group 4,0.999890279
BCB7B111-D145-45B4-9902-443FE1423470,"Neuroblastoma, subtype TMM negative",0.999890019
E5F4B4B0-7E0E-4D82-8316-8021970515F7,"Diffuse hemispheric glioma, H3 G34-mutant",0.999889677
37727555-15A2-4E69-B04C-FDDCA14AA0E4,Pituitary adenoma,0.999889369
49FAB467-C858-4F0C-9006-0F5DFC1AE12C,"glioblastoma, IDH-wildtype",0.999889303
BCE5E41E-D27B-42F1-8142-C962C60B3016,Rhabdomyosarcoma,0.999887355
200AB0DA-17FE-4E91-AD87-90DD484E992A,"Astrocytoma, IDH-mutant",0.999887062
7E9DB5A9-E28B-41F4-8083-2692B5E24F77,"meningioma, intermediate",0.999885424
556CE556-C1F5-4542-A593-1FDF9B095EB4,"glioblastoma, IDH-wildtype",0.999884439
E1C3E612-AD71-4C37-B319-96155B5D542C,medulloblastoma Group 4,0.999884195
BAA4AE78-37DA-46D6-817A-A16AECCA63FC,Malignant melanotic nerve sheath tumour,0.999884106
F77B3BE5-B89A-4D2A-AA01-B68AC6E3E6E0,"Astrocytoma, IDH-mutant",0.999884086
E412CF6D-F769-43A8-8462-17AAEDCD68D7,"Astrocytoma, IDH-mutant",0.999884086
EE17E485-5D90-4028-BE06-4C9A8BBE03A2,Pituitary adenoma,0.999883385
8C14CB8B-6071-4783-B726-0DD5B11C861D,"medulloblastoma, SHH-activated",0.999883156
5B522052-F71D-4C72-A6C1-23F0A732980D,"glioblastoma, IDH-wildtype",0.999882927
F9DA91D8-B864-4446-B79F-00A02A9A5EAC,"meningioma, benign",0.99988258
91678338-68FD-4BD3-987B-B2795BE617A7,posterior fossa ependymoma group B,0.999882578
70ED64E4-BE77-4DB1-BA4B-3BB2B93A16B8,"Astrocytoma, IDH-mutant",0.999882061
2C8728BD-6EB1-4EC3-B2EE-0D828AE27549,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999881984
94372EB7-51B5-406C-B7F6-840FE60889B8,Solitary fibrous tumour / haemangiopericytoma,0.99988179
B003CCFC-9CFB-4594-8D95-7C24027A2208,"glioblastoma, IDH-wildtype",0.999881601
F3756244-78C1-4F88-8971-2804F285D0B2,Posterior fossa subependymoma,0.999881339
FC3CD9B9-9CB0-4E31-A4FA-87B9E9F16A65,CIC-rearranged sarcoma,0.999880909
D50DF4DD-1530-4B32-A953-6D3805A5BD5D,"meningioma, intermediate",0.999880777
DE04E103-BB83-43B5-9229-6ECEC7C4C341,Neuroepithelial tumour with PATZ1 fusion,0.999880752
DC3D2390-4647-434F-938D-639E9419584B,"glioblastoma, IDH-wildtype",0.999880277
CCB11F2C-55E0-4B04-9AD3-C6E0B9DEAA76,"glioblastoma, IDH-wildtype",0.99988018
5AF3C7F1-7E82-4388-9B69-9D4101F943CE,"meningioma, benign",0.999879851
B3B1A6C9-0E6B-43DA-A75A-4D1EEFDE3060,"Diffuse hemispheric glioma, H3 G34-mutant",0.999879693
AD94D64B-22D8-4320-AE47-E84BBF4583EA,"Diffuse midline glioma, H3 K27-altered",0.999879587
3EA56A66-1C6A-437F-80C5-1A885B2B5956,"Astrocytoma, IDH-mutant",0.999879217
762F064E-AC2D-44DF-B16C-0FDC9931AD67,"Astrocytoma, IDH-mutant",0.999879217
3EFC638D-2539-4EBB-9FD1-E4F012442B6B,"meningioma, benign",0.999878331
04073178-5629-426F-946D-F330384B8AC6,medulloblastoma Group 4,0.999878153
195350A5-07D0-4713-9F2C-690EA93D54D0,choroid plexus papilloma,0.999877815
08E96B95-A519-4225-B252-118EB2750CAD,"meningioma, intermediate",0.999877802
FF17B5E8-3E4E-4B34-8026-E7559F0AC20E,Myxopapillary ependymoma,0.999877231
DDA9A220-4216-4C44-AD37-DC5DE2D981B0,Posterior fossa subependymoma,0.999877202
20301029-AE6E-4402-B4AA-2A9A424C8A25,"meningioma, benign",0.999877184
BB40824D-9A3A-4EFB-AA59-C0244FB82B5A,"glioblastoma, IDH-wildtype",0.999877043
DC4C5BEA-23E6-469E-B285-065F812ADE59,Posterior fossa subependymoma,0.99987642
657FE391-4792-48C4-9955-53C2A48A8541,"CNS neuroblastoma, FOXR2-altered",0.99987613
59F8612E-60B3-4707-8D7D-AA53BA22C3E9,"Astrocytoma, IDH-mutant",0.999876005
DDDC470F-5EA5-4C15-A6DF-DBBD595B440E,"CNS neuroblastoma, FOXR2-altered",0.999875617
3E7D0EE0-F950-4F35-ABB2-C7697E5A0E4C,"CNS neuroblastoma, FOXR2-altered",0.999875617
98D4D2E7-5AB9-46B6-8776-1FFF1BB2BB06,"CNS neuroblastoma, FOXR2-altered",0.999875617
8F33A677-B715-460C-A127-DBE761C95310,"CNS neuroblastoma, FOXR2-altered",0.999875617
1272893E-2482-40C6-B247-61F9E00B85BA,"meningioma, benign",0.999875523
5227C666-9396-460E-A2FD-ADA08281B220,"glioblastoma, IDH-wildtype",0.999874834
8583C79B-3F75-4AC5-9164-72FE6879EA49,spinal subependymoma,0.999874067
10C25298-83BF-4AB4-A514-1F599553B484,"glioblastoma, IDH-wildtype",0.999873966
23A8BE09-6E7C-4625-9898-1B6A2C2AA3D0,"glioblastoma, IDH-wildtype",0.999873966
48DAA1FC-0513-4CDD-B9CB-35C847A730F2,"glioblastoma, IDH-wildtype",0.999873966
505643DB-771A-42E0-9AD0-758511F4716A,"glioblastoma, IDH-wildtype",0.999873966
EAFABFD8-3A41-460F-AD52-80C0DC42476F,"glioblastoma, IDH-wildtype",0.999873966
BD4F018B-27E4-494F-8E13-D51D877FC21A,"glioblastoma, IDH-wildtype",0.999873966
A7B0EE58-2637-4857-A2E7-A21F14A72609,pilocytic astrocytoma,0.999873848
4FC64975-6DDB-419D-BE28-31694930A92D,Spinal ependymoma,0.999873758
17A2AAE9-13B2-4AB8-B0C0-0E7B3D5E63DB,posterior fossa ependymoma group A,0.999873725
FDB0C435-40C8-4CA7-B6DA-E77620D5FA0A,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.999873682
E21F1032-30F7-4EAF-B75E-F9C04D5CB104,"glioblastoma, IDH-wildtype",0.999872945
CA63C000-42D3-4811-90A4-C069E7389378,Subependymal giant cell astrocytoma,0.999872452
4A04A0E7-C914-4110-89F6-CC3CF89F7A68,Pineal parenchymal tumour of intermediate differentiation,0.999872441
FB822054-97AE-49DE-9B1F-0FFD34D7B8AE,Pineal parenchymal tumour of intermediate differentiation,0.999872441
E9633817-F804-4EB2-8206-5649BB511365,Pineal parenchymal tumour of intermediate differentiation,0.999872441
C55A4CE2-7CA2-405B-83E5-C4BB0037C121,Pituitary adenoma,0.999872277
4BBFE6DC-12B7-427B-AB09-00BB6827A6B0,"supratentorial ependymoma, ZFTA fusion-positive",0.999871825
454B6DD2-08AF-421D-B7F2-0EC4242E1E79,"meningioma, benign",0.999871696
8FB66416-626E-4F1F-9BD3-ACB6275287F2,embryonal tumour with multilayered rosettes,0.999871695
F2ED42D5-5F7A-4E14-AC18-21D3E5B54892,Atypical teratoid rhabdoid tumour,0.999871453
EAF50FF4-086B-45F7-8FC3-E9A386D68F33,Myxopapillary ependymoma,0.999871185
3405F89C-20B6-4784-99BE-54F916EA07AC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999871022
487EF126-A5B9-4310-9B8D-41C744B90C14,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999871022
F9E1318F-97A8-4359-8005-4177785446EA,Haemangioblastoma,0.999871001
678C8A8F-D5EC-41BC-861C-ED4D7DD77BC8,Haemangioblastoma,0.999870374
B9D35A06-A2F4-471B-830E-6F6952100CE4,"glioblastoma, IDH-wildtype",0.999870237
F89ACF47-3A5B-4FF2-9622-9F70889F398F,"Chordoid glioma, PRKCA-mutant",0.999870074
0C9CA66E-2BF0-4C0D-9DC6-6931DEC4CB03,"medulloblastoma, SHH-activated",0.999869607
36BC216B-F3D3-47D2-BBE1-73AFEBC64DB1,control tissue,0.999869457
2DA47899-F9E4-4697-B36E-401C11DACA90,"glioblastoma, IDH-wildtype",0.999869312
4270DCCE-A564-4F86-A7D0-CDC324604206,"Medulloblastoma, WNT activated",0.999869001
6BD66196-CCA9-4A2E-B75E-654355A02282,posterior fossa ependymoma group A,0.999868865
72C0686D-2279-4A0E-AB7C-C0C177486522,"meningioma, benign",0.999868512
B86A0833-45C2-4AAF-B6ED-717707D66A14,"Astrocytoma, IDH-mutant",0.999868441
8AEB36A3-92E5-4F38-8CE4-D4A622CBF655,Ganglioglioma,0.999868197
CE979412-A591-4379-A6CD-0DA37845BF15,"meningioma, benign",0.999867999
FA355355-11C3-488E-B20A-531C5223D67A,"Diffuse midline glioma, H3 K27-altered",0.999867994
302981DC-75D5-4E67-97C7-96F05B220E19,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999867519
0E8E2417-3D2D-410A-AF5F-EC42F8091121,"glioblastoma, IDH-wildtype",0.999867514
6BD41614-60A5-4FB0-9E4D-615F74FECB0E,"CNS neuroblastoma, FOXR2-altered",0.999866973
76AE89C4-3F7D-49AC-B29F-CD61FA6D457E,Subependymal giant cell astrocytoma,0.999866892
E52AAA99-2506-42E2-AE99-BEA4D45DA0D0,"Astrocytoma, IDH-mutant",0.999866402
6D34E4EC-8DAF-46D7-990B-C2D5F5C7720F,medulloblastoma Group 4,0.999865809
F19117B5-4899-41E1-859F-58E1A48D6752,Myxopapillary ependymoma,0.999865802
505F31C5-358C-44BB-B2F7-4C01E2DA124F,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.99986558
E9EB1688-E605-4D0D-A441-0FC81ABADB54,Pituitary adenoma,0.999865515
5A1A8923-E85E-464A-BA11-45387FA670ED,posterior fossa ependymoma group A,0.999865392
E53DE475-01C5-4A55-85EF-F28E7D8D0406,"Diffuse midline glioma, H3 K27-altered",0.999865309
A492F12A-2742-4486-85D8-BA5CC9AC1217,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.99986522
6A08ADC0-D07B-4FA8-93A4-D65A16FB281F,"supratentorial ependymoma, ZFTA fusion-positive",0.999864985
B7A685A9-8DE9-4C75-9820-5C126BC00891,"supratentorial ependymoma, ZFTA fusion-positive",0.999864985
6E40A395-9D2C-4C8A-BFC6-FED6EFA87131,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999864281
442CF96C-7426-49D4-B151-40843F714454,medulloblastoma Group 3,0.999864228
AFFC4C4A-1B8A-41B2-917E-202D0B111CBF,medulloblastoma Group 3,0.999864228
6764F1C4-1F01-4D4B-B676-727C944DF0F6,"Astrocytoma, IDH-mutant",0.999864125
7499E13E-C2E5-4070-9909-2A793D877FAD,medulloblastoma Group 4,0.999864004
450AA334-9423-4134-9A68-ECCF319441B1,"glioblastoma, IDH-wildtype",0.999863788
852DAE6E-C402-40F4-AA9A-8A250BF24727,Adamantinomatous craniopharyngioma,0.999863673
1C36238B-E3F3-4E99-86B9-63F4A30465A1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999862855
C31248CB-225F-4EB5-81DF-822629437664,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999862855
4809FFFB-39C6-4A7C-BE1A-9FD89D975AE2,"Diffuse midline glioma, H3 K27-altered",0.999862195
3C84B960-2DB8-4BBF-A739-137AA4166E4F,"meningioma, benign",0.99986206
988BC362-095C-4BB5-B6B2-3E2D11DD07E7,"meningioma, benign",0.999861468
544F8C50-7B7F-4E64-B723-0C5EF1A84BA7,Myxopapillary ependymoma,0.999861308
5FB7196F-AEFB-47B0-8A1F-E0B43278175E,"Oligosarcoma, IDH-mutant",0.999861306
F1606E26-10D6-4BCA-B276-91ECC91D9919,posterior fossa ependymoma group A,0.999861197
B4A85B20-06BD-4FF7-96D2-6F7AC267C9CD,"Diffuse midline glioma, H3 K27-altered",0.999861151
BF50C18F-7504-49BA-90F1-0FB396E7F457,Pineal parenchymal tumour of intermediate differentiation,0.999860706
D1F6DEAA-BDA5-4246-825B-489B952ABAA9,Atypical teratoid rhabdoid tumour,0.999860637
09D2E302-F2BF-43CD-9BCB-8D9E39B96DE9,medulloblastoma Group 4,0.999859928
21335E27-7142-4636-A3D7-36FD3FA465FB,"Diffuse midline glioma, H3 K27-altered",0.999859736
4FCE5DD6-13CB-42BB-8C47-02B8B070E06E,medulloblastoma Group 3,0.99985912
4F5A5D4E-FC44-4B0D-B873-F477F4EDCCE8,medulloblastoma Group 4,0.999858772
5C909795-5D20-49B7-8C81-1CF48EA2D3DE,"Diffuse midline glioma, H3 K27-altered",0.999857114
1E0D567E-B142-46B8-8652-58DD5329F0FE,"glioblastoma, IDH-wildtype",0.999856695
04069C97-01B4-43FF-AE00-2EFD5DFB6A25,"glioblastoma, IDH-wildtype",0.999856695
D379D431-2B63-43FE-9219-B9E9424A6CFC,"glioblastoma, IDH-wildtype",0.999856695
9DD414EA-5593-4D84-98A4-8726AB2F5237,"glioblastoma, IDH-wildtype",0.999856695
FA242658-0963-4555-BF54-3DA6F1A0CADA,"glioblastoma, IDH-wildtype",0.999856695
06EDD0DF-8805-4FB7-95C3-5616D7961FDE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999856663
B37189CE-1992-4841-8874-370D42A9CF10,"glioblastoma, IDH-wildtype",0.999856018
E7E81D72-B330-441B-9AA6-C58D07AB0A51,Supratentorial subependymoma,0.999855691
43DA9D1F-995F-461E-9FF2-E614ABB19430,Pineal retinoblastoma,0.99985539
4C0F9105-AAEF-4F43-82AE-50B5E85039B9,"supratentorial ependymoma, ZFTA fusion-positive",0.999854401
1D0BCC23-E166-4DE4-9BA3-4192FF4E151C,"supratentorial ependymoma, ZFTA fusion-positive",0.999854401
7DC3DA66-EA8D-4915-987B-DD867123B793,Chordoma,0.999853651
A83F2060-378F-4AD2-B013-C783017AAFED,Pituitary adenoma,0.999853358
406DC09B-66F5-4430-9CD2-5BF81EDF4790,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999852248
9599EC1C-55B8-4B38-B2DE-608B10F19037,"meningioma, benign",0.999852052
726EBAC0-12F5-4A76-8FAB-0E29325C3D84,"meningioma, benign",0.99985195
371C0A45-498E-42E0-80D7-C9603EC85A76,"meningioma, benign",0.999851934
E643D84C-BF2D-455C-BDF7-080ED27630EF,Pituitary adenoma,0.999851249
7B550AF5-212E-4F64-9E28-6D983B885A89,"meningioma, SMARCE1-altered",0.999850717
FEF7AE7D-C708-4F90-9F4D-8D3733CEA7F2,"glioblastoma, IDH-wildtype",0.999850407
B30DA245-AE86-416B-9D60-BA15AA2B0325,Posterior fossa subependymoma,0.999850222
23113CAC-C727-46D7-8C04-DE915C82C1F7,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999850217
D02E7B05-2DCA-4862-B9EC-2C1BEBE16970,pilocytic astrocytoma,0.999849996
9329085B-EBA8-44B3-8391-C7B3186763E1,"Astrocytoma, IDH-mutant",0.99984948
D6F42BF0-865E-4D75-95A5-2D24407F9A6D,Diffuse paediatric-type high grade glioma,0.999849447
21A2B5CA-8F84-4D49-AAC0-3F5BAFECDD68,"Astrocytoma, IDH-mutant",0.999849405
22A80A6B-3716-4C2F-B5B6-881774FAD2CF,"glioblastoma, IDH-wildtype",0.999849333
AB42C566-EA0A-4661-A127-01E0DD3C2563,"medulloblastoma, SHH-activated",0.99984874
69AFD12B-B78B-4F8D-82F5-11AA8C3FC184,pilocytic astrocytoma,0.999848523
AADE9C22-E667-4F19-AE7B-B62BD0580F62,"glioblastoma, IDH-wildtype",0.999848467
B71C2189-09FD-41E2-BC03-E9C14B52991C,Myxopapillary ependymoma,0.999848294
7F8AC76C-2C56-40C7-B9E0-73C2CFB04C37,"glioblastoma, IDH-wildtype",0.999846787
FBC4497A-265E-4A86-98E2-3068FF1B9ECA,Pituitary adenoma,0.999846504
3697C906-4927-4E83-BE29-AEDC097B3FAA,"glioblastoma, IDH-wildtype",0.999846435
B6252755-D7B9-41FF-B882-ADA19E75B7BC,Myxopapillary ependymoma,0.99984635
5A6972E7-A5E5-4FD2-BDC8-90FFF7036925,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99984622
3D65BECF-E9BD-4682-944B-49E13E93FE35,Ewing sarcoma,0.999845988
8BCD1519-5D00-4F55-9F26-B0F63E416114,Malignant melanotic nerve sheath tumour,0.999845468
A296C6EC-7405-4341-8CDE-6C2DFF07BAE9,Papillary craniopharyngioma,0.99984484
5464F883-E480-40DC-B74B-09301A9C4FAF,"glioblastoma, IDH-wildtype",0.999844709
693242F7-F004-4AE4-82C6-D1BC243E4EDE,"glioblastoma, IDH-wildtype",0.999844323
9F0E4D0A-C868-4427-AB1A-A53D50EE4504,pilocytic astrocytoma,0.999843195
6BC6F68A-D847-4A77-881C-634624A6A469,Schwannoma,0.999843113
38CBAB6D-5A4B-4D0D-AAC5-FA163EA1972F,"meningioma, benign",0.999842587
4A862F91-63E9-40BD-ABC3-CA82B323F494,posterior fossa ependymoma group A,0.999842571
550CD836-D9F0-442D-B598-E659E4521906,Posterior fossa subependymoma,0.999842485
5A7C3EE9-34EA-428A-858A-D869323D853B,Posterior fossa subependymoma,0.999842485
76B566A9-57BC-4083-ABE8-873C98D2189E,pilocytic astrocytoma,0.999841585
B7C47D7B-3FA2-4EA8-BAAB-FB97D039AB85,"Astrocytoma, IDH-mutant",0.999841257
C619715F-72EF-4D18-A41E-34606EEF27CC,"Astrocytoma, IDH-mutant",0.999841257
1649AE3C-7587-44E1-B8C3-3BC40F0B8080,medulloblastoma Group 4,0.999840359
4E3473FD-6631-4A2E-91A5-C6E9D5915DB3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999839812
4CD16437-E61E-47CE-AD12-6C7AA1DFA675,Haemangioblastoma,0.999839714
DF54B2C2-4B4D-47C9-80A8-49DC2D0EEA4E,medulloblastoma Group 4,0.999839503
69D3E594-B949-4CC7-A42F-2080B92FF27E,medulloblastoma Group 4,0.999838835
1D595417-3AA8-4170-B0E4-8DD14BA6DFAD,"meningioma, benign",0.9998386
7CEE2E59-C4DA-489B-ACC7-0FF08215F312,"meningioma, benign",0.9998386
5F2A2C03-F1B2-4FF7-9511-EF07889F7519,Spinal ependymoma,0.999838161
4D5A3461-543A-439E-BB0A-430F0E904660,Pituitary adenoma,0.999838133
F7B34488-6D59-4B97-AB86-A758BCD739C7,"glioblastoma, IDH-wildtype",0.999837949
3DFDADEF-4D95-4C89-A210-3CEE400C1992,"glioblastoma, IDH-wildtype",0.999837949
812ED0BA-B62A-4D04-A568-0388B7DB6973,posterior fossa ependymoma group A,0.999837837
D5BDA248-3BE4-4816-BB2D-AAF143F69D07,CNS Embryonal tumour with PLAG-family amplification,0.999837695
77A2386C-AF24-406B-AD37-6E81B277C264,medulloblastoma Group 3,0.99983693
BEC77BB6-B3F6-46F6-99A1-FC0C2BCD2D51,Myxopapillary ependymoma,0.999836039
D415A3D2-1400-43CF-A2B0-CC1A75047FF0,"glioblastoma, IDH-wildtype",0.99983585
CE824BF8-FDF6-4EBA-A5F2-5992343CB87B,Haemangioblastoma,0.999835559
F59E3E5E-6560-41CA-9A63-22F56D430522,medulloblastoma Group 3,0.999835166
AC797264-2058-4C2B-8198-DA9286CC70C1,Myxopapillary ependymoma,0.999835123
3126811C-EAB7-4DC9-BE6B-7F28B08B7AB0,Central neurocytoma,0.999834726
8DC33D7C-9370-40B4-9AD9-17A7C80304A7,"glioblastoma, IDH-wildtype",0.999834216
B11D5D52-F2F2-4E8D-B51B-D5523C8E1402,medulloblastoma Group 3,0.999833089
141938AA-C33F-4733-9D6B-E00505DFDF24,Posterior fossa subependymoma,0.999832907
B7E67432-5623-4D9D-AB01-80E67A0932D2,Posterior fossa subependymoma,0.999832907
E5950E14-F48C-43C3-B3F3-FCDBC9ED5242,Pineoblastoma,0.999832196
23639B2D-7B46-40D0-B79C-1BEB7E072EB6,"glioblastoma, IDH-wildtype",0.999830372
36691936-B442-4D77-B831-92DB38D5943D,Supratentorial subependymoma,0.999830305
A7EF7031-AE33-4D23-94E9-C6A382C1A2B0,Pituitary adenoma,0.99983022
544BF6D6-A6D5-43E6-BD94-506BB61EDA38,Solitary fibrous tumour / haemangiopericytoma,0.999830044
E3EBF01D-634D-49D1-8BDE-31876BA3DBE2,"Astrocytoma, IDH-mutant",0.999829847
E2BA2541-B513-4C80-ABAB-4B2765B8A979,"glioblastoma, IDH-wildtype",0.999829836
9703068F-6BAB-4635-A836-E710B4C7DDCE,medulloblastoma Group 4,0.999829739
85457D50-1B0B-4E80-B611-52680AE3B1D0,"glioblastoma, IDH-wildtype",0.999828635
441BCAB0-0455-4A13-8125-42D896A9CABE,"CNS neuroblastoma, FOXR2-altered",0.999828182
3950B489-D180-406B-B042-6765DCC99878,Olfactory neuroblastoma,0.999827847
ECCD7811-F8C1-47DC-8C8D-D241B9015FEE,posterior fossa ependymoma group A,0.999827276
9F2621A8-366F-4387-86EF-FD24E4D429CD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999827268
E1496010-E1AE-428F-A912-5E7E92249F0D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999827268
C37710B2-7C3A-4D5B-A80B-C4D036EEA682,Solitary fibrous tumour / haemangiopericytoma,0.999826369
233A954B-D9AF-49A3-A493-50F46F813773,"medulloblastoma, SHH-activated",0.999825669
35450903-5C8E-42BB-B599-FAFFA15E05A9,medulloblastoma Group 3,0.999825024
82DF7AB7-BEA2-48B5-B418-556C65BF8B18,control tissue,0.999824067
91E0F191-256B-44A6-B473-2D640D853AA9,"glioblastoma, IDH-wildtype",0.999824024
E7339AD6-E674-4D6C-937D-9694D02138C6,medulloblastoma Group 3,0.999824023
3C532727-DD6C-406E-87D8-B5D4EC2BFFF3,"meningioma, benign",0.99982384
BCFC8A54-7B43-4E61-825B-B9424E8AD4A6,control tissue,0.999823638
E747A5BC-7B6A-4A6F-9890-8A7411BF8228,"Medulloblastoma, WNT activated",0.999822588
B3CFED3B-8B43-4C04-8B2C-FFD255251E22,medulloblastoma Group 4,0.999821791
72EFD79E-0EEC-43BB-A163-E4622FF9B113,"meningioma, benign",0.999821714
EFAF44C8-91D9-4BBC-92EB-B439FD897A85,"glioblastoma, IDH-wildtype",0.999821032
AB310A95-6E6B-4609-8782-5B02C036A038,"glioblastoma, IDH-wildtype",0.999819462
22E17BA2-200F-44EC-8895-6C3CB801C3D0,Pineoblastoma,0.999818939
40958F89-A760-402F-AB3C-417DA5CA070E,Spinal ependymoma,0.999818386
FD4CBFCB-CC94-4587-97D7-4F46302A13DB,medulloblastoma Group 4,0.999817967
6B0AFCEA-BB36-4122-96FB-2C87648775E6,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999816831
7B286155-89DD-455D-A670-1DEC048F7B15,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999816661
88CE509B-D4C3-4812-BB56-553BD7E43CE7,"Astrocytoma, IDH-mutant",0.999816612
C6BC3C93-2767-4A0E-BB7B-D9A5D165A116,Olfactory neuroblastoma,0.999816402
131E31A9-384C-4934-8CDA-319DCBB3BE31,"glioblastoma, IDH-wildtype",0.999816231
1E97ACD5-48A7-42CA-96AD-119F0673EF26,"glioblastoma, IDH-wildtype",0.999816231
D5D63ABC-CBC4-4665-89DE-F24D750AD665,Myxopapillary ependymoma,0.999815747
13A12D62-D737-40C2-BECC-64D4D61F5DB1,Rhabdomyosarcoma,0.999815309
A07E3394-EAA5-46BB-ABEE-8A714E087CA5,Adamantinomatous craniopharyngioma,0.999814336
91D7CDAA-66D7-4334-93AB-A250F6589C2D,posterior fossa ependymoma group B,0.999813149
20AE5111-561A-491A-98D8-7A8211116800,"glioblastoma, IDH-wildtype",0.999813149
446F802E-6BA8-4815-8712-B19C6BD8D8B4,pilocytic astrocytoma,0.999812775
5EC2031B-A575-448E-9722-6FAFC4CD6968,control tissue,0.999812299
607F4765-0A1A-4990-B268-1DB10BBFC6F6,"glioblastoma, IDH-wildtype",0.999812296
A96B86FE-067F-4548-9F25-30F139D259BE,"glioblastoma, IDH-wildtype",0.999812052
562EE62F-7C6D-47E1-9CA5-9B338E55A4A7,posterior fossa ependymoma group A,0.99981016
F2004F97-5700-4997-9C72-4F97C7C5890C,posterior fossa ependymoma group A,0.99981016
378727D4-78E3-4F19-A687-A8974B1A5C58,Rhabdomyosarcoma,0.999809878
62EE45F0-9918-431B-BBB9-115C0735D22D,"medulloblastoma, SHH-activated",0.999808497
D18232CB-434B-4DDE-9C38-75E6FD2B759E,Pituitary adenoma,0.99980816
A99A3557-7DC0-442A-A8EB-133AFECA6FC1,Pituitary adenoma,0.99980816
B8F9A49F-B941-4A4A-8E36-EEE87F892060,pilocytic astrocytoma,0.99980816
39C27B8D-F6DB-47A8-8AA6-11BD3C397BA5,Ewing sarcoma,0.999808011
476477E3-5793-4612-BACB-C41F7F562278,spinal subependymoma,0.999807177
D81B73CF-B60F-431D-8640-D2A34831E0AC,"glioblastoma, IDH-wildtype",0.99980715
CB4E62D2-8ED5-444F-8FCE-23E550D97762,medulloblastoma Group 4,0.99980654
A76AC81F-3DD1-4C1C-8E1E-68750C6A855A,spinal subependymoma,0.999806003
893B256A-9330-424A-9808-DEAC81B31A49,spinal subependymoma,0.999806003
2E5F5223-7656-4323-AF00-9D268012D530,medulloblastoma Group 3,0.99980577
DCC13119-A11A-4B11-BFAA-2BF93FFB5328,Posterior fossa subependymoma,0.999805468
F658F54F-4E2B-41F3-91B6-12B2C7D54FC2,"glioblastoma, IDH-wildtype",0.999805333
F4796DF9-B097-4EBC-A23D-3296915692FB,"meningioma, benign",0.999805051
15A65B34-CCF4-40DD-AE54-95AFA87ED61F,"glioblastoma, IDH-wildtype",0.999805011
F6E9C765-2087-4FBC-9CE2-0EB0EB1F281A,"glioblastoma, IDH-wildtype",0.999805011
5FBC6970-F4ED-4858-871A-B57DC4874946,embryonal tumour with multilayered rosettes,0.999804308
807B009A-C102-4D14-8DC7-1312117DF40E,Myxopapillary ependymoma,0.999803919
8AE1FAC3-C096-452D-BBE4-9132682BB401,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999802559
E913BDB3-7C1A-4F40-8D12-6634B263E7B0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999802559
809C4E8C-3CCB-4BA4-8FD4-C8818E6ED094,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999802148
C46A4DC3-850D-4701-A949-A6DF9DF93F75,spinal subependymoma,0.999801266
AF6A3072-6738-4FFD-B584-DC5326C5AAD5,choroid plexus papilloma,0.999800723
9EA68206-5481-43DD-A9BB-4009A1C257D4,Pituitary adenoma,0.999800502
8AA35A69-5EB8-4335-BF37-964610B9CD8E,"Diffuse hemispheric glioma, H3 G34-mutant",0.999799767
82464694-AD7B-4A42-8689-5489EDD32839,"glioblastoma, IDH-wildtype",0.999797457
E688204B-2AE4-4FD9-A4BA-C3F520F3890C,"Diffuse midline glioma, H3 K27-altered",0.99979715
8E5211B8-F0F1-4593-BAE4-F4EF7A7F8825,"Diffuse midline glioma, H3 K27-altered",0.99979715
1A5B1B18-2A5F-41F3-8092-11798E41326A,Pleomorphic xanthoastrocytoma,0.999796844
14534C01-EDC1-4509-91B6-D0ADD5FE3C70,"meningioma, benign",0.999796635
C709B019-6568-4344-93DB-9FBAF8A72C02,"meningioma, benign",0.999796635
BF2AA2AC-2699-4DC2-9F52-8255582D3944,"meningioma, benign",0.999796635
9D780555-33F6-431F-A9BE-9A8FFF7B8ECA,"meningioma, benign",0.999796635
8D323C84-6BB6-4028-A33C-B2DDDFB9A1E3,Spinal ependymoma,0.999796062
9DC3C9D0-3C9B-4130-B5CA-01F028C961AC,pilocytic astrocytoma,0.999795677
29981B19-B357-4D5A-9F39-43B54EB8FA18,Ganglioglioma,0.999795439
A2E8CFF0-D1F8-4928-A37E-F5607EF43B93,Spinal ependymoma,0.999795193
88FB4DE0-39AE-4FD6-ACFA-68C35A57669F,Dysembryoplastic neuroepithelial tumour,0.999795008
4820CEF1-92E1-4754-B756-43204761312A,"glioblastoma, IDH-wildtype",0.999794822
E953A247-1B58-4D18-B895-5EAE10C8B765,"glioblastoma, IDH-wildtype",0.999794822
302CB2C7-A11B-415E-BAEF-880631AAE864,Rhabdomyosarcoma,0.999794748
C3409E6C-43A2-4C20-8736-5EC53B0F6F79,"medulloblastoma, SHH-activated",0.999794635
78F04E13-1168-43AC-9C4C-5B2DC24FBACA,medulloblastoma Group 3,0.999794444
348B8962-622A-4E3E-A491-B5707C038B9A,"glioblastoma, IDH-wildtype",0.999793674
76592B11-B14A-4C0D-A405-BB1FE1951B49,Central neurocytoma,0.999793533
D8656420-4108-4ED3-A0FA-EB288EF52CC5,pilocytic astrocytoma,0.99979349
F194CCB3-839D-4184-99E6-99EA323AD544,"meningioma, benign",0.999792897
D6409D94-F6C7-4302-847E-7ACC82C3B457,"meningioma, benign",0.999792897
36ACD6EC-9E53-4180-A57F-9B3B435626C9,"meningioma, benign",0.999792897
5163D8DA-896F-4ED2-89DD-974704815FC9,Pituitary adenoma,0.999792475
F40F1DEC-2147-40FB-9D24-0C0586AF4B28,Central neurocytoma,0.999791121
2649A0B3-7646-4B8C-9C2C-B34ECA505682,"Astrocytoma, IDH-mutant",0.99979103
54994E4D-118A-4C2F-97F2-FD2D13C6EE52,pilocytic astrocytoma,0.999790877
3BA9AE32-477C-4B7D-B2EA-68F25F618A75,spinal subependymoma,0.999790639
69D7FA6F-E611-472B-9771-55F7EB6554D6,Central neurocytoma,0.999790453
BA3B9EFE-10A3-43E1-B1F6-DE2C074A9BEF,"glioblastoma, IDH-wildtype",0.99978935
66A88473-AC01-43D5-B860-86FDF3E56912,"Primary intracranial sarcoma, DICER1-mutant",0.999788915
1A6EB4A2-7A90-4479-8C1D-12132B4F53D1,"glioblastoma, IDH-wildtype",0.999788461
2BDAE61C-AA61-4ED0-B403-92170B98FFBA,"medulloblastoma, SHH-activated",0.99978796
3D4F1386-A330-471B-A9F6-2EAFA2EB4694,"medulloblastoma, SHH-activated",0.99978796
5C161472-1C3B-4279-AE76-2DB9DC309826,"medulloblastoma, SHH-activated",0.99978796
E7CEDB6D-FEA9-4957-83A4-32289249371B,"medulloblastoma, SHH-activated",0.99978796
F68241B1-C098-4693-ACD6-37FCCE1E580B,"medulloblastoma, SHH-activated",0.99978796
5BD733E4-3F23-486B-B89F-AAC3483F70B7,"medulloblastoma, SHH-activated",0.99978796
55164FFC-E847-4840-9DC2-444D587B6B48,"medulloblastoma, SHH-activated",0.99978796
6BB1DD7E-7CAB-4926-A3D2-95588A21E3A5,"medulloblastoma, SHH-activated",0.99978796
7EAFC824-2807-4552-A3EF-CB11C7036C6E,"medulloblastoma, SHH-activated",0.99978796
6B7737D0-F6B7-4323-B62F-A0444DF3A2A4,"medulloblastoma, SHH-activated",0.99978796
9B2E4834-B0D3-46A6-9E08-098D0AC3F2DC,"medulloblastoma, SHH-activated",0.99978796
F3FD9062-2183-4086-9EAD-76EAC5649453,"medulloblastoma, SHH-activated",0.99978796
627B80AE-2041-427A-B8A9-A362E7644685,"medulloblastoma, SHH-activated",0.99978796
6F764C4E-6FF8-4164-9524-3787446D3EA5,Pleomorphic xanthoastrocytoma,0.99978776
3EE94FF5-E3F5-4644-913E-EBE148E55332,Pineal retinoblastoma,0.999787621
96D217BF-BD68-4166-BE19-16104E3E661C,"glioblastoma, IDH-wildtype",0.999787563
827D3B80-F814-4BC7-A2F6-0C627D9E55D8,"glioblastoma, IDH-wildtype",0.999787563
A4D98F39-8523-487D-8A44-A557AE5EC96C,medulloblastoma Group 4,0.999787456
93550332-7A7B-48B8-B7C0-EC9571A0CC97,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999787198
E18F5E20-C756-4E5F-99E7-E8A57EA6F8B6,posterior fossa ependymoma group A,0.999786521
21C991A1-5AC4-462A-AFE5-D296DF819030,medulloblastoma Group 3,0.999785182
14EC0F88-41D2-4AEB-8C92-D2F133FFC728,"Diffuse midline glioma, H3 K27-altered",0.999785
1ADB91BE-12C1-4D19-B844-400272831557,Chordoma,0.999784422
6A911D70-424D-409C-A07C-0F2AE77F0974,"medulloblastoma, SHH-activated",0.999783714
6907234B-D4D4-49A8-9E0F-A2A443B0920D,"glioblastoma, IDH-wildtype",0.99978181
5869D31F-E027-4E0B-B74F-03416A568ACD,"glioblastoma, IDH-wildtype",0.99978181
B21F8F03-5218-4AA4-8BC3-703386F8D0F1,"glioblastoma, IDH-wildtype",0.99978181
98A49107-EDD2-49D3-9769-0BC42605C9E2,Pineal retinoblastoma,0.999781773
1754B680-2F13-41BA-B90F-8A66F67184D3,"Diffuse hemispheric glioma, H3 G34-mutant",0.999780795
2BD263D4-FB71-490F-A59A-72F0D0B189CB,"Diffuse hemispheric glioma, H3 G34-mutant",0.999780395
B974D189-29EA-491A-B6EF-2931642EF705,Pituitary adenoma,0.999779365
FC12F537-D1F7-4111-AEDD-31F7F144E593,medulloblastoma Group 4,0.99977936
E6471DDF-5F3B-48E7-BFF4-73DF4E2EAC3C,choroid plexus papilloma,0.999779075
C897139F-F897-4E04-8C06-C2E7533DAC44,"Pineoblastoma, miRNA pathway altered, group 1",0.999778399
6AEC3365-49B9-4A82-A0C1-14AAFECE88F8,medulloblastoma Group 3,0.999778382
FDC6A54D-41F4-4368-AABA-B07E30A81D10,pilocytic astrocytoma,0.999778259
A691E81A-D2AD-493E-BBBD-E9A3241CA8CE,pilocytic astrocytoma,0.999778033
576EC024-DD58-420F-BF30-0754EBBCBB02,pilocytic astrocytoma,0.999778033
44163FE9-EC44-4C29-9FA9-38291B025709,pilocytic astrocytoma,0.999778033
AB3A37B1-C5EB-440D-932A-8846DB052A3D,pilocytic astrocytoma,0.999778033
E8950565-D547-455E-A2C3-33E2E3621BAE,Supratentorial subependymoma,0.999777897
01463B5D-784C-4330-946F-AEEA44856B55,Supratentorial subependymoma,0.999777897
A41A3A34-C237-4484-84C3-D7E71E904B55,posterior fossa ependymoma group A,0.999777888
ECC4BFBE-3822-48A8-9B3C-2058D914CE5A,posterior fossa ependymoma group A,0.999777306
4BADFF17-845F-4D30-B7F7-6A0E18A11C2D,Infant-type hemispheric glioma,0.999777093
8EF06E32-2C10-46FF-9765-2A30205D5FFD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999777085
2DAA23DB-7ED4-453B-8DD6-65B5DACD7999,Posterior fossa subependymoma,0.999776209
41A4103D-3B8C-4A9F-865E-2FF8C57582C2,"glioblastoma, IDH-wildtype",0.999775905
9567B819-36CE-4E69-A9DA-32CA5CED8ACD,"glioblastoma, IDH-wildtype",0.999775905
EB8E2FDF-732D-4FBC-9ACC-7DDD2A09C462,"glioblastoma, IDH-wildtype",0.999775905
84790C41-77CB-490A-8265-B2E522E6FCA6,medulloblastoma Group 4,0.999775384
0385473F-F02F-4D2C-976B-F6EB107E90D4,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999774842
6238970F-3E83-4403-AB3C-BC4D1E77D23E,"Astrocytoma, IDH-mutant",0.999774654
93B69E34-05E3-4613-B6BC-68ABEED1D5DC,Pineoblastoma,0.999774608
6DA6B7A0-4D51-49FA-9245-A087B728A5B1,Pineoblastoma,0.999774366
FC9D7044-EC27-4F2B-8665-BF514F59AC41,Rhabdomyosarcoma,0.99977422
55FD8482-25A5-4D8C-A4C2-7734D0EA479D,"meningioma, benign",0.999774199
8C52CF59-378A-415A-A461-1D7AAC37D832,"meningioma, benign",0.999774199
A648CB27-CD1B-44BE-AC54-597C1AED2163,"meningioma, benign",0.999774199
EF64BDB5-2DB1-427A-A740-71677A47BCCD,Central neurocytoma,0.999774155
4448F49F-33A7-4A8B-88D4-5FD37B6119E6,Central neurocytoma,0.999774155
7DBC91B1-137E-419F-A34F-58B0E679DEEE,Ewing sarcoma,0.999772772
D36FBBDF-A72D-428A-B48F-0B1C5FB13239,"meningioma, benign",0.999771434
B92D9296-0855-4377-B342-A422754E57F8,"meningioma, benign",0.999771373
50150EE7-97EB-45E7-A2A1-B0DD69BF3A20,"supratentorial ependymoma, ZFTA fusion-positive",0.999771351
E983F959-11DC-432C-9ED4-BCC5496D58A8,"medulloblastoma, SHH-activated",0.999771299
4F6CBFB6-DE3E-422C-9C3C-DB5E27A8D4EE,"medulloblastoma, SHH-activated",0.999770829
26F752BC-6E38-4F2E-8A75-3A6FDA35B1FF,Melanoma [metastatic],0.999770663
B1E931FF-6C4D-4D47-AE54-405FD69800FE,posterior fossa ependymoma group B,0.999770084
FD68347D-A740-47D7-8401-600191209093,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999770033
42DACEAB-BB63-413B-85A0-3CF78AF11DD9,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999769733
8233ACE6-4040-4FB6-A087-19D60BEE3272,posterior fossa ependymoma group A,0.999769191
4B6FCD59-DF28-4625-B2D1-36F75F3C7095,"glioblastoma, IDH-wildtype",0.999768261
24D73EF8-CDED-49C1-957C-EB7B6A412D8B,Atypical teratoid rhabdoid tumour,0.999767234
87EBC055-FEA2-4C07-9E46-3326A59BF47C,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999766627
7983E577-B177-4B7B-8D68-4E488502939A,Rhabdomyosarcoma,0.999766387
CD01C7F3-2011-4FA8-B7EE-F4F5F15D9DE9,Ganglioglioma,0.999765854
914CB3B6-05B4-4ABB-92DB-5B6C810E7631,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.999765561
36D3AFB9-50C1-4801-974A-796C72788E78,"glioblastoma, IDH-wildtype",0.999765228
ABB385EE-DDC8-4038-97A1-60F393109ACF,Posterior fossa subependymoma,0.999765152
5CD67E3C-24A4-4D13-B307-8658D930ACA9,"meningioma, benign",0.999764891
88CE00C6-15EC-4538-90CC-95D7D6A70B68,"Astrocytoma, IDH-mutant",0.9997646
7DD1E1D7-AB59-4639-82FA-E89F1AA74620,Myxopapillary ependymoma,0.999764178
4EE33788-273F-49D1-AB34-7FD4E9BC16F9,Diffuse paediatric-type high grade glioma,0.999764155
3B68D28A-2418-480A-A744-0D36D1B6A456,Dysembryoplastic neuroepithelial tumour,0.999764004
70EFBB1B-9A8A-4354-8FB0-C98EA2CF6D81,Dysembryoplastic neuroepithelial tumour,0.999762854
66EC0DD5-6A10-4B69-8F30-770DBBDF7245,Pleomorphic xanthoastrocytoma,0.999762192
60A06EC8-B231-46E7-AA1B-FA1198AB81F5,Pituitary adenoma,0.999761861
C8B7A71F-1025-4C60-99CC-B7951BE6AB46,"Astrocytoma, IDH-mutant",0.999760955
217BDB57-A4CA-4C52-968C-D9E93AF17A22,Spinal ependymoma,0.999760793
42BC2A2A-0E4C-4E86-99CC-560DD4F4A52E,"meningioma, benign",0.999760557
83D0F43D-B9A0-4AEA-B114-58E44ACD3F81,"glioblastoma, IDH-wildtype",0.999760494
BBD28780-F3B9-4B5E-BF29-6D2A06887CDF,embryonal tumour with multilayered rosettes,0.999760371
DB95C81A-19E9-4140-9327-283B8C1FF761,"Diffuse midline glioma, H3 K27-altered",0.999759976
6FAFA408-A50C-490E-BBD7-5DB4ACE27F05,Rhabdomyosarcoma,0.999759234
6F358514-7505-457E-87D7-290EF9E9365E,Ganglioglioma,0.999758029
8E863AA4-202C-46FB-B2F1-17614EB4387F,Rhabdomyosarcoma,0.99975735
0C3F64D2-FCCB-4F09-93A4-3BD3E8F613CA,"meningioma, benign",0.999756257
B975B72A-7C03-45C5-8FED-296B05D95033,Diffuse paediatric-type high grade glioma,0.999756217
939ECD77-63C0-4326-B5A1-7A14EDD7E218,"meningioma, benign",0.999755924
1CD657C6-7D85-4821-B085-9B94BB684676,"glioblastoma, IDH-wildtype",0.999755407
CD689803-FDDC-4E62-B2C5-76CF80CEE1EB,"glioblastoma, IDH-wildtype",0.999755407
9DC7C809-839E-4336-93F3-B763950E5844,"glioblastoma, IDH-wildtype",0.999755407
1D2247F4-CDE9-498F-94C8-5A3D08DD3F12,"glioblastoma, IDH-wildtype",0.999755309
F62DFEF2-BDEA-427C-A918-BEED046A9F0B,"glioblastoma, IDH-wildtype",0.99975465
C4E9691D-6991-4C95-AFC3-12734754EAB1,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.99975291
3C9BD380-A893-4086-AD8E-EC35A060C509,"Diffuse hemispheric glioma, H3 G34-mutant",0.999751843
6E425F24-5BE0-4979-B345-B2E878D54DF7,"Diffuse midline glioma, H3 K27-altered",0.999750927
B1A6B701-95C6-481F-AA38-C8CCA2679CFF,"glioblastoma, IDH-wildtype",0.999750291
5B8699F9-89DD-44B8-BDC9-4E5BF2F96828,control tissue,0.999750071
DBCA5073-4AEF-4151-B855-4BB01EA1CA9E,control tissue,0.999750071
0402E819-B3AA-484B-A152-6093DDCE0FBD,"Primary intracranial sarcoma, DICER1-mutant",0.999749902
8524D6CF-67CD-40CB-B37C-BEB69B95DA2E,"Primary intracranial sarcoma, DICER1-mutant",0.999749902
62F55AD6-39BC-40F1-A867-0D998E944B3C,"Primary intracranial sarcoma, DICER1-mutant",0.999749902
1E386CE2-4F71-4DE5-9CD2-73DF9678FFCB,medulloblastoma Group 4,0.999748274
92D69B99-7F81-4D34-89AB-C6A21F1FECBA,"glioblastoma, IDH-wildtype",0.999747996
15B865C5-8DB9-4E65-B77F-0AB1EFB618E5,Pleomorphic xanthoastrocytoma,0.999747834
40D1AECB-A817-47E2-864A-255656A6831E,"glioblastoma, IDH-wildtype",0.999747599
DE0BCE2E-0448-45A1-9829-6443433DAD1D,Spinal ependymoma,0.999747397
D12D9664-88D8-4567-8C78-71FCB0D4DBFE,Melanocytoma,0.999747306
BD65C569-FEF7-4DD9-9758-301715B661FA,Melanocytoma,0.999747306
3E15AD64-697E-4BA0-97C8-12C6CC91D5B5,Melanocytoma,0.999747306
BC8BD133-302D-4C4E-884C-7277804B308C,"glioblastoma, IDH-wildtype",0.999744372
48524748-8CCB-4287-B509-B14A70740CEC,"medulloblastoma, SHH-activated",0.999744283
FBBC9969-6A6F-40A2-94E7-4BB51D323A48,Posterior fossa subependymoma,0.999743499
B3326228-7141-4BEC-8BD3-AD514605C810,"medulloblastoma, SHH-activated",0.99974307
63FA43BA-42E5-4B13-87B2-FEC5DDB8F352,"Chordoid glioma, PRKCA-mutant",0.999742773
175117D0-D4CF-4424-BEB7-A8FAF5C1B967,posterior fossa ependymoma group A,0.999742665
287B2891-1F77-4E61-ADF2-4F0914F603C6,"medulloblastoma, SHH-activated",0.99974234
413F9158-2821-4606-912B-4C8EB86B9690,"glioblastoma, IDH-wildtype",0.999742272
72C3526F-49A2-4232-BC6F-50B174CAD41A,"glioblastoma, IDH-wildtype",0.999741778
920738CA-3DC0-44E8-8DDB-E683695941B5,"supratentorial ependymoma, ZFTA fusion-positive",0.999739314
266B95F4-97BC-4232-94AD-6B668FE47EAB,Adamantinomatous craniopharyngioma,0.999738945
DB94B54A-5B6A-4AA9-BA1B-331906FF324E,"Astrocytoma, IDH-mutant",0.999738271
A112AB32-3FD0-4370-95E1-D9DC182C52B5,"meningioma, benign",0.999737076
6BF5A82C-AB18-4B91-A761-AE051075710E,"glioblastoma, IDH-wildtype",0.999736102
BDE5DACD-8D04-411D-B1C1-95BD60BA3FC0,"Medulloblastoma, WNT activated",0.999735579
4698BBF5-1753-4804-9F9D-8AF9AB58DB51,"glioblastoma, IDH-wildtype",0.999735418
38C1C02F-2DA6-405E-935B-522492C4845E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999734959
BD63220E-76A9-4D82-86AC-804D0B09BFE7,Pineal parenchymal tumour of intermediate differentiation,0.999734358
B486AECA-20C8-4BD5-AB77-4FD59705BB8D,Pineal parenchymal tumour of intermediate differentiation,0.999734358
E2BA37E6-04EE-4829-9764-8DE3E97C4180,Pineal parenchymal tumour of intermediate differentiation,0.999734358
1343E633-77E7-4E73-A689-415E792F5807,medulloblastoma Group 4,0.999734284
F72D5131-FC55-4CFA-9629-ABF3DBE3024D,"supratentorial ependymoma, ZFTA fusion-positive",0.999734076
E1642E64-244F-49A5-BD5F-5FD9930FB6C7,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999734021
FE4423E0-4F9C-4897-BD72-48AB84AE8FC9,"glioblastoma, IDH-wildtype",0.999733772
C9E643D7-CC5C-46BF-B7A3-458419B73190,"meningioma, benign",0.999733399
238B1D7E-17CB-4E30-8EEF-CCE95451BC42,"glioblastoma, IDH-wildtype",0.999731312
5F023BB5-B29B-48FD-B613-1F61B70AC3B7,normal pineal gland and pineocytoma,0.999730738
2903C420-F7B5-4BA0-BD22-E2C1CD84E90A,"Astrocytoma, IDH-mutant",0.999729728
C910D91F-A989-4F7C-BE86-80A30289EACE,CNS tumour with BCOR internal tandem duplication,0.999729419
2279D64D-B734-4830-B33B-5B971CEC92A2,"meningioma, intermediate",0.999729128
382E6A2F-ED13-4D74-AE83-8633B53BB247,"meningioma, intermediate",0.999729128
14E53584-287E-474F-AC1B-CFFEA5405E6C,"meningioma, intermediate",0.999729128
C46B8472-CB1F-4C25-831D-1202DD96237A,"meningioma, intermediate",0.999729128
B7901D49-53CA-4942-A80F-2E009D9BD04E,"meningioma, intermediate",0.999729128
5C50BD3D-8FF7-4710-AA89-58260A55F112,"meningioma, intermediate",0.999729128
1313B97F-A39B-4B75-BBF6-CFD34BE5267D,Ewing sarcoma,0.999729019
36BD99C8-CEEE-4A0E-95B3-D4573FC8B926,"meningioma, benign",0.999728836
4C9445BC-46C5-48F1-9195-FB18D972FCE0,control tissue,0.999728303
B26CA9D9-E619-49B9-9A97-BAD2631503F1,Pituitary adenoma,0.999727615
48849B6D-049D-4A2A-85B7-F6F2C21680C1,choroid plexus carcinoma,0.999727599
FE562F75-E20F-480D-A608-993D3192B339,Posterior fossa subependymoma,0.999727527
47BF8070-43C4-4041-B86C-40E9A289799E,Central neurocytoma,0.999727199
147A5386-FF87-4226-A214-E620B681921A,Primary diffuse large B cell lymphoma of the CNS,0.999726541
64D20907-E4C8-4A3F-81D3-26F726A7DEF2,posterior fossa ependymoma group B,0.999725726
90C02F9B-8498-46B5-9154-9F0650A64F73,Subependymal giant cell astrocytoma,0.99972562
C97D0D37-8C53-4DC1-A40E-C498EB68AE1B,posterior fossa ependymoma group A,0.999725479
E2F10F5E-428D-4806-92D9-579DBA10C5AE,"Astrocytoma, IDH-mutant",0.999725459
73A7559E-D426-4E66-AFF8-6DB7CC75D9C4,choroid plexus papilloma,0.9997243
3ACA3E6F-B6A8-46E6-8006-DF64995EC9D8,"glioblastoma, IDH-wildtype",0.999723253
48189A99-5312-451F-AC61-B7AE0A6F3AFD,"Astrocytoma, IDH-mutant",0.999722852
6AF0C37D-9484-4A2F-A8E1-8E19D7655FF0,Ewing sarcoma,0.999721765
4A2BEE9D-BE46-4299-B834-3A139AE042E7,"glioblastoma, IDH-wildtype",0.999721497
6FB6FE9E-F503-468A-AEE5-A1D5259BD87E,"glioblastoma, IDH-wildtype",0.999721447
0B3D845C-1397-418C-A5C7-6C79471365F4,Schwannoma,0.999720723
8F883083-77E8-44E8-BFA7-9C19BC83CB6B,posterior fossa ependymoma group A,0.999720363
8B2B9447-0EB1-4EFB-9F32-A9EB5187C282,"glioblastoma, IDH-wildtype",0.99972023
D9A53FA2-068A-441A-B6BE-9AF3BDB51BCA,"glioblastoma, IDH-wildtype",0.99972023
81025037-202B-4723-9FE0-5000B4E4DC95,"glioblastoma, IDH-wildtype",0.99972023
D25CD9AB-B47E-4E8E-915E-127A09088502,"glioblastoma, IDH-wildtype",0.99972023
78D27649-C0A6-43C0-A17D-2BC5C2EE76DA,"glioblastoma, IDH-wildtype",0.99972023
B09170FC-73CC-43AE-A0EF-4C14E3C42F96,Pineal retinoblastoma,0.99972023
3861D0D1-0082-4D8D-8B74-98D31F006310,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.999719223
6D85E4E6-1160-436A-AC2A-4EA8AC3C423D,"glioblastoma, IDH-wildtype",0.999718924
307770B3-A9EF-4575-A7DC-B42B8A5CB885,"meningioma, benign",0.999716189
04727105-C86E-4ABF-9696-264816BD3907,"meningioma, benign",0.999716189
71786885-6234-4B48-8BAB-72D227E41A16,"meningioma, benign",0.999716189
CA9FA270-CF8B-4845-BE7E-0E5CB18FF16B,"meningioma, benign",0.999716189
7425C27F-A34C-418A-BA47-8FD174E57EA5,"meningioma, benign",0.999716189
95EF85A5-3559-43A9-88F9-1794AF1FF1B7,"meningioma, benign",0.999716189
22A9D410-EAC7-40AE-A813-CE59FFE3546F,"meningioma, benign",0.999715922
532D096E-19E1-41B8-93BE-AB5E2A7F1BCA,"Astrocytoma, IDH-mutant",0.999714985
34489501-7F1E-48B4-9367-18CA3F398AF1,pilocytic astrocytoma,0.999714661
FF72BD71-8586-452B-A46D-B03C3F09C508,pilocytic astrocytoma,0.999714661
4D3F47E1-7454-42AB-96B3-E07E78BB143F,"glioblastoma, IDH-wildtype",0.99971453
17961A57-C810-4CCA-86D4-603F1C7088ED,Spinal ependymoma,0.99971432
8BB16332-3760-44F7-AD68-E9F6099D6CB3,medulloblastoma Group 3,0.999713218
884AFC8E-D279-4630-8BAF-2B181FD95ED6,medulloblastoma Group 3,0.999713218
2394B1A9-26A8-43D1-BC66-F9CBCD8F2651,"meningioma, benign",0.999712754
E469606A-3C8A-48D2-9C3E-BC59DFFAC52E,Diffuse paediatric-type high grade glioma,0.999712428
E1E0D7A8-4E61-42F0-BBE7-A1703EB81384,Rosette-forming glioneuronal tumour,0.999711645
997BECCB-FD4F-42BF-BA31-DE1E35F95BAE,"medulloblastoma, SHH-activated",0.999710766
60F777AE-F990-4582-9B62-D0C221524E86,Dysembryoplastic neuroepithelial tumour,0.999710274
DD492D98-6BFB-4820-A7B5-A2FEB2B61D1B,Subependymal giant cell astrocytoma,0.999710118
9F5B7699-2777-40E0-B65F-81C089F4D850,"medulloblastoma, SHH-activated",0.999710088
2BA8054E-7287-4F43-8343-69F91DD6FF19,Pleomorphic xanthoastrocytoma,0.999709865
53B2AE45-F909-4C97-851A-E6D2E1C75B7E,Pleomorphic xanthoastrocytoma,0.999709865
6D7E85A5-D8C7-432B-8157-BB5E57F9981A,Pleomorphic xanthoastrocytoma,0.999709865
EADB6E43-2A04-4393-90C6-D71AC60B6A21,Myxopapillary ependymoma,0.999709814
B362764D-7C7D-40E8-801C-BB439683E52A,Myxopapillary ependymoma,0.999709814
ED570F4D-4F28-42D7-8854-DC485B96365F,posterior fossa ependymoma group B,0.999709727
54897602-A273-4118-B777-0F8E224E193F,"glioblastoma, IDH-wildtype",0.999709723
493E1451-F3C8-4666-8365-C96494FE0D3A,"glioblastoma, IDH-wildtype",0.999709125
1102255A-1FC7-401C-9BA1-7ECCA9CBDAC8,Myxopapillary ependymoma,0.999708517
679B0EFA-887A-43ED-B132-1349B115B730,Myxopapillary ependymoma,0.999708517
725681D0-F40B-4080-8CE8-CBEB808E0C4E,"meningioma, benign",0.999705976
605F850A-5563-4A34-8B72-B0F837F054E5,"meningioma, benign",0.999705976
F8018CCC-4BEF-48A2-A0FE-A90B2FB3CC9C,"meningioma, benign",0.999705976
D5F228C4-AED8-4C62-9A8F-FC9D5DDDB151,"meningioma, benign",0.999705976
2599974A-0F96-4FDE-A5A0-F7A535A3EB2B,"meningioma, benign",0.999705976
6C23FB55-4F62-4682-B040-1584123A2DB3,"meningioma, benign",0.999705976
ECCBE9CE-AA90-458D-9900-61B1B48ED962,"meningioma, benign",0.999705976
A152EA4E-2F4E-4DC8-9731-F76D4B66A83D,"meningioma, benign",0.999705976
84C66F15-3488-4361-B392-1D6F31CA5388,Pituitary adenoma,0.999704452
D56416D6-7F12-4153-8017-0731A2CA56DC,"glioblastoma, IDH-wildtype",0.99970437
10E0A391-887E-495B-AA40-A274EA43A6AA,Pleomorphic xanthoastrocytoma,0.999704048
CEFBE596-1281-4163-9D69-18D29A9226A6,Ewing sarcoma,0.999703858
8783F342-54F6-45D1-BE5F-1723574793A7,Ewing sarcoma,0.999703858
75DE8467-8215-427A-81FC-993E35D97A8B,Ewing sarcoma,0.999703858
436D8335-5DA5-4894-952F-13D28C98A548,"glioblastoma, IDH-wildtype",0.999703601
3737556B-82B5-483F-9B70-4F5ADDE36353,"glioblastoma, IDH-wildtype",0.999703601
EAEE0EBE-3F7E-4D76-A972-6FCC7E4AF2FF,"glioblastoma, IDH-wildtype",0.999703601
787334B5-7DCE-4F00-9542-457911C5EC17,"glioblastoma, IDH-wildtype",0.999703601
CFAE020F-EA9B-4F8B-88E8-C49FE918D467,"glioblastoma, IDH-wildtype",0.999703601
790F27CA-FBB6-4BA9-BE6B-34B9F7EB149F,"glioblastoma, IDH-wildtype",0.999703601
F7B292CE-5A06-4E60-9464-A256328ADE87,"glioblastoma, IDH-wildtype",0.999703601
CD2280FF-5059-4AD9-9248-E3AE15505C62,"Diffuse hemispheric glioma, H3 G34-mutant",0.999703275
ED9064A4-CBDB-42C7-A69C-2C51E6DA0B3D,"Diffuse midline glioma, H3 K27-altered",0.9997028
6AA456D0-0260-4FAA-8765-913CBAEEB2FC,"glioblastoma, IDH-wildtype",0.999701301
1B14607C-6C1F-4DED-9412-7E6C79AA95EB,"Astrocytoma, IDH-mutant",0.999697814
24D39BD4-471B-43E7-A23D-1647F9DD9F54,"meningioma, benign",0.999697535
B7243FFD-0EEE-4A25-95B4-44FAF2DB8F2F,medulloblastoma Group 4,0.999697112
2A8061B9-A6AE-4DC5-8DD8-E2DAFA4B43F4,"glioblastoma, IDH-wildtype",0.9996955
F9DEC5EB-28D1-462E-9C4A-871E4543F311,Infant-type hemispheric glioma,0.999694739
B7F0A2FD-D29D-42E7-9254-F4DFA259C7F7,"glioblastoma, IDH-wildtype",0.999694051
68D071EE-8820-4425-B76E-F8538C0B3BE1,"glioblastoma, IDH-wildtype",0.999694051
D60DB403-4E5C-4327-BC0B-CD723D6569C9,"glioblastoma, IDH-wildtype",0.999694051
8336FCEB-3158-495E-AEBA-EC2231B29F5B,"meningioma, benign",0.999692922
09A7C4C7-341D-4491-9642-30D166ADC150,"glioblastoma, IDH-wildtype",0.999692578
F89B6577-E325-416F-9458-FB3E2E3CE6CD,"glioblastoma, IDH-wildtype",0.999690984
91840C84-1070-461A-BB29-C953ED7FD26F,"glioblastoma, IDH-wildtype",0.999689352
EB807BA4-4E4C-40E8-9FD5-E1F5830B2CA0,"meningioma, benign",0.999687054
E4002002-3259-4D1A-BEFA-C50FEC858AF8,"meningioma, benign",0.999687054
1B322E4E-2C65-446D-B19A-878E48B69323,"Astrocytoma, IDH-mutant",0.999686567
24F0EB13-1885-45B2-A72D-9F3840CBAABB,medulloblastoma Group 4,0.999685348
A8F47D6F-ADDA-4C84-86C7-CEF1EEAE2503,medulloblastoma Group 4,0.999685002
1C6C278B-61EE-4EF9-ACDB-9906AE26487A,"glioblastoma, IDH-wildtype",0.999684742
3009FC12-4D69-4DE5-A126-ACF6F5FBB422,Papillary craniopharyngioma,0.999684366
191F2196-6AC6-4CE3-B03B-FE4EADD3133D,Pineal parenchymal tumour of intermediate differentiation,0.999683885
42325D2A-35D1-4B29-8B3C-56184EA4F71A,Subependymal giant cell astrocytoma,0.999681878
3A890614-D0BD-46D0-B393-C78AE9D36417,"glioblastoma, IDH-wildtype",0.999680424
29E9EAAC-EB8B-4E60-9405-2E06EF28099B,"glioblastoma, IDH-wildtype",0.999680424
896FDCA7-7023-4002-ACB1-3698876C09C2,"glioblastoma, IDH-wildtype",0.999680424
F58F3C16-B220-41FD-B299-A3B5F90CAAC7,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999678673
B0FE673A-2C33-4A82-B7D8-CE91CE397EF5,"glioblastoma, IDH-wildtype",0.999678058
70E84336-3C2A-4DD7-9FED-25A1609BD091,"glioblastoma, IDH-wildtype",0.99967661
BFF0B6E1-81D2-42C4-A0CC-4F85B230D402,Ewing sarcoma,0.999675836
0ECD69BF-5FE0-4458-95EA-37D0F2DBBC66,"meningioma, benign",0.999674634
35EFA63E-F648-4DFD-BB14-78901EA5184C,pilocytic astrocytoma,0.99967301
612AECB2-2F86-4262-B15B-B0FFDD001B39,pilocytic astrocytoma,0.99967301
AE67CFF4-09B1-4E78-A146-D384515C8751,posterior fossa ependymoma group B,0.99967289
D1447796-1C38-43EA-8E74-E79D7C59B8EA,"meningioma, benign",0.999672496
21260B2A-9605-4B13-838E-02C89BFCACD5,"medulloblastoma, SHH-activated",0.999671962
F56AE828-7307-449D-AC81-6DFBDF9E16A6,pilocytic astrocytoma,0.999671253
6D85D077-CD40-49C1-962B-1CDC889A54F0,pilocytic astrocytoma,0.999671228
B3783D88-FD52-4BAD-B70E-4F4FCF58B890,Rhabdomyosarcoma,0.999670224
23776E85-F541-4849-81E3-F013EB5AC186,"glioblastoma, IDH-wildtype",0.999669632
79DCA6BB-09C0-4A01-8A6D-7E32E153D52B,medulloblastoma Group 3,0.999669335
FA7EBEA0-6CD8-4BF7-9B6C-6DC9624A5223,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.999667218
6B961779-30EB-4AB6-AE37-5725BEA0D6CB,posterior fossa ependymoma group A,0.999666666
412CFA6F-301B-47AE-9D90-A27DA87099A4,"medulloblastoma, SHH-activated",0.99966643
F45FF8FF-9A20-42E3-82F7-61B9CEAB4534,"glioblastoma, IDH-wildtype",0.999666154
62A55B44-C046-4D88-8B9E-A9F52BE729EA,"glioblastoma, IDH-wildtype",0.999665725
07879B3D-987F-4324-98D4-8A7AA0BB3858,High-grade astrocytoma with piloid features,0.999665147
0F9A61B8-0AF8-4DB1-99B4-D730C1BAFD6F,Haemangioblastoma,0.999664668
A566FA6E-052C-4206-AE32-0F7F6DE3EB8D,"meningioma, benign",0.999664369
A2F240C5-54D0-4442-A95E-194B7EE77DA8,medulloblastoma Group 4,0.999661583
D26A6B42-84E7-402E-B30A-7232EC99D715,Diffuse paediatric-type high grade glioma,0.999661216
7327C390-2E66-4F25-A91C-577A2777C84A,"medulloblastoma, SHH-activated",0.999660903
28956B75-6EE6-49F8-92FA-54B273EBAF06,medulloblastoma Group 4,0.999658643
E03F3F3D-AF37-4CCD-9755-5829B0AE9347,"glioblastoma, IDH-wildtype",0.999658435
DA5C7945-0878-472B-8F64-30AB775793BD,"Medulloblastoma, WNT activated",0.999655815
D4BCAD1C-5F2A-4EDA-9590-CA0A2628D8E9,"glioblastoma, IDH-wildtype",0.999655764
91AF9E0A-3DA5-40B8-96C5-996CE314E8FC,"Astrocytoma, IDH-mutant",0.99965397
E02840F4-34A3-43AC-83AC-3221EA020CB7,"meningioma, benign",0.999653834
3D865D63-17F9-42BB-88F8-B033AE58987A,Ganglioglioma,0.999653368
BB8C5545-1663-4267-B24C-6F4307A1A55A,Ganglioglioma,0.999653368
EB68170E-160B-4FAE-B182-EA8F63EA2744,"glioblastoma, IDH-wildtype",0.999653304
8B313E21-58DF-48CA-99DD-8ED8F5621B10,"Diffuse midline glioma, H3 K27-altered",0.999652991
3BA3F8E2-0100-4BE1-A13E-523DF2837045,"supratentorial ependymoma, ZFTA fusion-positive",0.999652913
FCB5E467-C058-4C8A-9951-A9DC3B74D6D7,"Astrocytoma, IDH-mutant",0.999652299
FAA59492-1175-48BF-981D-7DA507ABC2CC,Dysembryoplastic neuroepithelial tumour,0.999650526
D5A0098E-20A0-48EA-BC0E-361C42105BB8,"meningioma, benign",0.999650243
0637579C-A3D6-4940-B466-94D0BBA2352F,Ewing sarcoma,0.99965022
C7EE072F-5E2F-4654-BD7A-2AC484A23A12,Ewing sarcoma,0.99965022
03673B70-E9CB-4194-B57C-D1B8FF23181B,"meningioma, intermediate",0.99964951
B363B8D3-0803-48B6-8244-867A15A3B8D2,"meningioma, intermediate",0.99964951
A64E5C74-41F2-4485-8E39-F5C3C2B50FAD,"meningioma, intermediate",0.99964951
652CC6EC-1096-451D-83C1-9F23F766CD24,"meningioma, intermediate",0.99964951
112B9851-BF91-466E-920A-1BC243FB7D53,"meningioma, intermediate",0.99964951
580E3600-7272-4D25-855D-D914F72FD0D4,"meningioma, intermediate",0.99964951
C7267B76-F5EE-44EA-BCFD-E3854D6BA3F8,"meningioma, intermediate",0.99964951
46CFC0C0-F728-4FC0-B7AE-A7041B410787,Dysembryoplastic neuroepithelial tumour,0.999649168
BEA44BB0-56E6-4597-B91E-A6AE270DCC4A,Pleomorphic xanthoastrocytoma,0.999647996
F4080624-A73C-4A27-9C66-29519B5C9439,"glioblastoma, IDH-wildtype",0.999647918
0DF95F63-3C71-4AF9-83B1-25D15D30336C,"glioblastoma, IDH-wildtype",0.999646746
8D763BDB-A49C-43BF-BA7F-871A22CD0EBB,"meningioma, benign",0.999644341
E6F0254E-98AE-4305-A6DF-BAA0993DCA7D,"glioblastoma, IDH-wildtype",0.999643985
D6283239-2540-480C-8FFA-41A07453E1E5,"Astrocytoma, IDH-mutant",0.999642253
1811BCF5-C747-45F5-93C5-59D2FB03BEFA,"Astrocytoma, IDH-mutant",0.999642079
F1BD04A1-53C1-4E63-8CF4-EA369CC86743,posterior fossa ependymoma group A,0.999642018
C0940F01-2D2B-4C5B-90DE-1DB148C51052,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999641633
CA3C6601-142C-4E27-AC6E-60FDCDA32FD3,"meningioma, benign",0.999641248
C650572C-B6DC-4182-AF7C-A0FA1CD3CDC8,"glioblastoma, IDH-wildtype",0.999640678
12A0A602-F554-439E-A38C-DAC17B6362F0,Rhabdomyosarcoma,0.999638078
49EA7B40-1223-4B3E-8F1E-1144A013FE0E,Posterior fossa subependymoma,0.999637982
C1DAF05E-B61E-44B7-9F2E-1EE1AE7FF624,Posterior fossa subependymoma,0.999637982
8E2A7051-D389-43D2-B129-8C3D95A3AA5D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99963651
BD7CD904-329A-466F-A4DB-3E9678288432,"glioblastoma, IDH-wildtype",0.999635292
07E961B0-492C-4858-80EE-5A6E2046CD72,"supratentorial ependymoma, ZFTA fusion-positive",0.999634795
4E802A0A-9F3A-404D-AF36-9C937B7FED18,"glioblastoma, IDH-wildtype",0.999633026
2F3507D2-D6A3-4444-92C9-B6710BC120DE,Spinal ependymoma,0.999631304
B536DDB3-E679-4985-A195-F85A19B20C71,Spinal ependymoma,0.999631304
D6FF9816-130B-42BE-B8B7-FCC54B0A3D0F,Myxopapillary ependymoma,0.999630381
929C7CC7-D956-4650-A012-345AACB3A95B,"medulloblastoma, SHH-activated",0.999630266
A5094A5C-E473-4CD3-A850-DE838727FD33,"glioblastoma, IDH-wildtype",0.999629801
59954D5C-AE25-497E-962D-B0E1DF257FF8,medulloblastoma Group 4,0.999629064
5A722B3E-3896-4C25-9239-FAA30DDD6432,normal pineal gland and pineocytoma,0.999628065
7DAC07B8-B4AF-4793-9B45-97200CE8AF73,"glioblastoma, IDH-wildtype",0.999627506
29CDED41-76E1-46FC-BA4F-EAC1EA748E1E,embryonal tumour with multilayered rosettes,0.999625514
690A27CB-D887-467A-98FD-8C1A8D5BAF07,"glioblastoma, IDH-wildtype",0.999625272
27E90D87-1652-4F8D-98CA-93A4E2C0F9B7,medulloblastoma Group 4,0.999624395
9E6D51E8-3C03-4A53-8437-FD6FA47D195A,medulloblastoma Group 4,0.999624395
E24B3409-D592-4FAC-8DFC-8FCB1184D3D4,medulloblastoma Group 4,0.999624395
99301695-7716-470C-A543-A0C3791537B9,Diffuse paediatric-type high grade glioma,0.999623549
06BBA93F-783C-4FC0-9ADD-306A8059FB5B,Chordoma,0.999623304
L4,Liponeurocytoma,0.999618587
2CE672D5-F731-4ADF-8A43-B0411B2E1BE0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999618304
836BF8DB-6612-4BA3-A6E5-BB445D74C5BC,Dysembryoplastic neuroepithelial tumour,0.999615354
C270F5A3-E216-4822-B7E6-0F2EDE77A383,medulloblastoma Group 4,0.999614925
320D09B6-DE9D-447C-A9C3-846BF0DCD0EA,"Astrocytoma, IDH-mutant",0.999614917
AEC7C9DC-A38A-4DDE-B4B3-662BCBF51DB2,"Astrocytoma, IDH-mutant",0.999614917
56188AFB-7D3C-4362-AEF3-15E1A37A7732,"Astrocytoma, IDH-mutant",0.999614917
A9C9BDC4-0F52-4D46-AC2C-459F308018B6,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999613855
0ACC3014-636A-42D3-8E52-19AC64AFA270,Posterior fossa subependymoma,0.999613783
8E19D5D0-128B-489C-9FA9-B0707112EBCB,"glioblastoma, IDH-wildtype",0.999613064
332A58D5-90BE-4DEA-9FE0-72590D1F4D6A,medulloblastoma Group 4,0.999611885
40F25E94-4533-4D62-B372-03ABFDEA52B4,"Astrocytoma, IDH-mutant",0.99961136
E4C030A7-2324-4F7E-BD5A-D25143467863,"Diffuse hemispheric glioma, H3 G34-mutant",0.999610735
EAAA2908-E86C-45B0-892F-59127DB5707D,Myxopapillary ependymoma,0.999610077
9D39DC05-4A84-42B3-A0BD-3861CB6EDF4E,control tissue,0.999610066
03E2AE3C-94B8-4F44-A7E2-91E8E3F16EB3,Dysembryoplastic neuroepithelial tumour,0.999609964
343D0A31-E92E-4BC6-9672-94E5E13BCCD5,"meningioma, intermediate",0.999609103
4E4375C3-9829-4894-866F-F9966826D0E5,"meningioma, intermediate",0.999609103
5296F80C-42F2-4B19-90BC-663D186165C6,"meningioma, intermediate",0.999609103
F38F4ABD-60F0-4A1B-8ECA-A6B2D1F14EC1,"meningioma, intermediate",0.999609103
A6A8FAB0-51DE-4BD1-A262-686B3A894F67,"meningioma, intermediate",0.999609103
CC298C9B-C85C-448C-812E-D73C6141527E,"meningioma, intermediate",0.999609103
3E54BB15-87A7-42D8-825A-AD0C40643CDC,"Diffuse midline glioma, H3 K27-altered",0.999608076
8E49D40F-BBAF-4F5B-B18F-8BA4D449525B,posterior fossa ependymoma group A,0.999605276
97D73355-3953-47F8-BF0D-ADA5397F577F,"glioblastoma, IDH-wildtype",0.999602792
7C8F3FFD-449E-4950-900A-27F280606AF5,"meningioma, benign",0.999602074
FCF7C8C4-91D5-45C1-9026-ED3E98765EE3,Schwannoma,0.999601014
67C2AF28-6273-4099-96E5-EF102DEA882F,"glioblastoma, IDH-wildtype",0.999595317
867ECE25-B72A-457D-918E-F377D1DE9078,"glioblastoma, IDH-wildtype",0.999593173
D01DFDE5-C119-4C01-858A-EF35AEA84297,"glioblastoma, IDH-wildtype",0.999591718
F82E03F7-3B19-4C41-AE0F-BD738281668D,"glioblastoma, IDH-wildtype",0.999591718
C1451B9B-473A-4AB6-BBD5-2C6EAE0DD114,"Astrocytoma, IDH-mutant",0.999591567
9AF750CD-6329-4133-A1D1-136A3CEF3AF1,posterior fossa ependymoma group A,0.999590319
FA4E0B71-6487-4CA0-9D43-B06F80379C59,normal pineal gland and pineocytoma,0.999589617
6152EF0B-497E-4E0A-9E77-0B0F0D197E9B,Pleomorphic xanthoastrocytoma,0.999589198
365C95DE-65EF-48AB-8538-DCDCE9F454EE,Pleomorphic xanthoastrocytoma,0.999589198
51945762-415A-4792-ADCD-06376DEE76B3,spinal subependymoma,0.999586266
C77AB7FA-B03E-4CE5-AD88-C7A38A760FA2,"Diffuse midline glioma, H3 K27-altered",0.999584541
58F78CCD-11C3-4039-80CB-B497AAA1DB08,"glioblastoma, IDH-wildtype",0.99958406
E792763D-56F9-4058-936D-25DAE14002A1,posterior fossa ependymoma group A,0.999582741
CEDFCA9C-203C-4670-9983-374763AB27C2,"glioblastoma, IDH-wildtype",0.999582672
28DD577B-10CA-4715-9EE9-1517546C7E19,"glioblastoma, IDH-wildtype",0.999582672
48247F2E-BEC7-4A17-8371-4D85A870E8A6,Extraventricular neurocytoma,0.999581212
FC4BE7A7-0DD0-491F-A155-71DB36A2423C,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999578883
478696DA-6F63-4628-A4A0-E5A3008C1892,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999578883
585495E9-738D-4283-B24B-9F5CFF700545,Pituitary adenoma,0.999576517
B47F34DB-EB59-4DA7-8FB9-E384DF0CE24D,Subependymal giant cell astrocytoma,0.999575269
BE26A402-3833-485E-A707-13EBE5B8EE46,Myxopapillary ependymoma,0.999575261
53C6135C-E4D5-4B1E-8BA3-DAD49EBDC742,control tissue,0.999574029
98EE146E-FAAE-4C14-93B0-5ABF4BC5DC66,"meningioma, SMARCE1-altered",0.999571762
F18AC0DF-CDFC-47C6-9097-A68514C88F36,Central neurocytoma,0.999571754
77EE0447-7B44-48EB-A72C-338BCC81C5C1,"Astrocytoma, IDH-mutant",0.999571272
BFE67010-7952-4428-8D29-3A1F41032A10,"glioblastoma, IDH-wildtype",0.999570003
B220552E-CBD6-4EA7-B7D7-E709C2B8C653,Pituitary adenoma,0.999569146
19CDCC70-C986-4481-81DA-D1A60F5AFF45,"Astrocytoma, IDH-mutant",0.999567628
35D311DF-9F5A-4A65-B630-7BD6275FCAFF,"meningioma, intermediate",0.999567298
A585C115-6B01-4503-B003-06615D038F57,medulloblastoma Group 4,0.999566565
8ADB355A-1E42-4AE3-8997-7337475BCDDB,pilocytic astrocytoma,0.999564287
BE36EAE8-2D9D-4718-96AB-F778614A79EF,"glioblastoma, IDH-wildtype",0.999563465
489B69A0-FC17-415E-8438-C2D1A8A652A2,Atypical teratoid rhabdoid tumour,0.999561073
L3,Liponeurocytoma,0.999558349
FC14B9CA-D26D-4485-BD0B-686C6BEB6E74,"meningioma, benign",0.999558303
FABDFC5E-D2FA-4C85-B347-706FC9431156,Spinal ependymoma,0.999556258
1CA1726C-7809-4770-8A60-365AB1EB39DC,"glioblastoma, IDH-wildtype",0.999555104
0AAE00F4-479B-4AA2-A0C5-3225DDAC5184,"glioblastoma, IDH-wildtype",0.999555104
CDCB1E7D-2FEE-4C99-BC67-FC118D6F1D7B,"glioblastoma, IDH-wildtype",0.999555104
882D0F3E-91B0-45FC-A747-6361880959EC,"glioblastoma, IDH-wildtype",0.999555104
7F777D00-9D61-4848-93CA-6A51548ABEE7,"glioblastoma, IDH-wildtype",0.999553718
1FDB7AFF-15D7-46A0-A96D-DEE4FECD843A,Myxopapillary ependymoma,0.999552087
A0792521-54D6-4EC8-9F45-B4FF197BFC81,"glioblastoma, IDH-wildtype",0.99955007
1E59C983-D1F5-41FA-936F-9CF59CC68B52,pilocytic astrocytoma,0.99954873
A5F41FC0-A827-47A8-978F-963E5A15F36C,"Astrocytoma, IDH-mutant",0.999548535
6BE6DE8C-448C-4A93-8F88-57E8C973627F,medulloblastoma Group 3,0.999546571
34E9FF0B-DFAD-414C-9547-F86303735F90,"meningioma, intermediate",0.999545948
A4804403-D5D4-405D-A908-21181B5B2FC1,"meningioma, intermediate",0.999545948
5F269808-C394-48E1-8FD8-2342BF638469,Posterior fossa subependymoma,0.999545268
04255A0F-B24C-41C1-A533-BA23777F10EA,Spinal ependymoma,0.999544694
74DFDC2F-2947-4A89-9012-23837D65E2D4,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999542534
A47200C2-9EAF-4A56-B1DD-D65282FB374C,pilocytic astrocytoma,0.999541946
DBEBB406-F7EA-49EA-901B-A9B9740E3BBB,pilocytic astrocytoma,0.999538737
3A10BEED-0C69-4336-B7B8-AA8FB026F188,medulloblastoma Group 4,0.999537912
0F458AF1-9BE2-4F9E-82EE-D0C396150099,"glioblastoma, IDH-wildtype",0.999537699
C198756E-9686-4D3B-B902-3D8333FE9CFA,"glioblastoma, IDH-wildtype",0.999537699
B4198DE3-8537-42E5-A620-291BCC279CCE,"glioblastoma, IDH-wildtype",0.999537699
2C3A1106-8DEC-4E2B-AA10-D30E58770417,"Astrocytoma, IDH-mutant",0.999537586
E923DC21-5BD3-49F8-9B85-1B7DED95556C,"Diffuse midline glioma, H3 K27-altered",0.999537464
5A10B046-2E46-4D0D-B553-E3E777AF9361,"glioblastoma, IDH-wildtype",0.999536312
745A9B7A-6F84-4D21-BEA1-907A4F0D916F,"Astrocytoma, IDH-mutant",0.999535459
E719EA91-631D-4928-BEBB-C1D07DFBA611,"glioblastoma, IDH-wildtype",0.999533687
E3634E42-26FC-4AEC-82AB-DC67204EEAB8,Ewing sarcoma,0.999533631
B0FF2612-41D4-4F6B-9D3F-42DE7163EEC1,choroid plexus papilloma,0.999532801
362D331B-EC43-4D28-B89C-347B724FC583,"glioblastoma, IDH-wildtype",0.999531614
075376CF-1F9D-4EE2-9988-89A96BA1A018,Central neurocytoma,0.999531582
A46E9F57-437A-4743-AC02-EF018D950C74,medulloblastoma Group 4,0.999531372
F000D648-DAC1-415D-901E-864E1656B6AF,"glioblastoma, IDH-wildtype",0.999530718
93A9BDAB-7EE5-40C6-B67F-92307DBE2780,"glioblastoma, IDH-wildtype",0.999529894
A65F0045-EE25-4985-814F-42F7DE727292,embryonal tumour with multilayered rosettes,0.999529452
669F182C-0DCC-49A7-82A3-DE42825C98F8,"medulloblastoma, SHH-activated",0.999528473
F1105DCA-C902-4FF1-87D8-A64C43907F99,embryonal tumour with multilayered rosettes,0.999526405
8A513E97-3821-49A1-85D4-7686E71187AF,medulloblastoma Group 4,0.999525204
A2626277-A56B-4F36-AC0D-52E5D7ED32A2,Pleomorphic xanthoastrocytoma,0.999521919
3A94E785-77B5-4832-B03A-C2E64FD49EF0,Schwannoma,0.99952094
90A46C9A-8C86-4673-AB7B-420BCA1B81CF,Schwannoma,0.99952094
99A9CFD8-C8F8-4048-AFAE-EAF54B3793F4,"medulloblastoma, SHH-activated",0.999517888
030F398D-A6B9-4C3C-8C4A-975E71D1D168,"medulloblastoma, SHH-activated",0.999515194
51B2B5DD-A353-4043-ADA4-861C53106832,"Spinal ependymoma, MYCN-amplified",0.999513944
741CA229-C224-47A1-94CF-56F3A1A415F9,pilocytic astrocytoma,0.999513211
CE155111-0FB0-407F-BC0D-DFCD90D8A668,pilocytic astrocytoma,0.999513211
F39D0F67-D98E-4DD3-A240-0FEA038D177B,pilocytic astrocytoma,0.999513211
CA0C5A89-A3D2-46EC-ABFB-71300D9276EC,pilocytic astrocytoma,0.999513211
5EE83A39-48F1-4AF9-A167-40AF39B614D3,pilocytic astrocytoma,0.999513211
4480BF2D-E8E0-4FF8-8432-F73C18EB0D0D,pilocytic astrocytoma,0.999513211
909A01E0-DE55-442F-B5A5-F1BD77562ADA,Posterior fossa subependymoma,0.999512708
C1832C1C-BE7D-4701-B67A-F2616869B875,Olfactory neuroblastoma,0.999512681
1E936869-58DE-4FD8-AC9D-2305C28CF265,Atypical teratoid rhabdoid tumour,0.999511073
2A3DBE58-E967-4483-A141-D42F36065866,pilocytic astrocytoma,0.999510977
AA2045A8-77C7-42CB-8B1F-B16FAFAADBA3,"Diffuse hemispheric glioma, H3 G34-mutant",0.999510235
8988AB58-A0A1-4484-8B45-15D9BED43B84,"Astrocytoma, IDH-mutant",0.999508841
71B4E18A-A620-427F-A4E8-43934B8B933D,"Astrocytoma, IDH-mutant",0.999508841
E997AA09-87B2-4CE1-83B7-95A5DE8EED0B,"Astrocytoma, IDH-mutant",0.999508841
5EF0985C-2387-4F0F-99BF-8A477AE8B6F5,"Astrocytoma, IDH-mutant",0.999508841
DD63C0D1-AE3A-4E5D-9A30-A1DF063AB5D1,Dysembryoplastic neuroepithelial tumour,0.999505212
F901A2A3-30AF-4FD5-BEE8-7B5231C2778A,Chordoma,0.999505124
905169E9-59BE-4867-811D-F2BE64B4C2E4,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99950501
37E04E04-E92F-45A9-B5BB-9B66E3AE70E9,Posterior fossa subependymoma,0.999504819
B13D505E-3BB2-4B26-A076-9C53D9F99305,"Astrocytoma, IDH-mutant",0.999503142
25954D6A-52D1-4CA4-8681-D52E6F66ACDD,medulloblastoma Group 3,0.999502366
07A87F90-DC34-4DA7-9D01-54CDF62B0331,"Astrocytoma, IDH-mutant",0.999502326
8323648D-2682-4A62-9615-A61E2243FB86,Myxopapillary ependymoma,0.999502112
F0A95B7F-19C6-48A6-AFEA-026460A1D50D,Dysembryoplastic neuroepithelial tumour,0.999501679
6629BA54-CB06-411B-A222-27D1A4AE5AEE,"meningioma, benign",0.999499813
9A5BCD61-050C-44FC-8777-6A730D3E018B,pilocytic astrocytoma,0.999499428
D3C435CE-5C61-459A-8FCF-4981E0A1BF7F,pilocytic astrocytoma,0.999497778
640BC975-B69C-4242-8E5A-45037C9215E0,choroid plexus papilloma,0.999492367
2993CBDB-580F-43F7-A441-297A33B66B42,"Diffuse midline glioma, H3 K27-altered",0.999489815
5804EEE7-A3D2-4A7C-B2BA-B6D5DCC62686,medulloblastoma Group 3,0.999488441
415EF29C-0461-4315-AC52-6F7000C21703,"meningioma, benign",0.999488244
D0433735-3A03-4746-9B7B-0E5EE3997D54,"supratentorial ependymoma, ZFTA fusion-positive",0.999488233
4F2DA90D-CD86-4BB3-A4B0-39972A19A124,"meningioma, benign",0.999487554
5FCE9DF7-467F-492B-B6FC-83F73A6CA06B,Melanocytoma,0.999486726
17D8B171-DBD8-4A16-B9E0-5E22F6F6966A,Solitary fibrous tumour / haemangiopericytoma,0.999484307
05F46194-0395-43FB-9D20-99FC166E7B72,"glioblastoma, IDH-wildtype",0.999483953
343E2B71-A490-4744-A9DE-8BE091F2BC86,"meningioma, benign",0.999482375
016BA749-0089-41B0-95CC-D4E01C6964E5,"meningioma, benign",0.999482375
CCF4E5E6-77A1-4205-A4E8-C2040F95FA99,"meningioma, benign",0.999482375
E70350EF-EDD1-4D3A-9C1C-58C8D33D5A04,"meningioma, benign",0.999482375
41C97EF5-D27F-4D2F-B924-D7C92DDA0E80,"Diffuse hemispheric glioma, H3 G34-mutant",0.999480998
B34B995B-9F87-493D-A7A4-1F07E8FA2F88,posterior fossa ependymoma group A,0.999478844
60B62DDC-AC62-4917-9A48-8AB27113AD1E,"Diffuse midline glioma, H3 K27-altered",0.999475105
46AE9150-1FCF-4B43-B474-4FBD75CF36BE,Myxopapillary ependymoma,0.999474261
C1C3850F-E15D-46FA-A05B-09273D404B9C,medulloblastoma Group 4,0.999474174
1EC84C6A-B7E4-4DB6-AC6C-884EC31A8A3F,"glioblastoma, IDH-wildtype",0.999472568
F90944C7-08AA-4F12-A36E-7A77439C7397,"glioblastoma, IDH-wildtype",0.999472568
23AB4ECF-3A07-4EE2-99DF-FBAEAC7AB50C,"glioblastoma, IDH-wildtype",0.999472568
96E9BB28-914B-4188-BD1C-F84D8802D753,Ganglioglioma,0.999472544
6DBB509C-EAF5-4EC5-AC7F-EA00C34F6134,"Astrocytoma, IDH-mutant",0.999472452
89CE5B4E-7FC8-409D-A1C5-05CB9DA97CAA,"Astrocytoma, IDH-mutant",0.999472322
4B2BF22D-3245-4E86-AB69-9BCF40995074,"Astrocytoma, IDH-mutant",0.999471638
0DD73319-447F-431B-AD07-8A1698F369CC,Spinal ependymoma,0.999470453
B511B619-0FFA-4301-8002-3BAB355588D8,Spinal ependymoma,0.999470453
7B626154-E15A-431D-B3E9-BC3F5103CCA7,pilocytic astrocytoma,0.999469742
A6DA31FB-2584-46FC-A13A-3C9AF94F149D,"Diffuse hemispheric glioma, H3 G34-mutant",0.999468942
FFF62FD7-B7F3-4B21-898D-813FE09231B2,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.999467511
F37B5847-B0DB-44BF-8309-B9AD9C11F54B,Pineoblastoma,0.999467179
FCDE1693-2E4D-457C-8C6F-BA6EEEC5E379,posterior fossa ependymoma group A,0.999467141
58041ACA-3944-4DFA-B9EB-49E1C9FE8C09,posterior fossa ependymoma group A,0.999467141
AAE8CA7B-36E4-49EC-923E-893BE4CBA15A,"Diffuse hemispheric glioma, H3 G34-mutant",0.999466399
63C588FC-B227-4152-B93C-515D0B4AFE4D,Pituitary adenoma,0.999458167
38E443AD-3960-4259-AFBD-45C0EFD011A7,"meningioma, intermediate",0.999456207
673324C0-5EE8-41FE-BA6F-3F9FC7C78427,"Medulloblastoma, WNT activated",0.999452997
05577087-2202-4869-823A-D174329AADF6,"medulloblastoma, SHH-activated",0.999451985
6CDD07DF-168C-4144-83AD-5927D1479E4C,"glioblastoma, IDH-wildtype",0.999447067
4941FF28-05C1-4AC6-A0AB-6860259DACE1,"glioblastoma, IDH-wildtype",0.999446654
A1410B8E-69C0-4BEF-BAA4-675BB9EB6FF7,"Astrocytoma, IDH-mutant",0.999444824
EDCC1360-502F-49B3-A2BF-FFE9141B519E,"medulloblastoma, SHH-activated",0.999444507
74D0DA1D-1016-4063-A76C-737636305AFD,Melanocytoma,0.999444203
53E89589-4391-4139-9E3F-5E68AC9C1059,Pleomorphic xanthoastrocytoma,0.999442849
5B8F48C3-28FD-42EE-8AAA-BD5FF2C7C799,spinal subependymoma,0.999442776
5677F33F-F346-4D2E-A3F6-7781B5A54008,"meningioma, benign",0.999439964
828746EA-19ED-48B4-B354-1019F073B2EE,"meningioma, benign",0.999439964
A261CD34-100B-4AF3-ADC4-7034A592B815,"meningioma, benign",0.999439964
05E98F3F-FDBE-4BD3-80DE-7D237BB7EA57,"meningioma, benign",0.999439964
23EDC5ED-7D1F-4262-A1A0-263646C9B2E2,Myxopapillary ependymoma,0.999435246
554489DB-B34D-407F-AA12-5CC4425EABA0,"medulloblastoma, SHH-activated",0.999433744
5D6B8F1E-6E1D-4C5C-9B4F-25882774D5CB,papillary tumour of the pineal region,0.99943326
346ABD2B-4A2F-4E2F-B031-C40DF65669A4,"medulloblastoma, SHH-activated",0.999431048
69FBBB3E-184A-400C-9B6B-B8E6D3192244,"Diffuse hemispheric glioma, H3 G34-mutant",0.999423695
2D0087FF-FA5E-4A5D-ADCC-162BFA8C6B2A,"glioblastoma, IDH-wildtype",0.999423191
BA6E20F6-599E-4C41-AD4A-FE0CF3CB8138,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999420363
8CA0E7FC-6F3A-4771-A671-1E2D6CE96DB9,posterior fossa ependymoma group A,0.999418997
611F5D19-3519-48E3-8475-4BB771FC3C79,medulloblastoma Group 4,0.9994185
DE2832DF-7923-4758-AC73-481A42BAA400,"glioblastoma, IDH-wildtype",0.999417194
88B47944-55D2-4EB7-BE92-6B77FA25ADBF,"glioblastoma, IDH-wildtype",0.999416666
90AA2781-B686-46B5-9BEB-6A09102AA342,medulloblastoma Group 3,0.999415782
D426AAB9-44D2-41FF-A628-3B73426BEF59,"meningioma, benign",0.999415318
CCBF3990-DD4B-4C63-AFE7-30BB2DE4E6B2,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999414112
F8C509E4-E799-4DFE-AB84-4FD9BAA50C74,posterior fossa ependymoma group A,0.999413513
FF73827F-5BF7-4F5E-ADB7-62B279B63066,pilocytic astrocytoma,0.999411528
3CC5E13E-D114-4CD4-BABB-71C22F2ACE62,"glioblastoma, IDH-wildtype",0.99941106
12EB7A9F-F0E0-4909-BC8A-B339F4AA32B9,"meningioma, benign",0.999405824
150B3461-475A-4C61-BC89-2C1611948553,"Diffuse midline glioma, H3 K27-altered",0.9994057
A7AD0C0D-3997-4BA2-95C5-9E1E7EFDF821,"meningioma, benign",0.999405338
DBF9ABAF-FB05-47D7-998C-0767D5796857,Rhabdomyosarcoma,0.99940321
6989621D-0DA6-4BD1-99B7-DFFBCD64D1AC,Rhabdomyosarcoma,0.999400275
6B896420-DE14-4AD6-BFD3-C801DCDDF8C0,"meningioma, benign",0.99939968
CF38397D-5BF5-4BE1-A281-6C6C3A21103C,Supratentorial subependymoma,0.999398192
D4608C2A-0E33-4594-B2CE-9C12137D9E4F,Supratentorial subependymoma,0.999398192
5DF9C2F0-9754-40EC-853E-FB1FB55D2C17,Supratentorial subependymoma,0.999398192
0768701B-079A-40B0-AEAF-2548507E60B7,Supratentorial subependymoma,0.999398192
D5BD6647-B8E7-4DBF-9435-1B01FFEB8B49,"glioblastoma, IDH-wildtype",0.999397861
5C4DF5F9-FEAF-4E10-BD75-26C0013EEE38,"meningioma, benign",0.99939783
4D3A1452-25CF-456E-A00B-889CF2A715B6,Posterior fossa subependymoma,0.99939588
D89BEA39-4546-46A4-BEDB-444701D972BB,pilocytic astrocytoma,0.99939557
81BF21A2-B7F9-48A5-866B-1CF7721869D3,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999394522
E716FA37-11A2-439B-9765-3F42A9168624,"glioblastoma, IDH-wildtype",0.999394005
1C230F97-3BEA-4ECD-8B45-8743F5C517E0,"meningioma, intermediate",0.999393487
AA71EAD2-7417-40B0-95E5-C8D1E4A203BE,Chordoma,0.999391807
BC2AEA73-F23D-4C00-8CB1-06FA4624AB7E,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999391774
76E99CF4-9685-4416-802A-A9FEA78748C8,Ewing sarcoma,0.999391159
F79136A7-1637-4700-8C6B-3B017B848C52,Teratoma,0.999390999
AFC15E15-9BF5-42CC-9800-BC45F8BDD388,"Diffuse midline glioma, H3 K27-altered",0.99939017
094DD9CF-CEA9-46F7-B94E-13488A9D750D,"glioblastoma, IDH-wildtype",0.999388689
C5EB9239-5814-4D78-A4F3-7D8924CBF6A3,"glioblastoma, IDH-wildtype",0.999388625
0797AC04-C277-4739-888A-1ED1B38D70AC,"meningioma, SMARCE1-altered",0.999385272
77B10884-66B4-4BEF-8DBA-58B5049098FD,Chordoma,0.999385142
692D7722-151F-4095-885C-9AF03B5D4673,"medulloblastoma, SHH-activated",0.999382094
82933E33-5ACF-4868-9128-293D1CED9331,Atypical teratoid rhabdoid tumour,0.999381909
E43C4425-B083-4396-88D2-800D86E01DFB,"Diffuse midline glioma, H3 K27-altered",0.999380616
BA3EE4FE-8747-41A0-829D-BDF93410C967,posterior fossa ependymoma group A,0.999379168
8421B109-72E1-4AF9-BDF6-C667593742E6,"Diffuse midline glioma, H3 K27-altered",0.999378313
23CE23F1-3A44-41D3-A420-E164C89FBAD3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999376138
1AC85269-1654-4F89-A4F4-8E50CA0F8C09,"meningioma, benign",0.999373264
7FE69C4E-B4CB-4185-B92C-E015C660F043,"meningioma, benign",0.999373264
8527A218-8467-467C-AE0D-BEDE9CD57A8B,"meningioma, benign",0.999373264
FB356425-FBA0-4BB7-9EC5-BAA6711D1EAF,"meningioma, benign",0.999373264
950C9E1B-87DF-4DD7-AC56-6A1E7AC3367B,posterior fossa ependymoma group A,0.999372032
C27541A2-56C7-4AF3-A37B-2723014DDB7F,"Astrocytoma, IDH-mutant",0.999365135
84821E20-26E5-4D85-8370-45610DEE9C8D,Pituitary adenoma,0.999363078
21D81833-6DBA-4F61-A7F1-6F6E013E8955,"glioblastoma, IDH-wildtype",0.999362034
EF491DCC-E0FB-42FD-8144-CFC87A1B5FD8,Pituitary adenoma,0.999359919
FCF0FBAE-F5DC-40EF-BB28-F7E3AC6EA45F,medulloblastoma Group 3,0.999357746
05C4A8A3-D979-487B-AE81-F3BBE6BE362D,"medulloblastoma, SHH-activated",0.999357445
B8EAD6E4-FBCC-46E2-B184-E43E80E8E50F,pilocytic astrocytoma,0.999356647
5AE93976-8692-4D5D-A606-4CE207C982ED,Posterior fossa subependymoma,0.999348141
C1EDE510-73EC-46A4-B8EB-C9182983BE7F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999335677
F02BF963-900B-43CC-BA59-B64249CB6111,"Diffuse midline glioma, H3 K27-altered",0.999335537
B67EA9AB-FE2A-404A-B413-C2130B45D8D6,posterior fossa ependymoma group B,0.999335385
E39C8151-B014-4DBB-8D42-E796E76D2FED,"glioblastoma, IDH-wildtype",0.999334905
D6C81CAB-BBD9-4972-A8C4-F1DB633AB360,medulloblastoma Group 4,0.999331293
1B9AD061-13FE-4F86-856D-113618C70BEB,"glioblastoma, IDH-wildtype",0.999329081
EBEB7CD3-1467-43F6-B946-3557D19FF448,"supratentorial ependymoma, ZFTA fusion-positive",0.999328423
3BF85741-C017-4DCA-82CB-C6AEEAE140FA,"Diffuse midline glioma, H3 K27-altered",0.999327769
27915AF0-CC43-4816-B480-8BFD41AB0F39,medulloblastoma Group 4,0.99932715
B8155826-4780-40A6-92AD-8E2ACC7DBC3E,"meningioma, benign",0.999325862
BD743385-7E41-4DEB-8328-2892B2D2C7F2,Myxopapillary ependymoma,0.99932564
D1A0C194-86BE-4725-8C03-F3E23DA23D84,pilocytic astrocytoma,0.999324015
8EED0F4D-A8DE-4BE3-B8A0-659A1580CE03,posterior fossa ependymoma group A,0.999322692
B5ACFC58-F01F-47DF-B126-E1A61B865D8D,"glioblastoma, IDH-wildtype",0.999322209
5FBF8B62-E994-44D3-AA62-FCF5E4BD4A9A,"glioblastoma, IDH-wildtype",0.999321963
3AA2D57A-3302-4C6C-B517-6CCD1408BBDA,medulloblastoma Group 4,0.999319588
11CE7F1B-8226-49E9-B7F3-912998AE884E,"glioblastoma, IDH-wildtype",0.999317396
ACB7DC35-02BC-4FB4-8A54-589C0E33C909,"glioblastoma, IDH-wildtype",0.999317396
2E96F264-BC21-4672-A70D-DBEE0A2D5E7B,Schwannoma,0.999315731
80ACC79F-84CF-4ABA-95D7-9621C388C536,"meningioma, benign",0.999313726
8D77EDD1-3527-4D3C-ABE1-DA1A4E3DE2CE,"medulloblastoma, SHH-activated",0.999311387
141FA33F-A67F-4942-A656-73561A3738A9,pilocytic astrocytoma,0.999310122
9725C493-E42B-49AD-9D7C-E94861702EB5,pilocytic astrocytoma,0.999309025
9CB390FD-0893-478F-854E-E9AB4ECBF924,Primary diffuse large B cell lymphoma of the CNS,0.999308772
AE82B702-65D7-486C-BEDA-93EB36DF6C58,"meningioma, benign",0.999305995
E340A98F-C2C6-4417-88E6-B8D3DE7D5644,Spinal ependymoma,0.999303482
CD9BA5AF-E255-4169-82C1-D20B8E8F398E,medulloblastoma Group 4,0.999303437
6924F8EB-4C53-4B34-905A-766918393BFE,Pituitary adenoma,0.999302079
8AC928E9-300D-4D1B-826B-4FBADD54E292,Ganglioglioma,0.999301337
E8DE2BC9-FC2E-4271-B1C7-CB57065E9160,Ganglioglioma,0.999301337
10BAE516-0D6F-4355-89F5-0482A3FE80E9,"glioblastoma, IDH-wildtype",0.999299416
27B01401-5EEE-4E7B-BEDE-38D647915A95,medulloblastoma Group 4,0.999297613
112C6CD6-2C8D-4CD7-8007-F65E4C84459F,normal pineal gland and pineocytoma,0.999297471
45D714CC-6137-4AA0-AC33-2EAE0FA62B1F,"glioblastoma, IDH-wildtype",0.99929522
AFAA28D3-0DDA-4E9A-8704-C585BAA72E10,"Medulloblastoma, WNT activated",0.999292594
1E183D5F-20C6-4080-A17C-8722BB431FB0,"glioblastoma, IDH-wildtype",0.999291909
E0B05252-F76F-48C9-99C8-F632491404E3,"Astrocytoma, IDH-mutant",0.999290599
7AD5309F-D7D3-4E62-8A97-9C4D8B522AFB,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999289848
50FC5BA5-B4B8-4B67-818A-F3CD80E98759,Diffuse leptomeningeal glioneuronal tumour,0.999289662
5B4DE287-4078-4B2E-AD7B-6040046B8E5C,"glioblastoma, IDH-wildtype",0.99928949
6D0DC683-A8FE-4268-BC8B-1905D76D5828,"glioblastoma, IDH-wildtype",0.999287681
28A78D8A-6B62-45BD-B991-B314E9301A36,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.9992841
7CAA66E3-4FCA-4E74-AA99-B65A41CCBEF6,"glioblastoma, IDH-wildtype",0.999281529
24561302-22EA-486F-9E0E-DE4192CA012C,"Diffuse midline glioma, H3 K27-altered",0.999279739
E9B93D01-39A4-4AC3-93AD-144A1B6D8DF7,"Astrocytoma, IDH-mutant",0.999276202
CB810163-DCB2-4EE6-B76E-0C262AF766D4,"meningioma, benign",0.999275882
D21067E9-5AEB-48E7-97AF-59F3F77FF5C6,"Astrocytoma, IDH-mutant",0.999271193
C3A77F58-6EFC-4C92-8F85-4F71470A3499,"glioblastoma, IDH-wildtype",0.999268409
63625229-69D6-4B7D-AFF7-BEF99BF94424,pilocytic astrocytoma,0.999268405
D287FBE5-876B-4D0A-A651-97C1C6707FC7,"meningioma, benign",0.999267507
2AD0CAE1-DAD6-4D62-976E-A7EC2E27830D,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.999266486
1912A1CB-1BA3-4AE0-85FB-B0612E0C307A,"Pineoblastoma, miRNA pathway altered, group 1",0.999266359
E8662346-65D0-4282-B0FB-8C76FBD7CC8A,"Pineoblastoma, miRNA pathway altered, group 1",0.999266359
1D809693-5F2A-4FBB-87AB-5B95E52693EA,Primary diffuse large B cell lymphoma of the CNS,0.999265429
B44EBBAC-0F4F-4D5E-AF6E-6D6614709659,Primary diffuse large B cell lymphoma of the CNS,0.999265429
ED6EEE0A-37ED-4B94-BD1A-0BF836D11311,"glioblastoma, IDH-wildtype",0.999263227
93072718-FD5A-485A-A5CC-F6DC37F6DCB1,medulloblastoma Group 4,0.999262492
F676B596-340A-4435-937F-B571A3150EFB,medulloblastoma Group 4,0.999258246
4C2621A9-16A2-45CB-87B7-0A93EB5FF29E,"Astrocytoma, IDH-mutant",0.99925808
DA9B3D13-86E6-459F-966F-E17E55E7BA33,Primary diffuse large B cell lymphoma of the CNS,0.999257636
D710858C-0FB6-4FC1-878B-06D425A7C845,"glioblastoma, IDH-wildtype",0.999248339
0876A5F7-F43D-4874-AE3E-C6DF436EF9D5,"glioblastoma, IDH-wildtype",0.999248002
5F404133-34AC-442B-8216-3B83C38611CB,"glioblastoma, IDH-wildtype",0.999246945
9B70C650-A41B-4721-9220-B33C17302757,"glioblastoma, IDH-wildtype",0.9992449
1ACCC89C-456B-4469-B8A1-0A2BF3316038,"glioblastoma, IDH-wildtype",0.99924487
6DCCA983-0D70-4ED6-BF8E-E5C2CF21A609,Myxopapillary ependymoma,0.999243005
B0423571-B5FB-4086-923A-14CB9D8C05F7,"glioblastoma, IDH-wildtype",0.999241756
E3C45F04-4E9B-4A65-BA77-4D430B1C5701,Solitary fibrous tumour / haemangiopericytoma,0.99924172
3D65A459-6F37-4FEC-8129-5B70401C7659,pilocytic astrocytoma,0.999240926
A73D51CA-AE7B-4D53-860E-5CC9C23CF69A,Schwannoma,0.999239493
054F13BE-EBC6-4BD1-9FC1-46DB9D275954,"Astrocytoma, IDH-mutant",0.999237579
6C2D9A2F-3449-49D3-95DC-8BF50B0AABAB,"Diffuse midline glioma, H3 K27-altered",0.999236737
D99A7E73-C44E-4514-95FB-86F487D13436,"glioblastoma, IDH-wildtype",0.999236726
2DE7C1E4-2F82-4FBF-BECE-DE456167DA63,"meningioma, benign",0.99923566
2C53170C-D916-41AC-9DA1-B71690B34E41,"meningioma, benign",0.99923566
DEDE4526-A6F2-4707-9036-DD8D42920836,"meningioma, benign",0.99923566
D2C8D282-2F03-46FE-8E01-500EB0B337C6,posterior fossa ependymoma group A,0.999228844
5CE8D8A1-B162-491E-9BE4-E189C50A8CA4,Dysembryoplastic neuroepithelial tumour,0.999228386
48B07418-853B-47C3-ADC5-E5C6BBDD0ABE,Haemangioblastoma,0.999227209
0BC407D9-AEA1-4AEB-AE28-11CB9CEF390E,"medulloblastoma, SHH-activated",0.999225287
F357E221-34A7-4842-9409-61FB9103C0FC,medulloblastoma Group 4,0.999224373
A30CF63B-68A9-4864-9566-BE701007295C,"diffuse glioma, MYB- or MYBL1-altered",0.999220985
FAC6B86E-60E8-4FAB-8610-D49B3500CB6D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999219962
46CEFF58-C2D6-4F63-9179-4AC89652C134,Solitary fibrous tumour / haemangiopericytoma,0.99921923
8273BA77-7861-4131-80B4-9A7588E59D62,"glioblastoma, IDH-wildtype",0.999215894
67CC66F8-CE62-4497-8447-5B56227751D8,"Adult-type diffuse high grade glioma, IDH-wildtype",0.999214489
560DCB2B-C2E6-4B1A-87C1-485CB7DFF3AF,Rhabdomyosarcoma,0.999211864
5CF7A4FC-27A3-407C-9D41-DC22F24AEEC0,"glioblastoma, IDH-wildtype",0.999211502
871A7D30-01AA-4683-BDAB-98166C773857,"glioblastoma, IDH-wildtype",0.999211502
D44B560D-AE0E-41E7-8A02-DF9BC978B9B5,"medulloblastoma, SHH-activated",0.999206479
635518BF-BAE4-4E19-924F-079E4F43926A,"Astrocytoma, IDH-mutant",0.999204466
600AB7A9-DAC7-44DC-BB73-7441F8B41D0C,"meningioma, intermediate",0.999201506
0E02E31B-24B2-4DE3-850E-E33B6D290E81,"Astrocytoma, IDH-mutant",0.999201261
556FBD99-58DE-45D5-9BAD-60D1F2B8E795,Pleomorphic xanthoastrocytoma,0.999199423
C9FBD7FA-010F-47EA-B342-ED6BD508A623,Pleomorphic xanthoastrocytoma,0.999199056
D3D01E0D-0128-4B50-9D1A-5F7D1992B2D6,"glioblastoma, IDH-wildtype",0.999198998
4555F70B-E876-469D-B6F3-E499BD2B37D8,"meningioma, benign",0.999198177
9BD44969-33A6-4BCB-9231-60FB6D94FE52,"meningioma, benign",0.999198177
9B2CA11F-A50D-4C57-983C-5AD110006780,"meningioma, benign",0.999198177
FE9B152E-96F5-4FF4-817A-E09BF3904150,control tissue,0.999197636
6D5C24C0-996A-42A6-8020-B59C1DE371D0,pilocytic astrocytoma,0.999197404
071C4555-949F-41F1-A620-E9C9CFEAF972,"medulloblastoma, SHH-activated",0.999195435
E8A87AB2-A531-42C3-81E5-234F52080F42,"glioblastoma, IDH-wildtype",0.999193529
6C122803-09F4-4921-984D-903973DFC77D,posterior fossa ependymoma group A,0.999191065
7B87A652-529E-4E53-9E5F-B999C00FCBDB,"glioblastoma, IDH-wildtype",0.999187639
4795385B-8566-49D1-88E9-D07EDC7BD64D,"Control tissue, reactive tumour microenvironment",0.999187136
EE7F4D5C-4F6F-4A21-9940-8FB459FEDFF9,Primary diffuse large B cell lymphoma of the CNS,0.999184847
35C9742C-78AE-4682-84E2-44FCC3D8FD84,"glioblastoma, IDH-wildtype",0.999184057
05311029-303E-42F5-8916-4779306026FC,"meningioma, benign",0.999179767
C57A0748-9444-415E-B78D-1B45B0CD03E5,medulloblastoma Group 3,0.999179622
8B0CE1D6-9C9C-42BB-B9EB-D356DF9B07AD,"medulloblastoma, SHH-activated",0.999173246
B41ECBB1-D7C9-4A05-A8A7-F2214FA158F2,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999171415
66D48DF6-1EF9-4BDF-B6BA-C856D016FB46,"Primary intracranial sarcoma, DICER1-mutant",0.99917128
D407AE08-A96E-42E0-82B1-99CD2AD4985A,medulloblastoma Group 3,0.999170836
BB6BBFA7-A823-420B-B848-57603CE65D7F,"glioblastoma, IDH-wildtype",0.999170088
097845C2-CF22-42B2-A722-AFFFF617F2DD,"Astrocytoma, IDH-mutant",0.999168369
539455AF-5C9C-4B5E-B484-9FCFD82DAAF9,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99916631
E5DFCDA4-AFEA-4B14-8435-FD12F64CEEE6,posterior fossa ependymoma group A,0.999164824
22F7A543-D3AD-4FEC-B463-661320419CDD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999163093
B3DF0F1E-53AB-4E64-93DE-A035489EF709,"meningioma, benign",0.999160179
C2D11044-C39B-4AF7-8721-0144F8B33F3B,"meningioma, benign",0.999160179
52897E49-0AA9-4117-A65F-4F66B0182988,"glioblastoma, IDH-wildtype",0.999158879
6F7FD674-BE87-481D-A5D8-91A2A3DD0D7D,Rhabdomyosarcoma,0.999156483
9463712D-42BA-4007-B0FE-9F1B084FAC13,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999155383
1C5D9BE1-21F8-4827-ACE9-D24429BF1432,Dysembryoplastic neuroepithelial tumour,0.999153023
C49F927A-6FEF-4B0F-802B-515E2CEDF95D,medulloblastoma Group 4,0.999151928
C06F3ED0-231C-4774-AB14-0D334C263EEB,posterior fossa ependymoma group A,0.999150216
72FD3EE5-16D9-474F-A286-DFB57BA2D7EF,"Astrocytoma, IDH-mutant",0.999146572
330DEB39-449B-4AAB-B720-F906E8818C4D,"Astrocytoma, IDH-mutant",0.999146572
BBD74ED3-BC1B-4B21-B82C-CBE8702E56EB,"Diffuse midline glioma, H3 K27-altered",0.999145226
2DE05A30-B98E-4E10-80C2-C0133596A95E,Dysembryoplastic neuroepithelial tumour,0.999143856
A1B95704-650D-4B5F-9220-C09E56548349,High-grade astrocytoma with piloid features,0.99914108
11FA3485-7A6E-457E-A5CE-7FCB65062603,Diffuse paediatric-type high grade glioma,0.999140758
2DD1C422-7E8F-41C0-8A60-29686B1F4E29,pilocytic astrocytoma,0.999137167
03A62830-1735-4B36-9A66-04178B08B9AE,"glioblastoma, IDH-wildtype",0.999134865
B00710CE-64DA-4AE2-B984-A0840628409D,"glioblastoma, IDH-wildtype",0.999134865
48785B33-E582-440A-B6F9-B86081ABC4A8,"glioblastoma, IDH-wildtype",0.999134055
FE5CFD20-48CB-4A73-8784-D0A4C67B843E,Ewing sarcoma,0.999130379
ACE14BFC-7471-4ADA-9370-C0482E608EB6,Ewing sarcoma,0.999130379
47276FC5-4F5A-42A9-A36D-2F71B5A9A492,posterior fossa ependymoma group A,0.999127827
24BAE5E8-219A-42BF-B4F5-55A46E46DB8E,"Diffuse midline glioma, H3 K27-altered",0.999120087
CDC37D90-E67F-497A-9184-8081293E18F5,posterior fossa ependymoma group A,0.999119353
71F01AB6-655B-4BB8-845C-5D90341E4C44,medulloblastoma Group 4,0.999112572
DED73BF8-C7D9-4064-B337-10D2B271E303,Posterior fossa subependymoma,0.99910969
FC8023A2-64AD-45B7-9F26-6749F54AE9BC,Dysembryoplastic neuroepithelial tumour,0.999107994
5E4526E4-CC16-4BB0-86F5-50B7A8BED98E,Schwannoma,0.999103524
F6874436-7A15-47B4-B38B-A7EF684B98CC,"meningioma, benign",0.9991034
0FA6AF76-0F19-4AE7-915D-C86383CBCD98,"meningioma, benign",0.9991034
591F9F8D-9C8C-4B33-A63A-AF30B2F48772,"Primary intracranial sarcoma, DICER1-mutant",0.999099225
9E8A2C9F-F033-4613-B510-5A91415133DC,"glioblastoma, IDH-wildtype",0.999098786
A4F5B737-AD93-45F9-9EEA-1B5AB11889B8,control tissue,0.999096855
5EFAB4A0-A4BF-4DEE-91CC-B540D2DB0E22,control tissue,0.999096855
3B20B527-4236-4A73-B4ED-6C4B97B3E525,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999093756
0B4B83A4-8AC7-48D1-8FD0-FFFA6E179C80,embryonal tumour with multilayered rosettes,0.99909277
61EAA515-43CD-41EF-BD5D-E87B3ECA4BC0,"medulloblastoma, SHH-activated",0.999092356
5DF6C9D2-5923-433B-8E6B-57274C46B278,Solitary fibrous tumour / haemangiopericytoma,0.999088496
1EE2D6AD-2F2A-4457-BA86-4CC8D137249D,Myxopapillary ependymoma,0.999086737
1B5AFF3C-53B5-4A85-B1F4-8B8EEAF37781,Spinal ependymoma,0.999085714
55012AC9-9D58-4B8A-B01C-100D70FD9525,Rhabdomyosarcoma,0.999085142
0EE7E04E-9582-406F-B809-BB22EE00B99E,"Astrocytoma, IDH-mutant",0.999084279
AF820BF8-173B-4667-B61C-7E27D8C208A1,"Astrocytoma, IDH-mutant",0.999084279
767097CF-3C6F-429A-9526-CD799FBC954D,"Astrocytoma, IDH-mutant",0.999084279
CBAF12F3-7A59-40DB-A503-C5776438088C,"Astrocytoma, IDH-mutant",0.999084279
3F7B089D-8921-4F65-AB82-77BEB583A252,"Astrocytoma, IDH-mutant",0.999084279
1C768A15-6957-4B54-A88E-D6BA2D243D20,"Astrocytoma, IDH-mutant",0.999084279
C052BA32-D112-47DE-8B43-618F7E9D6317,"Astrocytoma, IDH-mutant",0.999084279
043F5F6D-679D-45CB-8C65-543B834AA5D2,"Astrocytoma, IDH-mutant",0.999084279
197600E1-3323-4362-B8CE-027F83A4D90E,"Astrocytoma, IDH-mutant",0.999084279
409FE648-9FF1-4D97-862A-0CE510FFB44A,"Astrocytoma, IDH-mutant",0.999084279
C160FBC0-4936-42DB-9C88-CA991615F9CB,"Astrocytoma, IDH-mutant",0.999084279
25DC4809-B4F0-4696-96BE-A95C85E9DEE7,medulloblastoma Group 3,0.999083515
4FB234F8-12EE-42B9-9606-3B1B9FF0F552,"Diffuse hemispheric glioma, H3 G34-mutant",0.99908349
D98EE1A5-8C17-49B6-9328-31F8D81DB046,"medulloblastoma, SHH-activated",0.999083451
21A3F72B-5864-4C81-9BBB-5AF48CC0BA67,"medulloblastoma, SHH-activated",0.999083445
3439F54C-FC59-4B78-8B2B-9FBE2BD08BD0,"glioblastoma, IDH-wildtype",0.999078913
CEBC17F0-9E1D-4579-8648-FA4B9BD07FBB,posterior fossa ependymoma group A,0.99907852
0B014647-4306-4E59-A497-EFB0B8E52D8E,"Pineoblastoma, miRNA pathway altered, group 1",0.999077607
13ED1D45-9006-4BF2-B38C-DAFD3E1DA726,"Astrocytoma, IDH-mutant",0.999076205
4747B831-296C-4A6B-9757-EE3ABCB8F1DC,papillary tumour of the pineal region,0.999074409
E74E2ACB-AF2F-4130-BB15-5C0E82F3B2E2,"Astrocytoma, IDH-mutant",0.999074032
DD4A0C45-7580-4C59-8EDA-19BEEFF35AFF,embryonal tumour with multilayered rosettes,0.999071127
04DE14C3-B8F2-4F25-A0DF-829A8EA16A24,embryonal tumour with multilayered rosettes,0.999071127
28253C25-3B18-4911-BB72-3ADD2311F969,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999066079
37D535CA-217B-4D32-B55C-1E426FEA51B4,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999066079
EE07E17F-33EC-4891-B515-E30E22AAFF38,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999066079
F947EA89-4EB2-4F6A-9D11-87F7A7AB4740,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.999066079
D7E1E904-0C2F-40F8-8D49-E71BFECDA645,control tissue,0.999066013
FF5D87DE-342C-432E-831D-1CC6D1F26C01,"glioblastoma, IDH-wildtype",0.999064146
63A67A5C-13FE-4F8A-89CB-179458EC1147,"Diffuse midline glioma, H3 K27-altered",0.999060591
E242B968-2864-4789-B293-7D5F1152963F,"Astrocytoma, IDH-mutant",0.999059655
43046618-28E3-48BC-8522-FC053C528F4B,"medulloblastoma, SHH-activated",0.999058713
B4A06D09-B9D9-40B8-805D-73DBD0712F02,"glioblastoma, IDH-wildtype",0.99904978
D7FFDB51-66C7-461D-8214-09578D137E2B,"Diffuse midline glioma, H3 K27-altered",0.999040886
FC5AD548-DE28-4406-9816-5FE2B436D521,Myxopapillary ependymoma,0.999037348
B3353E98-25DD-4EC3-8578-50DF2B7404BD,Myxopapillary ependymoma,0.999037348
2AB887C8-18FA-4DB1-9156-F807DD02197F,embryonal tumour with multilayered rosettes,0.999036912
A83A5E7E-3123-4E5C-A02F-358C4ABB3E0D,CIC-rearranged sarcoma,0.999034016
402BF804-7680-49EA-A725-16DD3769A598,"glioblastoma, IDH-wildtype",0.999029022
F1947E1D-7AA4-48E9-8EE4-E9B48FF5BD95,"glioblastoma, IDH-wildtype",0.999029022
C5060FA3-4171-446A-BEB3-6B12F605479D,"glioblastoma, IDH-wildtype",0.999028164
F277C249-8D53-4860-9069-7C730F7584F2,Posterior fossa subependymoma,0.999026024
4D76129B-255B-4F20-9943-53EF1BCD6B1D,"meningioma, intermediate",0.999020728
96FF66E3-7583-41D3-BF87-3CADC2F17E0B,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.999020498
6E83EF07-5153-4CF1-96C2-5E03C64D1391,"meningioma, benign",0.999014073
F7882714-CAB2-4F12-8EF8-C66B02779430,"glioblastoma, IDH-wildtype",0.999013675
DCF32EE2-3645-42EF-A77A-8F84446AEAE5,"Astrocytoma, IDH-mutant",0.999009599
A9F8292E-1ECE-4109-98CB-A97F74A70477,"glioblastoma, IDH-wildtype",0.999008764
7849CAF2-DEC2-46D2-AD43-047FBCC8C992,control tissue,0.999007811
4A492453-594A-48B0-85EA-706DD8D81949,Posterior fossa subependymoma,0.999005518
A00BB50A-A011-45D8-8F85-5A4B3FF32295,Pineoblastoma,0.998995552
1A1EA0EE-E043-49B6-B4D2-B68D7B03A5A1,Primary diffuse large B cell lymphoma of the CNS,0.998990238
3D1B71A2-8724-4EC1-AECD-AC69876032FC,pilocytic astrocytoma,0.998988511
659B4E65-270F-4D4B-BB1A-5A485F84B77B,Schwannoma,0.998988261
23B5EC09-FA6F-46F6-9D4C-1674C1E2F3B2,Posterior fossa subependymoma,0.99898655
8713D21F-9C3E-4CCF-8346-5C120DB8C139,"glioblastoma, IDH-wildtype",0.998985903
E04A3A2D-BA9A-41C4-870E-4D24FC950894,pilocytic astrocytoma,0.998979763
45F6CA3A-965E-4224-AE3C-872134EF8883,"meningioma, benign",0.998977497
7F7B5784-CC46-47BC-86E9-AE49B9331166,"meningioma, benign",0.998977497
EE8A95FE-7E23-448E-B2B2-F0F113F076DF,"meningioma, benign",0.998977497
07CE5496-CCBB-4F33-84A0-B355D70DDF10,Dysembryoplastic neuroepithelial tumour,0.998977416
6DA4E51D-1CB4-4EFE-9828-1AEB96323FD2,Pineal parenchymal tumour of intermediate differentiation,0.998976716
69D2FB57-03FC-4A95-8F89-64D97F25E4DD,Pineal parenchymal tumour of intermediate differentiation,0.998976716
99DEE523-21C0-4258-AD51-B11C728E9AF5,"glioblastoma, IDH-wildtype",0.99897463
2BC914F6-078B-4B65-A825-EF1019654BC9,"medulloblastoma, SHH-activated",0.998971264
BF3393B9-3234-4562-9C38-DB1CCD1B6D84,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998968158
EF13BE84-97EC-4701-9732-331DA455A2DD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998968158
152ECED5-87AE-46EE-B8F7-4C1AB0A182CF,Pleomorphic xanthoastrocytoma,0.998963075
F00B00DA-FDE1-4F89-9A23-1B7DF3315C9D,"Diffuse midline glioma, H3 K27-altered",0.998962128
28A62AA5-F2CA-43F5-900E-558D90FD64A4,"medulloblastoma, SHH-activated",0.998962063
F95A0421-EC51-4C42-828B-7D93DCC95397,"glioblastoma, IDH-wildtype",0.998961656
F70A0D70-6336-4678-AE31-78991AC7736A,"medulloblastoma, SHH-activated",0.998959787
E5EBAC8D-D309-4717-8D64-F19C2CE5923B,"medulloblastoma, SHH-activated",0.998956927
366EA026-2E73-4AF3-B2C3-48C8DD6DB2F8,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.998954091
67C25DA6-D381-41B9-BBDB-16E2D9FF6840,medulloblastoma Group 4,0.99895249
62270C01-B629-46AA-A524-D1689116B87E,"medulloblastoma, SHH-activated",0.998952395
C3D39551-E937-435F-B0F6-E0E48A8E9DF8,Atypical teratoid rhabdoid tumour,0.99894987
7CBF040D-827C-46FB-B6B4-29DAEB086283,Pleomorphic xanthoastrocytoma,0.998949572
9BF4D693-B05F-47E0-9483-6E930E045BC9,Pleomorphic xanthoastrocytoma,0.998949572
F6EEEFCE-A5AE-45CB-9BFD-C9FC627D52D3,Pleomorphic xanthoastrocytoma,0.998949572
7535CC92-60BF-4D60-8CB6-309599931934,pilocytic astrocytoma,0.998945856
9B62B065-130C-4F42-A3A1-B1308BF04FF5,pilocytic astrocytoma,0.998945856
B2C65619-A06F-497F-ABA8-B17D78261B15,Central neurocytoma,0.998945002
AADF7BAF-D4A6-4FFB-BDC5-FD6C182B7AE1,posterior fossa ependymoma group B,0.998942562
6668786A-F76E-483B-9D0A-AE5740223444,posterior fossa ependymoma group B,0.998942562
5E39DDB4-D209-440D-A192-F74683D50C7F,medulloblastoma Group 3,0.998936583
F08DAC2B-F5EE-4B6A-89A4-D26957717EEE,medulloblastoma Group 3,0.998936008
5A3F92A5-AC1C-420C-97B7-92F410916999,"glioblastoma, IDH-wildtype",0.998931564
63454350-699E-4498-B842-096D9A55E236,Malignant melanotic nerve sheath tumour,0.998929069
082A300D-CBFC-4CFB-9134-5201F0C454EB,pilocytic astrocytoma,0.998925702
B8199FEC-61F6-4124-8314-C81EA35C905C,medulloblastoma Group 4,0.998925074
F234E14C-977D-478D-97E8-BEAD62C5C2AF,Primary diffuse large B cell lymphoma of the CNS,0.998923428
9E494109-346C-4440-885A-307D1D346D09,Primary diffuse large B cell lymphoma of the CNS,0.99892043
B6F30840-5623-4DA8-92AD-4D07E27E70FD,Myxopapillary ependymoma,0.998917695
1CE75308-1E26-4D2F-ACA0-65F8ACAAEC38,Pleomorphic xanthoastrocytoma,0.998916154
BFA1A349-17D8-4A2A-8F24-609DB078E4A5,"Astrocytoma, IDH-mutant",0.99891138
FB559EC0-2F92-4689-ABC7-756A9AE21F23,"Astrocytoma, IDH-mutant",0.99891138
2EE535B5-9014-48EB-8C76-A06BD2858068,medulloblastoma Group 4,0.99891085
0AD244DA-00E2-47EC-B34F-1698CCF20566,"meningioma, benign",0.99890863
6FAD8F33-CAF5-4C88-B0F2-F03EE02BA0E1,"meningioma, intermediate",0.998907576
F71CE73C-5309-494C-A01E-C8D08950DBB6,Central neurocytoma,0.998902108
9E5A46B0-381B-4048-9C93-EEEAF090BFA3,posterior fossa ependymoma group B,0.998900906
10695477-D2B7-43D2-B1AA-867E9E31A627,Pleomorphic xanthoastrocytoma,0.998899394
6AA5D0A5-3C8F-44DC-AE67-DFD71F2A2833,Primary diffuse large B cell lymphoma of the CNS,0.998897241
F7F9BBA5-BEB0-404E-9EB8-F9615974A7C6,"glioblastoma, IDH-wildtype",0.998894684
7381D64B-35B5-4B69-9BAA-C4CBE6965393,"Neuroepithelial tumour, PLAGL1-fused",0.998887974
5AC927FB-E7FB-4D11-9EA8-3C0A10CFC156,"Astrocytoma, IDH-mutant",0.998885959
1B12D6FF-D133-446D-88EB-0E449A3A7F8B,"Astrocytoma, IDH-mutant",0.998885087
B09AC7E2-DE17-4785-83B1-9CD0259D4E7A,"meningioma, benign",0.998879117
B0C38370-F72D-4B16-AC7A-434BA4D72C79,"Astrocytoma, IDH-mutant",0.998878651
4B462E80-21C9-4049-BED1-036004F2B5E4,"glioblastoma, IDH-wildtype",0.998878622
CB4622E7-90EB-4771-B2AB-1B852E9E1AB7,Myxopapillary ependymoma,0.998876933
17F71CD6-5F9E-420F-9683-FC7ACE1731F5,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998876874
78D25230-7DEB-4323-BB88-7FDD0046FF46,"meningioma, intermediate",0.998876126
02E55338-02F3-4491-B937-B8859D3232DA,"glioblastoma, IDH-wildtype",0.998874906
E68424D9-3C88-4050-9468-8A8DD4699715,Diffuse paediatric-type high grade glioma,0.998872583
5581F230-8467-44B1-90E6-FCA32B04FE46,"meningioma, benign",0.998871507
D256D067-D80C-4B09-86B9-95BA3717FCF7,"meningioma, benign",0.998871507
EAE50005-EC76-4E00-868C-64FFC887CC50,"meningioma, benign",0.998871507
5668C709-EF09-4309-A5A7-454693F14403,"meningioma, benign",0.998871507
F3ED3651-1559-4FA8-8EEC-2A9D78A87ACA,"glioblastoma, IDH-wildtype",0.998869553
L2,Liponeurocytoma,0.998869259
55F83112-9DCA-419E-8B87-1C5CB781DACD,"meningioma, intermediate",0.998868794
FC67AE5C-8F87-4304-9641-7851C44EAA88,"glioblastoma, IDH-wildtype",0.998865958
A0C66FBC-63C3-4CBA-B1B5-E1A1DB96CCB0,"meningioma, benign",0.998865263
10980197-5934-41EF-A5DA-D29CC058822D,"Diffuse midline glioma, H3 K27-altered",0.998864985
3900B2A6-3B16-4D3F-AD6D-D7C866DFF56D,"glioblastoma, IDH-wildtype",0.998861763
9BCECF62-0A4F-4CB8-AB11-D9F4173EB136,posterior fossa ependymoma group B,0.998859394
5A853B4F-ED32-4446-80F6-AC5257C42566,"meningioma, benign",0.998857712
EF139558-DC87-492C-B802-1DD3E556DF41,"Diffuse hemispheric glioma, H3 G34-mutant",0.998853596
105B57AF-6EF4-47B9-900A-05980CD95068,"Diffuse midline glioma, H3 K27-altered",0.998853135
7E46349D-E41A-42FB-BDEC-D93ED099E5F2,"glioblastoma, IDH-wildtype",0.998851184
2B6DA38B-8233-436A-A5D8-DBDD128D996C,Pituitary adenoma,0.998850943
4A2CBC63-14CB-4C58-BA37-D9AC800F8D3A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998849046
AAB165F9-6A45-4545-BCA3-67A0BE33AB26,Myxopapillary ependymoma,0.998848034
63D7D513-667D-4B77-ABB8-E853DD04924A,Myxopapillary ependymoma,0.998839458
33697EE7-FC7F-4F7C-B47F-162F69480C31,"glioblastoma, IDH-wildtype",0.998838951
FD6BABDE-A6AD-4034-AFA9-8BA6F22E6007,Primary diffuse large B cell lymphoma of the CNS,0.998830534
AADA5BB8-A519-4DBC-A67F-231C89B2CD2B,Primary diffuse large B cell lymphoma of the CNS,0.998819621
3990B76C-EEA9-4C8A-AAF8-DC06EBFE512F,"meningioma, malignant",0.998815136
5EF28679-AEE8-48C4-8C25-EDFFE5FB2B11,Primary diffuse large B cell lymphoma of the CNS,0.998814231
6D118325-990F-45B0-9A8F-7AF440D8B5AD,"medulloblastoma, SHH-activated",0.998803259
5533E37C-A9C8-40DF-AAC8-A4C8E7D69002,"medulloblastoma, SHH-activated",0.998803123
11F0C0C0-DB4C-4C7F-981E-99C798BAB045,"glioblastoma, IDH-wildtype",0.998801883
89A59D37-C8F3-4118-A141-D3D50671BE1B,"glioblastoma, IDH-wildtype",0.998801883
B595E760-DF9B-46EB-A664-46336AEAB93B,"Medulloblastoma, WNT activated",0.998800958
9027B196-7D2F-46D9-BAE7-AF9CDC4B7694,"Medulloblastoma, WNT activated",0.998800958
34CABBE3-5AFE-4ABA-87FE-A7E113067645,pilocytic astrocytoma,0.998800567
F00CA658-69C9-434E-8E9A-E6A8C3CA655B,"Diffuse hemispheric glioma, H3 G34-mutant",0.998796127
9F474386-6902-4D0A-B05F-AF48E3500C19,"meningioma, benign",0.998793015
25382A1F-42C2-4171-8CDE-8395AB0E1CD4,control tissue,0.998777594
2402E643-68FA-431F-A4C8-5CC649C5C99F,control tissue,0.998777594
DC570F74-1BCD-4B4F-B9AC-D792583A9F45,control tissue,0.998777594
41A6BBC7-E4DE-40C1-9CD8-5987D729A860,"medulloblastoma, SHH-activated",0.998777522
50001ED1-89E2-4D22-A8FB-23B31A9079FA,Dysembryoplastic neuroepithelial tumour,0.998773972
74E27619-AAE7-4B9C-9ACF-BB4F2FA2AB5F,medulloblastoma Group 3,0.998770493
220AB3D2-7757-4D25-8525-D491A0B8AAB0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998768324
CD52EDA2-3C82-41A3-9488-1AA9E62A960C,"Astrocytoma, IDH-mutant",0.99876777
7C40E684-CCC8-401C-AFCD-ACC985E3B792,Pleomorphic xanthoastrocytoma,0.99876767
2A9B5909-C8A7-407B-AB7B-B6F6F5041008,"medulloblastoma, SHH-activated",0.998767505
3C4811B3-9941-4865-86AB-C81D9856D232,medulloblastoma Group 4,0.998764137
BA637137-52B9-49F2-9BB1-6D8843C0D439,pilocytic astrocytoma,0.9987638
CDE7B4FB-E9B4-4453-889A-03BEAFDC6350,pilocytic astrocytoma,0.9987638
A6EF5D03-B797-4A4E-8848-43EEAAA42ACC,medulloblastoma Group 4,0.998763379
69C211EA-9F2F-42F7-BFCC-E4B96E74C6D3,"meningioma, intermediate",0.998760076
99096E47-D2EF-415E-9FDE-0EB4F665E2C7,"glioblastoma, IDH-wildtype",0.998757018
5B5AAF54-3A1D-4243-966A-03DAE3B7E1AA,pilocytic astrocytoma,0.998756549
4EB1C61A-D70C-4888-B476-3201503AB186,"meningioma, benign",0.998755382
E30B6564-92DE-4024-AC35-26F657435DA4,"meningioma, benign",0.998755382
937B6EED-0802-4161-8F0C-9BC30326A729,"Astrocytoma, IDH-mutant",0.998753249
9176A8E8-64C9-4ADA-B3F3-937727CFEFC8,"glioblastoma, IDH-wildtype",0.998752043
DA584B83-8A1A-4955-8CD4-A87482330B3A,medulloblastoma Group 3,0.998748792
E4323CA4-9A70-4ACA-A94E-9D501F473AD6,medulloblastoma Group 3,0.998748792
B13A25CA-3198-40C8-8021-D73944D58C0D,medulloblastoma Group 3,0.998748792
58AE6195-CFB2-44CB-8B5A-FDB6C4325AA5,medulloblastoma Group 3,0.998748792
DA2890BB-DFA5-4925-BC80-EC8D2FA1E347,"glioblastoma, IDH-wildtype",0.998748645
EAFFF5AB-9E7B-4EF3-ACD6-0B3B3BF08FA9,"glioblastoma, IDH-wildtype",0.998748645
DD03B3D0-0F55-41B0-9F9D-45D91EDE0B2C,"glioblastoma, IDH-wildtype",0.998748645
21A1E384-8C68-48FB-9CB0-28A225144EFC,medulloblastoma Group 4,0.998746814
38D20D15-92DF-48DA-8DFB-40EB8A2E3DDC,"glioblastoma, IDH-wildtype",0.998737319
DF0625CC-B17C-446F-9AA7-91F94900BF94,Central neurocytoma,0.998732348
B047DF0F-A374-4D30-A4DC-1985B8A8171D,Rhabdomyosarcoma,0.998728456
ED9E6E44-911A-4DC5-9986-D1111433F3F6,"meningioma, benign",0.998727416
5209BEC6-412C-44F2-8D21-D1389E70D466,"Diffuse midline glioma, H3 K27-altered",0.998726275
3095CF7D-DB10-470A-9DFD-F04B4E5F3A8D,"medulloblastoma, SHH-activated",0.998723255
05D94B72-3951-4907-97DD-81507E93F661,"meningioma, benign",0.998723108
22CD140A-657F-43B7-9CC3-9052F2386506,"glioblastoma, IDH-wildtype",0.998718618
485855B0-4857-4CEC-988A-4E58C1B982A8,"glioblastoma, IDH-wildtype",0.998718618
2E06E4CC-619F-4474-A8B7-54A174A95B41,"glioblastoma, IDH-wildtype",0.998718618
3B9A08DA-BC17-487F-9D76-2EBEDB39111B,"glioblastoma, IDH-wildtype",0.998718618
1D9A6994-10C4-41C3-A4F8-107FC084ACBD,"glioblastoma, IDH-wildtype",0.998718618
45D3618A-42A1-419C-8F02-FD591B295308,"glioblastoma, IDH-wildtype",0.998718618
9EF64E94-F046-49AF-A302-BBCE063B4180,"glioblastoma, IDH-wildtype",0.998718618
91F93738-564D-489F-A4CD-BAB955FB1678,"glioblastoma, IDH-wildtype",0.998718618
99750A0F-8AEB-41E2-A059-D5B7378546E7,"glioblastoma, IDH-wildtype",0.998718618
85ADA071-B691-4D7D-B9A6-A70C3D0E0877,"glioblastoma, IDH-wildtype",0.998718618
F327C298-16ED-4784-B5F6-859426AE06C1,"glioblastoma, IDH-wildtype",0.998718618
B26E1394-DD16-4BDF-A9EF-0B7503600007,"glioblastoma, IDH-wildtype",0.998718618
B5F46D8E-267B-469A-8B44-D6BC7C1BCD6D,"glioblastoma, IDH-wildtype",0.998718618
7B10A098-DD4B-4204-A398-A2B684DDE737,"meningioma, intermediate",0.998717582
7EF5FD2A-A0C1-4B02-881C-705D023327AC,"meningioma, intermediate",0.998717582
1E83F94D-8FA1-4646-BEAF-220C1038C3E9,"glioblastoma, IDH-wildtype",0.998711044
88334AA7-C8D1-4D1C-AFB0-905AD9ED6543,"Astrocytoma, IDH-mutant",0.998706958
D976E7A6-84BD-4D88-86A4-FD4A591C38F8,"medulloblastoma, SHH-activated",0.998705218
28AC1F1D-D6C2-478C-BCD7-3A0C75741703,"Astrocytoma, IDH-mutant",0.998704045
8BE882CD-C2D0-4860-996B-199864462BA0,"Astrocytoma, IDH-mutant",0.998704045
FDC82E45-E3B5-4437-95CE-3776B76BA40F,"Neuroblastoma, MYCN subtype",0.99870383
7FF5FE4E-3629-4A60-B563-FDE6C2BB59D6,"Astrocytoma, IDH-mutant",0.998697956
D3F6ABF1-A86E-49D3-B18B-477460ABC066,Atypical teratoid rhabdoid tumour,0.998697946
087451B4-EDC8-4863-8D66-97293F47F5DE,"Astrocytoma, IDH-mutant",0.99869646
62803854-51FD-4931-8772-6A3258939091,"medulloblastoma, SHH-activated",0.998695724
B3F53423-79C9-4464-9A43-B2E1020034A8,"glioblastoma, IDH-wildtype",0.998694271
6DE2CA29-45AA-43EC-889D-0F7A4A5C71D6,"glioblastoma, IDH-wildtype",0.998693275
F78F59B1-53E9-468D-BA7A-BD50737BC612,Diffuse paediatric-type high grade glioma,0.998692234
702B0D88-EAF7-4B54-97A4-14AD9C66349A,"medulloblastoma, SHH-activated",0.998688684
688103B2-8308-4106-9211-E03DDC5BC7EE,"glioblastoma, IDH-wildtype",0.998687896
DB592DDB-96C2-47A0-8D12-8CC3E0425E92,pilocytic astrocytoma,0.998685377
A1036EF5-F641-4483-BEEB-9D1F52B0F769,Dysembryoplastic neuroepithelial tumour,0.998680643
7A1ED78F-AC5D-46C5-A599-B3A22DF4DFAD,"meningioma, benign",0.998672353
FC7D60E3-4065-4017-9EC2-6EED7E59DE5B,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.998671734
545FB315-BE77-4DB0-84AC-038A8543C7BE,posterior fossa ependymoma group A,0.998671316
8E0905E2-C37D-4BBC-8B05-F52C0FE6AC1D,Pituitary adenoma,0.998671076
8C2C7423-830C-4F69-A0D7-CAED937B8195,"glioblastoma, IDH-wildtype",0.998668589
66407F4E-0E87-4E1E-9A72-1AAB7FAC8A7E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998654128
ABE83291-6CE8-4D39-A34B-AECF33CEEF53,Dysembryoplastic neuroepithelial tumour,0.998652536
BA308E73-DBDD-429F-82F1-5FC18F9619E1,Primary diffuse large B cell lymphoma of the CNS,0.998646549
994BEFAD-73DC-4AD8-A50A-814837E3DAFD,Ewing sarcoma,0.9986434
7544FFFB-CB1A-4E00-98EF-B764C43E8652,medulloblastoma Group 4,0.998642767
A25D6EDD-47C0-4326-B35F-202A1B2E33CB,"glioblastoma, IDH-wildtype",0.998638582
E9442F2A-ACBB-4156-82CF-D85DF101F9D3,posterior fossa ependymoma group A,0.998638059
25ABE6B6-BD2D-46BD-8522-CC4DE172F164,Ganglioglioma,0.998634486
C86E1D93-ECEE-4C7C-9D28-7A3F63C49428,Diffuse paediatric-type high grade glioma,0.998628125
30F3FCB1-007C-4A88-9F5A-ECE09215FC14,"glioblastoma, IDH-wildtype",0.998627639
FA4750AD-954C-4E8B-8A6E-2EF8F5156428,"glioblastoma, IDH-wildtype",0.99861203
DD2E4AA2-A155-4233-8128-CBB58BB8640E,"glioblastoma, IDH-wildtype",0.998607106
CFD290D9-219E-4C8B-8AFB-811574074065,"Astrocytoma, IDH-mutant",0.998605684
DA1C5F13-C61A-4F34-9D69-A87B28A9FB18,"medulloblastoma, SHH-activated",0.998602134
82D20CCF-9D72-40D4-9035-08CB6E5D0FFE,"meningioma, malignant",0.998596015
AB1EE3AA-34DE-4C35-84FA-6EDE10A5E6D0,"glioblastoma, IDH-wildtype",0.998587176
233AF019-AA17-4ABF-8B5A-B03878D5F3D3,"meningioma, benign",0.998586466
F269C161-D5F8-4EAC-A17E-D4B6F5CDE291,Pituitary adenoma,0.998585348
5DD30B40-5B15-4462-9397-3824B6C3B6C1,"Diffuse midline glioma, H3 K27-altered",0.998584885
E3072350-7CED-4DA8-83A3-D10145BC4BF9,"glioblastoma, IDH-wildtype",0.998574343
ACE5BC43-18A1-4152-8F9A-486B4400E243,"glioblastoma, IDH-wildtype",0.998574343
F029F9A8-910F-4EFE-B73C-166429039E22,posterior fossa ependymoma group A,0.998573706
0016D113-BBD1-4D9E-A4DE-B64CDCC390F1,"glioblastoma, IDH-wildtype",0.998570942
499B3713-3B71-4CA0-BB67-74CAE4324F1D,"meningioma, intermediate",0.998564315
7B78C2F8-789F-4F23-B14A-F61A2E8523E6,"glioblastoma, IDH-wildtype",0.998564164
A21D8DAC-6037-4D11-B0F0-3F49A4CCF23B,"glioblastoma, IDH-wildtype",0.998564164
C95077E7-A2F7-4597-8F3E-1B24DDC8DC7B,"glioblastoma, IDH-wildtype",0.998564164
20257F65-E49F-4B77-AC3C-871C90FAC91B,"Astrocytoma, IDH-mutant",0.998554359
0F30F138-1991-497B-B376-BACBD4474D44,"glioblastoma, IDH-wildtype",0.998549264
0EE283B1-C6D1-44D1-85D5-EEF19CED13FC,"meningioma, benign",0.998545296
05DCB5C8-4E35-452D-B718-E28734506337,"meningioma, intermediate",0.998537982
7403C40E-C71B-47DC-B0BB-D4CABE4F81B3,"medulloblastoma, SHH-activated",0.998532406
3DD5C605-71C4-41A1-A93C-0B001E89E814,"Astrocytoma, IDH-mutant",0.998530487
9F195A30-1F95-436E-A2DD-CE6A240C6E42,Spinal ependymoma,0.998525317
D664C32B-0B7F-48B5-BF13-D89273A46582,"glioblastoma, IDH-wildtype",0.998517263
762E992E-4E63-4FF7-B045-B4F3FE9CB411,"glioblastoma, IDH-wildtype",0.998517263
62DB9F33-53F8-4429-94E7-B9444376EA8E,"glioblastoma, IDH-wildtype",0.998513093
E5732353-B300-4089-AF43-A55D27CBA150,"meningioma, benign",0.998507464
EB0E3DC3-0281-4776-8A9D-882914175F11,"meningioma, benign",0.998490391
275492B3-2C00-4BCF-85A8-0A3709AA78C1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998489316
A1ACB614-BAF1-4077-AA6A-004570189F3A,"Retinoblastoma, MYCN-activated",0.998474537
B846EEB3-45D4-4633-816F-E3BE99FEA1DD,"glioblastoma, IDH-wildtype",0.998473848
60575DF3-9F85-40DE-9AC4-77424324F1FA,Atypical teratoid rhabdoid tumour,0.998473041
A721FF64-63E6-44F1-9251-83BD79176686,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998470469
486B6249-6674-440A-B2EA-AB333C00E774,Primary diffuse large B cell lymphoma of the CNS,0.99846961
88CF3159-7B44-438B-8EF5-DF52AD26E840,"glioblastoma, IDH-wildtype",0.998459545
A58276E2-F6F2-4DC3-A7D2-F3B59A65967D,"glioblastoma, IDH-wildtype",0.998459545
ADEB4552-30A8-40D9-85A1-220F259FD9C2,"Astrocytoma, IDH-mutant",0.998456974
A4A1A7D6-75C2-46CF-BFCC-EB795994C754,"Astrocytoma, IDH-mutant",0.998456974
3D24EE11-D853-4833-912B-838F708022DC,"Diffuse midline glioma, H3 K27-altered",0.998454482
32FBF24F-1452-445C-8574-94473F95CB17,Pituitary adenoma,0.998445991
E09836A7-D823-433A-A529-A75BE5C790D8,pilocytic astrocytoma,0.998443989
52BD8C6E-E1C3-4F9F-9627-58F2E140DAA9,medulloblastoma Group 4,0.99844123
88B5C0DF-F268-4D32-9AAA-21A1ECE60E5B,"medulloblastoma, SHH-activated",0.99842879
985E277D-BF41-41DE-BB3A-749FDE309BDF,"medulloblastoma, SHH-activated",0.99842879
5BA14957-EDD3-43AC-833E-E70B3FAD0761,Pituitary adenoma,0.998428107
9C12DCF7-ABE6-4930-998E-04CB727DEB23,Pituitary adenoma,0.99842437
4E0C55E7-FAC0-4572-881B-ADA07716D68C,"glioblastoma, IDH-wildtype",0.998420581
E4EF185C-E251-4F44-9CD3-A42DBF978994,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.998408219
8BAD6611-63BF-4DA6-948A-F636CFD6A966,"Astrocytoma, IDH-mutant",0.998399286
8AF54C50-FF9A-470E-8F74-CC34BCC27B71,"Astrocytoma, IDH-mutant",0.998399286
E60791D7-FC6B-4D2D-BBD7-60B24FF6B8AF,"meningioma, benign",0.998398714
DA602B8E-35E9-4255-9990-9E24B8D704B7,"medulloblastoma, SHH-activated",0.998395843
B23D0E85-7D2A-46D3-B513-BB547365A531,"Astrocytoma, IDH-mutant",0.998389562
416A7540-A58F-4081-A684-2276DC90515E,Atypical teratoid rhabdoid tumour,0.998384755
86D55B59-3775-4B57-87E6-468912AC0DB8,"glioblastoma, IDH-wildtype",0.998378055
0CE497BE-2D10-49D5-9206-8A570DD6F76A,Olfactory neuroblastoma,0.998375232
E3BE12B1-2384-4DC1-A35D-E21614CFC9A9,Olfactory neuroblastoma,0.998375232
CE36636A-F5D3-4ABC-AF78-2429B43819B4,Olfactory neuroblastoma,0.998375232
128BC94F-AEB6-4F85-A8BB-71449C5885B0,"meningioma, benign",0.998375222
15F26144-0512-4266-9DAC-1E26CC2ECC6C,"glioblastoma, IDH-wildtype",0.998374094
FF3B366F-535B-43AB-8C12-FE16E4F3BEA2,medulloblastoma Group 3,0.99837033
7DD81784-F081-42C7-A44B-1DD4ABBE8996,"Astrocytoma, IDH-mutant",0.998370265
070609F6-8E52-4A2F-96AD-6F0A54362D3D,Primary diffuse large B cell lymphoma of the CNS,0.998370193
C58B6E97-0ABA-4884-8969-18E9F92A06DF,Primary diffuse large B cell lymphoma of the CNS,0.998368824
572BB953-26B4-4466-A756-C936C7901F1E,"glioblastoma, IDH-wildtype",0.998363807
923494D0-8D4B-4B44-A035-D485C931B1CE,Supratentorial subependymoma,0.998362826
4CF80228-9A3E-49DF-BA7D-B44F349EBDD4,"Diffuse midline glioma, H3 K27-altered",0.998355037
87AD2752-777D-44D4-A58D-F65280518C52,Dysembryoplastic neuroepithelial tumour,0.998353478
57E2A29C-7E02-41D5-A174-11CC3FDDC651,Atypical teratoid rhabdoid tumour,0.998350554
F0414B34-ED16-4A3C-B3A5-0FCF292617B7,Myxopapillary ependymoma,0.998347672
2EC79815-6F9F-4A7A-A3C5-D45831D8BF7A,Supratentorial subependymoma,0.99834035
BCC7EAE0-4ADC-4143-ACD5-919B84CBCB7B,Supratentorial subependymoma,0.99834035
FCE8B73C-D202-401A-80DD-4B8D848C8100,"glioblastoma, IDH-wildtype",0.998322611
4783C468-1964-4BCB-A64E-CB1DC5BE2E30,"Astrocytoma, IDH-mutant",0.998315791
16FCA0BF-7F46-4E07-8635-347A3B6ABD88,Primary diffuse large B cell lymphoma of the CNS,0.998309988
060A0217-E687-4C70-B769-D3A1D9EBD306,"meningioma, benign",0.998309281
77F6DDEC-4C2B-46F9-A7DB-1E3C7CC8ABF7,"glioblastoma, IDH-wildtype",0.998308621
0B7A12AB-D17F-4D85-B5B9-781607C058E0,Myxopapillary ependymoma,0.998305655
EE2B793E-A45A-419D-BEE4-F8CA6265FC79,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998305391
931E0410-B42A-4625-BD5B-D4CD939809E6,medulloblastoma Group 4,0.998303906
FA803594-5922-4B83-B85C-B253ECE3879D,"Astrocytoma, IDH-mutant",0.998302061
EA228D76-05F9-4210-9563-641B498ABCD6,posterior fossa ependymoma group A,0.998299839
E49A03B8-2BC8-4BE3-8E0E-FB9815C8E377,Pituitary adenoma,0.998296809
48AE24D5-F281-4BFD-808E-61FFEFA0031A,posterior fossa ependymoma group A,0.998292377
A442536F-A667-4C94-8771-6B7266CDCFE0,"Astrocytoma, IDH-mutant",0.99828775
3B5F09D9-7442-4ADF-A528-6D61E8D262AD,"meningioma, intermediate",0.998277845
D0E4E625-B2E0-4058-B2F6-1AD346B915AE,"meningioma, intermediate",0.998277845
443EE316-FA76-400E-AA0C-499700DC66D2,"meningioma, intermediate",0.998266454
CFA5CB1B-CCCB-4ED3-A8B7-E224D9E91305,"Astrocytoma, IDH-mutant",0.998257951
6A108686-5FE5-4821-B6A9-9A1D0E2A1D18,"glioblastoma, IDH-wildtype",0.998254519
64250E93-A694-4415-838C-1836F4CC250A,posterior fossa ependymoma group A,0.998251908
24CAA1E6-EA6E-4EB5-81FB-39C2740795ED,"glioblastoma, IDH-wildtype",0.998251688
82C5FD9B-349B-4059-A8B0-CF9B646A50D0,Pleomorphic xanthoastrocytoma,0.998245465
0233F303-493B-4B3F-B3AD-D257437B3BA3,"Astrocytoma, IDH-mutant",0.998221994
B037BA66-8563-4264-946B-5F82E6F4F18E,Myxopapillary ependymoma,0.998217504
62A6EACF-0D90-4531-B8AA-BBD8AB606816,"medulloblastoma, SHH-activated",0.998215837
4E5963E6-D692-459F-B659-CAF317B0BE1A,"medulloblastoma, SHH-activated",0.998215837
9D4AE5DA-AB06-4874-B640-B97166BCCBD4,"medulloblastoma, SHH-activated",0.998215837
E10B7F17-218F-4EC4-9525-6DD9DE2D691D,"medulloblastoma, SHH-activated",0.998215837
A2682FA7-16C0-4325-B76D-964641CB1AC6,"Cauda equina neuroendocrine tumour [paraganglioma], subtype non-CIMP",0.998209727
50D5FAB2-CEE9-48BA-BF66-B30047273830,"Neuroblastoma, MYCN subtype",0.998202377
1218539E-FF11-47D3-8B1B-D448D5B437DE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998196277
90671E5E-CEFE-45E6-83F6-4AEFF6BDC6FA,"glioblastoma, IDH-wildtype",0.998187564
5085CE4F-09C9-4F71-BE8E-ADC188694B41,pilocytic astrocytoma,0.998187526
0BB8B78A-B61C-4E11-A8AC-DAB8DC52A03E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998185913
4D67A059-189E-4595-9965-7CA29F6C5D6D,pilocytic astrocytoma,0.99818551
E8ADBB9E-C9EE-4A83-B8AF-EB09AA1325DF,Central neurocytoma,0.998172802
87C24F13-3655-48E6-A8B9-214DCC7978A5,"Control tissue, reactive tumour microenvironment",0.998165401
AFFB3AE9-F32E-428C-9F7B-83E9B1C056E9,"glioblastoma, IDH-wildtype",0.998164997
03218057-D2F2-4094-8400-C5E1F2419A07,pilocytic astrocytoma,0.998159747
E8B550A6-9565-41FE-AE31-AA5A1C6861FD,"glioblastoma, IDH-wildtype",0.998155512
5DCDD76A-6A11-4219-990B-3047F516839C,"glioblastoma, IDH-wildtype",0.998155512
3E3348EC-E155-4031-838D-082D2E0B992D,"meningioma, benign",0.998153805
0445364A-BB7E-49F2-B1A0-BDF9E569EABA,medulloblastoma Group 4,0.998148806
92A150CB-DCF0-4524-9CA6-986E4EBD74BB,"glioblastoma, IDH-wildtype",0.998143876
CC584D05-465C-494F-AE91-311D294A0F53,"Diffuse midline glioma, H3 K27-altered",0.998135261
EF8AD540-4144-4356-91A1-BA7861CF8F1B,"meningioma, benign",0.99812873
FA91B0C7-C230-4EF4-8937-811D68C7AD44,"medulloblastoma, SHH-activated",0.998127175
2FFA5033-E0A5-4307-9658-F098B27F67AD,"medulloblastoma, SHH-activated",0.99811664
9E2F3D73-D8F9-40EC-AEB7-E09B4F3A5EE1,Atypical teratoid rhabdoid tumour,0.998116336
A1C0AFFF-ED29-49A1-B2E6-AEBE7A8FA720,control tissue,0.998101826
2344B66B-9659-4EE0-A97D-51B9CBAB9D5B,"Astrocytoma, IDH-mutant",0.998097078
D463AE03-C03F-41A5-9E6D-777750B481B6,"Astrocytoma, IDH-mutant",0.998097078
7721C11A-C308-453A-B8FD-A7F84D9C5767,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998087491
A170A30B-F281-4E3A-9315-F40E3F769E0C,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.998087491
D66ABD99-0120-4878-B907-5C3FD07B7E81,"glioblastoma, IDH-wildtype",0.998085997
502AAAEC-EE54-4FF7-9CD4-1DA78EC053F1,Primary diffuse large B cell lymphoma of the CNS,0.998064355
8DE745E9-F86E-4D30-A54F-9EABE05A58F8,"medulloblastoma, SHH-activated",0.998055981
D59F6215-23B1-4524-8670-D48CA96CBCC7,"medulloblastoma, SHH-activated",0.998055981
AF30CC26-078D-4FC0-BC49-D0F104E6FE8A,"glioblastoma, IDH-wildtype",0.998054506
F3BEBE97-54A4-4283-962E-BBA277E7D799,"glioblastoma, IDH-wildtype",0.998054506
589A0980-8D86-4D86-B7DD-F52921CD5304,pilocytic astrocytoma,0.998052855
E0BF7B6F-5175-4DB8-ABAD-C447CFEFC401,"medulloblastoma, SHH-activated",0.998051878
A00ADA73-9F88-4202-B7ED-02971BEBE638,pilocytic astrocytoma,0.998050238
0E96F2F8-1560-4373-9460-DD481C303E18,"glioblastoma, IDH-wildtype",0.998050189
A0D4A17A-C67B-4C3F-9582-98E5042D3E20,pilocytic astrocytoma,0.998048561
C35E4F24-FEBD-42E9-A5B1-6866D70B0BBD,"medulloblastoma, SHH-activated",0.998041565
C09523DF-E2C2-45D9-9083-C9815CDBC8F0,"glioblastoma, IDH-wildtype",0.998041189
4BB8AD1E-0526-4CCB-914B-5FE8F85BA919,"glioblastoma, IDH-wildtype",0.998041189
05CE6BF4-7E8A-4215-844E-49F02A5AFDAD,"glioblastoma, IDH-wildtype",0.998041189
C9F303EE-BDCD-4CC5-8A7A-2A9B28464F3E,pilocytic astrocytoma,0.998032593
87FA9CB9-D0E5-457B-9B56-915F6DFC7740,pilocytic astrocytoma,0.998030965
567FF8CE-264C-4B7C-BAED-B2AB1C40ECCF,"glioblastoma, IDH-wildtype",0.99802441
BEA208F4-5D88-414D-A7C0-A40708969C11,"glioblastoma, IDH-wildtype",0.998023972
57B80124-6FEC-4910-BC36-AD69BD820EEF,"medulloblastoma, SHH-activated",0.998015691
3A523274-4633-4D6E-95C9-6754E3097005,pilocytic astrocytoma,0.998015232
4512BEFD-DBFF-4865-8821-23483E873A30,Neuroepithelial tumour with PATZ1 fusion,0.998012042
F2E596E0-CD0B-49BB-9529-6B276CCE9C5A,"glioblastoma, IDH-wildtype",0.998011665
BF8A0424-FE13-4B3B-B26C-68700E85DDF1,Pituitary adenoma,0.998010061
E1B3EA85-CCE3-4165-BB0C-8D5A098CC6B6,pilocytic astrocytoma,0.997995785
3AA0DFC9-BB6F-4D9B-8527-943AD8B1378E,"medulloblastoma, SHH-activated",0.997995619
4C367B42-F660-4FC5-8B80-901393F76970,"medulloblastoma, SHH-activated",0.997995619
6C1A0090-B058-4DAB-84DD-D08499263D77,"medulloblastoma, SHH-activated",0.997995619
B0C9E043-82F9-4963-96DF-4D438C8871DC,"medulloblastoma, SHH-activated",0.997995619
DC7C46F2-44BC-4176-B5E8-7B9B62B95A47,Melanoma [metastatic],0.997995243
45729799-7CFC-41AE-8AD9-6CD933643611,"glioblastoma, IDH-wildtype",0.997991548
7FD09773-6FD0-4753-930D-C90848D548A3,"glioblastoma, IDH-wildtype",0.997991548
708E40C1-9C44-4BF7-B8BB-B713805D28C2,"glioblastoma, IDH-wildtype",0.997991548
B6F57CBB-09D5-4C09-9144-B47B4747F1E4,"glioblastoma, IDH-wildtype",0.997991548
EADD6951-6787-4A99-9ED9-6C3DC7E11A37,"glioblastoma, IDH-wildtype",0.997991548
00B763E8-4119-4377-9225-C3C72243951C,"Diffuse hemispheric glioma, H3 G34-mutant",0.997985541
90BE989F-9487-49C1-A2C1-E72FE2F663D9,posterior fossa ependymoma group A,0.997975421
76A6DA4B-58BB-459B-91FE-B3D849B32C4D,"glioblastoma, IDH-wildtype",0.997965714
67FA5266-A804-4574-8B9C-EFA12A6AAB81,pilocytic astrocytoma,0.997957925
3CE1BB48-C9F4-4B26-BE91-EC9474E92456,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
195F69FC-E04D-4910-B788-E2E4242E4BE4,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
6FB59578-6A78-4F6E-A2A8-ECF9A30C37E5,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
6BC0E1C8-F188-46A9-8649-3CA8EFDAAF15,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
C39F2F05-1FAD-4332-B702-DE4C1D200AE7,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
D9DCDF38-B0A3-41C0-9ABA-3BFBB6359251,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
819A7A6B-9B2E-4AD1-BC60-1F52E59D0B5B,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
39E11A58-2F1D-425B-8757-00FC4EC1D876,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
E9AF789B-1861-4DE7-94C6-FB3287FF03D2,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
5A02E8A4-37F6-4B52-A35D-0435D459BC61,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
2E8990FB-6EE3-4FBA-9D39-85158D9C43CA,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
DE1851DC-FF49-4D8E-8FD1-A627F45B198A,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
11F9ADF9-1847-418B-89AF-CE0EDABDAAB9,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
7200BB54-B2C9-4412-91B5-38E2C5368386,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
5067A299-85BA-4C1E-974C-F54475EA83AC,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
09082A72-2F57-44DB-83D7-FC27AEC3EB1E,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
65E13137-ED63-47E3-9C00-B8E547A62A60,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
2B8C09D2-E985-4303-BC31-C21112344083,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
2C9DD348-4918-4F23-9C50-B695D3BC7F9D,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
E030269F-86C9-401B-8031-3A7DDCEBAC74,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
4781F643-EC80-447E-B634-ECC8A2F94B20,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
C43C09AB-675B-4057-99A0-433862630D40,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
A19720A0-2ED1-49A8-A43B-E8ADDC165C5B,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
7FEDF25B-88D9-4A77-B093-48326F54D4DD,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
CE63DBAC-C770-45EA-B13D-D9485F24E2C8,"Adult-type diffuse high grade glioma, IDH-wildtype",0.997954841
4997934A-3BB2-47C0-B4A4-552C03225769,"glioblastoma, IDH-wildtype",0.997954839
7E4F9460-430E-4D1C-8332-5CCCB0CE772E,"glioblastoma, IDH-wildtype",0.997954342
96E85133-A4BF-4767-8365-4384D125E441,Dysembryoplastic neuroepithelial tumour,0.997954038
A1FE9FD3-3775-4C72-90A6-A9C6FB56A50C,Adamantinomatous craniopharyngioma,0.997948172
C4F8BB11-7FF1-46F3-A7B4-1CBEE481E2AE,"glioblastoma, IDH-wildtype",0.997946678
7F0D1EAD-0436-41C8-8F09-CADEF74B4E74,Primary diffuse large B cell lymphoma of the CNS,0.997943194
816F5D5C-0C27-433C-AF77-69E692ED55F5,"glioblastoma, IDH-wildtype",0.997925276
78EF004C-7718-4D35-B283-35E77EF27298,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.997925118
8EC61990-84D7-49A9-8E39-EE51EC435B95,"glioblastoma, IDH-wildtype",0.997924121
A375FD48-9B5F-4918-BA7D-347ED29C437E,"glioblastoma, IDH-wildtype",0.997924121
8F060E60-3E67-43F2-8A85-002D8F11C3C8,pilocytic astrocytoma,0.997917829
BB4D2FDE-A070-4931-8AF5-D4A164360701,"meningioma, benign",0.997914624
C3F635D0-A5AE-4A01-83BA-5FCFEDCB9AF6,"medulloblastoma, SHH-activated",0.997911504
3C367555-702E-4623-8CC8-ADA4AD97F846,"Astrocytoma, IDH-mutant",0.997903606
8FA857E9-598C-48DB-AD01-AE1DDD9BE471,"glioblastoma, IDH-wildtype",0.997895445
B4DB50C8-127C-468A-B400-647E91FA144D,"glioblastoma, IDH-wildtype",0.997890405
DF7F7C6D-6DF2-453E-A60A-B31F48ADC8C0,medulloblastoma Group 3,0.997888669
AF11E012-C243-4F83-A9C8-4F574A2F1760,"medulloblastoma, SHH-activated",0.997863732
32FFD1E7-86B0-4795-BD51-2C42B4BA87E4,"Astrocytoma, IDH-mutant",0.997861494
46C5B54D-4C63-4666-98C0-A7EEFE1F6DE5,"Astrocytoma, IDH-mutant",0.997861494
30BF8B29-24C7-4BDD-8590-32CF6ABFD988,"Astrocytoma, IDH-mutant",0.997861494
CBB5AC9B-DE96-41C8-BD71-D37CCDE4AE27,"meningioma, intermediate",0.997859707
CFBBF88F-1850-49AD-AD51-51C3993A7DC8,Pleomorphic xanthoastrocytoma,0.997850008
4C51CD0F-CEC4-4B6E-A7AE-50674DD6FF84,Pituitary adenoma,0.997842111
A8E99AD1-EBEB-4724-BBD8-62FD322EF6A1,Dysembryoplastic neuroepithelial tumour,0.997835931
4C686B4F-1069-4BF1-9E12-762BC0942758,medulloblastoma Group 3,0.997826862
6ED18536-3800-42B2-A521-BFA35F526124,"Diffuse midline glioma, H3 K27-altered",0.997813009
143CC821-0439-41A7-B1F0-41F1AD1DB1E4,"Astrocytoma, IDH-mutant",0.997808457
B5F82511-73E4-445A-A7F2-813E7158AF7E,"Astrocytoma, IDH-mutant",0.997803836
C1A200E2-BB81-4982-A842-E3B57E26CA1A,pilocytic astrocytoma,0.997796995
0B1C7E21-AAE9-4D3E-BFE1-E2E0F56A15C1,pilocytic astrocytoma,0.997796995
BFADD87B-435B-4F08-90B2-4B9946BE19B8,medulloblastoma Group 4,0.997795791
1DF77A15-C5CF-42FD-8AC8-5E8627539763,"glioblastoma, IDH-wildtype",0.997789374
700F31B4-071D-4EB3-9974-054C41F45F3A,"glioblastoma, IDH-wildtype",0.997781949
BD59DF53-2EA4-4CC6-9871-FAD2E01795F3,"Diffuse midline glioma, H3 K27-altered",0.997780882
DFFFF127-4928-4932-A3A1-639E86E9BDD2,posterior fossa ependymoma group A,0.997780726
28FAE3A6-A6CE-4ECF-9DFD-61F036D180DA,medulloblastoma Group 3,0.997753016
C8CE0A14-161B-4654-9C8B-26E1E46FDD15,"Astrocytoma, IDH-mutant",0.997752523
32EA23F5-F596-4D01-B638-787CFBC76E4D,"meningioma, benign",0.997749218
4D06954C-1DE7-4D9C-B92A-017FB3041380,"medulloblastoma, SHH-activated",0.997741663
459746E5-0AC0-4894-9119-ACF5DD240F47,"medulloblastoma, SHH-activated",0.997741663
4EDF16F1-A410-4961-9357-821D72F4401D,"medulloblastoma, SHH-activated",0.997741663
B34F163A-80BE-404D-947C-B404C3314393,"Sinonasal undifferentiated carcinoma, IDH2-mutant",0.997734745
229DB524-E160-430E-A9F1-22A1830FDCE7,Spinal ependymoma,0.997724319
7F1E3A94-78BF-4BFC-BBA4-6D20A4AEC1DE,Primary diffuse large B cell lymphoma of the CNS,0.99772394
1A07EC1F-F0D5-4E31-9309-0FE0D1D4242D,"Astrocytoma, IDH-mutant",0.997719168
A8D0ADC9-27CE-4B81-BEEB-684A51AA6D36,"medulloblastoma, SHH-activated",0.997714585
098BFF9A-940C-42A0-934F-C08C1AE3D9A1,"meningioma, benign",0.997714467
C0AF8DAA-BE73-423B-919A-C120B5F6BF7B,"glioblastoma, IDH-wildtype",0.997709391
2D75CA83-35EA-4F9D-8AB7-D6932F3B15A9,medulloblastoma Group 4,0.997698821
EB1952B0-B9B8-4DC7-BD11-7B52D1CD8FF8,"Astrocytoma, IDH-mutant",0.997675402
458228FA-638F-489E-AFC7-D8EFFF7040D7,Diffuse paediatric-type high grade glioma,0.997675128
AE3CA4CB-4EC2-42F0-A376-B09D17E412B2,Atypical teratoid rhabdoid tumour,0.99765954
1C88B432-F251-4A0E-8AC1-D2669F6A22ED,"supratentorial ependymoma, ZFTA fusion-positive",0.99765727
8AE7FBBF-ACBB-4428-8899-12CA2D348EB3,"glioblastoma, IDH-wildtype",0.99764674
E0D0247E-46AE-446D-AD40-62FAABB956EB,Pleomorphic xanthoastrocytoma,0.997643327
00F55E45-520A-4D4C-B051-DB3A853F395F,Pituitary adenoma,0.997636296
CBE3A1EB-FC34-476C-BBE3-5C0755C27485,"Astrocytoma, IDH-mutant",0.997633477
8F2AFC48-0D5D-4A3B-83B7-6F2E77B60210,"meningioma, malignant",0.997632653
55D06578-5740-4EEE-B9D3-BD8C49B1CDEB,"meningioma, malignant",0.997632653
C5A1DCBA-5347-4FDF-8076-6F0B3170E1A8,"meningioma, malignant",0.997632653
99E14982-843A-46D2-8201-9566EA178F03,"meningioma, malignant",0.997632653
D05F5D0C-76B5-40F4-871E-627F8C1D4146,"meningioma, benign",0.997629961
8FED155D-3238-4BF8-AB1F-FD433421C37C,"meningioma, benign",0.997629961
80BE34F5-838D-48E7-807D-F7EF7C628EA9,"meningioma, benign",0.997629961
12AEFD74-F08E-4690-A6C1-2E26A96DEC0C,pilocytic astrocytoma,0.99762925
F0A1A26C-4C98-4D83-8401-AAE3D94DA3DD,pilocytic astrocytoma,0.99762925
F631C590-4F83-4B05-B43F-B29876276C53,pilocytic astrocytoma,0.99762925
AFB671ED-88A5-47F8-B100-523DC2414E8D,pilocytic astrocytoma,0.99762925
29115419-45F5-4C29-850F-9CB4CFB17AB5,"glioblastoma, IDH-wildtype",0.997625857
802DC850-5605-4804-9B2B-1492B97A491D,medulloblastoma Group 3,0.997620348
CE62D7E3-5E0F-4E1F-A089-724B7F55ED10,medulloblastoma Group 3,0.997620268
F5EE3FF9-0781-4422-A28A-E3D6C739226D,pilocytic astrocytoma,0.997616311
567DB864-8752-4F04-B86A-C6ABC0B86C73,pilocytic astrocytoma,0.997615434
89C732B1-1648-420A-81B6-42236F8CD402,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99760888
003AC130-6B79-436A-824B-2906D9A495CB,Pineal retinoblastoma,0.997601389
3CFA804E-8C2E-4186-A5A2-BB6A39DA31D5,"CNS neuroblastoma, FOXR2-altered",0.997600527
D773DEBC-70FB-428F-BA32-5DB9FE5FBEB5,embryonal tumour with multilayered rosettes,0.997560612
05A1EBC3-22B4-4B4E-9BB6-F17A732BE3EF,"Diffuse midline glioma, H3 K27-altered",0.997560562
A10B3F5C-C58C-4BE1-B1B0-38340A7B1269,"meningioma, malignant",0.99756051
628B1A8F-9865-42E1-986D-120DF831C222,Spinal ependymoma,0.997552412
0BA3712D-A3E1-457D-B1D1-694D6A3B90F5,"glioblastoma, IDH-wildtype",0.997547279
D3D6131F-3524-450E-9889-A2A9D52473A5,"supratentorial ependymoma, ZFTA fusion-positive",0.997546625
3F7EE471-6291-4B28-B661-28CC1C607682,"Diffuse hemispheric glioma, H3 G34-mutant",0.997544758
AB05ADD0-6CC7-46D1-9BE0-29EBACBE592E,"glioblastoma, IDH-wildtype",0.99754441
9747D41A-E0B3-49AF-BEB6-A853E2422D89,"glioblastoma, IDH-wildtype",0.997537638
D1108E87-D055-47D8-83CF-E23469A56BA4,"glioblastoma, IDH-wildtype",0.997537638
8B202CDC-7C81-4115-8DD9-C4A27B3551FC,"glioblastoma, IDH-wildtype",0.997537638
BD92FA3D-175A-4C44-A841-229FD79A346F,"glioblastoma, IDH-wildtype",0.997537638
C93F5D51-3472-4B90-88E8-15221B7FE761,"medulloblastoma, SHH-activated",0.997525418
76AD04D9-4578-4CB0-840B-1E51C6F005E5,"meningioma, benign",0.997517039
17739E91-A4EA-4920-9607-CA1A261E7DA1,Spinal ependymoma,0.997517008
741CB364-C420-4887-9585-88081FE9B2C2,"CNS neuroblastoma, FOXR2-altered",0.997515982
05E08BDC-D550-401E-BB9D-9904B66005BC,Atypical teratoid rhabdoid tumour,0.997513806
D338D951-3403-4C1D-82C8-EE7456DB17FE,Primary diffuse large B cell lymphoma of the CNS,0.997505337
D410DB0F-4AED-4E86-9A34-0B37371C5D3C,Rhabdomyosarcoma,0.997499891
DFF32082-27A3-4CD1-BCE3-66C5DB9E9203,"Diffuse midline glioma, H3 K27-altered",0.997498967
08C9C57E-4EB0-43D7-8DB7-00AEF3FD2527,medulloblastoma Group 3,0.997497012
DF4EF493-B005-49AD-8727-579CDD385C89,"glioblastoma, IDH-wildtype",0.997492527
648A5CE8-A3AA-48A3-A05A-182F91D6E826,"glioblastoma, IDH-wildtype",0.997492527
F79648E4-5757-4F8F-BE4C-2394353869AC,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.997486633
DF6F5609-2271-411F-B8F8-94E0AAD2B8DB,Malignant melanotic nerve sheath tumour,0.997471172
2B4278DC-4685-4073-B1F6-7B12E1A0B6F6,Rhabdomyosarcoma,0.997446304
73445164-499F-4EC7-87D9-0FC9DABA0FAD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.997445126
74E2C2B3-27FC-4618-AEBB-719298E169CD,"glioblastoma, IDH-wildtype",0.997438201
760A38D2-11B9-43C7-AA2B-DCC4FEB8CD21,Rhabdomyosarcoma,0.997435618
B90E0620-6275-4B05-B467-14C5C36B1017,"glioblastoma, IDH-wildtype",0.997433633
597E5BAC-EB5D-4A62-8B53-585F4C509BB4,posterior fossa ependymoma group B,0.99743316
A447B0D9-E58B-4C27-BE03-DE2F6B4F0EB6,"Astrocytoma, IDH-mutant",0.997428777
BAE8A798-D799-4818-8368-AAC007469C97,Dysembryoplastic neuroepithelial tumour,0.997417109
715660E0-4CE4-4DB5-A131-537C787DF78D,Dysembryoplastic neuroepithelial tumour,0.997417109
C5E04EE3-F10A-49E1-A726-4D00D9EDC5DA,"glioblastoma, IDH-wildtype",0.997408387
0546F21A-A07D-4340-BEF7-CAB2B8356951,"glioblastoma, IDH-wildtype",0.99740352
347A9E89-9437-4807-A619-FADD20A67B91,medulloblastoma Group 3,0.997393465
CCCC00EA-75C4-4488-915F-D191AD8D4115,"meningioma, intermediate",0.997383016
183E12CA-0C9C-4B12-83B4-6F05C2A817CD,medulloblastoma Group 4,0.997376531
9DFDFA6C-AEB8-4E43-A12E-0BBEB02975ED,medulloblastoma Group 4,0.997376531
ACB6D818-74C5-44B9-8EB1-F9485E0CD369,Rhabdomyosarcoma,0.997372267
79C63121-CDD5-487F-B2E2-0BE90F3D49B2,"Astrocytoma, IDH-mutant",0.997368198
0578A2C4-0EEB-4CE2-9D56-82DC3508F540,"Astrocytoma, IDH-mutant",0.997365797
C29DC498-189D-47DE-BAB9-BDDEA4FE4E11,High-grade astrocytoma with piloid features,0.997335828
36070CCF-AE8B-4F81-AD6D-62623ABE2EC7,"Astrocytoma, IDH-mutant",0.997312014
65C368C4-F4CE-4F93-81B5-BF12132D760A,medulloblastoma Group 4,0.997309008
790521BD-2376-4DA6-9A1F-AF095F97C262,Rhabdomyosarcoma,0.997298386
C6BFFFE6-15BE-4A93-97F7-45D779CD7F86,Subependymal giant cell astrocytoma,0.997294177
6F1691A6-D768-4519-AF8D-15B646763CE0,"Astrocytoma, IDH-mutant",0.997289533
A37639BC-73B2-43EE-8D37-EB423EC7DF73,Melanocytoma,0.997248569
497679BE-056E-4BFE-8A4E-906B30990C2E,Diffuse paediatric-type high grade glioma,0.997247588
833A274D-111F-47DA-A81D-BD03BBC0873F,Diffuse paediatric-type high grade glioma,0.9972367
D007406B-341C-4329-9403-40EB845A2679,"Diffuse midline glioma, H3 K27-altered",0.997236035
D6B76330-F843-4308-894B-61A46FE316C1,"glioblastoma, IDH-wildtype",0.997235442
F703CE3D-70B9-4D4C-96BA-B326F65DF26C,"glioblastoma, IDH-wildtype",0.997235442
AAD140AD-D97C-4171-B03D-FA1D20DDF516,"meningioma, benign",0.997230903
D44321F2-3343-440A-B74F-4DDB34969595,"glioblastoma, IDH-wildtype",0.997230419
2F7C6016-ACB3-4567-9361-50B74FF5D55E,Pituitary adenoma,0.997224201
AACC41E8-4DF6-4857-B190-436B4AA403B0,"Diffuse hemispheric glioma, H3 G34-mutant",0.997223643
B550016E-FF9B-40F7-BB83-071BA8E0DADF,Dysembryoplastic neuroepithelial tumour,0.997215828
E9CA8A8A-17DA-4FEF-8773-250EFA94A69A,"meningioma, benign",0.997193943
1AE183CB-1357-4025-B89C-777EEE710264,"glioblastoma, IDH-wildtype",0.997190252
E457BF86-FB0D-4D8E-B2F3-E29380E3BD73,Dysembryoplastic neuroepithelial tumour,0.997185838
B30C87E3-E755-4CD0-A30A-09A8A3B51BD9,Posterior fossa subependymoma,0.997184039
E5BBF6DC-7E5A-455D-A17B-636D759E1185,medulloblastoma Group 4,0.997179482
F037AC33-6B86-429B-9905-5AB54222E369,Pituitary adenoma,0.99716185
E4D6DCC0-EDD1-4DEB-BD94-374DE64592D1,"Medulloblastoma, WNT activated",0.997159683
3EE80B81-D655-4D09-8F52-B251D587F64C,medulloblastoma Group 4,0.997158307
465E9F99-7928-477E-B4C3-0AEA7801E2BC,"supratentorial ependymoma, ZFTA fusion-positive",0.997149993
537E20FB-0303-49A6-A324-993F748FEE33,"supratentorial ependymoma, ZFTA fusion-positive",0.997149993
846D5F8C-C0EB-487A-B5F1-4641CA07A51D,"supratentorial ependymoma, ZFTA fusion-positive",0.997149993
9AA4373F-2F61-4A31-B354-3A5517088A3D,Diffuse paediatric-type high grade glioma,0.997144327
8AF85BCC-1D06-484F-B345-90D2C9208F4C,"glioblastoma, IDH-wildtype",0.997124722
F85FC077-5437-4865-AAB0-404915AAB66B,"Astrocytoma, IDH-mutant",0.997091097
B5F6D9C8-865C-42AD-8537-CA305F6C1F59,Posterior fossa subependymoma,0.997087446
AA93C113-D4F7-4E62-A7BA-4EB98CB2DB7F,Diffuse paediatric-type high grade glioma,0.997085993
6633B3C0-1F0E-4979-887E-8193337BB8AE,"Diffuse hemispheric glioma, H3 G34-mutant",0.997084374
E16399BE-8A0F-4DA8-96CA-CFE1A51299B9,"meningioma, benign",0.997083827
A164890C-0D18-444E-9CA3-C0678B48596E,"Astrocytoma, IDH-mutant",0.99706395
A3872673-EACF-41E8-9CA8-844BEDCBB10D,"Astrocytoma, IDH-mutant",0.99706395
0A225B1C-4B3D-4534-95E8-D7B17CAF9894,pilocytic astrocytoma,0.997055145
96C4FFB2-E430-49AA-AE76-D9DBF3247113,posterior fossa ependymoma group A,0.9970518
F5AE4CB6-8E75-4460-9E09-8707B28DF78E,pilocytic astrocytoma,0.997049944
1845D953-7BC4-4DE9-95C5-E5E83F72BA81,posterior fossa ependymoma group A,0.997029756
E5A948F3-2FA2-42E1-B35F-25282F55F602,"Astrocytoma, IDH-mutant",0.997020297
DC1C13A7-A85F-429B-B691-500B7631586D,"glioblastoma, IDH-wildtype",0.997009839
9F939383-0E52-47CE-9FB9-31D76AC2D68F,"medulloblastoma, SHH-activated",0.997004496
3DA60281-C3A8-481C-AB58-B3F18E60CDB0,medulloblastoma Group 4,0.996998251
EB7DCFE3-8E7F-4FF2-9CF9-C1AC9E300CC2,medulloblastoma Group 4,0.996998251
DA3EAC3F-4335-40B4-A7EF-099DA9B4DE1E,"glioblastoma, IDH-wildtype",0.996997258
63CEAD57-0175-4197-BE95-2AB0D0A9343E,"glioblastoma, IDH-wildtype",0.996997258
C6DFC224-6B60-48C0-8C17-2EB78898D629,"glioblastoma, IDH-wildtype",0.996997258
6ED61EAE-FAE7-4811-8DFA-22D65B6BBC3E,"glioblastoma, IDH-wildtype",0.996997258
E3B2FF6F-B3A8-49DF-BCC9-81136A343F03,pilocytic astrocytoma,0.996993716
361B69E7-AE3F-4AD5-A1B7-8DFDA66D7B17,"meningioma, benign",0.996993563
7EAC6859-88C9-4DD0-9FD7-DADCC759A9D0,control tissue,0.996981413
CB0B4C6F-7685-4BD9-A63A-1346A4A57013,"meningioma, benign",0.996974764
A56C679D-8A73-4A37-BCB2-FFDDCDCDCBE7,"Diffuse midline glioma, H3 K27-altered",0.996972786
482AAE67-63B8-4376-AAC2-65F90D0F4ECE,"glioblastoma, IDH-wildtype",0.99696245
AE70B037-1BC8-49E3-93E9-BC82EF6F4223,"glioblastoma, IDH-wildtype",0.99694034
E1585592-5262-44D5-A174-4B0840373F8E,"glioblastoma, IDH-wildtype",0.996938393
AD6F4FCE-6696-4E75-A776-A93F568EC203,"Astrocytoma, IDH-mutant",0.996936022
1E18F61A-C4E9-45F9-B729-871302CC38E6,"Astrocytoma, IDH-mutant",0.996936022
BE0EE521-5A9B-4395-BF57-410BC7B287AC,"Astrocytoma, IDH-mutant",0.996936022
A6D1C94F-43A8-48F3-9DA0-3EBD8C8F34C1,"glioblastoma, IDH-wildtype",0.996929483
A818F45A-97EB-445B-B56E-EBB6F88E26BC,"meningioma, intermediate",0.996927265
87CB973B-515C-45E9-8CE5-7E767865B1A7,Primary diffuse large B cell lymphoma of the CNS,0.996927176
15B46945-9067-4851-842F-26516B2C3665,"meningioma, intermediate",0.996925636
68881F55-A4AC-40D6-B365-8308DDDF2460,Posterior fossa subependymoma,0.99692427
03F2D833-DBF9-4FC7-BCD1-46E6376F8E7E,"glioblastoma, IDH-wildtype",0.99691889
EBF5EE2B-1553-44F8-A402-36A750CFCF72,"glioblastoma, IDH-wildtype",0.99691889
25498C4D-F103-46CA-B4FC-DBBA3E1355E8,Primary diffuse large B cell lymphoma of the CNS,0.996917553
52B865B4-838A-41DE-997C-600867AF9680,"glioblastoma, IDH-wildtype",0.996896612
050925FD-6C8E-4553-83A7-348FFD96B2CA,"Astrocytoma, IDH-mutant",0.996896477
95242288-05E8-4252-9358-D3530DBA6415,"Astrocytoma, IDH-mutant",0.996895426
38149E74-5E2D-443E-986F-A03CADD55813,Dysembryoplastic neuroepithelial tumour,0.996883485
EAC58DC8-E31C-4838-8AA4-89DD30205FCE,pilocytic astrocytoma,0.996863494
5D6DC625-8A53-412F-BACE-CAC979AF85EA,"glioblastoma, IDH-wildtype",0.996863054
1B76B9FE-7262-493C-B675-1E574B2DFEDC,pilocytic astrocytoma,0.996853536
FAFBED09-A6D5-4BB2-92FB-3F42F8C39B2F,"meningioma, benign",0.99685161
841D0226-149C-4C57-BDAA-29EA2BECE9DE,"glioblastoma, IDH-wildtype",0.996844083
4060CD3E-88D8-4634-8CF8-C4B13F5BA936,pilocytic astrocytoma,0.996831738
4E0F7EBC-0C22-4FC5-AD26-4CF219B06BA3,pilocytic astrocytoma,0.996822313
73F6C232-2C77-4E18-B8A1-AFFC4D0A8688,pilocytic astrocytoma,0.996822313
AA855890-4B81-40C1-95B3-6E8EE5A91BCC,pilocytic astrocytoma,0.996822313
DCE449DD-E80E-4113-BD5B-966CB6200B9B,"medulloblastoma, SHH-activated",0.996811175
3C93BE89-CA24-442D-972C-59D3465D887A,"Astrocytoma, IDH-mutant",0.996797016
9A132501-4638-45AA-8A4E-EFD4DEB49B63,"glioblastoma, IDH-wildtype",0.996791792
4D07C032-B8CB-4635-81BD-62EF7777A4D1,medulloblastoma Group 4,0.996777903
221FF6A6-E6A9-4EAF-B663-52A77483A133,"Astrocytoma, IDH-mutant",0.996774802
347E6D57-B283-48D6-A43F-0ED16A7A3762,"Astrocytoma, IDH-mutant",0.996774802
D2C3FC30-B2A3-4E19-B72E-38CC8EDECE62,"Astrocytoma, IDH-mutant",0.996774802
C6B0183D-C3C8-4696-A1CC-0A89CE588E43,"glioblastoma, IDH-wildtype",0.99677325
C6431CA9-AE04-4881-96CD-08B929D1612C,posterior fossa ependymoma group A,0.996764125
30718FEB-EA2C-46A5-9628-E1BB9FC5DE8E,Spinal ependymoma,0.996763108
C1014DC9-AF3E-442A-A9D3-EBCFD550CC66,control tissue,0.996744638
1D8C2BC0-039C-4EDB-9FBE-6310741E5A77,"meningioma, benign",0.996743988
E5B712FD-4080-4733-B60A-4ECDB07F65FE,Posterior fossa subependymoma,0.996736661
C8611C95-43CC-40C1-A174-3E2862AA2FAF,Primary diffuse large B cell lymphoma of the CNS,0.99672752
0DE8168B-8AEC-4835-A512-33981CF37207,"Astrocytoma, IDH-mutant",0.996721591
11BBF848-725A-47E9-99CD-AC4D7C69FDA0,"glioblastoma, IDH-wildtype",0.996703178
EC63D123-0DAD-47E1-961B-E53D7EF79351,medulloblastoma Group 4,0.996698686
1C99556D-21B4-441F-9544-98D7F0F96828,"medulloblastoma, SHH-activated",0.996697915
2405F0E6-291D-44BE-9618-D3E8D5B473F1,"meningioma, malignant",0.996690657
3AD97438-77D0-4D5D-B9A6-54581F864EA2,"meningioma, malignant",0.996690657
860BD1A0-41B3-4688-B858-FD003C4FE09F,medulloblastoma Group 3,0.996685414
0B00D63E-09DC-4CFB-84F0-0EB1FA25966F,embryonal tumour with multilayered rosettes,0.996680168
5B6B29F9-EAA9-4E38-AF13-DC6E6990B579,Pleomorphic xanthoastrocytoma,0.996679534
B4F4C772-854E-4A0C-987A-1680323ED7FF,"Astrocytoma, IDH-mutant",0.996675575
C17A5BE2-0C2D-4613-875D-90186CC1356C,Solitary fibrous tumour / haemangiopericytoma,0.996661117
40240127-BB04-4FAA-9E88-7485A01CC8A4,"meningioma, benign",0.99665731
3B10E177-EED8-4E93-9419-70714DA00C0F,"meningioma, benign",0.99665731
D765B754-9FE7-4932-BE8C-D861EFE75B2D,"glioblastoma, IDH-wildtype",0.99665147
A7502911-03D9-4860-807F-F116BAA0E3D6,"glioblastoma, IDH-wildtype",0.99665147
1B74F72D-FE12-49F2-B5CC-3BCAE8C0063D,"glioblastoma, IDH-wildtype",0.996641062
F28165D4-5D2E-4E93-A59C-0D937DC8DCF7,"glioblastoma, IDH-wildtype",0.996641062
9304D83B-9052-48E7-AA4F-66FD9BCA23DC,"glioblastoma, IDH-wildtype",0.996641062
88CF061D-51BB-4A6A-87D4-93E25D90F141,"meningioma, intermediate",0.99663625
8D8A1195-C136-49D7-9239-CA2D229C5872,Dysembryoplastic neuroepithelial tumour,0.996633281
CFA76783-2069-4CD3-B4B5-9D9A37D098F5,"medulloblastoma, SHH-activated",0.996622777
45037A0D-41B2-4ABC-A1CE-5D1F8C3E8F25,"Astrocytoma, IDH-mutant",0.996617907
FADD37DA-527E-42E4-BA0E-E385D3D7A5F4,"glioblastoma, IDH-wildtype",0.996606557
54270C52-FE7A-4540-B2C6-3DDB77E4FFA1,"Astrocytoma, IDH-mutant",0.996599865
3BF01E7F-2E21-4FBC-B6D6-0E909FDDDB9B,Dysembryoplastic neuroepithelial tumour,0.99658887
5E876B19-B3C5-42F0-9034-E171C9185A61,"Astrocytoma, IDH-mutant",0.996568093
FB077233-EDC3-4A52-BD6D-F2F330D7FA62,"Astrocytoma, IDH-mutant",0.996568093
23A493E4-3A63-410B-9659-3AFDF2C366EE,"Astrocytoma, IDH-mutant",0.996568093
479A7C36-0A45-4C54-9412-B9A46885E4D8,pilocytic astrocytoma,0.996545723
0A3E8F3A-704C-4AA2-89B7-ADA28EB5EEF9,"glioblastoma, IDH-wildtype",0.996535854
261C4C57-7F4B-45BF-BFC8-C31B50D17B19,"glioblastoma, IDH-wildtype",0.996515389
438BD43B-220D-4ABC-A139-97E23FBD2A50,Atypical teratoid rhabdoid tumour,0.996515083
7C00CEF0-9ECB-463D-9CA5-C93312AB1B53,control tissue,0.996503996
73DCFC28-36D8-4A50-8FAF-D84245A50B95,Primary diffuse large B cell lymphoma of the CNS,0.996492763
3A2348E8-5D44-476A-A859-0EB693BC5726,"glioblastoma, IDH-wildtype",0.99648781
D269E0BF-CDC9-43C5-92B4-22D3972B1394,"glioblastoma, IDH-wildtype",0.99648781
BAFAD221-E6ED-4EFC-9665-8C4969E1B8F7,Neuroepithelial tumour with PATZ1 fusion,0.996475895
6451350C-7DCB-45B1-A230-A36601C92961,posterior fossa ependymoma group A,0.996467149
76016968-3F0F-4B1A-B07E-F158CB6AD55A,"glioblastoma, IDH-wildtype",0.996464525
E61C7EBB-5268-47BF-AB6C-761CE2F582B9,"glioblastoma, IDH-wildtype",0.996464525
06052810-FF65-445F-BDF1-9246AD29B58D,Diffuse leptomeningeal glioneuronal tumour,0.996462707
F2DB57E2-31BA-4758-84D8-FECDAEDBDAEA,Pituitary adenoma,0.996447483
B8582449-1058-40B2-ACD1-E6EF85ABA943,"Astrocytoma, IDH-mutant",0.996447254
B111CD53-D871-42EA-B06C-B71C42FEA94A,Chordoma,0.996433792
5EB1287D-D1E6-491B-ADD3-23EA75AF6DC0,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.996431843
6BDFB960-D6BC-4758-A20F-95709BAC6B92,normal pineal gland and pineocytoma,0.996429943
C0F7F2BA-6A7C-41F0-BC6E-C06ED073B8B0,normal pineal gland and pineocytoma,0.996429943
1EC21D72-FCE5-4A06-99BB-769E97ECF05B,"Astrocytoma, IDH-mutant",0.996428118
EAF6B71B-8E61-44B8-8B62-999ACEC9CCF8,"glioblastoma, IDH-wildtype",0.99641978
2D137B56-BC15-49BD-B7E8-A7480611E5CA,"medulloblastoma, SHH-activated",0.996400067
72FAC66A-8240-4982-B081-047A17D994FE,"meningioma, intermediate",0.996397203
EB7CFB83-57FE-4519-A4EF-1461429B7641,Atypical teratoid rhabdoid tumour,0.996393006
88142A29-6D20-4C96-AF62-314C7F24BEDA,Atypical teratoid rhabdoid tumour,0.996393006
01097E3B-23DA-4E8F-BF39-9590D75A8C96,Dysembryoplastic neuroepithelial tumour,0.996388759
9521BD16-84E3-480D-B759-3A8A0603CF1A,"glioblastoma, IDH-wildtype",0.996362491
FA0D4F4C-0FA7-4A7E-A738-8B31345EE67E,High-grade astrocytoma with piloid features,0.996361941
6CA993AF-CB99-4C10-A167-665E2FD6936A,"medulloblastoma, SHH-activated",0.996345684
E5F02AB4-BDE3-467A-9625-1949F2DCF5E6,Pleomorphic xanthoastrocytoma,0.996344172
E96148EE-4A73-40A9-9E90-CC6894811FF4,medulloblastoma Group 3,0.996341289
9116E5AB-6140-422E-B949-6776278135D5,Pituitary adenoma,0.99634072
37F47E7F-6C9E-4081-984F-19B83D477383,pilocytic astrocytoma,0.996333319
101AA4D7-00CF-4C48-9ADB-8AB4AE667591,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.996302217
C5074B4F-8965-4EFD-8A08-BFAB4D83BBED,"Astrocytoma, IDH-mutant",0.996297157
458FF027-400E-4AC3-8D5C-3230D0615024,Pleomorphic xanthoastrocytoma,0.996266954
BE087DC9-6D4D-4A80-955D-F8CE907B59D1,Spinal ependymoma,0.996253132
C2F741C5-4F3B-4A99-BA86-D06A7796D2A2,Spinal ependymoma,0.996250348
CE740850-357B-49AA-B93C-3023CE2604D3,"meningioma, benign",0.99621736
975D41FE-B8CF-4122-995A-C969EE8574BB,Primary diffuse large B cell lymphoma of the CNS,0.996213699
24135D81-E6DE-41C4-A5CF-2C051BE8DE15,"Astrocytoma, IDH-mutant",0.996210917
06E885CE-C7B0-46DE-A586-187BE4FA02D3,Germinoma,0.996199575
3F514774-8C86-4311-8B9E-670D86E40FD6,CIC-rearranged sarcoma,0.996182596
B8DD5B90-1D33-496B-B97C-BB6A5E43939E,"glioblastoma, IDH-wildtype",0.996175471
04A1909B-A497-4A64-8A29-BBA3D5CA1104,choroid plexus carcinoma,0.996157355
5238BA6B-4ACB-4F27-BC00-2AF18F956B50,"glioblastoma, IDH-wildtype",0.99615465
102F1305-14F3-4503-A758-3ADD9EC64310,"Diffuse midline glioma, H3 K27-altered",0.996141048
C5AC5C7D-8FC9-497F-A6BF-2585A7FD659E,"meningioma, intermediate",0.996140984
EF2A6CC8-D0DE-4D4C-9224-116546DC3897,pilocytic astrocytoma,0.996134827
041B6FC3-B2F0-4278-A45C-0FB6FEA5247B,Primary diffuse large B cell lymphoma of the CNS,0.996134256
13270EEA-7473-4C24-AD6B-A5739EB065D7,Primary diffuse large B cell lymphoma of the CNS,0.996133867
81239375-139A-440C-8A91-94B4798B2B52,"meningioma, benign",0.996133785
39D8A141-4562-4D26-98C3-3BDFF37CB63A,"meningioma, benign",0.996133785
ACBC82C5-5E2E-42F3-A497-AFFC42A5CE41,"Astrocytoma, IDH-mutant",0.996129841
FAF624CC-30BA-4F04-823A-36D3860C4E7E,Myxopapillary ependymoma,0.996129009
3FEF93C0-4C51-4EEC-AEC9-5087C00B3617,Spinal ependymoma,0.996121478
2D4A27B5-E464-45EB-B39D-030AF4EA18A4,posterior fossa ependymoma group A,0.996113223
FDF304FC-2D2F-4308-9486-F9B6E53F0806,Pleomorphic xanthoastrocytoma,0.996108946
B7BF57EC-2CE7-4682-801E-3432259BA38F,"glioblastoma, IDH-wildtype",0.996105427
0C2E4FB7-38A8-4080-B9C3-4DD8641FD748,High-grade astrocytoma with piloid features,0.996097411
34E910BB-4B7D-4FE4-B324-241956111388,"meningioma, benign",0.996093341
E08A9972-A4EC-4DF5-BB7E-F2B8596433FC,Dysembryoplastic neuroepithelial tumour,0.996080352
E4310BFA-AB9E-42D4-8346-865D27FBF04E,"glioblastoma, IDH-wildtype",0.996034773
3EAF56D6-0854-43AD-B296-C3F541E463F2,"Astrocytoma, IDH-mutant",0.996034329
45CF8E8C-7B23-4225-AF92-DBD827AE5071,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.99603193
6E7E5DF9-ED6A-4148-9033-75D5904A8581,pilocytic astrocytoma,0.996026108
80CFFFDB-6469-4056-B523-E16758008540,Primary diffuse large B cell lymphoma of the CNS,0.99598116
BED2B505-826B-441A-AE3B-13E6ABF52785,"glioblastoma, IDH-wildtype",0.995975874
90BF0854-C569-4E17-ABDE-5249281C8767,Central neurocytoma,0.995971919
367FF2F8-02AB-4CF9-950D-268BB6BF6C8A,Rhabdomyosarcoma,0.995946323
22BD9880-0265-4614-8A96-BCAD47B5B7B9,Plexiform neurofibroma,0.995943574
E994DE90-F9DA-437B-BE64-D15D34075E82,posterior fossa ependymoma group A,0.99594079
1381E877-85F2-465C-B509-E20C83834359,"glioblastoma, IDH-wildtype",0.995936057
E1BE303E-FEE5-4647-A06E-E4F3EB632E65,control tissue,0.995902302
B73FBB4D-64E9-482E-B474-453D7CF5034B,control tissue,0.995902302
1A76BF17-2B21-4E01-960B-9B7E50EA3A43,medulloblastoma Group 3,0.995861822
82116384-C2F7-4173-BA25-297B100CBF7C,"Astrocytoma, IDH-mutant",0.995858238
F4590315-B9EA-4D60-A258-B6AFA43FF940,"CNS neuroblastoma, FOXR2-altered",0.995838335
3D3CD950-B8C1-4E71-AC1A-7FB17B646DEB,pilocytic astrocytoma,0.995815275
10B6F1A4-4211-4BED-AD95-149E24DCCD2C,"glioblastoma, IDH-wildtype",0.995814645
F3128DD8-EC49-4E5A-9D53-10122E45C6F8,"meningioma, intermediate",0.995807876
E164F84D-1BA0-49CA-971D-C6B4FCA43479,"meningioma, benign",0.995804571
D8F33B78-C4AC-442F-A936-913263D29785,"Astrocytoma, IDH-mutant",0.995796851
985ED738-0390-4B6A-9BFB-CA607A074649,Primary diffuse large B cell lymphoma of the CNS,0.995795965
016BBA19-2B81-414E-819E-43A7D016A5DB,"glioblastoma, IDH-wildtype",0.995781456
C52FED6E-CA87-44CC-A7C9-CB270E9FB3D7,Pineoblastoma,0.995780161
8DFBCBDB-2DA0-4688-B07E-2783E93507A4,Pituitary adenoma,0.995766204
BBC7DF62-4C8B-47A9-BB88-53867F0EF5F0,"Astrocytoma, IDH-mutant",0.995752671
F249A761-BF69-44BE-AC2D-7FD1FC1D411D,"glioblastoma, IDH-wildtype",0.995700831
784DA548-CF9D-40D2-949E-519E03B16D35,"Astrocytoma, IDH-mutant",0.995700689
311F3842-22A3-44AE-9058-CE68A9B8724D,Spinal ependymoma,0.995692035
E05CE3CF-8733-41A0-9D0C-4280483F26A1,"medulloblastoma, SHH-activated",0.99569028
D074572C-1A89-44D7-AB93-095284685DF0,"medulloblastoma, SHH-activated",0.99568565
8DA72B61-729F-4526-BCC4-5BF7491686E9,posterior fossa ependymoma group A,0.995677749
6C00D505-5E4B-4DC2-854B-832EEB710525,choroid plexus papilloma,0.995667847
9573D8AA-F80C-4DC0-97E7-C5873A95FB38,"Astrocytoma, IDH-mutant",0.99564747
3974382F-BB6F-4529-8C55-114387112B83,medulloblastoma Group 4,0.995644541
C2851E4E-8C87-4B1E-A5E0-B361AEB4FAA4,"glioblastoma, IDH-wildtype",0.995644073
A6202BDC-7DEF-4517-96E8-4159791A2DBD,"Pineoblastoma, miRNA pathway altered, group 1",0.99564358
36BC801D-1296-4918-850A-0FC4F5832C47,"Astrocytoma, IDH-mutant",0.995638431
42FC23F9-D977-4C13-9B6E-CDB588F148DE,"Astrocytoma, IDH-mutant",0.995634331
084E2FE0-8FF3-46C2-AA00-CD60FF585EAE,"Astrocytoma, IDH-mutant",0.995634331
39FF4EF3-7C10-4594-954A-46A5A3CAAA0D,"Astrocytoma, IDH-mutant",0.995634331
867C3304-09AE-42FC-8E79-30D457447F97,"Astrocytoma, IDH-mutant",0.995634331
D0FB726C-8BC9-49BF-A5F3-B3F02BE1E8CF,Central neurocytoma,0.995605173
6C46F77B-FC98-4EFF-A665-C840DEEC707D,"glioblastoma, IDH-wildtype",0.995593546
22D72CCB-CBB3-4D6F-8AE2-9295A528B80F,"glioblastoma, IDH-wildtype",0.995593546
DC13C804-B5E7-439F-AD51-B66E8BF80157,posterior fossa ependymoma group A,0.995593261
33167EE0-2E97-429B-9FF7-1E920725AAC5,"meningioma, SMARCE1-altered",0.995589482
9A98CB85-C604-4590-9C20-631BCC334896,"glioblastoma, IDH-wildtype",0.995583191
8714286B-6182-4125-B74F-F8FDF851925D,"glioblastoma, IDH-wildtype",0.995583191
0F79DE74-0182-42A4-BF1A-6D8397CCFDA3,"glioblastoma, IDH-wildtype",0.995583191
B163C70A-55AD-461F-AF52-3B94AC424099,choroid plexus papilloma,0.995568175
EE0B98A3-9693-46FF-8926-ECE7CE7A17A2,medulloblastoma Group 4,0.995564162
D17780FA-A544-4033-9B58-6DA453F29218,"glioblastoma, IDH-wildtype",0.995562935
D7F37B82-0BC2-42F8-AFF4-C1C1299F456F,Schwannoma,0.995546271
EC3FEE13-4A66-42BF-95D1-0F757E3AFAD5,spinal subependymoma,0.995544265
F969DCA5-5D50-4B9C-B4EC-781A17A9A6DB,spinal subependymoma,0.995544265
AA4E936A-5BB4-40B6-BE4D-A86DEAF0EA1D,medulloblastoma Group 4,0.995536267
5A8C4E6E-7FCE-440C-AD61-CAC6D7289ED8,Myxopapillary ependymoma,0.995496888
8DC6CB32-82A1-4C91-B2CB-69DB06A09FD6,"Astrocytoma, IDH-mutant",0.995444965
8EE5B67C-9169-4097-AA25-45239AB14D51,"meningioma, benign",0.995426533
3853CB86-21E0-4555-B1EA-B5F223719C7C,"supratentorial ependymoma, ZFTA fusion-positive",0.995392129
596340F5-A2BC-45A4-8D06-93BF96CD0FAA,"meningioma, benign",0.99537784
BBD7972C-336D-42F4-B34B-70EAE6E247E8,"Astrocytoma, IDH-mutant",0.995368635
ADA7E625-2FF7-4387-9D84-4B26CF2276F7,"meningioma, benign",0.995343446
FD0CC25E-27C8-4DE0-98FC-DD4DD0834663,"glioblastoma, IDH-wildtype",0.995332507
299A09D0-55AB-4F67-B88C-E9F728930485,posterior fossa ependymoma group A,0.995319495
2767FC53-470E-417B-9EEB-4D5148FAC8B0,"Astrocytoma, IDH-mutant",0.995316736
45DAC4E0-F006-40B6-A48D-9250506CD22A,pilocytic astrocytoma,0.995301559
5AAC9832-BAF7-41A3-AB2A-091786CFA08E,medulloblastoma Group 4,0.99529958
7AD45218-DF89-4C89-9E49-BD069CFE9693,"glioblastoma, IDH-wildtype",0.995261984
A76050AB-3C66-4A1E-A206-54A83B807F4A,Atypical teratoid rhabdoid tumour,0.995257701
0378B304-0BBD-4E25-A6DB-7EDAC31D6D0D,"medulloblastoma, SHH-activated",0.995255775
F91E6620-D3DE-4ED3-A5A9-18832A654FF5,"diffuse glioma, MYB- or MYBL1-altered",0.995247467
383F1EE2-887F-4847-9764-E68EFF54B0A3,"glioblastoma, IDH-wildtype",0.995235136
239A2C0F-3344-47A1-AEFB-97E7C8E06F47,"glioblastoma, IDH-wildtype",0.995221455
21C75E1F-F2F0-4143-97D6-04476415D775,pilocytic astrocytoma,0.995208931
F7B78C0D-B4FE-4229-B748-FC222844DA17,posterior fossa ependymoma group A,0.995205756
DF3C3C91-73B5-4ACA-BD03-2CE1F1646AA3,Pituitary adenoma,0.995185284
B7EAC63B-9FFC-4DA4-9A79-EB960B11F671,medulloblastoma Group 4,0.995170374
394A4524-0DCB-4FA7-AA66-143FFA1F6D39,"meningioma, intermediate",0.995142551
6FEDBA93-D312-41D4-A3A5-C894BB68BDBD,"meningioma, intermediate",0.995142551
CD90D773-2895-47A7-8C30-CA7A47EDAB92,pilocytic astrocytoma,0.995122458
1D084627-4D32-4729-BD04-3B6B8650E45F,medulloblastoma Group 3,0.995108432
6AAC7378-153F-4C5F-A4AC-430D127A802C,"glioblastoma, IDH-wildtype",0.995103204
AADCFD10-A659-4972-85C5-5D63F7FBAD51,Subependymal giant cell astrocytoma,0.995101382
67E2AEE3-8537-45AA-9D9D-330798E62882,"meningioma, intermediate",0.995083925
AF2BB2E6-BAE9-4CE7-A726-2EAA6E26AF72,"glioblastoma, IDH-wildtype",0.995080444
5C548321-C7E4-4CFA-9283-17BD289C21D9,"meningioma, intermediate",0.995074152
E8AF351D-3F33-4F5C-978C-5E3CFD45EEE8,control tissue,0.995062367
304B5D15-E867-4C46-9218-96DA5B9E420D,"meningioma, benign",0.99503363
D7B72775-E471-4681-8E0F-5AFB99439687,"Astrocytoma, IDH-mutant",0.995015501
E7A7E09B-4E25-4EC0-BC8A-5124D56D3612,medulloblastoma Group 3,0.995006541
23B414BB-8891-4B88-9D84-42D94520A30A,Atypical teratoid rhabdoid tumour,0.994990586
08D44C4E-806C-44DE-9888-1BC24C9E2F87,"medulloblastoma, SHH-activated",0.994953186
365FCE7E-36B7-4E7D-AD4D-69C06EF115B8,posterior fossa ependymoma group A,0.994934822
528E6FD1-425E-41EA-9416-D39201405AE4,Diffuse paediatric-type high grade glioma,0.994922964
E810E0F7-C471-42C3-BDED-0EE2C784E73D,posterior fossa ependymoma group B,0.994902955
7EB38DD9-C7F6-4941-B6F7-5ABED40EE012,Ewing sarcoma,0.994843966
6C99D4CD-71FD-43A3-838B-5418501015AD,"Diffuse midline glioma, H3 K27-altered",0.994832263
4C853E52-43F5-4879-BBF5-96F58B00033A,pilocytic astrocytoma,0.994785911
33809153-BD33-4302-A6E3-75C7C92B8882,pilocytic astrocytoma,0.994785911
C9984837-2EF4-4E19-83BD-24791A8217CF,pilocytic astrocytoma,0.994785911
C115C092-CE85-4846-8B73-9A792C364B33,pilocytic astrocytoma,0.994785911
9AA48BC8-67C9-4FC4-8934-3741E0EB5AA8,"glioblastoma, IDH-wildtype",0.994757793
91130D81-0879-4B33-96EF-06B0EAA2FE45,medulloblastoma Group 4,0.994739436
B74CD3A5-F2F6-464F-BBBE-2B9A6D0E1DFD,"Astrocytoma, IDH-mutant",0.994721478
7074A9B5-1C92-45A8-9D76-EFE41ADC47C1,Pleomorphic xanthoastrocytoma,0.994721283
344B4CA4-D559-488F-9877-432D3C4E0A72,"glioblastoma, IDH-wildtype",0.994720402
38362AA6-5F34-4FC8-9381-CCD01D978E9B,"glioblastoma, IDH-wildtype",0.994719663
732C5CA2-3D62-4A2B-8CA6-A1DD6702D9AC,Atypical teratoid rhabdoid tumour,0.994683931
EBF60F41-F4B2-49B9-9FC3-BC0CF9E311F8,"Diffuse midline glioma, H3 K27-altered",0.994655435
80CE69EF-DD22-428B-B8AA-1A4560F64C62,"glioblastoma, IDH-wildtype",0.99465075
F54E0E9C-EB27-49D7-B80B-5696730D0CCC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.994643179
7C05A66C-A839-40A5-A903-B2CED7C0EAC1,"glioblastoma, IDH-wildtype",0.994625695
B8F7432D-6031-483E-8156-721C41120E4B,"glioblastoma, IDH-wildtype",0.994590135
76A2F991-4DB3-4161-ACD3-428216234CE6,"medulloblastoma, SHH-activated",0.994584633
E3C6DD12-1EB9-4E52-934A-EC58A9FE990E,"Control tissue, reactive tumour microenvironment",0.994577227
AA63EE16-D6C2-48D6-8661-33ED02C906DA,"glioblastoma, IDH-wildtype",0.994550548
A1C5FCE7-D2F1-472E-A327-0527055EFC79,Dysembryoplastic neuroepithelial tumour,0.994521927
282EEC4E-C46F-4E7F-BD4B-815B3D7FCCB5,"meningioma, benign",0.994521085
3C504748-E77C-471F-814E-B2A9032A038A,Dysembryoplastic neuroepithelial tumour,0.99450092
B8C5A682-C2FB-451A-8556-4CC24D1C882C,"Astrocytoma, IDH-mutant",0.994488602
4F2AEAD4-0429-4C44-92EF-BBBB9A0DEB62,pilocytic astrocytoma,0.994484031
A528F07D-A7FF-462B-B0F2-8E86B6960CD0,"meningioma, benign",0.994476231
9D53AD54-29CC-414D-A74B-ED37E0DDAD2F,"glioblastoma, IDH-wildtype",0.994471162
A4672B7D-2DA4-4740-B68C-0451D558DEFF,"glioblastoma, IDH-wildtype",0.994453027
A0A8A941-092F-4568-8F1B-633D16EC94AF,pilocytic astrocytoma,0.994443292
1DABDE05-971E-481B-AB5A-6E1D4BBAD84B,Supratentorial subependymoma,0.994437254
3F6F0C4C-8920-4E3F-AFA1-4E0EFF4C0F5E,"glioblastoma, IDH-wildtype",0.99443279
11EE5A40-8F42-4985-B588-6A990EBA70DC,Dysembryoplastic neuroepithelial tumour,0.994347083
AA54CA80-48EA-450E-A8DC-DBC54834758C,"Medulloblastoma, WNT activated",0.994315572
48B7CAA5-93FB-4B4A-8175-FA3DA06CC7C8,"glioblastoma, IDH-wildtype",0.994311985
D32C6EAF-AE8C-4A25-8EF7-AD80F7D6224C,medulloblastoma Group 3,0.994308057
F841208E-507D-4842-9807-F656B1899CB6,"glioblastoma, IDH-wildtype",0.994273768
57C1CD81-2BBA-4D48-ACDD-0160D934BDA4,"glioblastoma, IDH-wildtype",0.994273768
6DDB36DF-9C65-402B-AAB5-B2C5D6947FD0,"glioblastoma, IDH-wildtype",0.994252064
C9F7849B-F8C7-4CFF-AA5C-CB48848DFCEF,medulloblastoma Group 4,0.994242632
E03B83A5-208E-4060-993B-2938C6CC1D28,"glioblastoma, IDH-wildtype",0.994239252
FBBE965E-B909-40CB-825A-F62DFBC2F275,"glioblastoma, IDH-wildtype",0.994236788
22E80427-723D-4108-AAB0-AE31E971BBB3,medulloblastoma Group 4,0.9942109
83ACA75C-5605-48DB-A8FA-82785199C720,"glioblastoma, IDH-wildtype",0.994198631
CFE76E33-8B43-4FFE-9C95-10B6B898B23F,Ganglioglioma,0.994191378
F43222AB-5352-491B-9906-1100A046795D,"glioblastoma, IDH-wildtype",0.994174004
4D896ADB-9ED9-4752-A18A-25E08653FD71,normal pineal gland and pineocytoma,0.994161578
B2DD76CB-CCEB-463F-A413-F614286BB527,normal pineal gland and pineocytoma,0.994161578
4A9E9FEC-69A6-4AE0-976C-35F2D09D893C,"Control tissue, reactive tumour microenvironment",0.994145131
F5BDB111-146B-43DA-A032-21B5611CCC78,pilocytic astrocytoma,0.994122403
9FE6EC73-EB9C-4DEF-8A3A-40E7C6165850,posterior fossa ependymoma group B,0.994097881
8E5BCDAE-8335-4F34-9260-A7C07C412BAA,"Astrocytoma, IDH-mutant",0.994095911
A230CD2D-A174-4680-ACE6-40CC922DDDC5,posterior fossa ependymoma group A,0.994081631
C58AAE7E-E6B9-4A34-99B2-63E9E91C9F4A,"meningioma, malignant",0.99403554
4042A2CC-7914-464B-B881-416A7884DA33,"Astrocytoma, IDH-mutant",0.994026653
3DA4A99C-EC20-45E9-8B3E-8CBBD9475D9F,pilocytic astrocytoma,0.994009061
92589F63-4268-4D42-A0CA-7F9E0C4F0ED9,"meningioma, malignant",0.994004877
32F504B9-18B1-4BB8-A62C-12D22639AA4E,spinal subependymoma,0.993999071
878D2058-F124-478F-9E4B-E75FB682C4D8,"Astrocytoma, IDH-mutant",0.993993729
B94150F9-85F2-4F79-BCBC-E7EFFDA46EC9,"meningioma, benign",0.993993548
6CFA6747-AFF1-4103-9440-1975B4C09CE5,"meningioma, benign",0.993993548
6644E901-4F30-4CF4-AAB7-1F66217DBD14,"CNS neuroblastoma, FOXR2-altered",0.99399099
AFE1F9C9-0DF8-456B-8B23-20266E993523,Malignant melanotic nerve sheath tumour,0.993988992
C085F672-26DC-4B1A-ADF1-0BA694ACDC40,"glioblastoma, IDH-wildtype",0.993965261
F76BD003-0D38-49FF-818E-21AFD08117A2,"medulloblastoma, SHH-activated",0.993948943
CB3E22EB-FF65-422E-976D-C5CD85691AF0,"glioblastoma, IDH-wildtype",0.993933635
2A135382-AFF0-418D-AC92-11F817C9D1A3,"glioblastoma, IDH-wildtype",0.993911893
963D5735-2248-4072-852F-F1147EC67D66,"glioblastoma, IDH-wildtype",0.993892849
DDBBEC18-B7AE-451C-9F34-5CD42F4E5C5B,"Astrocytoma, IDH-mutant",0.993884552
8962DAA3-9269-40A1-83B7-129E79AFEDAC,Diffuse leptomeningeal glioneuronal tumour,0.993871343
BCFE976E-5EF9-458F-965F-C6CF7A91A0E2,Diffuse leptomeningeal glioneuronal tumour,0.993871343
39587C13-D356-4172-AF86-9CDAEEDD2CE2,"glioblastoma, IDH-wildtype",0.993862212
7FD43D39-8330-49E8-9D23-6591E0BBF92D,medulloblastoma Group 3,0.993860994
A742C72E-AB2B-4D68-8291-DC578D8B36D8,"glioblastoma, IDH-wildtype",0.993849317
DA43A3A5-87C4-4D56-BAB1-0563BB2E7037,"glioblastoma, IDH-wildtype",0.993849317
918B1CB5-4CE4-4939-A34C-40ECB8D9FBC7,pilocytic astrocytoma,0.993843181
36D98ACF-6943-4CE2-98E7-6C0F1538E5CC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.993838521
59C9988B-5BB9-4104-982F-2F2B277A5793,"Adult-type diffuse high grade glioma, IDH-wildtype",0.993823654
E3ED3D40-A295-4E80-9A28-356B4E729060,Solitary fibrous tumour / haemangiopericytoma,0.993802024
D74C64B5-79D5-4F07-BF19-46CC5795B880,"Astrocytoma, IDH-mutant",0.993790268
67CFDC81-B31F-46EC-81B0-C0A24D9BCD5F,"glioblastoma, IDH-wildtype",0.993756242
AC9E35FC-9EEE-46C7-97B1-440D4923C6D0,pilocytic astrocytoma,0.993750255
13729256-2119-4277-88FB-05B558851998,"Astrocytoma, IDH-mutant",0.993742871
679A1104-F549-4934-9232-6174ABDB7D09,Ewing sarcoma,0.993720835
7D079110-C420-433D-9184-C3A9C0B5F9E6,"supratentorial ependymoma, ZFTA fusion-positive",0.993713737
9B896223-5188-42C3-941B-85659BA58063,"glioblastoma, IDH-wildtype",0.993659886
15F01CF7-3440-43BB-B65F-EF77A6408F1E,"meningioma, intermediate",0.993606917
84ECE9B1-F1C3-4D8C-A4AD-828F62A0FB48,"Astrocytoma, IDH-mutant",0.993599414
CA41D5ED-3AF9-4459-8F7F-E910CDCCA5E7,"glioblastoma, IDH-wildtype",0.993598853
90151A5D-3604-4CB4-BE84-E3CA8E3A4235,"glioblastoma, IDH-wildtype",0.993568402
C7DDB55C-B06F-4B16-B602-6C5208FE84F8,"medulloblastoma, SHH-activated",0.993561154
67931CF0-0067-4E0C-8EAA-A5CE151326CC,"Diffuse midline glioma, H3 K27-altered",0.993535994
FA21E973-F812-4C09-A44D-E113B5DBD173,Pleomorphic xanthoastrocytoma,0.993508313
0809742B-89B1-46CB-A857-3422C09E05F6,"glioblastoma, IDH-wildtype",0.993505102
67250B1A-10AF-4E4D-A941-BFB3A2281596,"glioblastoma, IDH-wildtype",0.993474778
6460687A-8E97-4E4A-A13E-AE12CE9A9F3B,"glioblastoma, IDH-wildtype",0.993474778
8AF3776A-DA73-4CF2-925F-0CCB52A2C7AB,"glioblastoma, IDH-wildtype",0.993474778
D03D308B-22B1-4841-8970-DC1EDA3431EF,Spinal ependymoma,0.993470389
81DA0E09-13BA-423E-9131-78810678772A,Spinal ependymoma,0.993470389
C8383883-3BE7-437C-B0E2-29A8F82B9119,Dysembryoplastic neuroepithelial tumour,0.993468811
87566246-9697-4014-8599-64A81D7E4CC7,"glioblastoma, IDH-wildtype",0.993466164
3946C781-9F99-4CA3-9AC3-02FF2B76C0D2,High-grade astrocytoma with piloid features,0.9934539
6B97D2B4-ED28-4D76-800E-FF0669C75A40,High-grade astrocytoma with piloid features,0.9934539
8E17677A-4875-48CE-9AEA-DB9E6619F0A1,"glioblastoma, IDH-wildtype",0.993419567
59D3B613-29FB-4AC2-A105-B7959B49FF47,"glioblastoma, IDH-wildtype",0.993419567
59C188BB-6E96-49B9-AB24-B71967024F72,Dysembryoplastic neuroepithelial tumour,0.993418895
5D2D3B37-3EAF-4A29-BEED-1BB4236034EF,"glioblastoma, IDH-wildtype",0.99339141
8A3C1B41-8E7F-42E4-81A5-C4107FD78788,"meningioma, benign",0.993354389
81F29453-E473-43A4-815E-06634047BD4E,"Astrocytoma, IDH-mutant",0.993344014
135CCDB6-748E-40DC-99E2-ABDF996D171B,"glioblastoma, IDH-wildtype",0.9933375
891F7098-8519-4FFC-9A22-F463135197B1,"glioblastoma, IDH-wildtype",0.993293685
C0A9FA8B-0CE9-415E-B5A0-EB6A3E33C8D6,Atypical teratoid rhabdoid tumour,0.993289309
494C266A-A044-42B3-AB2E-FE389A9FB28A,"medulloblastoma, SHH-activated",0.993266987
4CFA7FF0-7AA2-499F-A080-A53F35E230B4,posterior fossa ependymoma group A,0.993252311
68668A29-CE86-45E2-B7F9-046A03FC7FAD,"meningioma, benign",0.993211733
23283D19-1093-44CF-ABCD-9BE32022E344,"meningioma, benign",0.993211733
A3B7B460-03ED-4CC0-A9B1-709970B041F9,medulloblastoma Group 4,0.993199685
766B61E6-21C2-4123-90FB-EF0E31A9E6F1,"glioblastoma, IDH-wildtype",0.993189506
4FAD72F9-37CA-47F1-8077-066DC7CA12F3,posterior fossa ependymoma group A,0.993175241
0EED457B-DB7A-40A1-A01C-66F2DC50CE0A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.993164404
4FFE0EB5-F26F-4A6E-A87E-561073BB8089,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9931504
626FC136-8C60-48FC-8140-633987234554,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9931504
88F7907A-9FB0-4678-967A-5F18D80D3257,pilocytic astrocytoma,0.993149962
49B278BE-814D-4BEC-91EE-FA498BC3F31D,Rosette-forming glioneuronal tumour,0.993115103
407A81B9-6A61-4715-BE3D-1E776222CA03,Rosette-forming glioneuronal tumour,0.993115103
A25CE88C-329D-4FB5-8A53-D7D5B98A6F7B,"glioblastoma, IDH-wildtype",0.993111935
CB5DA51B-949D-42F3-9B1F-8C0A361804A3,"glioblastoma, IDH-wildtype",0.993058697
13B22F5B-0F47-48AB-8F92-BC19A0C6FD5F,"glioblastoma, IDH-wildtype",0.993058697
F7A5E424-F340-4E45-AF9B-80E7B087A301,"medulloblastoma, SHH-activated",0.992947702
BF270AEB-114D-4E85-AF2D-88C21FB6D3C1,Chordoma,0.992925143
6A999A3D-AD8C-43BA-999A-636D285BA77D,medulloblastoma Group 4,0.992917735
7D47D0E0-E438-4F8B-AD94-790AE1B796E5,"Astrocytoma, IDH-mutant",0.992898803
64E5E5AF-3EAC-4835-B943-1657553D49F0,"Astrocytoma, IDH-mutant",0.992898803
991963F2-DB94-47A6-9F65-146072580130,"Astrocytoma, IDH-mutant",0.992898803
712D99F5-CE6F-447D-BA52-86E72D5518D5,"meningioma, benign",0.992869663
600EA971-93D6-4399-B84D-FB5084B67B8E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.992835439
FF4B3A13-0456-40C0-841B-CD97B880FD74,"glioblastoma, IDH-wildtype",0.992829886
11542810-0751-49AE-A71A-ACAC9F22920A,"glioblastoma, IDH-wildtype",0.992829886
A1C7B5DB-4969-4FDD-BCB0-8F423A8702B7,"glioblastoma, IDH-wildtype",0.992788505
D46198C6-C16E-4A8E-89A6-792E9937A27B,Dysembryoplastic neuroepithelial tumour,0.992766477
1A894DC1-36C3-4757-AD38-74CCCFC8825F,Dysembryoplastic neuroepithelial tumour,0.992764508
7196CA41-98A1-45D0-BEE4-77A8BF992394,Solitary fibrous tumour / haemangiopericytoma,0.992717388
FE149F50-BD07-4CCC-B90C-4DDF50FE29E1,"Astrocytoma, IDH-mutant",0.992707298
6CA1665B-014D-4F8E-96DB-71E214DF9A93,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.992704227
AC8EA15A-8143-43F8-A871-B15B2DDCDFF4,Primary diffuse large B cell lymphoma of the CNS,0.992682637
E84D77C1-A409-463D-A054-E0716998A2E2,Atypical teratoid rhabdoid tumour,0.99267354
079C1470-824F-485B-9C4B-FA7937E6F36F,medulloblastoma Group 4,0.992673341
73ABDB34-2509-4225-A92C-A4276DF02623,"glioblastoma, IDH-wildtype",0.992666158
080555EA-4A4B-4C79-97BA-5B0F05C92B32,"meningioma, benign",0.992622495
476CA504-1873-4E2A-A3C8-B9211DE18B8C,"meningioma, benign",0.992615818
BFBBA88A-FC84-4B64-8C46-0E067D542BC3,"meningioma, benign",0.992601868
090005E1-D786-4A3C-8AC0-F399846889AE,"meningioma, benign",0.992601868
FE9AEAC9-0314-43FD-8C12-980DDAA25C15,"Astrocytoma, IDH-mutant",0.992593117
725379A9-09E6-495B-90D3-E68102780BA7,"glioblastoma, IDH-wildtype",0.992592579
81423556-5F15-420C-B616-45E9288AC892,"meningioma, intermediate",0.99258281
51A59EFB-52FB-4DCC-A965-9E87F5796D72,Diffuse paediatric-type high grade glioma,0.992569847
E636A927-8FC7-4CAC-80EB-273C6ED01532,control tissue,0.992550909
2827E210-356D-443A-9E66-923410F567CF,control tissue,0.992550909
BAD9C84E-3079-450E-97EF-9233EAB7B1E6,control tissue,0.992550909
CC9F82C9-EC83-4D25-ADB2-A69AAB69E545,control tissue,0.992550909
5FACB5D3-3F0A-436E-9CF0-DCF639F6B36E,control tissue,0.992550909
96FBD0D9-1688-4F0E-B718-4B8831DA7383,choroid plexus carcinoma,0.9925153
9BDFE78A-EEA0-486F-848F-C3ED3FE21E65,medulloblastoma Group 3,0.992485091
CE5F8336-4F43-4909-884B-E27729F2765E,"medulloblastoma, SHH-activated",0.992455912
8E43C2A9-9247-45B1-A07A-7E56A8606EAA,"glioblastoma, IDH-wildtype",0.992413103
D2E795BD-788F-4A3D-A760-66107F125214,"glioblastoma, IDH-wildtype",0.992413103
644FDF43-16EC-4E44-AB34-1E9E2F7B75BB,Pituitary adenoma,0.992397186
C486BD67-7586-4BC8-8CB2-7C31CBFEEA76,"Control tissue, reactive tumour microenvironment",0.992377759
454386A0-5136-43CF-9B94-CCC2BE7194FC,"medulloblastoma, SHH-activated",0.992351593
39E40140-74AF-434B-92C0-6EB0A04A80E7,"Diffuse hemispheric glioma, H3 G34-mutant",0.992325742
9293BFCD-39D8-45F0-8E56-FE21CB76CAD5,"Diffuse hemispheric glioma, H3 G34-mutant",0.992325742
B4E53176-3D4C-4195-B20D-AD2D71E667A5,"Diffuse midline glioma, H3 K27-altered",0.992316762
1F9C8F8D-1C25-4CE9-ABA4-423278E83F6F,pilocytic astrocytoma,0.992315803
F275C551-4715-41D3-BE23-EE2622090913,medulloblastoma Group 3,0.992288094
C6ABE654-6302-4610-99F9-0978FE9E3FE3,"glioblastoma, IDH-wildtype",0.992274698
D8812454-60A4-4E61-82DC-E693F2D958B7,"Astrocytoma, IDH-mutant",0.992177732
7602C716-5FBE-4458-ABD3-F4C843EB6FF3,control tissue,0.992165784
600BB6AD-9EB2-44A1-B021-105B253890AE,"Diffuse hemispheric glioma, H3 G34-mutant",0.992159141
31A516C8-F6CB-44B1-A774-0ACADF99008B,Diffuse paediatric-type high grade glioma,0.992145865
A94D467B-99A1-4527-A441-CE8AE6F1250A,"Diffuse midline glioma, H3 K27-altered",0.992126833
0BCF182D-AAB1-494A-8353-CC96B1F5A284,"glioblastoma, IDH-wildtype",0.992125396
80D864D0-73EA-48BE-B050-18324FEA004F,"meningioma, benign",0.992105302
6CE8E106-D677-44B9-96D4-E2E1D7EF8949,medulloblastoma Group 4,0.99208
3C274F78-9197-4900-A040-998A1CD34012,Central neurocytoma,0.992077017
580304FE-B4D2-4BC6-AFE1-7444AED6DB5B,"glioblastoma, IDH-wildtype",0.992076979
759C0645-A25B-4936-8BBB-963C7020CD7A,"glioblastoma, IDH-wildtype",0.992041736
89440B6D-D6F1-41FE-8615-3B4A4F455BA6,pilocytic astrocytoma,0.99203823
B7F2DE93-4424-4EA2-833B-C488F9547E73,"meningioma, benign",0.991987285
A3BEA72C-7507-4878-B562-FD44D35163C8,"meningioma, benign",0.991975496
2B7BB0AD-A9A6-48A7-B27E-9E738EF10F97,"Control tissue, reactive tumour microenvironment",0.991956937
0749D831-F7BC-49C9-A61C-B22822820C41,"glioblastoma, IDH-wildtype",0.991946488
0967152E-7B24-422B-A7B1-94B12A2BA505,"glioblastoma, IDH-wildtype",0.991946488
B757A179-7F80-4F6C-AFED-ACEDA78BE781,"glioblastoma, IDH-wildtype",0.991946488
FCEB326B-0292-4927-92A5-D956438792B4,"glioblastoma, IDH-wildtype",0.991946488
2DCA3154-35F2-4C18-AD1F-FF395B094673,"meningioma, intermediate",0.991925121
DF2CD115-AFF6-43C7-8514-07CD9FBEC919,"meningioma, intermediate",0.991909014
6CF60B68-A951-4AF9-8256-E0EA6DCBAA79,"glioblastoma, IDH-wildtype",0.991865908
98D42AFF-CA2B-448C-B646-648F2DAE2D6F,medulloblastoma Group 3,0.991844445
1F83B0E5-A4F3-4F6E-8950-4575C62B3D77,Diffuse paediatric-type high grade glioma,0.991780299
9E16FD3D-5905-47B4-9458-3648954B460E,medulloblastoma Group 4,0.991778297
86578FB6-F4F6-4300-BB1D-481200EABB5C,posterior fossa ependymoma group A,0.991773447
D6305FC7-8C3D-4B01-BDF8-5CD2B8DDB03C,Atypical teratoid rhabdoid tumour,0.991739989
A211A84A-CC7D-4061-A8F7-E81F4FC0E611,"meningioma, benign",0.991701875
22BB37F0-9E4C-4B59-A82E-723A285003B4,"Astrocytoma, IDH-mutant",0.991686472
D67662D1-58EE-4B0B-AD49-0C80EA152933,"glioblastoma, IDH-wildtype",0.991684304
33ED9241-D180-44E3-BBDA-FA8CEF73F22D,Inflammatory microenvironment,0.991677416
D4D2EA84-6F21-48F4-91CB-FCB7F3417408,Inflammatory microenvironment,0.991677416
0261BF15-837A-4748-9958-D37BAC5125DB,"meningioma, benign",0.991656755
10D1E73D-E00E-4587-8C28-E84F479EAD15,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.991639899
387C668F-484F-409D-A30C-AB9488CE90A0,Pleomorphic xanthoastrocytoma,0.991635059
7FC71201-7828-43E4-8CE6-AEDA2E0B85B5,"meningioma, intermediate",0.991603665
7AED0880-9368-4373-ABA3-3B2435C5CDD4,Diffuse paediatric-type high grade glioma,0.991595333
E1D6068B-A9C9-44D3-9190-C28B530104E7,"Diffuse midline glioma, H3 K27-altered",0.991556765
40A5AA0C-0EBB-4827-A6D7-D2B8E7AA6750,"glioblastoma, IDH-wildtype",0.991550998
FC0CCD2C-08DE-471E-AD91-43DEC24DCCBA,"glioblastoma, IDH-wildtype",0.991538472
11DEB363-479C-4747-88E8-E3CE17E30222,"glioblastoma, IDH-wildtype",0.991519633
ADC24800-F9A9-40B3-9D39-68E799AF3595,"glioblastoma, IDH-wildtype",0.991519598
A3E30E28-D5C2-476D-98A9-D4958D5CC2F7,"glioblastoma, IDH-wildtype",0.991519598
62343388-D271-4C28-A048-13824FD1A03F,"glioblastoma, IDH-wildtype",0.99147365
6D897F98-F2BF-44DC-A4C2-7E769572F437,"meningioma, intermediate",0.991472863
464F3236-0F1B-4DB0-A74B-92BA8A408630,"glioblastoma, IDH-wildtype",0.991471481
1CAB13D1-CF01-46C6-AF2B-B7A7DDE54355,Diffuse paediatric-type high grade glioma,0.991445148
9EE16EB7-714B-4B34-BEA7-0B124BDD2C34,Diffuse paediatric-type high grade glioma,0.991445148
C7DE29E9-F1FD-4DC3-82D1-D1CADA45464E,Posterior fossa subependymoma,0.991443625
DDB6CAE9-D6D7-4CA8-A0A5-CE7E4C47DB93,"meningioma, benign",0.991429194
7C95163F-2E91-4230-B9B1-1C8D2D68EC64,"Oligosarcoma, IDH-mutant",0.991408452
82FA916D-EB1C-4DDD-970B-D83BEFA7ACE9,"meningioma, intermediate",0.991390533
E98452B8-467F-4AF8-97A0-FF8E6E792661,"glioblastoma, IDH-wildtype",0.991389997
633C24C9-9376-4CC2-BB34-D332961F174C,"glioblastoma, IDH-wildtype",0.991389997
AD36A965-EEA5-4358-B1A8-7D26569C0D29,"glioblastoma, IDH-wildtype",0.991372391
54B5B41A-299F-48C6-8401-7C20B8694FE7,"glioblastoma, IDH-wildtype",0.991372391
A5A66FAB-EED2-48A6-B92D-41A4E2195FEA,medulloblastoma Group 3,0.991368912
BF2A49CB-0667-4F38-9098-63C79BC9D74D,"glioblastoma, IDH-wildtype",0.991368784
22DBF6D7-2C46-481C-86BE-8B52CD850B07,Malignant melanotic nerve sheath tumour,0.991339958
7E57739F-DFDF-4DB0-878A-76341C11EAF7,control tissue,0.991278363
070308F2-21C7-477F-AB69-6945CAE16C75,"glioblastoma, IDH-wildtype",0.991256924
CF2EACF4-B6D2-4B12-8BA1-0E004EC4E040,"glioblastoma, IDH-wildtype",0.991256924
20BAF45C-59D8-4D6A-BC51-19D87012AD49,"Astrocytoma, IDH-mutant",0.991252679
29255A10-2A6C-4929-8A33-7765CF1641B0,pilocytic astrocytoma,0.991229948
BDD83C6B-284A-4EED-8845-6D0371AAB28F,"meningioma, intermediate",0.991229756
E3F73979-EBD5-4ED3-9CA8-1279E065CF4F,Solitary fibrous tumour / haemangiopericytoma,0.991173358
C5C9A417-CD4E-4A33-A428-D1A6667A4380,"glioblastoma, IDH-wildtype",0.991141999
47D23751-0106-4B3A-AC3E-6F41936FFF29,"glioblastoma, IDH-wildtype",0.991135268
8FE36AB3-A217-4942-8044-12EBA6CE200E,Malignant melanotic nerve sheath tumour,0.991091536
C187F460-A5BE-4B8E-9C4D-0D314D1571A3,Malignant melanotic nerve sheath tumour,0.991091536
73EF37F0-8A32-48AD-993E-29B5A5A1E1E7,"Diffuse midline glioma, H3 K27-altered",0.991075188
30F3BBEF-F934-40AF-A547-93923F43BF9B,"meningioma, intermediate",0.991067181
DF80DEF9-342A-4228-9E5A-7BD667DDD51A,"glioblastoma, IDH-wildtype",0.991030377
689A303E-DA88-43AC-B5A8-5142E8B8479A,posterior fossa ependymoma group A,0.991030364
E8B0E585-A422-496F-BCD0-7D1AC1851042,CNS Embryonal tumour with PLAG-family amplification,0.991000743
A1D5C688-106A-443D-B374-AE875805DB13,Neuroepithelial tumour with PATZ1 fusion,0.990985239
BF823F21-4DCB-48BE-9E33-E8EECEA038E9,"glioblastoma, IDH-wildtype",0.990957964
ABE01868-8E8A-49AC-995E-9834B819F27C,Schwannoma,0.990862409
C5E93D25-0FDC-4068-BEC2-F384C0A74A18,"Astrocytoma, IDH-mutant",0.990827359
B723C54A-8EB0-47D6-A959-7FF7746751F9,Pituitary adenoma,0.990815743
20B308FD-28F2-465F-9FDC-6D92938AF1DC,"glioblastoma, IDH-wildtype",0.990784423
A670EA87-610A-4EF1-B1A8-589EF34AC096,"glioblastoma, IDH-wildtype",0.990784423
3F6B1250-A9C6-4E3A-AEB3-8A7C16AF772C,"glioblastoma, IDH-wildtype",0.990750974
5B83FFDB-2777-48A1-B25E-3A8494A1C919,"glioblastoma, IDH-wildtype",0.990750974
62C03A49-184C-42D7-9AC5-0D4E2BA73F21,"glioblastoma, IDH-wildtype",0.990750974
5FD19ADF-EB0B-46A4-9EB7-72DCE23D800A,"glioblastoma, IDH-wildtype",0.990750974
D0F4883A-80AC-41A6-BA40-20A2FE09D676,Primary diffuse large B cell lymphoma of the CNS,0.990743805
6033B1FE-FDD8-4DAB-9C06-F7F94098872B,Atypical teratoid rhabdoid tumour,0.990710378
25332A37-1679-48B2-92E0-8E8C21DE0C4B,"glioblastoma, IDH-wildtype",0.990690221
3CFB625F-7228-4470-BC91-4C815D6802CE,"glioblastoma, IDH-wildtype",0.990672809
F3393BD8-733A-4432-B8EC-3902DD9F9557,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.990662006
D7E4CE7F-212E-45B4-9050-D94969440913,"Diffuse midline glioma, H3 K27-altered",0.990635922
E8E17688-6098-47AF-8E82-9CC60E016366,"glioblastoma, IDH-wildtype",0.99060626
A072FBF8-C795-48EA-84B5-3408A47DEEE3,"glioblastoma, IDH-wildtype",0.990595867
37265239-6C36-48B0-9C0F-707F156C785A,"glioblastoma, IDH-wildtype",0.990592558
B5363A0D-A123-4088-BD05-4CA90BDB3908,"glioblastoma, IDH-wildtype",0.990592558
757D360F-2DCC-4DA6-A384-88732989DB43,"glioblastoma, IDH-wildtype",0.990591541
F1C09779-37C3-420E-86EA-6998A0CAE35D,pilocytic astrocytoma,0.990590762
0B5D8248-2DAF-44B4-8246-5155F4600F69,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.990586736
DF5142FD-D11F-4FFB-B87C-EEED141096EE,Solitary fibrous tumour / haemangiopericytoma,0.990462562
8F2AC8A8-1FCD-480C-96DF-930283277AEF,Atypical teratoid rhabdoid tumour,0.990458188
0323576C-B7CD-43AD-9F9B-692ED4B5A387,Diffuse paediatric-type high grade glioma,0.990433335
6F077AFB-9C34-4072-97F3-5383C004DD65,Diffuse paediatric-type high grade glioma,0.990433335
EAD02BA8-8EF9-4A12-865F-78D00C6B3996,"meningioma, intermediate",0.990401172
B5DE1BCC-89CC-482F-8AAF-4BE6B3E4DF63,"meningioma, intermediate",0.990401172
EA0B2D52-187A-4400-B3E5-86A54FBACA58,"meningioma, intermediate",0.990401172
B6BE599F-1754-4F2D-9B68-B579B4A11843,"meningioma, intermediate",0.990401172
43FEDAE5-1B3F-4FC3-9C0F-D7AC446A60C1,"meningioma, intermediate",0.990401172
A2A75C84-EB92-486C-A5DE-6D387443C7FF,"meningioma, intermediate",0.990401172
FB5D52BE-56E7-41C1-B73B-49DB34833BCA,Atypical teratoid rhabdoid tumour,0.990390336
23CCA24F-6C36-4E30-B7B0-F29824FBE4D8,Spinal ependymoma,0.990387215
CDCC280E-1D5F-4212-9621-6448858A88AC,Diffuse paediatric-type high grade glioma,0.990359168
E7BA4286-6547-4952-92D7-4DF74C2CFC21,Diffuse paediatric-type high grade glioma,0.990359168
1D78B1A8-0BB6-4B72-B1B4-A8F8438DACBF,"Astrocytoma, IDH-mutant",0.990346529
174C496F-7076-435D-90A6-A2DF8491DD22,Diffuse paediatric-type high grade glioma,0.990334908
D4EDB4DB-39C4-4BE8-BA0E-90672BB14AB6,"meningioma, benign",0.990210838
0C7B9513-3C30-4BC2-B957-2C3F4BD24939,"Astrocytoma, IDH-mutant",0.990191769
3C95FEE7-4BEC-4CDC-9F20-851565B530F6,"Astrocytoma, IDH-mutant",0.990161355
75B5D2F0-41E9-444A-AD84-BC254692C949,"Astrocytoma, IDH-mutant",0.990161355
5CE78AE4-531C-48F4-9CEE-E69F4AAF1088,"Astrocytoma, IDH-mutant",0.990161355
C3FD3FBF-AAA2-4266-99CC-2466044BC8DB,"Astrocytoma, IDH-mutant",0.990161355
3DD37F6F-4A37-4044-93CA-55AE79013CDA,"Astrocytoma, IDH-mutant",0.990161355
57213C1C-E64F-44C5-9187-EE4119FBD3DF,"Astrocytoma, IDH-mutant",0.990161355
EFA433E2-17A8-427A-89DA-793A3826FE09,Myxopapillary ependymoma,0.990113113
D2885594-37B2-41CB-AFD2-681006EECEDD,"Astrocytoma, IDH-mutant",0.990096769
5D6A4DB6-30DA-4F3B-AA1E-413A9F10B035,"medulloblastoma, SHH-activated",0.990085753
799AB28D-E96C-46D0-870E-FF6AC3B7CF4F,"meningioma, benign",0.989991858
564E8588-A09E-43EA-9FFA-05D13CE3F1CD,"meningioma, benign",0.989991858
ED1CE093-5FBE-4D8E-ADD9-3C5387EF7DF9,"meningioma, benign",0.989991858
5CFBFF82-8C40-4779-8EA1-4EAE822D2BAC,"meningioma, benign",0.989991858
F2C4799A-A90D-4E76-AB57-578E8AA6B579,"meningioma, intermediate",0.98998912
5EDC45C0-1087-4035-9E99-EBFC9E9B91C6,"meningioma, intermediate",0.98998912
02E04648-01F7-479C-BA08-6BEB50132FD4,"meningioma, benign",0.989929554
C4C66643-2631-4F13-9EE2-7F6B6960BE1A,pilocytic astrocytoma,0.989874653
F1DF9C6B-CD2A-489F-BD99-F3350AD28C9A,"glioblastoma, IDH-wildtype",0.989869353
54F6885B-EEC1-4818-BC09-D4C6BDAB59EF,"Adult-type diffuse high grade glioma, IDH-wildtype",0.989799789
B7CC5142-2F5D-470D-BA7B-7E9B6FEEA8F1,"meningioma, intermediate",0.989702906
274FADB4-D0A3-4D35-A4C4-D91C9731AE20,pilocytic astrocytoma,0.989696146
9780F675-02D0-4A3E-937B-7C70D30D8785,pilocytic astrocytoma,0.989696146
B00AE9BD-1895-490B-8652-21F7E669D99C,"Astrocytoma, IDH-mutant",0.9896867
82481185-0DB7-40C9-907C-314A89DCED77,"glioblastoma, IDH-wildtype",0.989673702
8E21D80E-7722-4178-9CB4-263CF20C15DA,"glioblastoma, IDH-wildtype",0.989656588
7D31C133-90FD-4A20-AF52-48097897FA5B,posterior fossa ependymoma group A,0.98962022
152C049E-FB53-4411-B34A-0FB1E00F9859,"glioblastoma, IDH-wildtype",0.989599927
D0A239AC-AE17-4B98-AC86-3438B0689D15,Diffuse paediatric-type high grade glioma,0.989588827
24470DC2-2B28-4469-A443-CD068256C747,Ewing sarcoma,0.989521594
336EA318-20E2-44DC-B63F-18B8C1B56AA5,"glioblastoma, IDH-wildtype",0.989452345
51233AE9-065C-4DC2-8DA8-044DA1A84013,Pineal retinoblastoma,0.98942415
9CAC65BF-7AF2-4487-BFD0-A0648896E494,pilocytic astrocytoma,0.989396674
FCDBC801-B688-46F5-9ABF-6F4C7CB83045,pilocytic astrocytoma,0.989383578
572FD989-C492-40EB-97E0-AFE2718CA120,Pituitary adenoma,0.989368006
5DA7FDE0-91EC-4176-92E9-27EB2C815C45,"glioblastoma, IDH-wildtype",0.989315
7499A5A6-A7BC-4B2C-A732-066671D0F50D,"meningioma, benign",0.989221125
A8E199FD-A2B9-4D03-A4DE-FE4D261A05CD,"meningioma, benign",0.989221125
F0FD5D16-D76D-4CDE-AF34-1133AB6672BD,"glioblastoma, IDH-wildtype",0.989215609
4624B1E3-1189-49D8-BA33-CAC94EC98EFC,"glioblastoma, IDH-wildtype",0.989166016
692C6733-932F-432D-9B82-82A55DCB5701,"glioblastoma, IDH-wildtype",0.989166016
3A0A5CC2-6A72-4CAE-9410-A1C4BCC9150D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.989138369
5D93C6B9-395F-4D38-BE9B-C5A847F81F2E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.989138369
FB7E4C21-878C-4082-B7D9-6A852BE79A70,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.989138369
8BB47BEE-2335-4859-9630-20B5295CB562,embryonal tumour with multilayered rosettes,0.989129259
C23CFB41-749B-40A8-B7CC-BC2468FDCFCB,"glioblastoma, IDH-wildtype",0.989093454
24ABABAB-F743-4178-B329-ECE44424CA3D,Schwannoma,0.989077177
B7C4FD3D-B45A-4571-AFE2-452137A49912,"glioblastoma, IDH-wildtype",0.9890331
78943FF5-840E-48B0-BDDA-202951752B4A,"meningioma, benign",0.989000821
C51F41E1-97E8-4984-A5D0-8FF97C80EBA7,Rhabdomyosarcoma,0.988988829
62BFDF8E-9EDD-4688-9FED-9C3DC07E791F,High-grade astrocytoma with piloid features,0.988984796
3427E0D8-93D7-450C-8D46-0A63C2288BBC,posterior fossa ependymoma group B,0.988984113
B1C8C8CA-A1F8-4B4A-88D5-86294A025A21,"glioblastoma, IDH-wildtype",0.988974832
52E58B08-CC91-438B-AA12-2936FC0100B7,"meningioma, intermediate",0.988901966
FB37B9A2-406D-4C5D-9D60-323F7988B810,Infant-type hemispheric glioma,0.988886254
3ED6A709-B2FB-42B4-A756-821C39DBC7C3,Diffuse paediatric-type high grade glioma,0.988817512
862FAE0B-699F-44EC-A8E0-A61CFAFC5B14,pilocytic astrocytoma,0.988798476
9AC2DA67-4262-442C-966C-3DFBFBFDCFF3,"medulloblastoma, SHH-activated",0.988797305
B4A699B9-44A3-4BE0-94F7-0124C15AA868,"glioblastoma, IDH-wildtype",0.988689675
9727FE00-FF35-43D7-A676-25AF3A43AC6B,"medulloblastoma, SHH-activated",0.988681159
3E328A79-C3FB-48D4-AAD6-625297B23794,"Medulloblastoma, WNT activated",0.988671865
C20915B7-22C6-4AA1-B8C6-3B6CBA8B267C,"glioblastoma, IDH-wildtype",0.988671684
A6BB412C-9A2D-4911-9471-E63F65DDE630,Adamantinomatous craniopharyngioma,0.988658936
6EFB0129-2533-4F07-AA3E-B9E8690174F2,"meningioma, benign",0.9886583
C18A05A8-4D1C-4168-9ECC-2236BB52F93E,"medulloblastoma, SHH-activated",0.98857858
4C5D3014-F65D-4270-ADB3-8456A83C2B87,"glioblastoma, IDH-wildtype",0.988554981
328072F1-D50E-4684-A05B-AEF8B1171541,"glioblastoma, IDH-wildtype",0.988554981
B2B8F950-FED8-4435-A426-90D3E49AF51F,"glioblastoma, IDH-wildtype",0.988550307
E43F8761-BA31-4746-9A54-942E49BCB11E,"glioblastoma, IDH-wildtype",0.988550307
4A44599E-C209-4714-8B8C-CC60CB3E605F,"glioblastoma, IDH-wildtype",0.988550307
5E02C2C1-B911-40DB-826E-E546A5DB2A5B,"Astrocytoma, IDH-mutant",0.988532763
7D5D4FFA-6914-4F0B-8FD0-66A1146FA7D4,medulloblastoma Group 4,0.988511245
79C809BD-1AE9-4517-B3D7-08020063F9DE,spinal subependymoma,0.988470629
44CA490D-2DAB-4570-AD4C-C48A11246A05,Primary diffuse large B cell lymphoma of the CNS,0.988466317
013A1CFA-1CA9-4B36-BAC8-5A88842FE723,medulloblastoma Group 4,0.988458504
56A0B831-9E6B-40AF-AD10-BAB261C22C56,Schwannoma,0.988443152
4C86CF76-FEB5-4D77-AD9A-04F15865212B,Rhabdomyosarcoma,0.988415366
1A371E12-6047-4C2E-9581-6E372BC88F2C,"Pineoblastoma, miRNA pathway altered, group 1",0.988353666
AFB7FA19-FF01-4567-8D9A-D973CEB6B96A,medulloblastoma Group 4,0.988327794
8638D5C3-BB4B-415B-9F7E-89B9DA220D3F,Primary diffuse large B cell lymphoma of the CNS,0.988326996
1B36CE7A-F577-46EB-AF2C-5B00C329C5F5,posterior fossa ependymoma group A,0.98827651
B69F30FA-125E-4B8C-968A-8CB57BDECE37,"Astrocytoma, IDH-mutant",0.988257794
CF1799D0-D453-43DA-9EA5-103346A4969D,choroid plexus carcinoma,0.988229332
0D73BDC9-5612-4768-85F2-A6BF54270DA9,"glioblastoma, IDH-wildtype",0.988197172
4AFA01AB-FA79-47F0-9592-7CE69A8EC65F,"glioblastoma, IDH-wildtype",0.988197172
BD8B8CA0-BF2C-4E8B-8C3B-CD27EDE9BD62,"glioblastoma, IDH-wildtype",0.988197172
EC6311EB-74E8-4464-A0F0-BB583B126897,"glioblastoma, IDH-wildtype",0.98814508
81E2F754-8C98-4753-81C8-05413E641EBD,Olfactory neuroblastoma,0.988143655
E32E72E1-2074-405C-9678-DBB3CB73B14B,Olfactory neuroblastoma,0.988143655
E56502BF-A0F0-4DFF-9A79-ED1EA6CEF9FF,Olfactory neuroblastoma,0.988143655
7FC67ECC-C03D-47AB-8D02-98E49F316066,"glioblastoma, IDH-wildtype",0.988132953
F45BC273-3722-4B81-835F-0DAAA011E071,Atypical teratoid rhabdoid tumour,0.988108704
FA6D1D2C-7C95-4E1D-98D0-BF5668B3B897,"glioblastoma, IDH-wildtype",0.988081593
0FFCEAB0-D94E-49D0-8183-37EAD1BE723D,"meningioma, malignant",0.988080591
39778DB5-5D95-4D02-9578-68E9CD59B2AB,"meningioma, malignant",0.988080591
4C5138A1-3A07-4D76-8D5C-A9930536898D,"meningioma, malignant",0.988080591
F7797CA4-0741-49C4-9279-D52AAC54123D,"meningioma, malignant",0.988080591
CED81BCC-5B16-4D05-AE76-FAB6383F36C7,"meningioma, malignant",0.988080591
DE71AA36-90BC-4479-9730-63376E3DA1BF,"meningioma, malignant",0.988080591
A6259EE4-36AF-4C0C-8B7C-CE6CD5957B62,"meningioma, malignant",0.988080591
FFEA8092-4E89-4B45-90EF-C5234455418D,"meningioma, malignant",0.988080591
CF346FBF-B90B-46FA-951B-BB3824131415,"meningioma, malignant",0.988080591
A314473A-8AB1-459F-B0F3-D9B344A49C64,"meningioma, malignant",0.988080591
9BA8283A-B815-4D50-B216-7BADE8F2A0E2,"meningioma, malignant",0.988080591
5D1A7DBC-892C-4865-BE6B-023434120EE3,Rhabdomyosarcoma,0.987846166
C259BFD0-69F8-44FC-A448-ED50CEE9BA3D,"Diffuse midline glioma, H3 K27-altered",0.987836134
CA7F1F4C-3202-497F-9EEF-EEA1AF3CFD9D,"Astrocytoma, IDH-mutant",0.98779213
46C5A5AD-3704-450A-9DA5-2050D9E7E5D2,medulloblastoma Group 3,0.987759088
F488896F-A788-4EAA-9B34-DB063CD29189,Dysembryoplastic neuroepithelial tumour,0.987715022
3DE141FA-75F3-4CFD-92C6-62F51FB29D49,Malignant melanotic nerve sheath tumour,0.987695291
B80C2885-2052-4D1D-9BDD-34554C14B0AD,Dysembryoplastic neuroepithelial tumour,0.987627742
A8804F29-70F6-4453-9408-AE0740C5FE44,"meningioma, benign",0.987615998
D2440752-9C1F-456F-818D-F866F8BCCFB3,"glioblastoma, IDH-wildtype",0.987601205
B75527CE-2086-425A-9997-B3A85CA1D283,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.987599911
1635320F-C8E0-4476-B04C-50B2D31E4685,"supratentorial ependymoma, ZFTA fusion-positive",0.987579994
A5FB94A9-3CEA-4D6C-BAFA-5750DF578397,control tissue,0.987548756
A2A709A7-1C0C-4992-966D-F13F995E0828,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.987535836
55DF41A8-ED26-4EE8-9A93-E0B5181351F9,"glioblastoma, IDH-wildtype",0.987453967
254BF0E6-0027-471A-B9DD-E0E662AD0647,"Astrocytoma, IDH-mutant",0.987404
133E621F-1B3C-414D-9B39-4C3CFC77A928,"glioblastoma, IDH-wildtype",0.987403106
F680F487-F954-4263-8BDB-C48CCA6FB924,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.987400909
46278A2A-D945-4F9D-B592-D29E29BF1F9D,"glioblastoma, IDH-wildtype",0.987397022
25EBBAEC-DD5D-4712-91D7-CA0F6232FA15,"Astrocytoma, IDH-mutant",0.987371497
8DAF7B59-D787-4FE4-BA42-69AEA9CEB8C1,Diffuse paediatric-type high grade glioma,0.98736276
A9FA7C8C-DB24-41B9-B167-FB2E2D893DCD,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.987326345
20AB5CCB-9674-48E8-91D4-7A264E740F90,"glioblastoma, IDH-wildtype",0.987299378
25334AA1-4C19-424C-BAF7-81E5EE6A8C49,"glioblastoma, IDH-wildtype",0.987299378
471BF834-D8CC-48E9-A2BA-528C81CD62B4,"glioblastoma, IDH-wildtype",0.987299378
7C639BBE-82A4-4B6C-8172-7C252E9FCAF6,pilocytic astrocytoma,0.987229544
CB3B163A-2769-48AC-8296-7BCC707B4D10,pilocytic astrocytoma,0.987229544
9DC19EC5-8F0B-42F3-A453-251CB0C24014,Schwannoma,0.987206754
24F4AFDA-5BFD-4816-B064-41023ABB99BF,"Astrocytoma, IDH-mutant",0.987145734
53B89683-30B9-4028-A2DF-ADD852A533B3,"Astrocytoma, IDH-mutant",0.987145734
FB4D062E-ED6C-4AD4-B868-3CE5F528B7C1,"Astrocytoma, IDH-mutant",0.987145734
A3BC951A-0879-4664-82D2-E9B7D764510F,"Astrocytoma, IDH-mutant",0.987145734
8D4B4BCB-02CF-47A2-8003-071C9D006AB4,Inflammatory microenvironment,0.987032869
C4E64E53-4DE4-4479-B2DA-D4E5355B0FA2,Dysembryoplastic neuroepithelial tumour,0.98699761
C90AA3B9-29D0-49B7-8AF8-D066D0C18FFE,posterior fossa ependymoma group B,0.986972653
BDE4C528-A8D8-42BA-9CB4-636F54339867,"CNS Schwannoma, VGLL-fused",0.986916396
9D153E31-0C73-49FF-A516-69F05D18A873,"Astrocytoma, IDH-mutant",0.986872619
10E3D7C8-EAF6-4A32-8BFA-69E49ED032E5,Pleomorphic xanthoastrocytoma,0.986843712
C1A64A65-03D8-4CDC-BD82-5A40E84F57BC,"glioblastoma, IDH-wildtype",0.986789156
1E8D9D23-210F-4C3A-A008-626B4DB2F8DE,"glioblastoma, IDH-wildtype",0.986784489
30E73E00-18C3-46BE-8EC2-C5F530008417,pilocytic astrocytoma,0.986770612
8FBE3DAF-DEFA-4CA3-924B-F4F17B12C6F0,"meningioma, benign",0.986749525
CA9A539E-2F4C-4A33-BF1C-E4A5A5D28C10,medulloblastoma Group 3,0.986713154
423410CD-D724-4494-9900-3F1CB592B356,Malignant melanotic nerve sheath tumour,0.986673904
696CA195-1F57-4D67-A71A-F1505D3D166C,"Pineoblastoma, miRNA pathway altered, group 1",0.986656963
674864AE-F118-48E1-A14B-0C9D56468C0C,"Astrocytoma, IDH-mutant",0.986653594
5A5F0949-FD00-4FEA-9A6B-2EFCC2B8AF01,Ewing sarcoma,0.986650207
BA2231B4-BC83-4806-B616-5D978610BD59,Atypical teratoid rhabdoid tumour,0.986595437
9272FBEE-53D1-4C08-84B7-8CD6088EEDB4,"Diffuse midline glioma, H3 K27-altered",0.986412318
FABFB0A4-0DF9-4978-8224-AB4250A8EAD4,"glioblastoma, IDH-wildtype",0.986409764
42703058-887F-41BF-9AA2-7FA27DF20440,"glioblastoma, IDH-wildtype",0.986348153
68A57458-8416-4693-9A1A-E84BA9210302,"glioblastoma, IDH-wildtype",0.986348153
BA5D2417-0CDE-4554-83A2-A97FBF93EE3C,"meningioma, intermediate",0.986312368
13713233-8966-44C2-95D5-486F46D570DB,pilocytic astrocytoma,0.9863071
B966EA6A-1736-49D5-9903-8F50A6247352,"Astrocytoma, IDH-mutant",0.986282181
DA7371CB-F47F-4AEB-BCAA-2FE3EAC4F409,"Astrocytoma, IDH-mutant",0.986282181
87C2A0CF-9DCB-4410-9D99-3D7A02AA3610,Ganglioglioma,0.98627816
F63A8C4F-F468-455D-A647-0980EAC41F85,"glioblastoma, IDH-wildtype",0.986194269
FB927243-3CCF-46AE-949B-947809D1CEA1,"glioblastoma, IDH-wildtype",0.986141953
72BFDDE1-2649-4CC9-B2B2-23C3605AB9CB,posterior fossa ependymoma group A,0.986106284
456C195F-9F04-4AA3-A775-BCECB6F248EC,"glioblastoma, IDH-wildtype",0.986100899
30F5B132-2D9A-4CD0-AFE9-D29B2F258CAE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.986047679
659BB8F4-FEE4-42BE-BF5B-2E409C0211F4,"glioblastoma, IDH-wildtype",0.985982051
91295DB4-484B-4FBE-884C-2056DF1DC3D6,Spinal ependymoma,0.985965602
C485FC7E-3F5D-405C-B83E-8AF088095D44,Atypical teratoid rhabdoid tumour,0.985860173
88CFCF3F-FE08-46FB-A7ED-84D3F2D14DEC,"glioblastoma, IDH-wildtype",0.985814802
74570A9B-2866-481D-B1DB-8764DC0FE829,"glioblastoma, IDH-wildtype",0.985814802
AF982657-B52F-4F09-AF57-1246B7B3B3C4,"Astrocytoma, IDH-mutant",0.985812927
CF583672-EFB9-4E11-B6B6-ECB72FE355D9,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.98570264
40427273-432A-4EF2-8E90-64002247B74D,Rhabdomyosarcoma,0.985701136
AB2D20B1-EED5-4E51-AD45-2388006FBC12,"meningioma, intermediate",0.985699417
0981BD3A-0FBD-462F-8584-09D6AE26F029,Atypical teratoid rhabdoid tumour,0.985698737
6D028131-6EDA-4215-B499-05C3ED77E3E1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.985683736
43A33417-F848-4213-95FE-5C44EFF463CD,"glioblastoma, IDH-wildtype",0.985583741
2CD0CDD0-8413-4FE5-923A-5FA15D3059AB,"Astrocytoma, IDH-mutant",0.985556984
8E7CAEDF-CCFD-48D4-AA7A-DE99270111AB,Inflammatory microenvironment,0.985537986
5AA6873B-A7C3-4777-84C9-35B0A5EDF6F1,CNS tumour with BCOR internal tandem duplication,0.985527367
43DB92A1-56B3-4048-9818-2B51F71DAFCC,"Adult-type diffuse high grade glioma, IDH-wildtype",0.985511597
026733B2-CA85-4516-96FC-116C24AE8ACF,"Adult-type diffuse high grade glioma, IDH-wildtype",0.985511597
88657B92-1DD2-4F02-9628-1D5442611DA5,"Adult-type diffuse high grade glioma, IDH-wildtype",0.985511597
B730A431-2869-4F8E-BF8B-BEFF08E7B656,pilocytic astrocytoma,0.985334119
444B3FF3-F161-472D-AC75-372F15C3C228,pilocytic astrocytoma,0.985334119
E26175F4-4CB2-4540-AAEB-C94C3263CA0A,"meningioma, benign",0.98532112
2FC73720-F9F0-410C-8AC5-F71082F0E235,"meningioma, benign",0.985298637
6AB0E410-81FF-4177-BA76-A02BF25F1D1D,"meningioma, benign",0.985298637
C1B895AE-3277-42FE-B95A-6577B3FB4891,pilocytic astrocytoma,0.985292549
CE43B9E6-494F-4139-9A72-94B3B66BCDB0,Rhabdomyosarcoma,0.98526821
A4AA36EE-403E-43B4-9804-F56B7A311BEE,"glioblastoma, IDH-wildtype",0.985179813
44426F41-DE7E-40BF-8C04-7BCE4F16C0DD,"glioblastoma, IDH-wildtype",0.985173538
4C58D6C3-42D3-4CE7-BA3A-90068898BD4A,"medulloblastoma, SHH-activated",0.98516636
0D86C752-3C24-44AC-BCEC-994220C67488,"glioblastoma, IDH-wildtype",0.985152102
C011EB27-6345-4FD9-B9F1-3E436456554D,Diffuse paediatric-type high grade glioma,0.985004681
BD7E5984-B777-4C95-BA96-64B14BD62373,Rhabdomyosarcoma,0.98499904
9A17FE9E-404B-44D4-848C-1FEDE25CC01A,Rhabdomyosarcoma,0.98499904
747AB16D-DC15-4E3A-AB8F-31572318E8A1,Rhabdomyosarcoma,0.98499904
368AD57E-F7C2-497C-93AD-A168A5BFD86E,"Diffuse midline glioma, H3 K27-altered",0.984989477
F6B4644C-A08C-4C66-942C-452AB3838B63,"glioblastoma, IDH-wildtype",0.984976921
1C53272A-0301-491B-A32A-70777FB3A2D8,"glioblastoma, IDH-wildtype",0.984962371
7EE27A88-C8D4-4EAE-A8F3-D8978B1E098F,Spinal ependymoma,0.984950849
4701FD47-0105-47A0-8E01-807A904C60C3,Pituitary adenoma,0.984931975
77F27E0E-0019-4934-A87C-41B506837C89,pilocytic astrocytoma,0.984920252
78802BEE-10B0-4D5E-901F-898BB37D7A68,"glioblastoma, IDH-wildtype",0.984902757
A92F650E-3410-4B92-A141-E75BF00EC38C,"glioblastoma, IDH-wildtype",0.98487937
3F55633E-5992-4C31-8F4B-37A5DC652E86,medulloblastoma Group 3,0.984736311
6143F371-A972-4FDB-9781-76A8895959FA,medulloblastoma Group 3,0.984659413
3FFF2F8B-6675-499E-B910-DFFCFC6D92F9,"Diffuse midline glioma, H3 K27-altered",0.98461017
BA4F9AE3-CAB2-4567-8211-330406BEFBF8,"glioblastoma, IDH-wildtype",0.984593545
AB96951C-BDC1-4D0A-9537-46F09F3D55A0,"meningioma, benign",0.984569107
E9F34F89-EF9C-4A88-AD2A-51A9BB13141B,pilocytic astrocytoma,0.984540689
6BA8A56F-A792-4015-8B30-FD4B8BA93F8E,"meningioma, benign",0.984510304
7C80F965-7CFA-4154-A9F4-EA3701D47F94,"glioblastoma, IDH-wildtype",0.984437229
D133EABB-8018-441E-9EAD-0D709356A45D,"meningioma, intermediate",0.984429586
B5602470-9257-424C-946C-CFDA25D73C6E,"meningioma, intermediate",0.984403394
BCDFE2CE-3C2F-477C-B904-F813731C23DC,"glioblastoma, IDH-wildtype",0.984402383
51DEA379-4599-41E9-BE15-4AEA3727160D,"meningioma, benign",0.984310544
3657DC67-A2C8-4B18-8439-2D6F0F311D1A,"meningioma, benign",0.984310544
BF388D6E-33B2-4B68-950A-0F3A3CF6BC32,"meningioma, benign",0.984310544
D3464A94-A807-49F8-8D3A-D7F1F4429DE0,"meningioma, benign",0.984310544
A15BB7FE-82B4-4DC1-B997-E8B247F4CF1F,"meningioma, benign",0.98430004
9C0081E2-EA05-4908-9DFD-BDAC03608F61,"meningioma, benign",0.98430004
8042B3E5-881E-4EA5-8FB0-DD4AC6678398,medulloblastoma Group 4,0.984141524
779D7BF4-E620-43F3-9A5E-45A21BF4AEB3,"meningioma, benign",0.984119765
C918DB29-3765-4E79-AE97-A440CC47F86A,"meningioma, benign",0.984119765
EFAFEE21-B768-4564-9017-85AEDA684697,"Astrocytoma, IDH-mutant",0.984039814
E8D0EC26-583E-4094-A7E2-EDE4DA407A54,"Astrocytoma, IDH-mutant",0.983990591
D6596468-AC21-421B-AE7E-C15010A3D6BC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.983982382
445D674F-BEBA-4C1D-86CD-02AE7E7ACD1C,"glioblastoma, IDH-wildtype",0.983973967
13D3BAC1-5931-4204-AA66-B2CF8C24EB0B,Ewing sarcoma,0.983965813
62079351-C422-405B-889F-7FFA92EA3EEB,medulloblastoma Group 3,0.983924904
E16210AF-5280-47FE-8380-460CE7EB0DB5,"meningioma, intermediate",0.983883597
AE1C8DB1-846C-49A1-9AE4-176C83494EC1,"glioblastoma, IDH-wildtype",0.983881949
68271114-E87D-4438-B25A-A5C166A32EC3,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.983813393
D638449E-1A2E-4A4D-9A53-663C14DBC481,control tissue,0.983796505
665E2F68-676D-4ED7-BB61-D5554F0CFBD3,"medulloblastoma, SHH-activated",0.983770632
8ABE537A-CF1B-43D5-AA1D-7D54B5B7BED2,"Astrocytoma, IDH-mutant",0.983683298
EB47640B-A1B6-40EE-874E-F8EEAD97E69C,"glioblastoma, IDH-wildtype",0.983670911
789F5F05-1FA7-48A1-A63D-60894BEBAF42,"Adult-type diffuse high grade glioma, IDH-wildtype",0.983660743
DB7BF03D-8699-4B59-9D87-881605663F5E,"Adult-type diffuse high grade glioma, IDH-wildtype",0.983660743
F53C44E2-A6FC-4948-97C6-791CEEEEFB64,"Adult-type diffuse high grade glioma, IDH-wildtype",0.983660743
17C5FBB8-AE47-46A6-8438-015C4F69CF35,"Diffuse hemispheric glioma, H3 G34-mutant",0.983658107
7D45AF7F-486F-402B-95FE-1541BCF5827B,Rhabdomyosarcoma,0.983610792
5A6CF06C-8941-4B3C-89F9-568F79BB19FA,"glioblastoma, IDH-wildtype",0.98357306
43515B7D-3CA1-41E2-A367-3051F78D15C5,pilocytic astrocytoma,0.983546528
F0BD358E-88CD-4E31-9C58-76C9CB230DFD,posterior fossa ependymoma group B,0.983530066
E55F57DB-2ABB-456E-BAA0-AECC9CEDC785,"glioblastoma, IDH-wildtype",0.983516479
56CC6A65-6F40-4BBC-B6F4-0D0F8FBC1A29,"glioblastoma, IDH-wildtype",0.983515636
1B2EF1D2-0FC0-44E0-AAD2-0ED4BDB68210,Pineoblastoma,0.983349291
D3838FD1-8E62-47C9-928E-5ABD3A036E6D,Pineoblastoma,0.983349291
BFC76173-9A85-43D4-87F3-EF42105D4AD5,Pineoblastoma,0.983349291
EB1BA8F5-421C-4261-80F1-B4DA748E69B9,Pineoblastoma,0.983349291
F503112A-E9DB-4B23-B006-9B8062B170D8,"Diffuse midline glioma, H3 K27-altered",0.983331122
37302FD9-F307-4635-BC3C-00ED225CAE5B,"meningioma, intermediate",0.9831904
DA9FA652-C691-44D4-B96F-770CFDEECAB4,pilocytic astrocytoma,0.983058196
5C8E302D-0A53-4566-80A1-00452C495932,"meningioma, intermediate",0.983041241
AE56B968-3A6A-4E21-BD45-33222E168826,"glioblastoma, IDH-wildtype",0.98296879
B4DF75C0-B18B-477A-B1C0-A2BE645F1D1B,"glioblastoma, IDH-wildtype",0.98293219
B4640AC9-4F90-4B86-AC90-04FF29E9E609,"Astrocytoma, IDH-mutant",0.982867241
4CB62E2D-48AA-4390-B5C0-2126E101E882,medulloblastoma Group 3,0.982864191
D1F80B07-9D68-4F2C-BB4B-96FCD164DACB,"meningioma, benign",0.982723674
8FE3527F-2EF3-466B-B751-133DD6E03BAC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.982690558
84EE7E92-916F-4599-A07A-4C4F0BC86F2A,"glioblastoma, IDH-wildtype",0.982653182
E56AF9E2-60B3-4E3A-B91F-5F6CBBF9699E,"glioblastoma, IDH-wildtype",0.982639654
F738E7E2-958B-4D47-8654-627EE2B8957E,"glioblastoma, IDH-wildtype",0.982614583
A990A772-B6D6-4913-B231-319168948FEE,Diffuse paediatric-type high grade glioma,0.982594486
D69FE483-491B-4F53-879C-4C35C95D27CB,"glioblastoma, IDH-wildtype",0.982560735
FDDFEC85-D839-4C7D-BF05-C5178D5D52D2,"Astrocytoma, IDH-mutant",0.982530882
24B69EA2-FD01-41C3-8FF9-216D55A49B3D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.982498001
E2958431-E3D3-4F04-B70A-1875E84E0F9C,"glioblastoma, IDH-wildtype",0.98248401
364D960F-611B-483F-AEF5-FA901F5AD9A5,medulloblastoma Group 3,0.982450801
C02747A5-CC6F-46A0-81DB-5B141A79247A,"glioblastoma, IDH-wildtype",0.982435681
2B412264-9E5D-4E04-BDB4-53B0B4DC7EF1,"glioblastoma, IDH-wildtype",0.982435681
10CF1014-7D9A-46F1-A83E-6CF2225CB3FB,"glioblastoma, IDH-wildtype",0.982433391
0005EE67-7F1F-402E-A23C-48DE5BDE5E07,"glioblastoma, IDH-wildtype",0.98242749
78742D4F-7BB3-47DF-B2C8-300CC07BE10A,"glioblastoma, IDH-wildtype",0.98242749
A16B4EC5-5734-4A61-A055-4B7DAC52D276,"glioblastoma, IDH-wildtype",0.98242749
D9A1946E-268F-4471-8DD6-08AB63671D5F,"glioblastoma, IDH-wildtype",0.98242749
8BDFCDA5-6F5C-48EB-B2E5-6E7C17345063,"glioblastoma, IDH-wildtype",0.98242749
466F3861-2874-40F1-BFE2-5D01F92B93E1,"Astrocytoma, IDH-mutant",0.982335909
0F5BBA07-F364-4CAB-A3A7-36C65F12C056,"Astrocytoma, IDH-mutant",0.982335909
21F8E3C3-EFE2-4C7E-8D99-58259F269148,"Astrocytoma, IDH-mutant",0.982335909
B4E05947-DD6B-478E-AA16-4F8CFAB73D18,"Astrocytoma, IDH-mutant",0.982335909
78829473-6B71-4490-9EA4-0E1BF7CC49EC,"meningioma, intermediate",0.982312442
332D67DB-5884-40B4-BF50-73F985146AB1,Atypical teratoid rhabdoid tumour,0.98220395
517D45D7-6C6F-4445-9CF8-9BB6B0AEEA5F,Atypical teratoid rhabdoid tumour,0.98220395
9858E44B-9403-4237-B841-79387B67EDEC,Atypical teratoid rhabdoid tumour,0.98220395
D48E6094-7626-4E80-8537-ED373B79F709,Rhabdomyosarcoma,0.982200508
32DDED66-6CE4-493A-AB67-D039E7FE6F19,"glioblastoma, IDH-wildtype",0.982196115
739C2BB6-ABC7-4D0D-805C-2A222A60D1D4,"meningioma, benign",0.982064384
4DFA577B-9D88-447C-82DD-6C91B2B71D99,"meningioma, malignant",0.982056471
D14B8135-0A01-4C0C-A2CB-087EDB770C50,"meningioma, benign",0.982047734
0EEA120C-1F8F-4800-91DF-17F54304AD76,"glioblastoma, IDH-wildtype",0.981963015
79113054-F888-4C4C-BC90-D8EFC652699C,medulloblastoma Group 3,0.981961545
CAE16A7D-9A3D-48B3-A601-AA6C925C3DCC,pilocytic astrocytoma,0.981846946
D03937FE-5D46-40E7-A4A5-95D99DEA146E,"glioblastoma, IDH-wildtype",0.981822552
42D80090-01F2-48F4-8207-FD85961B4C1E,pilocytic astrocytoma,0.981729471
BC240826-BA27-44B1-BFC8-1D0DA4ED0E4A,"glioblastoma, IDH-wildtype",0.981690191
67184C3D-BB66-47EF-9EE2-36B1FCFA913C,choroid plexus carcinoma,0.981670446
A8E84E25-A947-41E3-A956-768C9EA0AAA9,"Astrocytoma, IDH-mutant",0.981599081
BC3B2F37-8D64-4F7D-BB19-FFE5E48BF411,"Astrocytoma, IDH-mutant",0.981599081
EC164F51-2FD8-468F-819D-B661D438BBF8,"Astrocytoma, IDH-mutant",0.981582285
32C57CB9-FA3C-45A9-B5C9-7523249DF5A9,"Astrocytoma, IDH-mutant",0.981582285
2D9C78FF-26EA-4528-B788-7335E5154344,Diffuse paediatric-type high grade glioma,0.981554264
8BE806A9-61CB-45C6-896C-70F046D1537E,"meningioma, benign",0.981552891
77045971-2413-40A9-9A43-212CEC0DC445,"glioblastoma, IDH-wildtype",0.981454799
AEFB024F-B730-4378-B9B5-55011E13BD80,Schwannoma,0.981343414
AF5962BD-287E-418B-A3F3-834C9E3CC49D,pilocytic astrocytoma,0.981333176
1BD385A4-DE6F-4A78-9FF7-9185B37D7C93,posterior fossa ependymoma group B,0.981322726
CA01FF49-17E1-44B0-9785-CABF9F366A0F,"glioblastoma, IDH-wildtype",0.981297819
29C53A6E-4F83-4D52-A11E-F9F4E708C094,"glioblastoma, IDH-wildtype",0.98127032
A4477619-91EB-4AD8-8161-CD3BE4E7EC07,"Astrocytoma, IDH-mutant",0.981257943
0EF5434B-F150-4BEA-803B-34FEB82EA39C,embryonal tumour with multilayered rosettes,0.981220901
6E05C79D-3027-4568-97A1-964DADB2BE4A,Spinal ependymoma,0.981171164
0FC2A785-C36F-44E1-A5E3-1787CF9D817C,Schwannoma,0.981145698
2C2417D8-C320-41B2-80AE-70DC7E7A2B0A,Haemangioblastoma,0.981060528
EC3DEACD-6946-41C9-9992-2579F11AF522,"Astrocytoma, IDH-mutant",0.980994113
326514FA-D483-439B-998E-1E8B6F1EA924,pilocytic astrocytoma,0.980936252
3825370B-7006-4774-ACD8-DFCBEBCFBE46,"glioblastoma, IDH-wildtype",0.980928324
0D3606A1-0892-44F7-9AC8-80E2FF6C48A7,"Astrocytoma, IDH-mutant",0.980902289
D4B91681-B263-4F06-BAC9-5614CF81C8E4,Dysembryoplastic neuroepithelial tumour,0.980882926
F2803204-7072-49B8-9A7E-B240F20B9932,pilocytic astrocytoma,0.980845762
B32F551E-D92F-4AD7-B005-46D884B803BD,pilocytic astrocytoma,0.980845762
A8B4316C-B439-4509-A276-65F6F4EABB1D,pilocytic astrocytoma,0.980800278
88E5F75C-657C-4554-82A5-E5F0142F6A25,"Astrocytoma, IDH-mutant",0.980725003
8027AB44-36ED-4E41-9186-CB7EE318ABC3,"glioblastoma, IDH-wildtype",0.980575339
9B2E0FB5-74EC-47E8-8945-889D9A82B6A0,"glioblastoma, IDH-wildtype",0.980565831
65B9AD99-B680-490A-8557-E554EF0F9267,"meningioma, benign",0.980537462
41950EF0-636B-4788-9321-FDBFD8A41BEC,"glioblastoma, IDH-wildtype",0.980502539
68B3808F-5113-4D2F-81C4-19FB302A4FD0,"glioblastoma, IDH-wildtype",0.980502539
C769ECBE-7F59-4396-BDE8-8763FFF3142E,"glioblastoma, IDH-wildtype",0.980467754
B1317DFC-0CA2-4957-8B69-F848B63B23C0,Infant-type hemispheric glioma,0.980446108
7ADCBED3-AE6B-49EA-B834-77A7F4C6D375,"Diffuse hemispheric glioma, H3 G34-mutant",0.980440722
6B149965-C751-40B5-A01F-90399D4D2EE6,Spinal ependymoma,0.980422699
506CDC83-160E-4E70-B65E-19190DD02837,"Astrocytoma, IDH-mutant",0.980337222
3BCCE3DE-1E9D-4BE2-876A-458BBDC2B707,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.980238101
E137D807-87E3-4953-89FB-983F7F2ACDC7,embryonal tumour with multilayered rosettes,0.980166056
EB095F77-AF34-42EE-BA15-14F0AE23120A,"meningioma, benign",0.979921875
080D2866-3355-490B-BD55-0F2DC133EB3D,"medulloblastoma, SHH-activated",0.979909835
C6CC6094-537A-4CBA-BD00-B61E699D67C0,"glioblastoma, IDH-wildtype",0.979861809
1FBEADB8-CD94-4777-9B5A-EC49F94DA9F1,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.979837856
68271B42-1C84-4AC6-9CD5-069E6EB601B5,pilocytic astrocytoma,0.979763977
50C7F72C-B339-4911-AB1F-D5966DA2848C,Spinal ependymoma,0.979741007
6AD3AE6C-A9FA-4476-9CE4-BB6E7113C1AB,Schwannoma,0.97971989
54EA28B8-553A-49FA-8372-24D9DE82F90A,"meningioma, benign",0.979716392
CFF8E839-81C6-4366-A91D-69FF58DDA795,"Diffuse midline glioma, H3 K27-altered",0.979519012
2BD0ED63-8764-46C1-B822-056304C49506,"glioblastoma, IDH-wildtype",0.979494296
34846042-6F65-4B58-9B2F-A0406F0991A5,"glioblastoma, IDH-wildtype",0.979494296
084D2262-CBD1-4C4E-9796-B9882318C55E,"glioblastoma, IDH-wildtype",0.979494296
FF34DC22-7C5D-4FC4-9E1A-E20798266F52,"glioblastoma, IDH-wildtype",0.979494296
DAF16BCC-ADDA-4A6C-8961-A28712155051,"glioblastoma, IDH-wildtype",0.979494296
AAC6AF4E-2FE8-4581-B790-F076FA40E441,"glioblastoma, IDH-wildtype",0.979494296
F0AADB84-9DCF-4E2A-A377-70ABBB351B44,"glioblastoma, IDH-wildtype",0.979494296
D37A0EFC-8E00-4C2C-A33A-7CE1032F0134,"glioblastoma, IDH-wildtype",0.979494296
CD02D185-7FE0-405E-BFB9-18EBDAE26BAE,"glioblastoma, IDH-wildtype",0.979494296
587D1D78-0037-4BCB-8A52-8601C713C02C,"glioblastoma, IDH-wildtype",0.979494296
45B27C88-757A-45A5-8DC2-24F538CCA1C3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.979426221
EEF206D1-E30A-4231-A3E6-A56B593AE073,"medulloblastoma, SHH-activated",0.979410352
6A1F66D1-FFDF-4830-BBB6-C04A18A75026,pilocytic astrocytoma,0.979384368
B67D39F2-A606-471A-A7A2-C036104B62AE,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.979270608
427842AB-E272-437E-86CA-210E73448FC3,"meningioma, intermediate",0.979226469
01EF8AA1-950C-4A23-8B4D-7A8073BDE4F5,"meningioma, intermediate",0.979226469
C068C778-4BC9-406A-8D99-D126FA48B105,"meningioma, intermediate",0.979226469
CC6089C3-6E1D-4A2A-B075-EC1BB7AF64C0,"meningioma, intermediate",0.979226469
F429779F-0EB7-4BFE-BB5D-30024898C2A4,pilocytic astrocytoma,0.979188901
2186E5C7-2B68-47D1-AC3F-6410F65E3611,"glioblastoma, IDH-wildtype",0.979004965
2594C2F9-389D-4FE2-BD00-F0BEA8220F91,"glioblastoma, IDH-wildtype",0.979004965
E80994C0-5A16-45D4-AD9C-8C342590E4CE,"glioblastoma, IDH-wildtype",0.979004965
9E35E852-FF6D-4515-B79B-388B30A7DCEE,"glioblastoma, IDH-wildtype",0.978938325
89A61FD6-7599-4A1B-940E-CD36292A99C0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.978762283
C26ACADA-C5A9-4EF0-BA70-920183996286,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.978762283
5BAD3C0E-1A6E-454E-A078-ABC4D875BE8B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.978762283
C18675E8-99FA-42E8-9E11-7024A93CA9A7,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.978720927
57DFE0E5-42EB-4C88-9604-BF9A62864140,CNS Embryonal tumour with PLAG-family amplification,0.978703372
45C338F3-C961-402F-A484-8DC24DB3B674,"glioblastoma, IDH-wildtype",0.978470207
18940ED6-0717-4147-BFE3-18BDD030B318,"glioblastoma, IDH-wildtype",0.978417431
1A6B40E3-0A7A-4A39-9AAD-C04E00FE0601,"glioblastoma, IDH-wildtype",0.978401939
822618A6-FFA9-4C12-B633-C5F9F39B261B,"glioblastoma, IDH-wildtype",0.978401939
9AC958B1-8E5C-4EF1-8726-D225D3C66B14,"glioblastoma, IDH-wildtype",0.978401939
48B3D19F-3C20-4366-A108-27046EB64C55,Diffuse paediatric-type high grade glioma,0.97837667
B073F09E-A01C-464F-B9D4-FDA5709970F2,Diffuse paediatric-type high grade glioma,0.978155426
02662BD9-38A4-484C-B40A-34EAEF321308,Diffuse paediatric-type high grade glioma,0.978155426
B822D7AC-8598-413F-A6DE-31F1FB52711B,pilocytic astrocytoma,0.978144535
B063768C-36FC-448C-9F01-9D7BE644F2AA,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.978124263
8214EB2B-95AF-42A0-ADFA-8545E7FE6299,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.978112559
97D1E519-165F-4355-BC93-44B452387619,Inflammatory microenvironment,0.978064466
D6CB3623-C505-44EC-85C7-003F85424FB8,Inflammatory microenvironment,0.978064466
14EA1ECC-E938-44A5-AE20-34FE23C5898B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.978008843
98A1FC97-91D8-45EC-9781-D39370273C39,"glioblastoma, IDH-wildtype",0.977963622
EADC44E6-E8EE-4DB2-8CCA-D43295B5FEDF,"glioblastoma, IDH-wildtype",0.977958722
E74CEF0A-CD17-4AA7-A69B-922BF72E9CA8,pilocytic astrocytoma,0.977924536
5B92F97A-D3B8-413C-B079-A06FB3B3E9AC,pilocytic astrocytoma,0.977924536
9C17F458-C22C-415F-B53A-91C305214BD4,Dysembryoplastic neuroepithelial tumour,0.977882244
AAC9548B-9C11-4FDB-A954-CC9B60135570,posterior fossa ependymoma group A,0.977851048
779B3C8B-A584-43E5-B26C-92D5DDA5C0A5,Diffuse leptomeningeal glioneuronal tumour,0.977798306
C73AD7C8-074F-4706-A872-16E234DC31E9,pilocytic astrocytoma,0.977787043
A0A58EDA-29BC-49D1-AE47-1E4716963F2B,"glioblastoma, IDH-wildtype",0.977768827
8C86E9CC-B37B-42F6-BC07-4D2970253C10,CIC-rearranged sarcoma,0.977759557
68E97672-B9EE-4946-891B-5B907A90F525,"glioblastoma, IDH-wildtype",0.977710301
03CE577E-E9D0-406F-9241-3503F4565C1D,"glioblastoma, IDH-wildtype",0.977685622
3E85D626-6CBF-4DF4-A9E5-29D16D05D406,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.977674465
25B9B939-0CD6-4435-90E0-36CF071DDA44,Neuroepithelial tumour with PATZ1 fusion,0.977473413
62142D47-A6EE-4FF9-B63D-D43CC7575444,"glioblastoma, IDH-wildtype",0.977413743
8B91E4C3-8831-49E9-A368-325A0757639C,"Astrocytoma, IDH-mutant",0.977325924
CEAF2E0C-348E-4602-947C-B2D588231DAA,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.977305001
0A6D96A7-B0B5-4240-B54F-2DE5F1B22299,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.977305001
D5B56F44-6D09-4D5F-8DCF-280A1BF9C8F9,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.977305001
675B76D1-CE81-46BC-86EE-76588F86A48D,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.977305001
DD876F8C-AE04-4C9E-8738-C67F570C8BFA,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters,0.977305001
E813357D-00A1-4FCA-97ED-81935C9C83E1,medulloblastoma Group 4,0.977295302
F40428B8-4C4B-472B-804F-7DBC384FD624,"glioblastoma, IDH-wildtype",0.977283867
37473423-9EC5-431E-943C-AB1EE1E025F5,"meningioma, intermediate",0.977205256
D63255C6-715C-4064-9A5D-5CCA985086EA,Dysembryoplastic neuroepithelial tumour,0.977099679
8E04A2C0-BA75-409A-83E8-A8307F53B5C2,Dysembryoplastic neuroepithelial tumour,0.977099679
6116A488-3FC2-4BBA-AAA5-96CB5F245B40,"Astrocytoma, IDH-mutant",0.977035991
0216BD2C-917B-43D3-9E9D-7990E3916212,Yolk sac tumour,0.976879868
14DB97BD-EF86-495C-AED6-AC836BAB80BE,pilocytic astrocytoma,0.976865854
4A2BA784-BAB7-45B7-9F20-0EB1CFEE8480,"meningioma, benign",0.976842634
FF0C319D-E69A-4FFE-A00D-BA3A9E94D6A5,"meningioma, benign",0.976842634
ABFC6186-4A03-4450-A80B-B53EDADC8422,Spinal ependymoma,0.9768225
18881C7B-CA02-482D-9FAC-EBAA6F67290E,Atypical teratoid rhabdoid tumour,0.97672425
03BD93DA-DC0C-4A66-B58D-78E07743DF84,"meningioma, intermediate",0.97664284
CCE018E8-1B97-4329-99BE-8570DFA48712,"glioblastoma, IDH-wildtype",0.976607423
87A1C6D0-38B5-417E-B0D8-0C08FD558606,Diffuse paediatric-type high grade glioma,0.976421671
E79AFF7B-ADF0-4A6A-989B-1D6D6530AB23,Inflammatory microenvironment,0.976256741
5CB96477-9F5B-482C-92CD-3FFF586A19E2,"meningioma, benign",0.976166083
3A0247FE-A090-4F97-B824-A5C770A07A8A,"glioblastoma, IDH-wildtype",0.976106013
8D2DB8B9-1ACB-444C-B10A-2569F822DE9C,"glioblastoma, IDH-wildtype",0.976088996
CEA3F9CB-D94A-4A26-A74D-32FCEE7E08B4,pilocytic astrocytoma,0.97607667
172DABFC-9B52-4787-9194-92577B8F303A,High-grade astrocytoma with piloid features,0.975943631
AE95267F-5941-482D-9154-141994CAF1F0,"glioblastoma, IDH-wildtype",0.975904024
6A50DCB3-8E89-414A-A072-243C87085772,"medulloblastoma, SHH-activated",0.975818818
CB994FF5-8485-4EAD-839D-87F7876A81B9,Dysembryoplastic neuroepithelial tumour,0.975808435
45992A98-BCD4-4FCF-9A62-3CE2D8E9E680,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9757118
77DE242F-3543-4330-9D6C-9FB618949126,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9757118
BB406E61-67E5-41C1-8ABA-212319D153F9,Diffuse paediatric-type high grade glioma,0.975590537
7AFEA415-E696-49AA-A8E7-958C491643F0,medulloblastoma Group 3,0.975565416
F49D0272-1A96-4195-A09F-8F54868B1541,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.975497506
3DB94DFE-AB33-4664-980D-6E9A4A6C6780,Chordoma,0.975436438
266E356A-135A-41D5-AA25-6B835D9B5039,"glioblastoma, IDH-wildtype",0.975311853
C796522B-6231-47D5-BBDD-61D86C74FACD,"meningioma, intermediate",0.975284054
FDD13E72-EF71-47C5-AD6B-757F0C30C4E3,"Astrocytoma, IDH-mutant",0.975018865
70C7EB90-0B29-4EF6-8EE5-2B997936933C,"Astrocytoma, IDH-mutant",0.974904266
788B609E-1D3A-45A7-AA8A-F238CF488FF7,medulloblastoma Group 4,0.974825893
4D97DF50-3E63-4F18-AC07-240C32220F6B,pilocytic astrocytoma,0.974789902
06762DD1-4111-4E17-A5BA-48844E7B7310,Dysembryoplastic neuroepithelial tumour,0.974589635
B7A89B30-3B6A-4051-90A8-76F8A15C93A5,"Astrocytoma, IDH-mutant",0.974441868
443B5D38-1A6A-497F-9713-5AE0E8A6F620,"meningioma, intermediate",0.974220133
4C9DE92C-362D-4DF0-A1D3-4FDB592FC34E,"meningioma, intermediate",0.974220133
8F36C2E2-FD6B-4960-BE13-B9D26BE2F7DB,"meningioma, intermediate",0.974220133
3092FC90-170F-4EB7-A286-50283F90A37E,"meningioma, intermediate",0.974220133
4E151C77-A87E-4CD6-AC70-BB863B06EE09,"glioblastoma, IDH-wildtype",0.974109044
9837FF6E-9D03-4D16-9738-DB469BBC3780,pilocytic astrocytoma,0.97406383
A4C2791B-9943-48B0-8E1E-F39DC6A7F236,"medulloblastoma, SHH-activated",0.973870953
B1191C35-42C3-4D07-A6B7-27D78CC80D22,"meningioma, intermediate",0.973839589
E86EF106-1D9C-41E8-90D9-D157AA0B2377,Inflammatory microenvironment,0.973782201
E64E8032-E4B7-4596-919D-3A19DFB66419,"glioblastoma, IDH-wildtype",0.97359372
74894A88-98DA-44E0-94B4-AFCD38BA2A7D,"Astrocytoma, IDH-mutant",0.973452239
4E5A447E-D741-4E7D-8974-1D7E147BB4BD,pilocytic astrocytoma,0.973425102
F7572BBA-6605-440C-90B9-1F3DCC240F2F,"meningioma, benign",0.973247749
372A9BFC-F7C6-46BC-BC4C-E75231612E77,Diffuse paediatric-type high grade glioma,0.973246184
E6FD0B43-A6D4-475C-AA2D-196559628CBB,pilocytic astrocytoma,0.973179218
CADDF04F-C9A1-4A84-A840-1AA1053A982D,"Astrocytoma, IDH-mutant",0.973080938
247A47B0-84E9-4B23-A0D8-8FB3A39EB599,"glioblastoma, IDH-wildtype",0.973022211
5ABD0AC8-F899-4874-831B-3BBE4E7E5ABA,Malignant melanotic nerve sheath tumour,0.972985544
3E456746-6812-42F0-82D0-30EB50EEB995,"CNS neuroblastoma, FOXR2-altered",0.97293496
28C4F6E5-4882-4516-B4C7-3F93FAD43B18,"medulloblastoma, SHH-activated",0.972929979
2B57B822-E770-4B2E-8F64-D6692DE06717,"Astrocytoma, IDH-mutant",0.972851815
FEBF9C03-4B4B-42B6-A9D6-ABCD7A4F6377,"glioblastoma, IDH-wildtype",0.972824618
9334F045-EC6C-4F89-9218-E45505D753CD,"glioblastoma, IDH-wildtype",0.972797501
64EA011E-3095-4542-9345-AE81FC32416A,Germinoma,0.972750276
1886D5C1-B25D-4C7C-B04C-D24E1FD153CC,Diffuse paediatric-type high grade glioma,0.972568643
E8FB9EF9-2E5F-4699-B327-78F1A624A4A0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.972538758
3F70C36C-0058-4AD7-ABAA-0E50397551A4,"Astrocytoma, IDH-mutant",0.972490981
951B6801-3FB9-46FB-A0D7-D425C2B66F01,"Astrocytoma, IDH-mutant",0.972437039
BF34B026-B082-4660-8165-3362FD23A824,"Astrocytoma, IDH-mutant",0.972437039
03987CF1-8C8E-4572-889E-F9F214A7683A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.972371795
483683D7-36EB-4D5E-9604-8DE3B94D1E12,"glioblastoma, IDH-wildtype",0.972361536
9D005B31-4194-4EB4-8EF2-6526285CDACC,"glioblastoma, IDH-wildtype",0.972353377
25E90253-F0D3-4C15-BA99-31D7A653229F,"glioblastoma, IDH-wildtype",0.972353377
07218DCA-5044-4D02-B976-4252A98AF947,"CNS neuroblastoma, FOXR2-altered",0.972349545
439A511C-7132-4D3F-8188-D061ACA44139,"glioblastoma, IDH-wildtype",0.972174202
39564C47-35AD-48FF-A375-9618FA97BA7C,posterior fossa ependymoma group A,0.972135808
90FDCE61-36B2-4C1D-ACFD-502B372DFB75,"Astrocytoma, IDH-mutant",0.971885938
A9FBECFE-02E6-40A4-AF89-25F1D5123B40,"Astrocytoma, IDH-mutant",0.971838894
C919467D-848B-4EF1-919A-1F02FBADB5A1,Myxopapillary ependymoma,0.971628445
0A4B632E-BE5A-47FB-B3D6-9275D6DD6561,Myxopapillary ependymoma,0.971628445
32B5574A-3379-43D1-9878-43E35C1FEACA,posterior fossa ependymoma group A,0.971620538
4B5DA602-A5CC-4DE1-A00C-23779596198A,control tissue,0.971616322
D0D5B5C5-1B67-4722-8B6B-5DB763B36391,control tissue,0.971616322
E54A5B91-36B7-4345-A7A5-C589C8FC30F5,"glioblastoma, IDH-wildtype",0.971360762
AFFDB877-398F-43AB-8605-E7315E48E1A1,"glioblastoma, IDH-wildtype",0.971360762
FB1A0093-F8E7-4C39-8CA3-6B1E9361DEFA,"glioblastoma, IDH-wildtype",0.971360762
A7661B75-5635-4C57-9930-A0028846D627,"glioblastoma, IDH-wildtype",0.971360762
82B1345C-43A7-4016-BCA3-98C597B34141,pilocytic astrocytoma,0.971318402
8C64D68C-1EF5-4A58-8305-2537A84974C7,Dysembryoplastic neuroepithelial tumour,0.971254369
E3652A0D-150E-4A81-A79D-1188C0340CDC,Dysembryoplastic neuroepithelial tumour,0.971254369
35594ADA-3FAA-49BD-8247-B74DCE98605A,Dysembryoplastic neuroepithelial tumour,0.971254369
CF1A05CE-42E8-47E0-897D-13F9B3BA6685,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.971119023
C5803BC6-0D3B-4048-85AA-A1A4A753FE0F,High-grade astrocytoma with piloid features,0.971074849
D730FAA3-DF25-47AA-87E8-3813E9E32AA6,High-grade astrocytoma with piloid features,0.971074849
ED205E53-8665-4862-9497-D81FEF402869,High-grade astrocytoma with piloid features,0.971074849
F93C45B9-7FC5-44BF-8908-3B317EB919C5,High-grade astrocytoma with piloid features,0.971074849
7A8A6569-3007-45B1-ACB7-1EABC684E0B8,medulloblastoma Group 3,0.970978805
15F4CEC6-96FA-4712-B48B-5DB3D6B4E9A0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.970946971
97B70627-C81A-4C2D-A82F-0F5E1F23814E,"glioblastoma, IDH-wildtype",0.970906283
84B20A50-4CE4-41E6-B942-32CC4C3CBBCA,"glioblastoma, IDH-wildtype",0.970896465
98DDE5FA-DC0C-4B9E-AE8E-80FAEC9BB418,Papillary craniopharyngioma,0.970888496
2635BB47-178A-4242-A1C3-D9548B32DBE4,"meningioma, benign",0.970866433
2484D93B-BA05-414E-AD8D-1755553352E4,"glioblastoma, IDH-wildtype",0.970860088
7869CB63-C6B0-42DA-972A-AAAC60F4D951,"meningioma, intermediate",0.970699048
7D2CCB5F-6A5D-48A4-AE57-E47FC2EBCCC9,"meningioma, intermediate",0.970699048
70DEBD54-A5BC-4F2E-83F1-7FE761CCE205,"glioblastoma, IDH-wildtype",0.970691601
3818CFE0-9033-4E63-9C9E-15C50414212B,Pituitary adenoma,0.970665538
EEBE7AB1-3D01-4010-8441-AF88BA1CC8A4,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.970644307
E8467BED-65ED-4BD5-B27A-D31BF0A51700,Neuroepithelial tumour with PATZ1 fusion,0.970583
821B0BE3-90E8-401C-9C52-CCEF6DCA8A61,Neuroepithelial tumour with PATZ1 fusion,0.970583
BDF16051-4B51-4048-9614-51DA83FF4920,Neuroepithelial tumour with PATZ1 fusion,0.970583
51F500D1-5937-403B-A1B1-04A659B9B537,"meningioma, intermediate",0.970568266
E65ACDF8-1024-4941-9022-1BC8750D79A6,"meningioma, intermediate",0.970452583
05105EC8-AF76-487F-BD74-ADFB466CA962,Schwannoma,0.970413082
45587C71-B6D9-42C1-AD39-3795ABCF0734,"Astrocytoma, IDH-mutant",0.970102156
7DFEB1EA-E2D9-4E25-B2B2-D29440609EDA,"Astrocytoma, IDH-mutant",0.970102156
23FD8250-7062-4EBB-9C48-F6BFA61099C5,"glioblastoma, IDH-wildtype",0.970098629
27304D13-3D96-41A0-83DD-F73ABACCE236,Malignant melanotic nerve sheath tumour,0.969925718
6DD4BDC0-D217-4509-9BBB-1B10EF0E8AFF,Dysembryoplastic neuroepithelial tumour,0.969869688
34FC0B6E-40F0-4B22-B95D-7B1C6AB3217D,"meningioma, intermediate",0.969655284
E1694157-5259-42DD-BEBE-4FC19B70A521,"meningioma, intermediate",0.969655284
5B562D15-6984-4F7D-932A-4DC8783F7875,"glioblastoma, IDH-wildtype",0.969646199
DD16B369-D8D3-467D-B506-5D623ECE978F,Diffuse paediatric-type high grade glioma,0.969617038
D8952F93-C499-4EE2-9199-91E3DFBF1877,"Astrocytoma, IDH-mutant",0.969593835
50E1C941-2D93-4B2C-A35F-F2DEE1874F8F,"diffuse glioma, MYB- or MYBL1-altered",0.969587748
C487E442-57C7-497E-9C9E-D1112E3AB30F,"meningioma, benign",0.969481498
370BAC7C-364D-415B-B9A8-5C8590F0100D,pilocytic astrocytoma,0.969325912
78872BD7-F630-4DF3-8782-83B4F89E6DAA,"glioblastoma, IDH-wildtype",0.969312918
13432AF5-C619-4E08-B799-EBFC8B2162D5,"glioblastoma, IDH-wildtype",0.969312918
A9AFDA03-2455-407F-9FFD-1C6052C5400A,"Astrocytoma, IDH-mutant",0.969308527
05573275-B4C8-48A0-9B18-AD9039DAF2CD,"meningioma, benign",0.969297924
5ABA5971-3AF2-444B-BC03-D781334ADADC,"meningioma, benign",0.969254761
BDD5FDBC-383B-4113-AD07-8EB4FFF32D0F,"meningioma, intermediate",0.969197582
86839DDF-B561-4D88-B6B1-0890182DF40F,Infant-type hemispheric glioma,0.969175184
DD9FE6DD-79AF-4CCE-A925-61EC06514A40,"glioblastoma, IDH-wildtype",0.9691746
44B7B8CF-F351-4280-893F-40390F194ED2,medulloblastoma Group 3,0.969014879
7750A777-CAF9-4065-9333-277F51906E61,"Astrocytoma, IDH-mutant",0.968916323
F69F7E62-FC59-465F-9539-92F5FAE66B24,"Astrocytoma, IDH-mutant",0.968916323
8245D92C-DCF7-4D4D-820A-3F3227DCEF19,"Astrocytoma, IDH-mutant",0.968916323
648A026F-BDD9-47C9-91A0-F48069864425,"Astrocytoma, IDH-mutant",0.968916323
51C220F0-23B5-4774-8667-2F169B828B42,"meningioma, benign",0.968858578
12926DF3-FACE-4478-B7D0-221665B3AFFB,"meningioma, benign",0.96867567
90082E75-C98C-4711-87F2-4ACF1AC818D9,"meningioma, benign",0.96867567
1C91F588-C400-4A3D-974C-27DA11DD8D63,Diffuse leptomeningeal glioneuronal tumour,0.968657231
BFABF4A8-E09C-4F84-BC64-23438B6CB375,"Diffuse midline glioma, H3 K27-altered",0.968628578
282890F0-38D7-49FE-A60F-051CEA7AFC5B,"glioblastoma, IDH-wildtype",0.96853261
D039389E-4336-4CCB-B15C-ECF20D938483,"glioblastoma, IDH-wildtype",0.968486907
85396A30-AE81-4699-970A-AEE5738BE600,"glioblastoma, IDH-wildtype",0.968486907
381DF416-8A35-46CA-8B6D-EA194311B86E,"medulloblastoma, SHH-activated",0.968480362
572A8B57-5193-4593-888A-3C700D0F645B,Ewing sarcoma,0.968358662
9FB52EF3-1E60-44A6-8D87-BEDFF2C01258,"glioblastoma, IDH-wildtype",0.968336694
B8D2EDFA-791B-485D-80E7-3A4B9476CEFB,pilocytic astrocytoma,0.968329859
D7407490-32C2-4481-853D-7163447405B4,Malignant melanotic nerve sheath tumour,0.968309818
9EC18E0F-395D-4359-A6ED-A7AB15CDD013,posterior fossa ependymoma group B,0.968058579
CED14F90-8EFE-4E76-BECB-64263EF6B0D1,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.968025888
7B7B631F-84C9-4470-AE79-BF5DED568E2A,pilocytic astrocytoma,0.967994469
A49E8932-0AB2-41CF-9216-544EBD65C76D,posterior fossa ependymoma group B,0.967530753
6C5C4786-5087-4309-B035-D0F916DB1689,medulloblastoma Group 4,0.967505806
B1F277D7-CA8E-4E86-A4C4-24BBFB8026E8,"meningioma, benign",0.96750521
22FA2ED2-F136-43A7-9F2A-FCEF1F4BAB8F,Dysembryoplastic neuroepithelial tumour,0.967254812
43E50D76-A3CD-4514-B043-F01F1CC9132D,"Astrocytoma, IDH-mutant",0.967222091
FF57D76C-38B2-4648-96D1-D2337158CA42,"glioblastoma, IDH-wildtype",0.967122949
4FEB628F-DDB9-4CAF-BDC0-94F5967E24B8,"meningioma, intermediate",0.967031913
92D8CD0A-17D7-42D6-8939-169DDD890E90,"meningioma, malignant",0.966998801
5C4D166C-F87C-409E-B6A9-8949996661B3,Dysembryoplastic neuroepithelial tumour,0.966982147
56024D14-1E73-42EE-AAFE-FF8A85002A39,"glioblastoma, IDH-wildtype",0.966892273
53579FE9-0CA7-4E66-BDB8-AF2AD07A8A0F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.966860657
7E082B16-EE24-44EE-8333-C6A9CE07E59C,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.966838659
0D2E3183-BA0E-4444-AA0A-90EEF5FA14EC,"Astrocytoma, IDH-mutant",0.966715109
BFA66A58-E0B8-48FD-90AC-8FE265EF8272,Solitary fibrous tumour / haemangiopericytoma,0.966695878
6FA59435-70A1-47D6-A5C8-8F624A2C46F0,"meningioma, malignant",0.966634933
215BE9C6-8F75-4E80-8590-234E44FB4496,"meningioma, benign",0.966580871
5DEA1225-0D49-4011-BD00-B8849707BCF7,"meningioma, benign",0.966580871
EB4792E6-9C0D-4197-9D34-9D71AC556A1E,"meningioma, benign",0.966580871
4997803F-409F-4485-8B57-FE3585A41D7E,"glioblastoma, IDH-wildtype",0.966325315
3B1DD285-7129-48AB-B6FD-A6E937DEED0E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.96611075
C5E6882D-07A9-4BE6-8F87-CE0ED25DD83D,"Diffuse hemispheric glioma, H3 G34-mutant",0.965926661
BC5CBCC0-9749-4573-AC5A-86A5451F9F89,"meningioma, benign",0.965876531
B9FB9CC6-A527-41E6-BA03-4E2781DC1D95,"meningioma, benign",0.965876531
62228376-1399-4FD1-8F70-F2ADA39E5717,"meningioma, benign",0.965876531
DFE02BED-457C-4029-9537-1DC2257EC229,"meningioma, benign",0.965876531
426FDB2B-0B20-4901-99FE-2A51CCCF7740,"meningioma, benign",0.965876531
B5F5F0F0-BADA-4785-8AA2-AD537EABA5A8,Chordoma,0.965811001
B519B484-48E1-4805-95B8-42CB614E7B23,"glioblastoma, IDH-wildtype",0.965712283
30EA0356-D939-4124-8191-A9EEE106285D,"meningioma, benign",0.965704173
C0DE7EC5-648E-4ADC-930D-AA56740B8781,"supratentorial ependymoma, ZFTA fusion-positive",0.965417066
1B72F5B6-6B64-46FA-94D4-9B50E10B8B9C,CIC-rearranged sarcoma,0.965370349
91887C4A-07B4-4371-B0A5-5683FD6AC7BF,"glioblastoma, IDH-wildtype",0.965347475
71F817DE-7D85-49AF-8BD5-FC006603D5E6,"glioblastoma, IDH-wildtype",0.965347475
7D153E0C-B335-4F88-91D9-64C8060D3300,"glioblastoma, IDH-wildtype",0.965320408
9CF127D6-1656-415D-A3EF-32D2296C5F51,Atypical teratoid rhabdoid tumour,0.965160371
12146E9F-575A-4C9C-8326-54E15928C69C,"glioblastoma, IDH-wildtype",0.964853306
9E1ACD39-BD7A-43FB-9EEC-44860C85266D,Primary diffuse large B cell lymphoma of the CNS,0.964735317
AA8DEB29-F1C4-4470-AFC7-9A6EA3DC6AA5,"glioblastoma, IDH-wildtype",0.964732255
A680A71E-2BEB-4B91-B5C8-9193D0AA5716,Diffuse paediatric-type high grade glioma,0.964582721
91539527-4321-40EA-A286-7212BE1C8E8B,Atypical teratoid rhabdoid tumour,0.964399171
4301855B-1306-45F2-B1A9-E1ABCB352C09,"meningioma, benign",0.964395525
644BCB06-11DB-49FF-BE1C-453AA45BF85B,Pleomorphic xanthoastrocytoma,0.964360084
88D0BB89-DEA0-4C45-85FC-CF2E7C444228,Polymorphous low-grade neuroepithelial tumour of the young,0.964359845
960E2557-372B-438F-9C73-5DE6D634C3A1,Polymorphous low-grade neuroepithelial tumour of the young,0.964359845
F30BF9BE-B440-4F60-8AD6-DCDAB4D26947,"meningioma, benign",0.964153263
91E941E6-6CEA-44C5-99DE-C788DEDFC6EB,Diffuse paediatric-type high grade glioma,0.964003116
734129D3-0884-4EB1-972B-5797EC3A2AA2,Pituitary adenoma,0.963976943
D2FC50C3-E0EA-45F0-BBBE-745B47FCFAD2,"glioblastoma, IDH-wildtype",0.963976643
A0409BE1-6725-4285-AC34-456F4CE99E19,"glioblastoma, IDH-wildtype",0.963976326
D2643860-27F4-4A1B-B768-ED5AD3F04180,choroid plexus carcinoma,0.963919509
907B3E7A-F5F3-43BA-9D16-43817A3DB86B,"Astrocytoma, IDH-mutant",0.963914611
221B0455-6418-4A5D-B9CB-049CF7A0E517,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.963897078
B0DA981C-13A0-4CAD-AD3D-C5D34BCADE8E,Dysembryoplastic neuroepithelial tumour,0.963868396
7305DF17-B2C1-4655-914F-9B38789F8A5B,Dysembryoplastic neuroepithelial tumour,0.963868396
B1F65FA8-0585-439C-B2CE-2A0A784781ED,"glioblastoma, IDH-wildtype",0.963832923
A79D7F32-691E-48C3-AB0D-4AA52539644E,"meningioma, intermediate",0.963716423
E2CE6F29-0BF2-4E0A-ACF7-3BA90E45F6CA,Inflammatory microenvironment,0.963702259
C059B08D-B261-4229-A364-06482E65314C,"Astrocytoma, IDH-mutant",0.963632012
C5DDB49E-689D-4BA7-A03B-B1C445BC31B7,"glioblastoma, IDH-wildtype",0.963418634
9187886E-0993-42EA-874B-B446C6499E2E,pilocytic astrocytoma,0.963396926
0F235795-1B9A-435A-B854-7697A0EF18BC,embryonal tumour with multilayered rosettes,0.963264309
16958BC3-17E1-4AB7-9EB7-B725805FFE92,"meningioma, benign",0.963261568
E536E04C-A96E-4613-886E-AFE60ADD993E,"meningioma, benign",0.963261568
4F303C99-B990-4189-B5F4-10326F69E251,"meningioma, benign",0.963261568
0FF513D9-F755-4EE5-B6BE-5759C6E260E2,"glioblastoma, IDH-wildtype",0.963198801
5A9314C7-B4A2-40A3-94FB-14C8FC8C4F47,"glioblastoma, IDH-wildtype",0.963198801
AFA20FC7-297E-4FB7-945F-D048F0989364,"glioblastoma, IDH-wildtype",0.963198801
63D84F87-3797-49F4-8044-ED1FA772775C,"glioblastoma, IDH-wildtype",0.963198801
B07A85EF-39A2-4185-9277-63F5D4E19AB4,"meningioma, benign",0.963132993
0A9A79AA-C537-4863-9856-C2AD79DE97F4,"medulloblastoma, SHH-activated",0.963040391
EF17EDA5-961D-4EE2-A134-954EB7453406,"glioblastoma, IDH-wildtype",0.963035945
B4757CCF-9DB4-45B7-96AC-1B24B31E1C43,"glioblastoma, IDH-wildtype",0.963035945
6C985E54-C835-4269-9C80-B183A7356A6B,Ewing sarcoma,0.962961765
0CC1552E-9B3C-41E2-ACF9-7A9BAFF615A9,pilocytic astrocytoma,0.962953214
E9B0AD6C-C98C-4502-878F-869000404B54,pilocytic astrocytoma,0.962953214
97F6F177-601D-4AE6-910B-44F36BFBAEDB,pilocytic astrocytoma,0.962953214
C63DC782-7632-44AB-9D46-957C58F3FED4,"Diffuse midline glioma, H3 K27-altered",0.962868522
2362DB1A-49E9-440E-9D22-CDACF780F56B,"Astrocytoma, IDH-mutant",0.962861042
B2C73ECB-ADAE-42E7-A33A-21B6591194D2,Primary diffuse large B cell lymphoma of the CNS,0.962804662
FC948703-B171-4E73-B129-C5E31D9C9903,"supratentorial ependymoma, ZFTA fusion-positive",0.96249554
F3E5586E-57E0-4B67-9B85-F011A2388C78,Melanoma [metastatic],0.962301121
08BA5809-60B9-48F2-A3CE-B7EFA2A73B60,"glioblastoma, IDH-wildtype",0.962190414
E70C2DC5-3017-4CF1-9122-6C040F868562,"glioblastoma, IDH-wildtype",0.962190414
83D4CF59-375B-4081-8C1D-B7095DD300BA,"glioblastoma, IDH-wildtype",0.962190414
BAED9563-1F42-4216-9E3F-8A6390AA6AB9,"glioblastoma, IDH-wildtype",0.962190414
BD78F060-E713-412F-9E26-3133DE7CDE03,"glioblastoma, IDH-wildtype",0.962190414
B1CEF05F-115A-4AB7-B7FC-903FC29B4B60,"glioblastoma, IDH-wildtype",0.962130513
B466F0C7-4323-487E-977F-0CA7026B479F,"meningioma, intermediate",0.96195391
A6D1AC0B-919C-466F-9948-5348553D4FB3,"glioblastoma, IDH-wildtype",0.961820489
27541F76-A079-4E83-B972-CB4BE4652E3E,medulloblastoma Group 4,0.961730492
B5A3BC28-5704-4347-988D-D0867DA79AD6,Pleomorphic xanthoastrocytoma,0.961656898
264A126D-BBE5-45B4-BD1C-A092448C8DAA,"glioblastoma, IDH-wildtype",0.961652435
DADF9923-B757-448E-81D2-9B9769A49D00,"glioblastoma, IDH-wildtype",0.96159636
046CE86D-4911-4DE7-9E31-AA682D56BB5B,"glioblastoma, IDH-wildtype",0.961586052
CC1B3D0F-D6BC-4D26-A06D-C89AD3F0DB91,"Diffuse midline glioma, H3 K27-altered",0.961425699
AB631F76-4E36-4CCC-B81C-6D10B6C935A0,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.961281609
61FD4C4B-EED3-4055-92F1-9E5477865912,"Adult-type diffuse high grade glioma, IDH-wildtype",0.9611124
B1769874-FE8E-494A-90C0-70C7F6DA4F09,"Astrocytoma, IDH-mutant",0.961043335
A5F3099F-465D-440C-A81D-B768AB78574C,medulloblastoma Group 4,0.960960837
4884DEB7-97E3-437B-A136-2E6BFA032B2E,medulloblastoma Group 4,0.960951772
1A85AD0C-3706-4319-9221-974C84E79731,"Astrocytoma, IDH-mutant",0.960854569
67E00173-92EA-41E8-8A84-2F6597C64738,"Astrocytoma, IDH-mutant",0.960854569
96A00D3A-CB0D-433A-9C2C-4CC4B1C471E6,Pleomorphic xanthoastrocytoma,0.960847413
C77D35DA-E29C-46F6-A2BC-3EA6D5EAC14B,"meningioma, benign",0.960749313
1B2FFCB7-5E83-4676-A06E-C11EFBA4489D,High-grade astrocytoma with piloid features,0.960661895
F04B4EC6-7980-45DC-A3B9-60A5BB38A439,High-grade astrocytoma with piloid features,0.960661895
0FB8C919-9B6B-4FEF-84A7-CE5EC28244F6,"Diffuse midline glioma, H3 K27-altered",0.960604327
703D158F-E357-4F19-BA14-3A55E211FA48,Neuroepithelial tumour with PATZ1 fusion,0.960485541
1866097C-6028-4044-B110-4138DC30A310,Haemangioblastoma,0.960244007
04198C2B-08BB-42D3-830A-51C57E41474D,"glioblastoma, IDH-wildtype",0.960178534
0D4390E6-0A32-40E5-AB8B-A34E3847EC3A,"glioblastoma, IDH-wildtype",0.960178534
7962E3A5-07F9-4B0F-A345-BDBC803467DF,"meningioma, intermediate",0.960081554
0AAF4ACC-2882-4DEB-A1F7-FFD492AE666E,Pineoblastoma,0.960039678
BB471384-105E-4A8F-9EF9-D5A63F609EC3,Chordoma,0.959902507
D6D12CA2-CA17-4434-9FF5-7C5F60D07A2B,posterior fossa ependymoma group A,0.959696981
70759933-D5C9-429F-A147-270AB774F712,"glioblastoma, IDH-wildtype",0.959276845
43AD9958-325E-4AA9-B92F-3F689F087593,posterior fossa ependymoma group A,0.959207156
778A7BB6-861B-48ED-8819-8DE4CCCE0302,"Diffuse midline glioma, H3 K27-altered",0.959131726
F675B9E9-F00B-4403-8C79-5DAFE1478685,"glioblastoma, IDH-wildtype",0.9590058
9CB31CCF-27F0-48D5-8FA0-124BF86E3CC6,"glioblastoma, IDH-wildtype",0.9590058
54958E85-20E1-475E-88EC-A5A4FE45C470,Diffuse paediatric-type high grade glioma,0.958784657
E7E66A2D-7A78-40CE-BB0A-375795B68B83,"glioblastoma, IDH-wildtype",0.958719933
9412E43D-8B9B-4548-8C55-E36C4470FE9D,posterior fossa ependymoma group A,0.958531494
64416261-7DE0-437C-A855-56BB846063CB,"glioblastoma, IDH-wildtype",0.958302798
4663A46B-3D1A-4BE9-894C-F5818B221188,Pleomorphic xanthoastrocytoma,0.958269231
4F416D03-5754-4770-8BE0-42F6B8D48887,"Astrocytoma, IDH-mutant",0.958179852
EAE65F86-5E5A-48BE-8F06-A3B0420708AC,"meningioma, benign",0.958176135
396A3B61-E823-4F22-ACD0-1F20EFDF6181,"meningioma, benign",0.958176135
3100C2ED-BF24-4933-BDB6-264CDD2D149E,"meningioma, benign",0.958176135
2BA1B88E-3FCC-4CBC-B385-EECE406D227C,"meningioma, benign",0.958176135
AB6A51FD-DBA8-416F-99A5-6C98695B9A72,"glioblastoma, IDH-wildtype",0.95804828
2C05319F-5544-4CC2-B425-9D07EE9B5B37,"glioblastoma, IDH-wildtype",0.958029503
D4C29F4C-F8F7-4A9C-919C-71B83E328487,Haemangioblastoma,0.958028761
9D3AEB32-A1F4-4D91-AF2B-DCE2EB91E7F4,Schwannoma,0.957955215
4436E79F-44E0-430B-B747-BC6EB4756491,"meningioma, benign",0.957906003
FBCD2BC2-1E76-445E-8A1E-173DC1E7D3B5,Pituitary adenoma,0.957813912
11F2ABBE-2B22-4278-8D7F-053DD578DD7A,"meningioma, benign",0.957601017
C77F4C91-F60F-4071-8BAD-F7039ABABA64,"Pineoblastoma, miRNA pathway altered, group 1",0.957021015
3F7E3DDD-DB7B-4375-819C-65466645D9AB,posterior fossa ependymoma group B,0.957020184
47EEFC05-F20A-41EF-91C8-7F6D2C37C067,"Astrocytoma, IDH-mutant",0.956984156
DB006373-D98E-4D74-9DED-6ED742B52348,"meningioma, benign",0.95688927
0E990A27-410F-4F9A-941B-8426D7736256,Dysembryoplastic neuroepithelial tumour,0.956579678
C68F73D5-5260-4895-BD3A-E81136983802,"Astrocytoma, IDH-mutant",0.956295623
6FD2FFB3-FCDE-4244-81CE-D3AEAC9D7B45,"Astrocytoma, IDH-mutant",0.956295623
7345BEC2-3190-47F2-93C7-31487D9BF0DF,Myxopapillary ependymoma,0.956236881
6B7E21D5-41E7-4F2C-A2FC-0E9B3CF37994,"glioblastoma, IDH-wildtype",0.956231808
7D9E9A5F-0148-407B-A111-CF257AD93D0E,"glioblastoma, IDH-wildtype",0.956231808
8C936E94-6A62-4138-8779-62CA337848DA,"glioblastoma, IDH-wildtype",0.956231808
9AB28383-A31F-4638-A518-B35AC94E284F,"glioblastoma, IDH-wildtype",0.956231808
9D96C29F-360A-4A8D-A039-88B1514127D0,"glioblastoma, IDH-wildtype",0.95616375
C86210F5-E051-4985-A81D-3AEBA2B2CA16,"glioblastoma, IDH-wildtype",0.95616375
3BD19E42-6919-491D-B282-845D9FE4338A,"meningioma, intermediate",0.95589309
EEE36F23-339B-4210-8884-FB29373A9EC9,"medulloblastoma, SHH-activated",0.955882886
2B528003-0F65-4A17-BBE3-6120F8CEDA63,"Astrocytoma, IDH-mutant",0.955810862
A328D2CB-FFDC-41F5-9486-5721E35853B9,Intraocular medulloepithelioma,0.955780835
D5ECABAB-5CB0-4F5E-8C07-5C9B8B726153,"Astrocytoma, IDH-mutant",0.955668344
D61A17B1-98BD-47C4-A82E-9A75D95073AE,"glioblastoma, IDH-wildtype",0.955663319
929F72BA-F481-4739-A379-92127B27D3CE,medulloblastoma Group 4,0.955283176
81A74269-CC25-4BDC-8B6D-0CEFB467DE61,CNS tumour with BCOR internal tandem duplication,0.955278075
AFC898C6-B550-41E7-86CD-B66B1784AF29,Pleomorphic xanthoastrocytoma,0.955200388
E37EE917-D1B0-4EF2-8B6F-A89E0C8E7978,"glioblastoma, IDH-wildtype",0.955178205
AB262FCC-77F3-4877-8AAB-F92DC34B639F,"medulloblastoma, SHH-activated",0.955159682
33C0E526-279D-40CD-942A-90B07BD7657D,Diffuse paediatric-type high grade glioma,0.955082305
7D185DBD-8EC7-47BB-B7B6-1574891187B8,"Astrocytoma, IDH-mutant",0.955063066
160614CE-3C3D-4BAE-9A81-830F348C5BDA,"glioblastoma, IDH-wildtype",0.955025858
48C49EC7-645C-4A5E-B0BF-37E3D279DA39,"Astrocytoma, IDH-mutant",0.954881628
432B5F1A-C7D3-467D-8DD6-323DEDB9538E,"glioblastoma, IDH-wildtype",0.954821732
8EB96C9F-AF53-4D57-9CD6-DAB01F7631C4,"glioblastoma, IDH-wildtype",0.954821732
7FA26680-37A5-4A13-8DAB-E69FD23F2A93,posterior fossa ependymoma group B,0.954769632
267278D2-EDEA-49EA-BF8D-2DB077B08488,Dysembryoplastic neuroepithelial tumour,0.954715755
9A5251CA-CF7B-4EB2-BE0D-3F49A5C46FB1,Dysembryoplastic neuroepithelial tumour,0.954704352
8CA681C2-4107-47C8-A4EE-FA106AFF796D,"glioblastoma, IDH-wildtype",0.953849793
39E2C83E-46CC-4D5F-84F0-B14651A26F00,Inflammatory microenvironment,0.953776892
D2E8E50D-ADE9-4E1F-A702-62A3B2683B3B,"glioblastoma, IDH-wildtype",0.953757996
04486DB9-D6CF-468E-9E2D-D55AA713DD7A,Neuroepithelial tumour with PATZ1 fusion,0.953665893
248F87EE-188A-47F3-B92E-8CFD213C1D83,"meningioma, intermediate",0.953475815
D72EC940-71B6-4C54-A130-A693FD41B50D,"glioblastoma, IDH-wildtype",0.953242582
55F1B3FA-954C-4852-8F7A-C8C7FDB5301D,"Astrocytoma, IDH-mutant",0.953144257
09365604-9ABC-43CA-8B38-A2821CB93396,"glioblastoma, IDH-wildtype",0.95308214
DD0874E2-ED36-4319-9F5A-25EEA2F7E38C,"Astrocytoma, IDH-mutant",0.953026973
778AC572-6651-40A3-9048-99C3CE0EDEAF,"glioblastoma, IDH-wildtype",0.952970723
547581FB-B3EC-413A-803F-2DA392D3C358,"glioblastoma, IDH-wildtype",0.952899128
B1A17FDA-FBA3-462A-9025-4EEA257DBB51,"glioblastoma, IDH-wildtype",0.952899128
38F177EE-4A46-4635-8D88-F22BA3F35ED8,"glioblastoma, IDH-wildtype",0.952899128
6B3185E7-21D7-4CD1-A43F-186511F75A59,pilocytic astrocytoma,0.952827598
6B9C4238-0DB9-41F3-8747-1ACA63547AB1,High-grade astrocytoma with piloid features,0.9527747
179C4644-ABA7-421C-9AED-A2B872AD1F44,"glioblastoma, IDH-wildtype",0.952463777
3F932B71-A854-4E8E-B5A1-428503A68732,Myxopapillary ependymoma,0.952191625
EEAF4849-C8C1-4616-9A9D-D42CA65AA2D0,Diffuse paediatric-type high grade glioma,0.952120986
46C25B7B-B45B-491E-94B2-D1144A7D2028,"glioblastoma, IDH-wildtype",0.952073917
F8A75592-ACB0-400E-8B13-95A5E006CDC0,"glioblastoma, IDH-wildtype",0.952067942
0FC100F2-C058-49CF-A301-7AE09EE19803,Inflammatory microenvironment,0.952048078
A077C471-C7CD-442E-A0DE-3C39873329A4,Inflammatory microenvironment,0.952048078
6AD0CF2E-8730-45C9-A07E-445F7EC2F272,Inflammatory microenvironment,0.952048078
C195620F-ED5D-4BDC-8202-048FAD30E190,"Neuroblastoma, MYCN subtype",0.951980144
39B74B09-E428-4FDE-AA8F-E918C324B31A,"Astrocytoma, IDH-mutant",0.95187457
785AB807-98CC-4858-8FD0-7AB76EB91658,control tissue,0.951870024
C4EFC915-08B6-4335-A31B-5F7ABA1EF52F,control tissue,0.951870024
3CE2A1E3-8F30-4E5A-A7C2-170C9021B7EC,"meningioma, benign",0.951859925
F4A11F87-3E00-4068-A083-0FEB4106EB60,"meningioma, benign",0.951859925
E04804E0-BF87-40F3-A369-E70A30936544,"meningioma, benign",0.951859925
8C31B199-FB6A-427C-81A1-96E9538FB40C,"glioblastoma, IDH-wildtype",0.951805075
7A897D0A-B092-45DE-929D-F59A28D06AC2,"glioblastoma, IDH-wildtype",0.951805075
B3E58918-0593-4561-B615-81FA36044C77,"glioblastoma, IDH-wildtype",0.951805075
89E336C5-B9A7-44C8-8DAF-A89D9B133A94,"glioblastoma, IDH-wildtype",0.951805075
E5F9543C-DE97-4B69-A818-9B3C62227CE0,pilocytic astrocytoma,0.951790672
7A220333-2E46-44BA-8AA8-7CC216AEDEDB,Diffuse paediatric-type high grade glioma,0.951711725
8161BAF4-E099-4E83-855E-AD86BDDB12BE,"medulloblastoma, SHH-activated",0.951660661
CBA4798C-39F3-40D7-9E08-0F32E5B6F3F1,"medulloblastoma, SHH-activated",0.951660661
233993F5-1F2D-43C5-98BA-D1CC185F8810,"medulloblastoma, SHH-activated",0.951660661
A1355CCD-6C62-45C7-8F8A-2CE823DAC8C0,"medulloblastoma, SHH-activated",0.951660661
9FF6BBC5-CBB4-4021-91CC-B33B1C9DB4E8,"medulloblastoma, SHH-activated",0.951660661
29320F4A-9913-4F1E-B14F-59CF7002C0E9,pilocytic astrocytoma,0.951582286
6EA9EF9E-0028-477E-8770-9D85DCD7D865,"meningioma, intermediate",0.951335938
190F5810-8F53-4F3D-AB93-A9A54913083D,"meningioma, intermediate",0.950732255
326F876B-48A9-4995-8FAC-6DD3A74171BE,"Control tissue, reactive tumour microenvironment",0.95073088
BD849E07-6D3F-45E3-9C4B-B1D9F4EDC1A7,pilocytic astrocytoma,0.950728469
7328E60C-B88D-41B7-863D-3B1FB668D5DE,pilocytic astrocytoma,0.950728469
20949C9E-2F31-4FEA-9B01-A2279F059971,pilocytic astrocytoma,0.950514611
C9FBEBDA-5DEA-4F02-BD24-89C83AAB478C,"meningioma, intermediate",0.950502517
26D66BB8-2158-4668-947C-FCB47D1E3182,"meningioma, benign",0.950440446
1B5C9D21-FCCC-4450-86E8-351F724FB8C0,"glioblastoma, IDH-wildtype",0.950213482
41363DA1-7606-4C8C-B76B-91FF2A5F30C9,"meningioma, benign",0.950171627
153FCB0E-FD25-4D2C-8A82-7DC62154D3D4,"meningioma, benign",0.950171627
7814F6B7-AEA3-48B9-B5CB-CB4D547B7A9B,"meningioma, benign",0.950171627
6AD91F87-4215-4B7B-B39F-F8C25E0EF0B6,Diffuse paediatric-type high grade glioma,0.950122798
D7510C9C-8E70-4388-9D8F-10EDAE5C1C6E,Diffuse paediatric-type high grade glioma,0.950122798
2525C04D-05FB-4736-9E3C-AF579C9910EE,Spinal ependymoma,0.949865337
B2D8DF2B-143A-4320-8787-3E9A31530D95,"glioblastoma, IDH-wildtype",0.949822409
DB083C8F-11BF-4D74-AF03-8ABC7F3B7F74,"glioblastoma, IDH-wildtype",0.949822409
B2A22B48-6A61-46A9-8FF5-00EE713B05B9,Diffuse paediatric-type high grade glioma,0.949407416
A6BA3C68-76D0-401C-BF73-561EF15C4911,Diffuse paediatric-type high grade glioma,0.949407416
7DD36CB2-9327-479A-B92F-EBA312ECF5E0,Diffuse paediatric-type high grade glioma,0.949372363
2E09B5B0-B89D-4CB1-A888-960CC60AC9C3,"Control tissue, reactive tumour microenvironment",0.949247305
D1B90C9E-E43F-4F45-A5A7-921D1F5C020C,"Control tissue, reactive tumour microenvironment",0.949247305
989AD8EE-132E-4712-BCE7-465662BE5114,"meningioma, intermediate",0.949202988
73B9C3EB-E3F2-4087-90F6-73603AE9029B,"meningioma, intermediate",0.949202988
7A24F882-C8B4-4657-A502-425F6EF07275,"meningioma, intermediate",0.949202988
6E623D10-3B82-40AC-B9FA-8996E0C7294B,"meningioma, intermediate",0.949202988
6B5C5C78-A661-4A56-A6D0-DDC7842815A7,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.948992568
B2C3883D-222E-4F0E-BC51-9B1174937776,pilocytic astrocytoma,0.948961105
DE1660BB-A078-4766-8478-DE14A248400A,Diffuse paediatric-type high grade glioma,0.948915894
F1E00FC3-6ACB-4983-AD0A-E0ABB844FB4F,"glioblastoma, IDH-wildtype",0.948818309
170A81E2-1A16-4B4C-83AA-AD2D25B91ACD,medulloblastoma Group 4,0.94877834
628690F0-BA56-4B2B-9A46-42C7DAB9954D,"Astrocytoma, IDH-mutant",0.94847077
2A54E6EF-6ED1-473A-893E-097D7A7E3F3E,"Astrocytoma, IDH-mutant",0.948453901
1CBB0554-EFE1-4063-9691-33474F434BD4,Pleomorphic xanthoastrocytoma,0.948175938
F1CC79C3-9990-4399-8275-86C01CDD495E,"meningioma, intermediate",0.948064564
6CBDE5F0-7961-4D81-B49E-95B601DFD3D7,"meningioma, intermediate",0.948064564
2064E961-D1F4-4EDC-B2AC-5801AD1D1ED3,"Astrocytoma, IDH-mutant",0.948017082
A6DA95FF-33B1-4F71-A54A-3DE64BE7E03C,"glioblastoma, IDH-wildtype",0.947965762
2B6E12F7-64AA-4459-8FCF-9D4B0099FCE2,Diffuse paediatric-type high grade glioma,0.947846323
AEA9E8DD-4204-4513-8D38-32F8ED3A0383,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.947805591
359D5B10-723A-40B8-A975-D58F456C518D,"Neuroblastoma, MYCN subtype",0.947618806
8D5BF261-7421-4C70-A471-05F07DD8748B,"glioblastoma, IDH-wildtype",0.947504779
F515CA2C-947C-4868-83BC-4B2E95CC442C,Pleomorphic xanthoastrocytoma,0.947430099
ED007B59-30EF-4FB5-8F6B-4D69968AAA59,"meningioma, malignant",0.947250815
B0E04096-11F5-4B1A-9F1B-E67B8B33F0FF,medulloblastoma Group 4,0.947076127
F9114937-94A6-4037-9387-8B6E25BF6269,Diffuse paediatric-type high grade glioma,0.947057821
CF3561A7-B084-4CB0-AA70-B296984540EC,"glioblastoma, IDH-wildtype",0.946999731
40C3213D-F8D2-42C1-831B-B78B4030A3F4,"glioblastoma, IDH-wildtype",0.946922678
CA4CCA33-9580-40A1-B7A7-D695E701C33E,"glioblastoma, IDH-wildtype",0.946550807
7418E939-A70C-4319-9EC2-5FD7A49B5F2F,"meningioma, intermediate",0.946416769
9AD656A7-70FB-419F-84DD-6338790B4F90,"meningioma, intermediate",0.946416769
390D665F-68BC-47A8-8A6A-348F9541E039,"Astrocytoma, IDH-mutant",0.94640912
D9AF5DBA-1AEB-46D9-9BFA-AE6DFF9CE920,"medulloblastoma, SHH-activated",0.946318527
5DA97330-D2C1-4EDD-A584-F1603D4E921D,"glioblastoma, IDH-wildtype",0.946169226
75806AB8-DBEF-4C36-B9D4-716B32F8853F,Atypical teratoid rhabdoid tumour,0.946163768
D3AE8BFB-9B2E-492D-81E5-839BB3450C51,"glioblastoma, IDH-wildtype",0.94593207
4656C714-8B3A-45F9-B278-CA2FBE86E598,"meningioma, benign",0.945926891
CB154E6A-AEFF-4DC8-B19A-D2688824BDF7,"glioblastoma, IDH-wildtype",0.945781936
BC8A8EDF-F6A4-4CD4-B232-C11611F8A6BB,choroid plexus papilloma,0.945629929
B0250F69-2019-435C-8C95-A59B2A8CB70F,pilocytic astrocytoma,0.945202938
F6E21BBF-9E43-44FB-BBE2-B6DF69E441B9,"glioblastoma, IDH-wildtype",0.945144479
5586C0BD-B747-4549-97CF-73CDE676B1BD,"glioblastoma, IDH-wildtype",0.945073627
AD6CCD79-E4CA-4B95-8DE1-9B56A7DF0846,posterior fossa ependymoma group B,0.945019717
9469A532-0622-4227-B2CB-1128F8B9DB8B,posterior fossa ependymoma group B,0.945019717
1F1A9791-C30E-4F96-9347-049995E6076F,"glioblastoma, IDH-wildtype",0.944978903
839BEC50-272A-4428-BECC-EC163AA865E3,"meningioma, benign",0.944919761
93AA4C19-233D-4773-9D52-F184C379CBA8,"meningioma, benign",0.944919761
5BC78371-2D7C-4355-8895-21744192E4FB,"meningioma, benign",0.944650427
E493D4E0-41E2-4C27-92AF-056D675B1536,"glioblastoma, IDH-wildtype",0.944586455
2CC489AB-951C-49E6-98B9-AFCDFAEA0F8C,"meningioma, malignant",0.944405449
0F39BF35-5117-44FA-B3AC-554533DD5687,Pleomorphic xanthoastrocytoma,0.944247718
D9089596-4F07-4C85-83DF-38CCEE708E21,"glioblastoma, IDH-wildtype",0.943953351
26E038BC-7ACC-437C-B720-50AD9382FB05,pilocytic astrocytoma,0.94377766
DD8A19D6-9239-4F5E-BD00-C71072B10E2D,Atypical teratoid rhabdoid tumour,0.943681794
5581AEAE-434D-41FF-8173-2D0616FE9399,"Astrocytoma, IDH-mutant",0.943641299
9986167A-1EAB-4027-B58D-92AE04100BB6,"glioblastoma, IDH-wildtype",0.943247844
DA87CC5E-54B5-477E-81C3-B70EF5995F3E,"glioblastoma, IDH-wildtype",0.943247844
A82551E9-293C-4CFC-A6C9-E8BAAED10E27,"glioblastoma, IDH-wildtype",0.942925161
68454E3A-CA13-4F24-8311-1903D3732D62,"glioblastoma, IDH-wildtype",0.942925161
22B828C3-8655-420C-8B1C-D5F0CEF997CF,"glioblastoma, IDH-wildtype",0.942918055
37194CA7-1D7D-453E-A89A-6357FE93F2A4,"glioblastoma, IDH-wildtype",0.942918055
2460E57B-778D-4493-AE45-E94165505936,"glioblastoma, IDH-wildtype",0.942918055
8ECBD2D5-D047-4FC1-A4F2-49E6C55B3EDA,"glioblastoma, IDH-wildtype",0.942918055
3F6DAC57-2FAF-48A1-B397-82E097D20407,medulloblastoma Group 3,0.942799386
7F34EF11-2F58-493B-A090-B2E6CC0260B3,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.942499166
F5EC80A0-1E0F-422A-BAEF-A43B1AB1454A,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.942476759
2F57B497-670E-430D-B9ED-7C98761458C3,Pleomorphic xanthoastrocytoma,0.942278539
3BF22FBA-8B92-4565-98D5-7352AFFC2FBC,Dysembryoplastic neuroepithelial tumour,0.942258262
715CC2D6-5010-4E65-B32A-63D280008384,Dysembryoplastic neuroepithelial tumour,0.942008391
D60BF3D0-CB7F-401A-B4B2-AD1BD57929BD,"meningioma, intermediate",0.941583476
BDD6C34D-FD0A-4E8C-97B8-DF779FED17F4,Diffuse paediatric-type high grade glioma,0.941215483
5050ECC8-43C0-4A9C-8A81-73509B3237B6,pilocytic astrocytoma,0.941195047
94EC3378-3BB8-46FF-8ECF-BDED6B448818,Diffuse paediatric-type high grade glioma,0.940979196
34A9D4F9-9CB3-4690-9915-E4F043AE0664,"glioblastoma, IDH-wildtype",0.940603967
424785CB-E1A3-45B5-9BFE-86FA1C9E5C35,Pleomorphic xanthoastrocytoma,0.940195159
D4288DA7-C43C-4EA9-8895-0DDE3165E80B,"glioblastoma, IDH-wildtype",0.940099359
1DF3E101-4ABA-4F3E-99DC-F90E234492D5,"meningioma, intermediate",0.939902888
AB248834-7C39-4122-86CE-923B6BB1579A,"meningioma, intermediate",0.939902888
3F662B66-B844-4046-A915-BEF738D5458C,"glioblastoma, IDH-wildtype",0.939856085
DFF84A16-68B7-4DE7-9A5D-7E7FFAD9703E,Dysembryoplastic neuroepithelial tumour,0.939837654
579BC500-B846-42FF-BE7D-DC2ABAA8B6DC,"meningioma, SMARCE1-altered",0.939729355
0EE6FA72-BCCF-47B5-95A0-855FF2E90B9F,"glioblastoma, IDH-wildtype",0.939643742
C2FFAF74-2003-4EB3-82F4-EAECAA07F286,"glioblastoma, IDH-wildtype",0.939631394
446151D5-82D4-402E-B846-0DA1E383BC12,"medulloblastoma, SHH-activated",0.939604091
8E6C76F6-07EC-4E7C-91ED-C0D00C8FBAD0,"glioblastoma, IDH-wildtype",0.939505173
B16CD52B-59C9-434B-ACD7-939F7B9DA4D4,Neuroepithelial tumour with PATZ1 fusion,0.939159906
EE48D74A-1B11-476B-864E-ED2A245D5B9B,Diffuse paediatric-type high grade glioma,0.93909093
06AEEBD1-B374-4584-8CCA-F0C4236BC3A9,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.938600896
60506EC8-FEE6-471F-BBD3-FA0D624D73D6,medulloblastoma Group 4,0.938589444
E2F2EF81-3813-4BE8-910B-5BFB222D649E,Melanoma [metastatic],0.938206096
3F8DE6A8-5FE1-4A15-8A76-C6FB90223A8F,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.938135773
0DD1F2AE-6A39-4E2D-98CC-EF11DBE53803,Malignant melanotic nerve sheath tumour,0.937554469
07B654E9-56DF-409F-8ED5-028C1854D8DB,"Astrocytoma, IDH-mutant",0.937017884
E2ED0FC2-5A65-4B83-B1D1-A212DBD1EA17,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.936562593
F2821BA8-BC2A-4EAB-9138-AA25E5F4EAD3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.936562593
EE189259-F966-4787-B56B-A44E36CCE7C5,"Astrocytoma, IDH-mutant",0.936154783
F314AD91-17FE-41CC-B4F3-D7904214BD66,"meningioma, intermediate",0.936078963
92E6C53F-1439-48B5-B6E7-DA18FCA96423,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.936060726
44EB3E02-A4D8-483A-95DB-859B0CD6B446,"glioblastoma, IDH-wildtype",0.935981114
9CB27E87-B517-47B4-974B-930CD650447C,"Astrocytoma, IDH-mutant",0.935943953
956DE099-A83F-4109-974F-74F2BC97DD4A,"Control tissue, reactive tumour microenvironment",0.935898077
FF5CECEA-7D4E-425E-88E2-B042FC3846FF,pilocytic astrocytoma,0.935578473
56023AFA-732A-4ADB-9AEF-B7F35A7E7759,Dysembryoplastic neuroepithelial tumour,0.935440824
7EC3E6A7-029A-48E0-B840-4B0E4CA68ED5,"glioblastoma, IDH-wildtype",0.935331695
071AA91B-1BEC-4A2B-89EE-5DEACE3BD434,"glioblastoma, IDH-wildtype",0.935119806
CC6EE823-9F14-43BB-BD30-9EFADF7DD4F1,"glioblastoma, IDH-wildtype",0.935119806
09371D59-93E8-40B1-972F-3233A758C96A,"meningioma, intermediate",0.93497098
94B21661-56ED-4F63-9352-DD40281DD1A1,Myxopapillary ependymoma,0.93492942
181D8454-B76C-4ACB-B661-F71280B9E049,"Astrocytoma, IDH-mutant",0.934886607
3AD98914-1570-4F3C-AB52-8ABDE142DC3A,"Astrocytoma, IDH-mutant",0.934803901
E393363F-F5A6-433D-A0CC-5EF62509EB2B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.934663885
AA73255A-B0BD-4491-95CC-E5B8928884D6,"meningioma, malignant",0.934444932
3C930749-0466-4387-A049-137BE6F1373B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.934332274
F5C496C6-BF02-4076-9247-3FD9EF99B92F,pilocytic astrocytoma,0.934008704
D88687EA-66D0-4CD8-8BA5-2D4760B15116,"Control tissue, reactive tumour microenvironment",0.93399998
71E40C93-84AD-43AE-B700-CC67C139648E,posterior fossa ependymoma group A,0.933882207
06C4A0EC-51CA-4750-AB4C-1B73197A5982,"glioblastoma, IDH-wildtype",0.933710478
2B55D4DE-1231-49AC-9F4D-BFD36F8FF288,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.9336637
38E52CDB-3D25-459D-9C1F-E5DD4474225D,Diffuse paediatric-type high grade glioma,0.93351184
AF2943F3-C701-4D41-8354-18CF0BA76EF9,"meningioma, intermediate",0.933458784
73EEC08E-5CEA-462B-A647-E2C1BE5EF76B,Malignant melanotic nerve sheath tumour,0.933052297
A528C24F-81CC-4176-8A5B-A003639BC69C,control tissue,0.933025053
C6B14AEE-8886-437E-94DD-8C5DA224CE0F,"Control tissue, reactive tumour microenvironment",0.932981558
E4123D27-74AA-472F-93A9-F8853814E464,"meningioma, benign",0.932327911
D7F7CC97-2096-48F7-85D3-4AC066B1F782,"Astrocytoma, IDH-mutant",0.932249278
82F65795-85F5-4183-B925-3E97E9D04041,"Astrocytoma, IDH-mutant",0.932249278
F3A5F5D3-55D5-4E75-95EB-EC3ED9E1AAA3,"glioblastoma, IDH-wildtype",0.931996313
FB9CD6D3-D195-48B4-B85A-5A302C3B48E6,"meningioma, benign",0.931984805
3B10C986-2027-4F96-A219-374A691F723B,"meningioma, benign",0.931984805
E7CEF529-97C6-430E-85D3-F1F03D0A5661,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.931670107
53855637-A595-4EC7-9DAF-8EF256216EFD,normal pineal gland and pineocytoma,0.931447942
735B4F06-2AE2-4A41-ABD6-177D830D7703,Chordoma,0.931329997
05761032-D329-4DD0-9339-719E1423C003,choroid plexus carcinoma,0.931328503
EDB02CAB-CB46-4114-B07B-C783C2493540,choroid plexus carcinoma,0.931328503
965DEE8D-6AC3-4FD5-BA53-41ED7EAE796D,"glioblastoma, IDH-wildtype",0.931179381
F0FE1C93-C0F4-44AD-B5AF-F11A42E8E3A8,"glioblastoma, IDH-wildtype",0.930706413
36816B3E-7539-4227-9C7A-9553ED8A8C37,"Astrocytoma, IDH-mutant",0.930506302
A65C20F9-B66D-4E89-94C2-B3B2B142C367,"glioblastoma, IDH-wildtype",0.9304874
27F48BBD-51BC-40CD-8ED5-E4B8237E27E4,pilocytic astrocytoma,0.930471192
44C991F9-1CAA-4E8A-942C-08227626AC8A,"Oligosarcoma, IDH-mutant",0.930325938
B183DBEC-1C9A-4499-99AB-23F66F7CBBA5,Pituitary adenoma,0.929200212
0B3FF05E-B57C-46A2-A62F-A4F02C1B8054,Pituitary adenoma,0.929200212
F505EE9C-4F80-49F2-855B-893953305DC4,Schwannoma,0.929033714
64FC196A-C215-4051-9743-F2CAFF2AD5C3,"glioblastoma, IDH-wildtype",0.928999805
0412EFC7-4FCA-4CDF-8C51-1158D7CF9C89,pilocytic astrocytoma,0.928996196
6EB7AB92-F906-483E-A0C4-8F639B058DBC,pilocytic astrocytoma,0.928996196
4151DBE3-9F7C-4063-BD55-A5619D931E7C,"glioblastoma, IDH-wildtype",0.928547303
6673D944-CFFB-421D-B24D-2B87E8743529,Diffuse paediatric-type high grade glioma,0.928441953
8EAF9306-25AD-41F5-B9FE-9490C95CC481,"Astrocytoma, IDH-mutant",0.928441859
A86279B9-7D0F-4C9E-80D6-7093CF564480,Atypical teratoid rhabdoid tumour,0.928368053
5320FC65-BC11-41B8-AF65-104F6A041F7E,"glioblastoma, IDH-wildtype",0.928268642
BA8C31F4-BFB3-4033-A9D2-254B7DE54AD8,Primary diffuse large B cell lymphoma of the CNS,0.928231241
833A3945-0542-426E-8C36-4C887C67611C,Diffuse paediatric-type high grade glioma,0.928171995
5C9DD694-4A71-4A64-8649-CF2B840D3FD9,"meningioma, benign",0.927922408
9CF864F5-AA5E-4EF5-9B81-00C620A9106D,posterior fossa ependymoma group A,0.927730364
7ABA78F5-AEFC-4F28-AF74-9CAED4D79E71,"Astrocytoma, IDH-mutant",0.927645648
87330EBC-6821-4215-B8C6-DAF4F048C0F1,"meningioma, intermediate",0.927524151
0B6554CC-2522-4270-87C4-94878286C337,"glioblastoma, IDH-wildtype",0.927472754
12C998B7-E7AC-4BA5-83BC-1970B357A695,Dysembryoplastic neuroepithelial tumour,0.927431603
242AC40A-041E-4C64-99E1-7C5353C143BF,"Astrocytoma, IDH-mutant",0.927406671
11625A95-BE09-48B5-8462-5DAD3DAE3836,Diffuse leptomeningeal glioneuronal tumour,0.927311318
8794E88E-01C0-4981-B9A1-ABBC9279F0CA,Pineoblastoma,0.927063115
354A334F-C664-4414-AD5F-8D42088A7CA3,"Control tissue, reactive tumour microenvironment",0.927061922
77A3D4D1-F4EE-4E6C-B88F-1F27B40470E6,"glioblastoma, IDH-wildtype",0.927026849
60BBF636-7E0A-4D7D-BBEA-49BE01E1158B,"glioblastoma, IDH-wildtype",0.926814705
4DC650EE-CDA0-4D70-BED0-3666AAD03AF8,"medulloblastoma, SHH-activated",0.926793404
CA8D99CC-17B1-4451-ACCB-12DA27377CCA,"Astrocytoma, IDH-mutant",0.926585399
FB15C9BF-F053-434B-B765-9AF467D833BD,pilocytic astrocytoma,0.926486467
520135A5-48EB-4808-8DF4-6000669731A9,pilocytic astrocytoma,0.926204368
645615AD-E941-41EB-ABC9-C535F23E45A9,"Astrocytoma, IDH-mutant",0.926176367
A9A5009A-2645-4316-9DAA-5EA88D568249,"Astrocytoma, IDH-mutant",0.926176367
F536297B-9E42-460C-97AB-1364EDF8562D,Posterior fossa subependymoma,0.926066115
BBB6B94E-37F9-483C-8A60-1E9FA0081BF0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.926011395
F8600DD6-6004-4A96-B40C-D2FE0B92D4D4,Myxopapillary ependymoma,0.925524166
119349EB-3B05-4AD2-9E39-774372A729D1,Dysembryoplastic neuroepithelial tumour,0.925309652
A62BDD77-683F-4858-9C64-F21E1C6CB178,pilocytic astrocytoma,0.925244909
953E7039-AC02-440F-A639-5EED3BA8B081,"Astrocytoma, IDH-mutant",0.925229403
6A41ECB9-D2CB-433E-8C95-9B071F6C5ABB,"glioblastoma, IDH-wildtype",0.925133891
56C468D0-C749-4B18-B716-E5C1027EE451,"Astrocytoma, IDH-mutant",0.925071699
B1AD30C8-16B4-4D21-A739-7E112E6D7C95,"glioblastoma, IDH-wildtype",0.924735697
5458E7E1-57F3-4DA0-B586-C0DC7AC57AB8,"glioblastoma, IDH-wildtype",0.924681054
8F9CDB47-5B71-45D3-85B8-088A7C5086C8,pilocytic astrocytoma,0.92468047
6F44198E-B6B4-4AA4-9F48-51CACE93DC9D,pilocytic astrocytoma,0.92379585
D2E0CD52-BCC1-4795-B8AA-3AB25D840F53,Rhabdomyosarcoma,0.923457123
C29DC9AC-AD02-4AB4-9598-EC4F64FA0CF1,Ewing sarcoma,0.923307738
540FF3A6-0ED9-4BA1-9FD4-BDBB995D7E31,pilocytic astrocytoma,0.923165242
21F6DCA0-ACD4-42F0-8BA3-D62D05877E77,"Diffuse midline glioma, H3 K27-altered",0.922542934
42B804F5-AD11-4E93-864A-3431C25D0806,"Diffuse midline glioma, H3 K27-altered",0.922542934
F5BC13DD-8F37-482E-B694-FC69E5711341,Diffuse paediatric-type high grade glioma,0.922523528
88CA76AF-DB80-43B5-9650-92574A876603,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.922024792
0B8A23CA-C3EF-4F4E-83BA-14C4CE47B502,"Adult-type diffuse high grade glioma, IDH-wildtype",0.921613982
69997206-A1A0-4364-ADEF-CFA768F41406,Pituitary adenoma,0.921474414
80199137-EE49-47E8-AB0B-3B8117A8AB57,pilocytic astrocytoma,0.921357983
E4CE4E7F-06D7-4A2F-8153-9D9901D27F9A,"glioblastoma, IDH-wildtype",0.921334729
DF87CB58-D388-49CF-B205-96E417BD3E88,"glioblastoma, IDH-wildtype",0.92088264
469E015B-FCBD-420A-B210-AAD69CB31A8F,medulloblastoma Group 3,0.920703099
A0D8386E-19D1-4ACF-9D12-BC67E30DD9EA,Pleomorphic xanthoastrocytoma,0.920680706
9E4C0DDF-4C3C-497B-B0BE-F6AA42DD6DF6,Pleomorphic xanthoastrocytoma,0.919847855
AC16E61F-CF03-4770-BED7-89EF698167B0,Inflammatory microenvironment,0.919770886
4600BEB6-FF01-4559-8A30-08B3BACCAF3A,pilocytic astrocytoma,0.919459479
B25EACF3-2C08-424A-A78A-86216FA377B3,"glioblastoma, IDH-wildtype",0.919205314
8BBFF781-89D2-4B9F-8D69-FD5AA170B1C4,"Astrocytoma, IDH-mutant",0.919187087
D2FD6F8F-5671-4728-8010-D326E0A569A1,"Astrocytoma, IDH-mutant",0.919187087
E1719E6A-F394-4706-A493-D53CBCF25B49,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.919042517
11F00BE1-02E6-4EBF-889A-D97A0B40EEA3,control tissue,0.918843579
96976A8C-BBE6-48FB-8153-FC8D29BF591B,"meningioma, benign",0.91879154
4EC565D4-5A26-47AD-B17B-24F444F17652,medulloblastoma Group 4,0.918126042
C77E6B04-3028-4E4B-A4C7-B740C0C0E0E5,Posterior fossa subependymoma,0.917103282
7B30D0D9-98EA-440D-838C-73A1945F57AC,"meningioma, benign",0.916610545
2B4268C2-D596-4BD9-8FFB-B5CD87143871,"meningioma, benign",0.916610545
4272828C-617C-4908-8AFD-9A38C9D55822,"meningioma, benign",0.916610545
A91AF228-8DD5-4C14-B3C6-607822308FC4,"meningioma, benign",0.916610545
9672B74E-F1CE-4023-A92F-B86F45AFCBE1,"meningioma, benign",0.916610545
BF2F421D-6636-4A78-B5A3-417FF070586D,"meningioma, intermediate",0.916253692
BDD9AABA-89D1-4FA2-8174-42BAB580C355,"Astrocytoma, IDH-mutant",0.916170604
9AA15BB8-DCD0-4283-BAD0-C2B1B1C52FD5,embryonal tumour with multilayered rosettes,0.915560789
5E156687-6981-4533-91C2-20930E730F5D,"glioblastoma, IDH-wildtype",0.915551348
D5F1A545-61F6-4D54-B2DD-541B6942F4D2,Ganglioglioma,0.915370303
AF7D1EEC-1D24-414E-83E4-E63934F2B0C7,Diffuse paediatric-type high grade glioma,0.915101383
A77B833D-51B2-4B22-9B32-C2D28E299215,Haemangioblastoma,0.9148079
B8DC0287-45A1-4318-8175-1AB17A796F23,"glioblastoma, IDH-wildtype",0.91452645
78A048F6-FEA0-4787-AA8B-0B4A30C275BD,Dysembryoplastic neuroepithelial tumour,0.914521399
D01CE319-C728-4D7E-9FC7-78A096F449D9,pilocytic astrocytoma,0.914470607
13AF8652-FF66-4410-8730-CD2346B0C3DD,"Diffuse midline glioma, H3 K27-altered",0.914270098
DF369E47-7E5F-46B3-9CA9-1335B8BC8ECF,medulloblastoma Group 4,0.914150147
23502A57-69E9-46CD-A03F-BBDB1B2E201A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.914042599
7E1400CC-88AA-49A5-8F1F-83069BF02ECB,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.914042599
685D2EB0-EBAC-4911-9757-17D013C62339,Pleomorphic xanthoastrocytoma,0.913760157
D52379D9-18FD-4D66-9B2C-113AD5F394F9,Pleomorphic xanthoastrocytoma,0.913760157
FE9D0939-9486-4EB6-AD61-5B7936F6FAB4,Rhabdomyosarcoma,0.913491961
A7691667-A3EA-4BA6-9730-5F51932B5F64,"glioblastoma, IDH-wildtype",0.913284424
60245A13-6D07-46C1-A89D-61290CB0A20B,"Diffuse hemispheric glioma, H3 G34-mutant",0.912896729
CAA4D291-AFD6-4A5F-8BF0-2C93736412D4,Neuroepithelial tumour with PATZ1 fusion,0.912807546
719E51DF-001A-45D0-9B08-3A0928EC481B,"meningioma, intermediate",0.912680286
D6F9EFF8-FC37-40D5-B08D-C86183C79318,"meningioma, intermediate",0.912680286
AC6E111E-59EE-41D6-9686-4444D57192E7,"meningioma, malignant",0.912466743
D09BCD31-EFEE-4B90-93A2-EA63EDC6E5FE,"meningioma, malignant",0.912466743
DC0EE872-59F2-48B9-B2B1-9C018BB52AD9,"glioblastoma, IDH-wildtype",0.912444005
D368FE3D-4E39-41ED-A74B-2CF2BDFD5A7F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.912188052
708C4C70-0C7C-4CC9-AD48-0CF96AFBA92D,"Adult-type diffuse high grade glioma, IDH-wildtype",0.912160088
9AFB7B44-65A3-486E-9A6E-85DEB05D4CFC,Neuroepithelial tumour with PATZ1 fusion,0.912159682
CC06F549-B69E-4390-8391-45673343B7E7,Atypical teratoid rhabdoid tumour,0.911667635
A53E684F-2E38-44FF-A7C9-A7DB39CC1472,"Astrocytoma, IDH-mutant",0.911646235
8BCCB10A-8929-439F-B6F6-F085127DE301,choroid plexus papilloma,0.911594827
A3ACF0B4-1F04-4E57-95E1-E470D54B70D0,Infant-type hemispheric glioma,0.910608659
81876FB1-7A4F-40D3-8DC5-B74D4F38E9B0,posterior fossa ependymoma group A,0.910471417
58CAABEC-17A6-47CA-B532-54252CE7E7D9,"meningioma, intermediate",0.910428778
413BE0DC-B52D-488C-B903-458B0BC814D3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.91035712
3F60FEC9-6471-4B73-B586-3984B5D885C2,pilocytic astrocytoma,0.910162501
F8B1CE4E-7A24-4526-95C7-B06E3801AF0D,pilocytic astrocytoma,0.910155833
13658155-A534-4FE5-82AF-CDCF225EA041,"glioblastoma, IDH-wildtype",0.909883683
7176B3A6-1DCE-417A-872A-94C2D43D4A4E,Spinal ependymoma,0.909858558
78155EED-D1CF-494C-9FE0-3B0DA0139229,medulloblastoma Group 3,0.909502978
6BB26CB2-6626-4C4F-8081-912BEB823FE7,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.909455509
203AA56C-6B7A-48AE-89F3-A6A4ABA44AD0,"glioblastoma, IDH-wildtype",0.909209915
4F6EBC67-6241-4B10-BD99-C3BD3238A76A,Anaplastic neuroepithelial tumour with condensed nuclei,0.909161456
FFBE0367-95A1-4284-AA5E-679F5A2790BE,Anaplastic neuroepithelial tumour with condensed nuclei,0.908346899
789F07B5-699A-43F0-9DE4-304069F2F961,"glioblastoma, IDH-wildtype",0.908330675
BBCFCD35-4199-41B7-8C2C-9B7ECB317E8D,pilocytic astrocytoma,0.908219989
6D863564-D98F-4947-9F8C-6996EF948759,pilocytic astrocytoma,0.90791025
5430D3F8-19FE-4B43-98B2-AC622FC3B9E7,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.907834451
9B5A1F1D-1CD4-4E50-AC06-3CC13D6A6C3A,"glioblastoma, IDH-wildtype",0.907736173
CBDE885D-6301-4C2B-B7B9-80AA3A934418,"glioblastoma, IDH-wildtype",0.907728652
EA617535-FC86-4964-9F02-C651CBE9D0EE,"Diffuse midline glioma, H3 K27-altered",0.907382823
FEF64D4D-F362-4AE0-9EAC-94620029C03F,"glioblastoma, IDH-wildtype",0.907226335
256004F3-2705-4FE3-BEB2-DF0A5AB27AFF,Atypical teratoid rhabdoid tumour,0.907172605
78F1B3E1-D04B-4590-A649-9A3829628E36,Diffuse paediatric-type high grade glioma,0.906958908
288FA5C8-51B7-429A-91D9-81E94DEF80E4,"meningioma, benign",0.906879033
F0499BF9-65F4-4E5A-86DF-0AFAEAC62E2B,"meningioma, benign",0.906879033
C880BE1B-F908-4F09-9087-35BA7E044799,"Diffuse midline glioma, H3 K27-altered",0.906562218
274C3872-7AD7-4CD2-88F1-6A64743B2F08,"Diffuse hemispheric glioma, H3 G34-mutant",0.905911807
8BFBD4E6-0EE5-4845-8290-2BD226312210,"meningioma, intermediate",0.90574512
759CD250-2465-4D4F-A881-0805421B920C,"meningioma, benign",0.905525916
435C805F-F627-4DEF-A1DE-F6435B5A6C93,pilocytic astrocytoma,0.905500048
F56D03FB-5DCB-4BD7-99F6-4936F94DFE9C,control tissue,0.90537233
D3DC49A4-74D2-49BB-A5AC-DA966E75F6D3,control tissue,0.90537233
70B582EE-9AEA-4151-A09C-5C33B0BA4D4B,control tissue,0.90537233
FE87B872-58EE-4E35-B2DD-69324EE2C33A,pilocytic astrocytoma,0.90522395
1CC8624B-55E7-41AA-A7E0-74BD4BAC5E2A,"Astrocytoma, IDH-mutant",0.904818785
E425812F-A8CF-4F28-A504-61F2B5C1B4FD,"Astrocytoma, IDH-mutant",0.904818785
EC0C5D51-2560-418B-B794-257913CD4290,"Astrocytoma, IDH-mutant",0.904818785
B03BFBE8-2CBC-4BB5-BDB4-2C2E0118AED5,"Astrocytoma, IDH-mutant",0.904818785
AF69D601-83BF-45F7-A3BF-26F0D400B993,"glioblastoma, IDH-wildtype",0.904678509
35470915-2DA4-4724-A33E-DB4CBE3B6AF1,"glioblastoma, IDH-wildtype",0.904678509
65C12B51-A6B5-4FAF-AD5E-8B3B70685E88,"meningioma, benign",0.904538279
DDA58AA8-FAD7-4695-9163-CDE6707ECD06,Pituitary adenoma,0.904273186
F666E591-C25F-4B41-A4EA-A1B1CC9935F2,"supratentorial ependymoma, ZFTA fusion-positive",0.904162916
011455F8-B36A-4575-A26D-E40DF45470A8,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.903767304
FDDA37DA-5A75-4A6A-8A6C-85AC8096B02A,"Neuroepithelial tumour, PLAGL1-fused",0.903494851
2D679D88-ECF4-4788-BFC9-CC66EF499DD3,Spinal ependymoma,0.903412755
D5ADBE2E-FBE3-44A0-AAB8-982C9A7A5AC2,"meningioma, benign",0.902880011
8584C67D-AB73-4F10-8475-0245095CB9F5,Primary diffuse large B cell lymphoma of the CNS,0.902404446
BDE66517-D1E8-45D4-9592-B102AD6D47E9,pilocytic astrocytoma,0.90142353
71E5B425-2D37-43CA-BAEE-6D55FE0AF26D,pilocytic astrocytoma,0.90142353
0B223B2D-C25F-4E31-93F6-02AF162DBB1C,Pleomorphic xanthoastrocytoma,0.901242651
194E0197-98D1-4247-BD28-73ED50F85695,"glioblastoma, IDH-wildtype",0.901162261
FCA7B7AB-182B-4B21-8784-39655A18289B,"glioblastoma, IDH-wildtype",0.901162261
830758E8-A715-434E-8E21-51B5DFC9643E,"glioblastoma, IDH-wildtype",0.901162261
F5B9EAA6-E107-4669-91E8-3D7C91896777,"glioblastoma, IDH-wildtype",0.901162261
7CAF47F0-7FA3-4A6A-A977-2A2867CA2DAB,Ganglioglioma,0.901003876
F9BD4A31-59BD-4203-AB27-1B23B160C936,"glioblastoma, IDH-wildtype",0.900850069
6374A310-6170-48F0-AF6F-D84C23629C05,Inflammatory microenvironment,0.900810627
C6406F0D-745F-4E6A-9B0E-0554E9F4BC5C,Inflammatory microenvironment,0.900810627
8854E1F5-D317-43C7-BE7E-436AADD2B3C1,Inflammatory microenvironment,0.900810627
0EDDB747-D295-4EB6-86CE-72798DAFEDC4,"glioblastoma, IDH-wildtype",0.900662612
BF1FD7F6-036E-4A2B-8DE9-CA600BF39C2C,"glioblastoma, IDH-wildtype",0.900662612
7EB545E8-483C-4589-975E-8811D9FC4532,"glioblastoma, IDH-wildtype",0.900662612
8C9AAFD5-A127-4440-9C32-7E68D0403784,"glioblastoma, IDH-wildtype",0.900662612
8DA3E56C-1737-4908-A001-896A63A81938,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.899641034
044BC8EA-A6BD-4B33-9374-74D461D828A2,"meningioma, benign",0.89885378
E4A7DA38-43DD-42F8-9AA3-0B7B8060A691,Diffuse paediatric-type high grade glioma,0.898244745
E1C61B09-D930-44A6-BA2D-8BAA5ADD676E,"Astrocytoma, IDH-mutant",0.898101402
1A956B58-8328-421C-8107-23B93CA8E9B6,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.897701208
45111418-2AD6-4676-B06F-CAE38D6334D0,pilocytic astrocytoma,0.897660032
6AC99FEE-A43D-466D-97CB-481C6D533724,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.897172919
ECC6BF10-B67B-4D4B-AA66-8BA83F8BB42F,"glioblastoma, IDH-wildtype",0.897151922
336BA8D1-0ABC-4CCD-A884-B9CAD23C98B5,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.896997332
B412F1C7-81EF-4075-A4EE-309D529D726C,"glioblastoma, IDH-wildtype",0.896639974
D43124EE-4FA7-4C36-B429-5354816F81CB,"glioblastoma, IDH-wildtype",0.896639974
3A2FA432-C805-4A77-BD38-5AA36672F2CE,"glioblastoma, IDH-wildtype",0.89628406
0705D6C2-4BA5-4935-AC66-C33A21953D51,Primary diffuse large B cell lymphoma of the CNS,0.89617966
2D19D9E7-C0EE-4589-ACE1-6A2419CCA1BC,"meningioma, intermediate",0.895851572
FFFDCEFF-2F85-4336-89FA-131E6AB167FA,Primary diffuse large B cell lymphoma of the CNS,0.895849573
0356F259-A78E-400F-AE8B-4B217E722B3B,"glioblastoma, IDH-wildtype",0.895672138
2E695659-9948-43FB-B96D-597D7E5E80C2,"glioblastoma, IDH-wildtype",0.895672138
3226E06E-660B-4733-933B-57D5C33C85C3,"glioblastoma, IDH-wildtype",0.895672138
774E21A0-9A9D-404B-8F61-FEE4A5941AF9,"glioblastoma, IDH-wildtype",0.895672138
9BFBFB63-2AF6-4C28-B9EE-0F071A3A884F,"glioblastoma, IDH-wildtype",0.895653676
47255E7B-0ECD-40D9-9115-7C547E213731,"glioblastoma, IDH-wildtype",0.895285066
326684E5-BF81-4326-AF5A-D7221994C0ED,"glioblastoma, IDH-wildtype",0.895285066
BBABF655-84A3-4440-B77E-2229F100F0FC,"glioblastoma, IDH-wildtype",0.895278211
13680FEA-D53E-481E-975E-C06255542C28,"glioblastoma, IDH-wildtype",0.895278211
420FB676-F8E5-4BAD-8F31-5F9BD29867F2,medulloblastoma Group 3,0.894995845
AE58CE83-2969-407C-82C8-1CCF13B78FE3,"glioblastoma, IDH-wildtype",0.894938422
108D21FD-F60D-4E90-9D3A-0B62D5F1EE08,"glioblastoma, IDH-wildtype",0.894609454
7EC4A50F-B422-413F-983E-2418103F347F,"Astrocytoma, IDH-mutant",0.894565064
8E9C96BD-BE10-4BB4-BD9B-5F4195AC6B12,Diffuse paediatric-type high grade glioma,0.894208469
D6C70BD6-E532-47F5-8327-07375D4E0EB9,Diffuse paediatric-type high grade glioma,0.894208469
1ACC00F8-27B6-49B8-AD46-372D8EE1A246,Dysembryoplastic neuroepithelial tumour,0.894069771
131086D6-5A5E-4E35-80A8-B9C8DACC2A87,"meningioma, intermediate",0.893757551
70257713-516A-4E0F-8B18-0D9C41F8E116,pilocytic astrocytoma,0.893454691
A7F06324-EF9C-41FA-922E-EBC68323D19E,"meningioma, benign",0.892733272
25DAFC79-825B-4051-AF5E-8C6C5CB4DC96,pilocytic astrocytoma,0.892527156
827C76E5-B85B-4378-A8C6-F43C31D5297D,Atypical teratoid rhabdoid tumour,0.892478948
86281A39-4C7C-4183-9D37-47489851B3CD,"glioblastoma, IDH-wildtype",0.892067333
E5CEC9F6-DF7E-4ABB-B5E7-200D17195E49,"Astrocytoma, IDH-mutant",0.891890088
E4C3C6AE-4941-4AFB-804C-03F3B72C39B6,"Astrocytoma, IDH-mutant",0.891890088
CD9160CE-64E4-4933-83E4-71D074F9EA7D,"glioblastoma, IDH-wildtype",0.891878222
DA657F6F-7F3B-4028-8F10-B07F8E6FCCE5,Plasmacytoma of the CNS,0.891180457
FB2CE226-9D1D-4B76-881B-1C31AABC40A8,"glioblastoma, IDH-wildtype",0.89110474
A7D56BC5-EA1E-4F3F-AF91-42C7DE6A3C64,"meningioma, malignant",0.890457501
6F962301-DAD1-4E97-A3B3-C12F3A8DF7F4,Dysembryoplastic neuroepithelial tumour,0.890359777
DB33D0C4-D607-4779-ADE5-07823BEF8547,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.88992492
94894264-D5C0-4E8F-8806-A856489DDB0D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.88992492
27FF3EC2-39F0-47A2-B668-78B3210A6184,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.88992492
9691E59B-5BA6-4175-9C3C-14189CCEC211,"glioblastoma, IDH-wildtype",0.889875893
10CAF552-A8FD-414E-A9BF-F376164A43AA,Diffuse paediatric-type high grade glioma,0.889627312
05065E28-F87C-4E10-A99F-D0A6AD81F4C9,choroid plexus carcinoma,0.889179594
CDFA1DC9-2340-4C1A-B449-C566C3DE23D4,"glioblastoma, IDH-wildtype",0.889020507
6C7FCC3F-8D8A-43A8-813D-9748FDE92AEF,Diffuse paediatric-type high grade glioma,0.88862207
E6171BB4-A1F8-4A21-ACF5-8E493A249181,"glioblastoma, IDH-wildtype",0.888244422
1CC491BE-EDC8-4270-803D-F68D779F3BA1,"meningioma, benign",0.888164255
8AAAE6B2-90A3-44D3-9F89-24095249D65A,"meningioma, benign",0.888164255
48BBAC71-FCD7-4170-84C1-B0D53F0C0EDD,"meningioma, benign",0.888164255
D95C4758-5209-4151-9C98-B66A92BAA9F7,"meningioma, benign",0.888164255
ABDD07EC-417A-47B7-8840-B3432C361549,"meningioma, benign",0.888164255
C63E0287-90CD-4AC5-AC23-6413EEA9BD4D,Ganglioglioma,0.887924449
874470B7-BA8F-462F-8CF9-3951B489D85F,Ganglioglioma,0.887924449
2826B60F-7A0E-4C18-A79E-18564AA26476,Plexiform neurofibroma,0.887784334
BCEFA729-FF8F-4FC9-B96F-01D6273C59B4,Plexiform neurofibroma,0.887784334
E013D874-BAAD-4E73-9471-8C1FE8338BD1,"Diffuse hemispheric glioma, H3 G34-mutant",0.887728018
4BC80BFF-DAF1-4C2E-A18B-DB69239FD75C,Pleomorphic xanthoastrocytoma,0.887611462
E31DB81B-E04F-498F-BDBA-E5D8E3C97EF4,pilocytic astrocytoma,0.887575845
A956D626-D0E4-4B72-9E66-7540B47ADAF7,"Diffuse midline glioma, H3 K27-altered",0.887003548
F47F0DA4-FEB1-49E1-A464-61B623E8E80B,"glioblastoma, IDH-wildtype",0.886768674
4F746822-AFE1-4E8B-9A57-C845903BE4BE,"meningioma, benign",0.885919039
6936A1E9-D6D8-4A44-9CA7-989485943185,"Control tissue, reactive tumour microenvironment",0.885581248
ED09BACD-8475-4E12-82F9-B479520B7923,"glioblastoma, IDH-wildtype",0.883972825
6D89DBEF-6BCB-442F-A303-6D90DE12C61E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.883786345
C13A011A-65CE-4ADC-8A4C-0399DB72BE03,medulloblastoma Group 3,0.883576447
096EB2CB-D84F-4DDA-81F6-3CA15E28F064,"meningioma, benign",0.883208771
5AB58057-A0A0-4B04-8F79-A57E135F1AD1,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.883037585
BCD84366-F4C4-49DA-B3E8-C1AAB51A4D88,"Astrocytoma, IDH-mutant",0.882534555
7F9C43CA-F6E1-4EAE-B26A-A607A7A83F40,"glioblastoma, IDH-wildtype",0.882358493
A7EE29C2-B373-4F06-AED8-0007752D4970,"glioblastoma, IDH-wildtype",0.882358493
9195FA5B-3DD2-429E-AC01-6CDF58E81377,"glioblastoma, IDH-wildtype",0.882337702
8D3C31AD-226B-4BAC-9A6B-6DC7F93089DC,Inflammatory microenvironment,0.88205744
A98485F8-C314-46F4-AA07-669B0BC7BCBA,"meningioma, benign",0.881949694
AE4F2749-178A-48CF-9D87-3F17A87C1569,"meningioma, benign",0.881949694
0E8306A6-4352-42B8-B267-5E32311A4757,"meningioma, benign",0.881949694
2C7D944B-4E27-4181-9F9F-E71A67B1CD8C,"meningioma, benign",0.881920929
CBFEAE99-117C-49AB-9524-03150B4E1A50,"CNS neuroblastoma, FOXR2-altered",0.881872034
138044C0-781C-47B8-9EA2-87A10308B22E,Rhabdomyosarcoma,0.881655113
534CA84F-2283-4CFE-A04A-36950A1CF5B3,"meningioma, benign",0.881519146
5F76CC58-1199-4B98-AA46-F20FE731262F,"glioblastoma, IDH-wildtype",0.881103006
22542305-D10D-4E7C-9471-5EC091669BA4,Malignant melanotic nerve sheath tumour,0.880981297
CB8142E7-8673-45A8-BF39-4C749E15BCBA,"glioblastoma, IDH-wildtype",0.880918656
F65826E5-F076-4C25-A3B4-8EB6562EC04A,"glioblastoma, IDH-wildtype",0.880810847
6D9187E2-6DF0-4676-A050-894DB63AAC18,pilocytic astrocytoma,0.880710557
0DE2C57A-7E67-4F91-9DD7-B92234589A37,"glioblastoma, IDH-wildtype",0.880481766
391F709C-3DB7-4D53-A279-E0E346D355A3,"glioblastoma, IDH-wildtype",0.880481766
5D5ABF32-E109-46DC-B165-CF86FF9070AF,"glioblastoma, IDH-wildtype",0.880481766
4DCD925E-3C4F-4595-AC95-A866FD9925DF,"Astrocytoma, IDH-mutant",0.880083343
30F98C5A-136A-41C2-8D87-67DD064F8050,"Astrocytoma, IDH-mutant",0.879581192
3CBAEED0-D1A2-4C01-A5A2-88F96EE0D4F9,"glioblastoma, IDH-wildtype",0.879547994
6472201A-33E6-4C5A-A837-1D27EF6DA83D,pilocytic astrocytoma,0.879503605
55D141FB-BA8B-40CF-B1B4-F77057F13B1F,"Astrocytoma, IDH-mutant",0.879421322
8E8C7F29-F6FD-43E9-A5FA-AC6D68609721,"Astrocytoma, IDH-mutant",0.879421322
663A47E5-003C-463F-8314-EE896FE01219,"Astrocytoma, IDH-mutant",0.879421322
543E78B7-DC00-4A7A-B324-08B7A050745C,"meningioma, intermediate",0.878792039
A4C7B881-7820-403A-9AA7-66EA7B2C0E4B,"meningioma, benign",0.878566493
16171A6E-33A0-4972-8EE2-297E7930DBDF,"glioblastoma, IDH-wildtype",0.877424989
C7783A76-59D5-43A5-A4F5-0D2C53EE8EDD,"glioblastoma, IDH-wildtype",0.877276863
4DF780AC-E4B0-415A-B6CA-D776260E033F,"glioblastoma, IDH-wildtype",0.877263262
4CEDF384-00FB-4833-9B4C-AD5595463872,Inflammatory microenvironment,0.877191891
A905EED3-8847-4452-8FAF-7430C611B1A1,"glioblastoma, IDH-wildtype",0.876908325
DA0CF1C5-C543-4A8B-956E-10307F582993,"meningioma, benign",0.87659792
3536A2B6-BBD3-4613-9B82-77A245C9F716,Pleomorphic xanthoastrocytoma,0.876458247
CC925DBD-276A-4964-8D6E-0418231EF554,High-grade astrocytoma with piloid features,0.876142919
DDB9FB9E-8664-4A65-A1B0-FBD9A9E35962,High-grade astrocytoma with piloid features,0.876142919
403A2AC7-DB73-4F05-8457-91BC9AA7321D,High-grade astrocytoma with piloid features,0.876142919
BD0C3B6A-19EA-4B1E-9E79-DF785BF1E954,"meningioma, intermediate",0.876061762
64D10D80-F4F8-4D1E-8DDF-01F799FD5C07,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.8756756
9F006DB8-8DB9-459C-8161-0E85813EB13D,"Diffuse midline glioma, H3 K27-altered",0.875326789
D00972EE-6E87-4BAB-955F-C873E9FA763F,pilocytic astrocytoma,0.874239581
6C1AAB3B-570D-4862-B22F-F40CC7502142,Pineoblastoma,0.874172272
EF7942A7-5C0C-4060-B30F-57778EE66832,Pleomorphic xanthoastrocytoma,0.873828086
26E155D3-BD26-4E5F-B197-8B85916CEF70,Diffuse paediatric-type high grade glioma,0.873736729
C9E0B34F-3323-4837-907B-EDA2034FF46F,"glioblastoma, IDH-wildtype",0.873659765
1D5411FA-17E0-4281-92C4-9ADC9CDACADE,"glioblastoma, IDH-wildtype",0.873659765
6DB3A017-D198-47D9-91FB-8A54BAC16326,Diffuse paediatric-type high grade glioma,0.873577775
EC30A1EA-B177-4DA2-ACC2-C68C3A54D70C,"Medulloblastoma, WNT activated",0.873366251
4496425E-3750-45FB-B818-4946B2633E3C,Malignant melanotic nerve sheath tumour,0.873325577
AD0BA73A-8644-4C49-A111-2EBBB131A1F5,"meningioma, benign",0.872807457
BB02CF97-E3B1-42CC-A27E-ED6344907BBD,Dysembryoplastic neuroepithelial tumour,0.872719604
74961834-20DB-4D1A-80CC-3DDC8D7E5692,"glioblastoma, IDH-wildtype",0.872237589
BDC45EDD-45AC-473E-85F0-FC21E17109DB,"glioblastoma, IDH-wildtype",0.872119086
F487B8AD-64B3-4A03-A3FB-E719A7253124,"glioblastoma, IDH-wildtype",0.871543194
A94B23F8-E9D3-4026-ADFC-E51CA384F680,"Adult-type diffuse high grade glioma, IDH-wildtype",0.871400323
C74537A8-C3F8-4FB2-BEBA-5EFA2C7A6EEA,Primary diffuse large B cell lymphoma of the CNS,0.870917159
28A09B96-472B-4C6B-8820-5775449268A4,"Astrocytoma, IDH-mutant",0.870862009
2105C1A2-E82E-4437-9B28-DEE7B18FB765,"Neuroblastoma, subtype ALT/TERT TMM positive",0.870717755
FEC6457C-0D22-4984-8305-10D50A19F90A,Pineoblastoma,0.870572183
F53176C2-43F4-4858-B8DA-7112FDCAEC63,"Diffuse midline glioma, H3 K27-altered",0.87050343
8F9D53E3-F377-436D-B1E7-E6FEB54B07BF,"Astrocytoma, IDH-mutant",0.870469049
41BA77C2-D3C2-4A61-9F07-495A3E047ED7,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.870108641
86241131-6952-4166-AA27-A25E8A90B30E,control tissue,0.86996542
B1738177-FAE0-49DD-AFAA-7A394BF5E9EE,"meningioma, benign",0.869806458
31E5ADCA-F37F-4A64-8DC4-04382D149247,"meningioma, benign",0.869806458
DBDCDA46-16A6-42EF-9C21-D1968CFDF295,pilocytic astrocytoma,0.869779986
5A9F7B8A-E320-4FF4-87B3-84F3CB03FA8C,"glioblastoma, IDH-wildtype",0.869678553
1B013681-FD64-474A-8C29-A363BAD37FE6,"glioblastoma, IDH-wildtype",0.869387848
D92009EA-45C1-49BC-8FFC-D2FF6210A1AE,"glioblastoma, IDH-wildtype",0.869387848
8E2B5FBA-FD22-4FE7-B69F-7DF210FA8B3F,"meningioma, benign",0.869255913
356AB232-17B7-4765-93C8-EAB829DF5EA3,Pleomorphic xanthoastrocytoma,0.868790814
E9BA3891-A7D0-4BA2-904B-EE245CE1EABD,"glioblastoma, IDH-wildtype",0.868303619
C66679C3-8DBF-4CDF-8839-4A2425B27763,"medulloblastoma, SHH-activated",0.868095542
71C92016-4249-4FD7-AC94-990E26CB20FA,Diffuse paediatric-type high grade glioma,0.867575669
E5662ECA-D47F-4432-9B53-C4320B3EC1D0,Pineoblastoma,0.867346628
63E67723-701E-4B3B-B396-055717768D42,control tissue,0.867136344
BC2179ED-4E2B-41F3-B2C2-00BB2522A051,"meningioma, benign",0.867098286
4837D416-73A4-4B2A-A3BC-B58A820B177C,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.866434767
F36A7E05-6C62-4465-BB81-3C071984262E,"Control tissue, reactive tumour microenvironment",0.866033312
B07703AC-B354-4317-9A63-1A4EB684957E,"Control tissue, reactive tumour microenvironment",0.8655644
620253F9-45C4-488B-8567-3BBA3E63AF08,CIC-rearranged sarcoma,0.865269518
FF4F18B7-B545-4A89-AB6F-E831CE3BA30E,Olfactory neuroblastoma,0.865096106
7DDF4B32-4D41-4F2D-AB61-5071402D6C3C,"Astrocytoma, IDH-mutant",0.864970605
651E9FDB-0C43-4C19-AD4C-1382CBEFBF48,"glioblastoma, IDH-wildtype",0.864185059
AF617E28-02BB-47D0-A860-820FDADACD81,"glioblastoma, IDH-wildtype",0.864185059
43D7B246-F503-4EC9-BFD3-E141F0A25B8B,medulloblastoma Group 3,0.863916993
E8EE17C4-A1DD-4833-8A62-F1292BE84247,"glioblastoma, IDH-wildtype",0.863836251
2DBEF5A0-9E3F-495A-B042-CC8182E09E45,"Diffuse midline glioma, H3 K27-altered",0.862539924
50992AF0-192B-4F63-99AF-F4399C5A93DE,Central neurocytoma,0.861539047
76CA4AF4-50B7-4050-BC50-124C4FB8FDF8,"glioblastoma, IDH-wildtype",0.861378846
89692CC6-C159-4CE4-B59B-207CC0ADCD43,"Oligosarcoma, IDH-mutant",0.861006722
020D6200-932B-4EAA-B564-7B607C25E27B,Diffuse paediatric-type high grade glioma,0.860040309
7FF0CB28-446D-40AF-90C9-ED5955B1F681,"medulloblastoma, SHH-activated",0.859881338
94F7C912-406D-4E49-BB1F-2CA36FCD1245,spinal subependymoma,0.859858718
7F1CD6ED-06F7-41A9-85B1-D38FC6735244,"meningioma, benign",0.859707825
CCCECCA8-E811-4F02-A46C-93D9488C1822,Diffuse paediatric-type high grade glioma,0.859581488
4F221E41-B83B-4244-87FA-19D816DA8C3F,pilocytic astrocytoma,0.85949953
A05348C6-2EF8-4595-91F0-1446C1B044A4,Ewing sarcoma,0.859028148
2BADF8B7-EA00-4091-931B-9EE14BA006B0,"glioblastoma, IDH-wildtype",0.858297933
24505B47-42A4-4C3E-BEED-7D5C049CC37C,Solitary fibrous tumour / haemangiopericytoma,0.857779265
51F89E8D-3867-4234-8665-93A49095F5F0,"meningioma, benign",0.857770552
64F3A170-DF3D-46D7-828C-58C8C5979C88,"glioblastoma, IDH-wildtype",0.857719355
ACC2084C-8B95-497F-96D2-20F22BA832CC,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.856763184
A6AEF4A1-A81E-46EF-A5EB-1E603A587176,"glioblastoma, IDH-wildtype",0.856639061
326DEC1F-5C60-42DB-8E11-4FC1284C1DC6,Pleomorphic xanthoastrocytoma,0.856618152
B53D1012-D5B4-468E-A111-ADCF3153792F,Olfactory neuroblastoma,0.854538432
A90942C8-58F6-4996-BD92-391623C8D8F5,Atypical teratoid rhabdoid tumour,0.854079929
A0452FBB-1135-497E-8E4C-2FCE3ED810BE,"glioblastoma, IDH-wildtype",0.853367845
0E46638C-68E8-49CA-9E0F-66D7B985ED8A,"Astrocytoma, IDH-mutant",0.853364543
B7A1BCF4-F956-4C99-9558-B4546C29F7EA,"Astrocytoma, IDH-mutant",0.853364543
34B083AD-4D99-456B-896B-0AAEA15DB298,Dysembryoplastic neuroepithelial tumour,0.852030316
4EABE210-5E2D-4092-89E9-0E91280591C7,"glioblastoma, IDH-wildtype",0.851671719
13D03EBB-7AAD-4CD2-80D3-51B2AA76A16B,"Astrocytoma, IDH-mutant",0.851566194
00B9588D-B842-4364-B853-AB52355ACCA6,"Astrocytoma, IDH-mutant",0.851566194
D5746BAB-7FF0-4655-8DA2-E7AAA55AFDF0,Dysembryoplastic neuroepithelial tumour,0.851422769
A8E18A33-DA61-4F37-AC8D-BE6E85135435,pilocytic astrocytoma,0.851153122
25F0E042-89E7-4554-B24F-E3A81F9084C2,"Astrocytoma, IDH-mutant",0.851087696
9DCE60FA-A253-41DE-8E11-B17ED1F31422,"meningioma, malignant",0.850381576
8C7FEA18-4A06-4C45-8AF6-9C4B669D0ABC,"meningioma, intermediate",0.850319259
5DB2FE1A-2CC2-46C4-8C2F-C98AFADAEB58,Atypical teratoid rhabdoid tumour,0.850091418
BDEC8A31-EC6E-4C53-B838-2513C6937495,Atypical teratoid rhabdoid tumour,0.849907532
9AF9354C-365E-49F7-8C7B-341448F56357,Papillary glioneuronal tumour,0.849552237
E7B93080-1B3C-408C-9B82-9B0D25E68B1F,"glioblastoma, IDH-wildtype",0.849511205
E3BBE833-2F27-4770-955F-0E0F29C99804,pilocytic astrocytoma,0.849128983
CC6899B9-B476-4B7B-A186-B2CACA68EA28,"meningioma, malignant",0.849060675
8A965B15-058B-4133-BBF2-45EBCF16B38A,control tissue,0.848536464
46DC881E-3CE9-4C81-AEC1-1E361FD334B9,"meningioma, intermediate",0.848521368
D04F544D-16BE-4B30-B1A5-885EB8642A72,"meningioma, intermediate",0.848521368
6CD7F97F-4E76-4879-8E74-BD87C70A10B1,"meningioma, intermediate",0.848521368
DCA3AF72-E133-430A-B069-2D78509A7AE2,"meningioma, intermediate",0.848521368
B2B634AF-388D-4C74-9ABA-65E05921272F,Ganglioglioma,0.847312185
02CE1658-6C09-4F5A-BA88-3A13B185CEC3,Atypical teratoid rhabdoid tumour,0.8461129
039E5C7B-0FC9-4117-BE98-1CA607BAF7E5,"glioblastoma, IDH-wildtype",0.845781487
708D6622-05CE-47B4-AA5E-157BE683D422,"glioblastoma, IDH-wildtype",0.845781487
804F4974-3C0B-4193-8D78-3F2675E0C9A5,"glioblastoma, IDH-wildtype",0.845781487
9A9A9805-C2FC-4834-A9CD-51C31152F7D8,Neuroepithelial tumour with PATZ1 fusion,0.845682831
7AB61BA9-C5D2-465A-93DB-987950F84609,"meningioma, benign",0.845162936
D80B3833-6675-4AFD-8A33-23A2017718E3,Spinal ependymoma,0.844468704
CA74D866-5115-4B5F-85B6-5809C5A1E1D0,Dysembryoplastic neuroepithelial tumour,0.844467333
47E4112D-210C-48A6-AFFA-73A8C9D1086E,"glioblastoma, IDH-wildtype",0.844424217
9698F1E4-9DC8-4990-B171-0D5D63523165,"meningioma, intermediate",0.844152295
C5ECBB2C-302E-41EF-A93B-82875650F05B,"meningioma, benign",0.843920661
039019CB-4AC1-494A-865C-421AB83CCE1A,"meningioma, benign",0.843920661
EC532742-35AB-46D3-A54A-5489DA9F5227,"meningioma, benign",0.843920661
46EE36BD-1C96-480C-8F1D-ADB02635C8C1,Diffuse paediatric-type high grade glioma,0.843336352
D88A74B6-F09B-468A-B463-798761131358,Posterior fossa subependymoma,0.843047216
B1EE7641-9F59-4A03-9525-FA079695B230,Pleomorphic xanthoastrocytoma,0.842973355
1F905CE6-4C4F-4A6E-959C-8A0284617880,Dysembryoplastic neuroepithelial tumour,0.842721051
94DF5583-1A6B-4637-8D36-80DF4F44C3B8,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.842718385
537ECFDA-2526-479C-BE05-E3701A272684,"meningioma, benign",0.842183654
66A1B8EF-273F-42B8-915D-7E67CE4498F9,"meningioma, benign",0.84205239
C52999F6-E0BD-4B6C-ADF6-3CA05C6E940D,"meningioma, benign",0.841816973
731C99B9-E5BF-49C0-AE11-D8045269F66A,"meningioma, benign",0.841816973
811E1EE9-3339-4AD5-A990-F4BD0F76A6DB,Diffuse paediatric-type high grade glioma,0.84135318
FF446A99-8587-4E20-A3B4-0CE557388A26,pilocytic astrocytoma,0.841183945
A0FA7A1E-FFB5-408E-ABA8-8CAE9A554A2D,Diffuse paediatric-type high grade glioma,0.84109423
3D880300-D1F1-451C-93E4-FABFE0EEFDD6,Myxopapillary ependymoma,0.840809674
ECC13E0B-D0B0-406E-A55D-57B2D91EC116,"glioblastoma, IDH-wildtype",0.840665649
7D85F906-8C85-4661-9080-BC258FE1265B,"Astrocytoma, IDH-mutant",0.840469344
678E726E-3BB6-4F6B-B040-FAC58114634C,"Control tissue, reactive tumour microenvironment",0.84040152
4B6F1354-A9C5-4150-90C5-FB6A1564D789,pilocytic astrocytoma,0.840159536
4DE46501-DA84-4897-86A9-C083947DD9FA,"meningioma, intermediate",0.83981922
C31192E5-E995-47BE-B9BF-A3E4916B461D,"meningioma, intermediate",0.83981922
DB2DE771-316D-4EBF-81B4-0B8DB159B31E,"meningioma, intermediate",0.83981922
C51F1D7F-DDBB-4630-8686-19575D56E7B3,"meningioma, intermediate",0.83981922
EFA075E2-F4E9-4A08-B184-D7D6CFFAEF8C,"meningioma, intermediate",0.83981922
A977C9BA-D979-4C68-ACF1-5E47FF8C2F73,Medullomyoblastoma,0.839240473
3287F078-404F-4317-B17A-A691DA283585,Medullomyoblastoma,0.839240473
DFD5E414-4AED-43CD-956A-4E1E58DD8E47,Diffuse paediatric-type high grade glioma,0.838747781
1114E26D-F8A1-4EF1-8C9D-BB48FD294AD0,Medullomyoblastoma,0.838688862
CCB5853B-A064-493E-9DE4-9886D86C6D64,Pineoblastoma,0.83831305
1CC86A66-E579-428F-9DF7-A8B13D618444,"meningioma, benign",0.838047275
CF17CCD7-5D99-4CB0-AB5E-8B9796AE2CBE,"Diffuse midline glioma, H3 K27-altered",0.83780134
9D87AC7B-875C-4A16-8C3F-A4747B25B40B,"Diffuse midline glioma, H3 K27-altered",0.83780134
6C3D45BF-80CC-495D-8B54-9095602228D7,Dysembryoplastic neuroepithelial tumour,0.837678522
621CD02F-753A-455E-BE62-86D99B6B3598,"glioblastoma, IDH-wildtype",0.837446618
8FE62E68-83D0-4E05-B8FB-DF9C3A830A41,"glioblastoma, IDH-wildtype",0.837446618
CB790F8E-2DF1-4C30-8AA9-16C1B286D244,"glioblastoma, IDH-wildtype",0.837446618
ED7831D9-7D5C-4725-8C25-144F05554A08,"glioblastoma, IDH-wildtype",0.837231207
C2D619F3-66E7-48F8-8666-1819796D2CE6,"Astrocytoma, IDH-mutant",0.837081787
45D7C6EF-84DC-42FF-A279-35C8F393617B,"Astrocytoma, IDH-mutant",0.837081787
BE98B4F7-1E28-4B3D-B755-1C60C9CEFB20,"Astrocytoma, IDH-mutant",0.837081787
1897BB68-28D1-4D1E-96D5-28BD45B0241D,"meningioma, intermediate",0.836905575
92D1C751-0996-4456-B540-B4E2F344ADCC,"glioblastoma, IDH-wildtype",0.836865922
87268311-1FB5-4DF1-92F9-5A25EB01269E,"supratentorial ependymoma, ZFTA fusion-positive",0.83675064
66220DC8-DB79-47A4-B0EE-BDD2F73F17C1,"glioblastoma, IDH-wildtype",0.836568157
74230796-02B6-4880-B9D0-B9A8EA1BA584,"glioblastoma, IDH-wildtype",0.836568157
53DCF065-F547-4347-8CC9-2DB210070B76,"Diffuse midline glioma, H3 K27-altered",0.836542657
A3FECF6A-570C-4219-8750-90E36CDF7B9D,High-grade astrocytoma with piloid features,0.835895525
8D05C4DD-C34C-47E1-BE26-367AB9D74686,"Astrocytoma, IDH-mutant",0.834295847
3D859E1B-FE47-4F36-8BE8-2E3E3D8E1143,"meningioma, malignant",0.833169029
90BDB3D8-8CDA-4F71-82A3-6839746A3205,"meningioma, malignant",0.833169029
A490A87E-F237-43C3-8A92-E1068DFAE0C1,"meningioma, malignant",0.833169029
CBD88E2E-759C-453A-B822-04FC667232D9,Infant-type hemispheric glioma,0.833066762
0500BF3B-0564-4E93-9D0C-BBA43C7CAFEC,"Neuroblastoma, subtype ALT/TERT TMM positive",0.832799413
0A450B29-F059-4917-B78D-6F8607AAB7D0,pilocytic astrocytoma,0.831799015
C19E57F7-D119-4099-B524-7F0CCD9E1809,"meningioma, benign",0.831547102
0D250847-BB05-49FD-AFB8-F49579611506,"glioblastoma, IDH-wildtype",0.831318807
BD227D00-9DDF-41F5-A205-C508C2953917,"meningioma, intermediate",0.83089975
297D9DCC-D12C-4BC7-82A1-0071A4A4E344,"meningioma, benign",0.829603983
A26E624A-E243-4E44-A426-0FCAA20D0104,"glioblastoma, IDH-wildtype",0.828626007
668E5A16-C9B8-4D7A-B1AB-66A68DB7DB6B,"glioblastoma, IDH-wildtype",0.828626007
145D56E8-6F7D-4743-96AD-E7B3CD372CA3,"glioblastoma, IDH-wildtype",0.828095001
FB37B4AD-31B0-434B-A118-D4F372276CF0,Plexiform neurofibroma,0.826688176
2CBD9920-2415-406F-978A-FAF94E6F63EC,"meningioma, benign",0.826018757
38FD1BE6-0452-4D3D-AE95-C23C63A5C91B,"meningioma, benign",0.826018757
EFB008D9-2C46-4F51-B208-3B7CDAA068CF,"meningioma, benign",0.826018757
9D1B62DA-305B-472E-A1CF-85142AE9C415,"Neuroblastoma, subtype TMM negative",0.825947099
00FFFC01-6400-41B9-92CE-7217B22E17A6,spinal subependymoma,0.82556226
8D24A608-F0A7-4621-9F09-CFFA3645B0C3,pilocytic astrocytoma,0.825458644
0E9FD2C7-3271-44C0-B967-5ED0AE36BE5B,"Astrocytoma, IDH-mutant",0.825274026
CB9BA748-A787-4CC9-8533-A986FBD5B0E4,"glioblastoma, IDH-wildtype",0.825080495
63E2444D-7F62-4AF6-B3AF-F8659874B260,"meningioma, intermediate",0.82458836
B6DA1F51-CB17-422F-8E38-CEB978F19AE7,"meningioma, benign",0.824479923
97DE64C3-8B95-4AF0-916A-F68DD295D88B,"glioblastoma, IDH-wildtype",0.823907329
EE0BED2C-5FBD-48B3-807E-58B4DC384CA8,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.823346249
C2E61920-7C6F-4762-AB20-F34256927875,"glioblastoma, IDH-wildtype",0.822620849
50D470A0-492D-4827-BC2B-5D5B1FA63F10,Ewing sarcoma,0.821570994
299EDB21-BD63-42D0-8F98-B179B586F4E1,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.821133653
6CB92381-8021-4657-A940-B96E5253DF63,"meningioma, intermediate",0.820878275
3595E4CC-2E1B-4ECF-89CF-942D225C757E,"meningioma, benign",0.820736716
932A76C8-DE07-440A-8864-A8E3EBF15496,choroid plexus papilloma,0.81941386
DFB2E6C5-D69A-422D-B87E-C830125934B0,High-grade astrocytoma with piloid features,0.818758763
EFB223E6-AD57-4EA2-B451-BC20E066B3A2,"meningioma, benign",0.817976599
9F061F2B-4374-4AA4-BC25-0060F5D6317B,"Astrocytoma, IDH-mutant",0.817710312
4BA4C115-618A-428A-A5B0-9EA709EE169E,"Astrocytoma, IDH-mutant",0.817172166
C3FBAFCF-D6AE-429D-96DB-012CDD181CF5,"glioblastoma, IDH-wildtype",0.81697963
4F21A2E7-2520-4D1E-A306-3F0284AF6A8C,Neuroepithelial tumour with PATZ1 fusion,0.81623866
A25981B4-96BD-460B-91AB-4CF957C7EBEB,Neuroepithelial tumour with PATZ1 fusion,0.81623866
64B4774D-1013-4B3D-8B9C-91D91B500A71,Diffuse paediatric-type high grade glioma,0.816062154
6CC9655C-3F24-4BAA-95C6-4A36B3AAF1A6,Diffuse paediatric-type high grade glioma,0.815310737
1D724069-A255-4EDB-A26C-122F33AD273E,"meningioma, intermediate",0.815071467
8DD1A3C5-2E3A-4FD9-8D45-264859FB70F1,"Astrocytoma, IDH-mutant",0.813415561
DFF9AD87-C4EB-4255-94DF-2503EC588865,medulloblastoma Group 3,0.812959297
E37D7CE5-E70E-453E-969A-B61C0C51DB2E,Atypical teratoid rhabdoid tumour,0.811677772
CAF58C84-FE0E-40DF-9DC5-6F8C3F5F3754,Atypical teratoid rhabdoid tumour,0.811677772
8A6FD8D2-36A9-40F1-9ABE-7BF637828F54,Atypical teratoid rhabdoid tumour,0.811677772
2E147211-0B0C-4887-B44E-1EA7B56EF3EF,Neuroepithelial tumour with PATZ1 fusion,0.811024239
39B0AACE-0C78-4684-94B4-0B5A5C1265E7,"glioblastoma, IDH-wildtype",0.810775135
F5EF5B41-3E9E-4D62-8F5F-0B7A5E551661,Dysembryoplastic neuroepithelial tumour,0.810353176
8AF45F36-E6F2-44AA-9AE2-6C9D8ABB95B9,"glioblastoma, IDH-wildtype",0.809487368
E7E72753-1B05-4D08-9285-95B26B507315,Malignant melanotic nerve sheath tumour,0.809150342
E95B038E-B47E-49B0-AF4C-6B634B5F2294,"glioblastoma, IDH-wildtype",0.808617449
D91BE32E-0CD1-413A-8551-FCEB2EE0DAF8,"Astrocytoma, IDH-mutant",0.806413076
3C2CA59F-2566-48A3-A897-3D89953A67CA,"Astrocytoma, IDH-mutant",0.806413076
DF66D3F9-5283-48DC-9438-9A0F8407F766,"Astrocytoma, IDH-mutant",0.806413076
057E0EE8-207B-4618-BE9D-19B8C3D46181,"meningioma, benign",0.806057402
D5A80109-012F-4B71-9297-7E58F3CE1C6C,"meningioma, benign",0.806057402
E0E0526A-7926-4512-8F99-BA871D3237E7,"meningioma, benign",0.806057402
744D3967-CAB9-4957-A213-0598540D9EEA,"meningioma, benign",0.806057402
1E2D2368-0391-46E5-9AC1-5CF51D395F72,"meningioma, intermediate",0.806057121
FA2EC81E-1F43-4153-B0EB-93982DE5076E,Diffuse paediatric-type high grade glioma,0.805726353
187E0099-F451-478B-9B5B-AB4504E6A7C7,"CNS neuroblastoma, FOXR2-altered",0.805533973
9E9E14E8-6513-43CC-BA7B-BA58B839A0DD,"CNS neuroblastoma, FOXR2-altered",0.805533973
4D4BF61D-4BB9-4C42-AA39-BA5738B00591,Dysembryoplastic neuroepithelial tumour,0.805432588
ACBB7477-9D22-40A6-8F96-16425A1C9D04,"Astrocytoma, IDH-mutant",0.804954799
1E50FB47-27B0-4F67-ADE3-12B58788ED7A,Liponeurocytoma,0.804728999
92251EBA-FFC4-4F1C-9BA6-67B11FED68AF,CNS embryonal tumour with BRD4:LEUTX fusion,0.803541928
4974AD08-4D2E-4441-918B-921618D01480,"Diffuse hemispheric glioma, H3 G34-mutant",0.803505883
3BB2F06D-7969-4314-9A4E-A0B7CF848190,"meningioma, intermediate",0.803187465
14D085BE-DDD3-4EF1-80EC-7B929B2F7626,"meningioma, benign",0.802539599
1037AC2B-410A-4DFF-89A5-2F67FD302145,"glioblastoma, IDH-wildtype",0.800738506
353005CE-8563-462F-ABA7-F3B8C6F80ED5,"glioblastoma, IDH-wildtype",0.800738506
37422FEE-4666-4951-802B-8336B80B20D8,"glioblastoma, IDH-wildtype",0.800738506
5C2419DC-6003-46F6-BF0F-FD17C8F86FCD,pilocytic astrocytoma,0.800519302
22E839E5-DDC7-42F8-991C-6C789291E329,"Diffuse midline glioma, H3 K27-altered",0.800504638
CC76C907-E9E3-4723-88F2-6BF400FD530F,"Diffuse midline glioma, H3 K27-altered",0.800504638
B7AFA4C9-C760-463A-9F5A-FD8A944A5EF9,"Diffuse midline glioma, H3 K27-altered",0.800504638
F05D3582-8FAF-47AA-9EC4-B53FD3B89791,"Diffuse midline glioma, H3 K27-altered",0.800504638
CA43E0FD-CB5E-4405-A4CD-0919B4E0E311,"Diffuse midline glioma, H3 K27-altered",0.800504638
D57C153E-A870-405D-AA2F-753A7758B901,"meningioma, benign",0.800056092
55872FEE-B623-4BFF-8EDC-A6FE110D4DD4,"meningioma, benign",0.798023412
B00DEB32-3B1E-4F2B-BA98-1A26F1E73B4C,Langerhans cell histiocytosis,0.79699595
D38EEF35-CC60-42BA-AE8C-2383AD00C999,Diffuse paediatric-type high grade glioma,0.795867017
02AAAD9B-6223-4415-891C-79008F5CE803,"Astrocytoma, IDH-mutant",0.795847998
7394EA64-BF3A-48AD-9D20-1A61368DD4FD,"glioblastoma, IDH-wildtype",0.794350625
A03EC0CE-0CF2-4A2D-94C1-A5E07FBDCAD2,control tissue,0.794276548
A3A7D25A-17BE-441D-B26C-C8D46B0F0C2B,pilocytic astrocytoma,0.791961995
B9FBCD09-19E4-4937-BDF5-BBE6F2760CEC,Diffuse paediatric-type high grade glioma,0.790712039
0267E218-5F7B-47D8-9C42-C93DD6D868D5,"glioblastoma, IDH-wildtype",0.790069017
B87AB6FB-918F-4380-9D50-5FFDE8DB2131,Rhabdomyosarcoma,0.789156301
0D7293ED-5A0B-4B56-8F42-9BD00D216C53,"medulloblastoma, SHH-activated",0.787870134
CAA806CA-24A7-4C48-A339-E4C20557DA60,"meningioma, malignant",0.785161337
0D48B691-2886-42D7-B588-4CDF5AFA4129,Malignant melanotic nerve sheath tumour,0.782815527
62C7EE59-295B-4DBC-9E64-8E26ED4B1800,Pleomorphic xanthoastrocytoma,0.781307626
C2F36A10-4A49-435C-ADC7-FAB9D6CFF56C,"glioblastoma, IDH-wildtype",0.778587027
7B8BFE1A-80BA-49A7-84ED-BC865F15191C,"meningioma, intermediate",0.778314854
4F466F3C-7D0E-474C-B80C-E3F02A300A4B,"glioblastoma, IDH-wildtype",0.778222462
761C73B9-3D0F-4231-AD34-6B42D9230D0E,"glioblastoma, IDH-wildtype",0.776446953
D2193EAD-BC58-496B-A026-28E8487F9FC9,"Neuroblastoma, MYCN subtype",0.776020706
199F298A-46E5-48B8-895A-205530CD4188,Dysembryoplastic neuroepithelial tumour,0.773981913
670F4D3D-40EC-49D8-9FD6-EBB0FB5ED135,Dysembryoplastic neuroepithelial tumour,0.773981913
E88FC80F-1EE7-40E8-90D7-160FFBF541C0,"Diffuse midline glioma, H3 K27-altered",0.773391404
D1C8B375-91C5-4D9C-84F0-A823B36454D1,"glioblastoma, IDH-wildtype",0.771912839
1BEDB66A-3EE4-4044-8D03-FB86A53F4B20,"meningioma, malignant",0.770816344
6BA43FF0-54C2-4B64-84E0-26FE3FE831F1,"meningioma, malignant",0.770816344
94FD8179-5355-47D4-846E-51447A983CBB,"meningioma, malignant",0.770816344
81018DC5-BF5C-48D3-8114-AF38266F03CC,"meningioma, malignant",0.770816344
670F18FC-6D23-4213-8414-F861EA348EE2,"meningioma, malignant",0.770816344
BD9152D1-799B-43A9-A6FD-1D8E174D6D7D,Myxopapillary ependymoma,0.769928852
89B108E7-92B3-45B7-ABCB-2D7F0311F2D0,Myxopapillary ependymoma,0.767631757
77107814-D00E-4FCD-83F4-83F1A8F14BBA,Melanoma [metastatic],0.765635577
01AD53EB-422E-4E3F-A7B2-F81EF273216D,Subependymal giant cell astrocytoma,0.765028877
727AC7CA-9C36-4C98-B767-86C088A55653,"Control tissue, reactive tumour microenvironment",0.76458866
B931EA55-6CC9-42F8-B6F4-711FE7ADC1E2,"meningioma, benign",0.763728987
E32211E6-0618-4BCA-BCDA-95EC5D23514A,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.762841033
88DBA986-3C90-40DF-80C2-877A7F7D2E5E,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.762841033
58E97159-C3B3-4D3E-8862-32A9924A756E,"Astrocytoma, IDH-mutant",0.761886356
78AAC3C0-5BF3-4603-9EEE-0D3206411C38,"Astrocytoma, IDH-mutant",0.759544601
2F7B3AA3-A370-4D56-A061-A7C2AFE4A14B,Malignant melanotic nerve sheath tumour,0.759117519
6EA1295A-4A02-4328-9F46-A00323E69BC4,choroid plexus carcinoma,0.758544149
2351065C-20AA-45EE-BB2B-D65EDA271662,posterior fossa ependymoma group A,0.756271182
CB9ECF0C-68FA-4827-A01F-4F14A1DA98CD,"Control tissue, reactive tumour microenvironment",0.754987253
7C77FE03-2973-4C46-967A-2EDE0910D0BE,"glioblastoma, IDH-wildtype",0.754419335
470D7DF2-AA48-4883-ABA1-5B0489379E41,"meningioma, malignant",0.754107773
DF23E899-9BC4-40F5-B59D-6FD9807D81E3,Ewing sarcoma,0.752855111
48264798-65B3-4492-9E41-832802E60056,medulloblastoma Group 3,0.751203113
8C59A9C6-92EE-4AD8-B95E-D66377A10516,Dysembryoplastic neuroepithelial tumour,0.749100646
1F88CA83-9B66-4834-97A5-2BFDA10BCB9F,"glioblastoma, IDH-wildtype",0.74884944
F1B8DBB6-688C-45B8-9401-B68FAB32ABB2,"glioblastoma, IDH-wildtype",0.74884944
7C4E60E4-FD28-444E-9A09-E736AC0E314C,Pleomorphic xanthoastrocytoma,0.748804796
BCED15F2-3402-41BC-912B-70AC7C2DB601,Pineoblastoma,0.748626391
9A3A9E2D-0587-4672-BFB3-880B1BB80461,CNS tumour with BCOR internal tandem duplication,0.748326726
4954CF50-3936-4821-BC1E-1EFD0D1711C9,Ewing sarcoma,0.747993664
4E8BF31F-895A-496D-BAC5-1D47A6936E3B,Diffuse paediatric-type high grade glioma,0.747259578
6F8DD089-CC39-470D-8B72-F82B91E01708,Diffuse paediatric-type high grade glioma,0.747259578
71F7F175-D90F-4437-AB65-F1F7A25979F2,High-grade astrocytoma with piloid features,0.746078317
2C0F435E-FCB5-45CA-A23D-D8BA58221FE8,pilocytic astrocytoma,0.744723253
90AB2DFB-9C30-4575-A33B-1F2C46E1F4C7,"glioblastoma, IDH-wildtype",0.74204258
EC42213A-E4A7-4668-9CFA-F3C0C12938DD,Langerhans cell histiocytosis,0.741287533
28E8438F-CA46-4B4B-890D-561EB5D9C4AC,"glioblastoma, IDH-wildtype",0.740298836
3FC4C32B-C789-4678-ADC6-F93565D9649C,"meningioma, benign",0.739285739
431948E8-0BC3-4533-A68C-F0AB2FEE4E62,"meningioma, benign",0.739285739
C3FAAA11-CE11-4119-BEE1-8DDCB7932631,Diffuse paediatric-type high grade glioma,0.739073185
95F131B6-6A9B-4DE6-AAF9-F2F9FE218D37,Diffuse paediatric-type high grade glioma,0.739073185
019E7846-6413-430A-A2A5-5F96D10DAAE2,Primary diffuse large B cell lymphoma of the CNS,0.737910202
5CFFDDC9-C57F-4AE0-8665-D78A699EDB78,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.737088216
C3CF879D-9C13-4AFB-875B-2E251DE0F0CE,"Adult-type diffuse high grade glioma, IDH-wildtype",0.736019561
5120C695-83E3-4AB5-A8F9-F39C22F27D50,"Astrocytoma, IDH-mutant",0.734877109
0F5C2192-FD1D-4DF1-B232-485A83DCAFA9,"glioblastoma, IDH-wildtype",0.734248636
17996A99-363D-49C7-A859-40CA99A1EA92,"meningioma, intermediate",0.733254197
F0F301DC-B170-468D-BC40-2812E33AC031,Rhabdomyosarcoma,0.732998506
3F04C239-6EF0-4D4D-BC6A-77EE7956E17E,Malignant melanotic nerve sheath tumour,0.732746185
58D8DE42-7C1B-4318-BFB0-04BE015D8531,"glioblastoma, IDH-wildtype",0.732068516
EAF41E39-CCB6-4862-B67F-AE18FE50FC57,"glioblastoma, IDH-wildtype",0.732068516
FE4F9FE7-CCD9-46B6-BC9B-888BC2CD9DD6,"Control tissue, reactive tumour microenvironment",0.731038436
8B9BE40C-1494-41AB-90E6-24D7BC2C473A,posterior fossa ependymoma group A,0.730511603
E2612679-83AE-45D5-BCA1-C889048F9E61,"glioblastoma, IDH-wildtype",0.729717724
8E3C803D-A4B7-40B9-9C55-32FDA4CD1344,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.72924286
EBF240E3-BDC7-4433-9EEF-1FD015ABC31E,Olfactory neuroblastoma,0.728460928
5EBE4B40-66FD-487A-866A-DFDC32C3E656,"meningioma, benign",0.727988243
E71A92E2-D823-466C-9E62-95ADC6EA87EF,"Control tissue, reactive tumour microenvironment",0.72608963
F1A08B51-74B0-4F35-B138-F03BDCFFF12C,"Astrocytoma, IDH-mutant",0.72535003
BEBDE9AD-8FA0-4289-B610-64DA2DBC3C92,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.725126908
5D7F2965-AF91-45EE-9EC0-7007FD650570,"glioblastoma, IDH-wildtype",0.724246577
6C27EE25-79F8-4686-BD80-D903AB77E43B,"glioblastoma, IDH-wildtype",0.724246577
3E86C9D3-AE9D-408A-B456-94336F16CDB3,"Neuroblastoma, MYCN subtype",0.723938416
37519758-A233-4B02-A8AF-A8CBE9A02504,Rosette-forming glioneuronal tumour,0.723496975
5521FFCC-AFDC-4A03-B526-D02CE6492E10,"Diffuse hemispheric glioma, H3 G34-mutant",0.723336161
15184DF9-0D24-4270-8D77-BED70B476F00,"meningioma, benign",0.722066368
613F1D14-0592-43C4-BCEF-011CFD74E829,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.719770542
5F5BC88E-15C6-46CC-9E99-C94C812CC9BE,"glioblastoma, IDH-wildtype",0.719043147
BD35C952-2A33-4E9C-81D3-BB3338B09431,medulloblastoma Group 4,0.718691419
EEFA1A73-9445-4F70-A0A2-32F640FF0FF5,"glioblastoma, IDH-wildtype",0.718176285
7263DE04-F3D0-4246-B107-CFB883AF912D,Olfactory neuroblastoma,0.71732938
98D122C3-297A-432D-B785-35FE5E26C5C9,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.716169341
A2AB1BDC-263F-4AF9-B142-EEB9E0511B96,Spinal ependymoma,0.715413302
F8B82188-159A-46C7-922C-55737C0103F0,"glioblastoma, IDH-wildtype",0.712199896
E03EBA6A-1F01-414D-A2A6-BE225CF28A3C,"meningioma, benign",0.709764893
2C89522C-6311-4586-90DD-13CF6B3C069E,Ganglioglioma,0.708981806
0F3CC351-EFCF-4944-8ACB-93B3A7ED34BE,Pleomorphic xanthoastrocytoma,0.708280724
0611E0C0-2662-49ED-A06B-239D4A3F7107,Dysembryoplastic neuroepithelial tumour,0.707962403
7F6C083C-7C2B-45AB-9412-88737C0C6D1A,Dysembryoplastic neuroepithelial tumour,0.707962403
DFAA615C-378A-4CC7-A219-F036E9DAAC17,"glioblastoma, IDH-wildtype",0.707790557
272F3745-BA89-4931-8D52-10D48E17777A,"Neuroblastoma, MYCN subtype",0.702626979
56CE1028-94B7-4C62-B1B1-48C4C4662ECC,"Control tissue, reactive tumour microenvironment",0.701322112
93B2F0EF-D13B-4287-B38D-8DE7894CC363,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.700975976
58B74503-D053-493B-A2A9-BEB41F8D5B1B,Dysembryoplastic neuroepithelial tumour,0.700500299
DFAE1C74-2ED0-460D-AF60-6A5B414A5321,Infant-type hemispheric glioma,0.700035788
1681ACEF-AEBC-4340-B1C6-DC5B79DA958E,Pleomorphic xanthoastrocytoma,0.699711166
A8820598-2382-49E7-A31C-CE05781669F6,Diffuse paediatric-type high grade glioma,0.699411102
95F131B6-8EEF-49BC-9BE6-5DE6DAE0E46A,"meningioma, benign",0.698475642
FA0C21A0-3B82-45A7-9ADE-CAE9EBE34BC0,Myxopapillary ependymoma,0.69750748
F4B5DD37-02BD-4E95-901B-1D44FFD9381D,Atypical teratoid rhabdoid tumour,0.696498877
205D87CD-5A8B-4D99-BBFC-19CA6BA20ADC,control tissue,0.696177468
FBA8E015-31CE-47B9-8634-9A003C2C6081,control tissue,0.696177468
BA21802C-F375-4330-86AC-DD3F51F72C7B,Diffuse paediatric-type high grade glioma,0.694821123
87096BFA-35C2-45BD-8C67-2D34D35A0502,"Adult-type diffuse high grade glioma, IDH-wildtype",0.693731771
A4E6C44B-4696-4ADC-B6D5-15BB04ABCC72,"meningioma, intermediate",0.693582005
9143FE42-68A3-48B3-A2B0-39A2B107F356,"meningioma, benign",0.692356781
2C24E43F-F3DA-405F-A68C-E5CFF1FD205F,"meningioma, benign",0.692356781
613006E3-E87E-44A7-A6D3-BD59E80B71F7,pilocytic astrocytoma,0.6915519
D47302A3-C6EF-45C0-9265-CC8F75762F51,"Control tissue, reactive tumour microenvironment",0.690873023
DAA794FD-AC1D-45BE-A23F-D4F404341F3A,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.690846647
9411E736-71E6-476B-9EA4-09A33BA8D923,"Astrocytoma, IDH-mutant",0.690696518
D0194773-4C84-4861-BE85-34EE4ECA93B5,"Astrocytoma, IDH-mutant",0.690696518
4A743C56-D692-4BB5-9BB4-40BD2D966169,"Astrocytoma, IDH-mutant",0.690696518
139F1B24-9535-42C8-9A12-7EAA21AD86DC,"medulloblastoma, SHH-activated",0.689083075
BF6D018B-2400-4E79-889C-7E887BEB8FF5,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.684843318
A2DDD6B2-C231-4EFE-B59A-B18C514EEE6F,pilocytic astrocytoma,0.684684867
581F9021-E9A9-40F9-BF43-5A45BF48C255,Teratoma,0.682807964
FD1C7B9A-80A5-4E96-BAF0-D610FFBAD9A8,"meningioma, benign",0.680251732
7FD3B08E-FDF9-4044-98A1-24A4ADCF1F30,"meningioma, intermediate",0.678345235
9884CD58-8EBE-4EB1-B83D-0D7DE0DF3CC7,"Control tissue, reactive tumour microenvironment",0.677951201
E111417B-461D-4268-84EC-57FC132B460B,"glioblastoma, IDH-wildtype",0.677088883
19E1A965-0DE2-4C5C-ABA4-C7B2A0D9FD1B,"glioblastoma, IDH-wildtype",0.676762248
4512F599-CCB1-4803-9406-9ABD0BDB4BB9,"glioblastoma, IDH-wildtype",0.676270306
452F909F-1ADA-404E-8183-C6AAB807EADD,"Control tissue, reactive tumour microenvironment",0.675590163
CA1D775B-7A92-4C5B-922D-A7FCB884B416,"Control tissue, reactive tumour microenvironment",0.675590163
DDCED4F5-612C-4B7C-B07D-130C15BD17CF,"Control tissue, reactive tumour microenvironment",0.675590163
C2CF9703-1C97-457B-81DE-680021852EF7,"Control tissue, reactive tumour microenvironment",0.675590163
48456332-F319-48D5-8C44-ACE3A4E2F162,"meningioma, malignant",0.6749085
8F724728-F16B-4518-AF48-3D19A49AFE8E,posterior fossa ependymoma group B,0.673904623
2A96CAE1-A195-4EED-A6E6-A479E5C00DDF,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.67281789
372E1502-4A17-4AC3-82F7-E911EA955989,"Adult-type diffuse high grade glioma, IDH-wildtype",0.670198456
BF63B66C-3F05-4F5D-AD62-AA793FB5572B,"meningioma, intermediate",0.666438134
E32B7356-72CD-4119-B4B1-68161FC1C9D8,Diffuse paediatric-type high grade glioma,0.666390395
8BA41778-D03E-4472-BAE2-AE9C33A74553,"meningioma, benign",0.666313806
D0A87AE5-760A-42E8-8785-BFDD9C9FFA3E,"meningioma, benign",0.666313806
CB0078EB-6E40-4509-9C4A-C6B43DC05FB3,Primary diffuse large B cell lymphoma of the CNS,0.666313751
511E6804-59C4-4D40-A93A-BAF1BFB1AAD4,"meningioma, intermediate",0.665045488
B7453539-7ADD-4999-BEA1-F1B188F91D05,"meningioma, intermediate",0.665045488
834B0F4A-173D-497E-A684-E0F2D76EB704,"meningioma, benign",0.664985277
25495C4F-1632-40EA-A163-86B3FA78E84F,"meningioma, intermediate",0.663412377
ACD6E1DE-9733-4E48-AC2F-478F98C10860,"Astrocytoma, IDH-mutant",0.662702556
0A61C9B8-746E-47E0-B85E-E4F037C3382D,"glioblastoma, IDH-wildtype",0.661019799
AAE1943B-7341-4C1F-BFA6-95CBA94BC661,Atypical teratoid rhabdoid tumour,0.660327852
9B3E57ED-AB04-4C7D-A212-5D9D9B409DC2,Atypical teratoid rhabdoid tumour,0.660327852
6F2F681D-97A5-448B-89B7-61AF1A5D3758,"glioblastoma, IDH-wildtype",0.659646408
86060A13-032B-40AD-BBDF-0834ACA17B04,"meningioma, intermediate",0.658622672
7577AAB9-337E-478A-81DD-0F50C250B277,Malignant melanotic nerve sheath tumour,0.658600094
A329010F-36CA-4163-BEA5-91A492146141,control tissue,0.657714949
363C5E3C-03A0-4939-A3E4-335D0423E70A,"Control tissue, reactive tumour microenvironment",0.655960954
FDA3461C-CBBF-4161-9BF6-BA4B3CB61718,"Neuroblastoma, subtype ALT/TERT TMM positive",0.654810547
6BEB3194-772F-4912-A24D-CA93B526A097,"glioblastoma, IDH-wildtype",0.654291299
79DC2EEF-C8C5-4C1E-ACE3-006396771954,"Control tissue, reactive tumour microenvironment",0.652683873
F50805B2-682E-484E-AB01-42959DFFCD9D,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.649026705
CC97DB94-725A-46F7-AEDE-6D471EDB5241,"supratentorial ependymoma, ZFTA fusion-positive",0.648478642
AD123E21-34A8-48F9-B993-A3A6500E289D,pilocytic astrocytoma,0.644547929
1833BBF5-7FB4-4D02-940C-EA05ACADA2F6,pilocytic astrocytoma,0.64323598
B738A087-E21D-48A5-B5A7-508F4175FBEC,pilocytic astrocytoma,0.64323598
2490C3BC-0C09-4D1A-BAF5-6367B0002698,pilocytic astrocytoma,0.64323598
00146F73-A7BB-4374-BF05-6D72269C386B,pilocytic astrocytoma,0.64323598
30D63FE1-F9ED-4D0D-A013-47757E6E5709,"glioblastoma, IDH-wildtype",0.642371522
3AB6AAE2-2E78-4C08-9040-ACFB4A3F1521,pilocytic astrocytoma,0.641408478
6AE663C1-6BE9-4968-B2CD-A63730AF896E,pilocytic astrocytoma,0.641408478
B49BBD5C-5D72-4E61-8C4F-5846A119AEA3,"medulloblastoma, SHH-activated",0.641081858
3F7D9906-014E-4054-9BF2-9C091E8E34FE,"medulloblastoma, SHH-activated",0.641081858
7282F24B-53E7-4B3B-9A49-E73DC21C8B1C,"meningioma, intermediate",0.640384406
9C158194-A6F8-4965-AF37-A53D1D1E6732,"meningioma, intermediate",0.640356234
3BCF8D2C-073B-489A-9A6C-2418350368F6,"meningioma, benign",0.63715773
360B93D2-6D1D-41C7-9877-C8608384D7A2,"glioblastoma, IDH-wildtype",0.635200875
17DA1972-AFE6-4E46-ABC9-0A999EC7F965,"meningioma, benign",0.634737986
01C67448-2CC9-4051-AFA7-C7737C0CEE65,"glioblastoma, IDH-wildtype",0.633912436
371E3EC6-5D94-4DE6-A614-FFB3B71937C4,"glioblastoma, IDH-wildtype",0.633912436
84A2B2ED-93C7-4DFB-98C1-08E2BF042127,"glioblastoma, IDH-wildtype",0.633912436
E8AFB3C1-9083-46F5-964C-1766246D49F5,High-grade astrocytoma with piloid features,0.633459653
3C6A328F-A40D-459C-AE70-D874B33C96BE,"meningioma, benign",0.629661334
F3640E0C-85A5-4655-A3F8-0BABAB7833EB,"Astrocytoma, IDH-mutant",0.629113141
A210C666-6D02-466B-8D80-CDDA6C6E6B36,"glioblastoma, IDH-wildtype",0.627918484
EE4BB683-941C-4285-9D7A-851C6D24498D,pilocytic astrocytoma,0.627619181
418C0551-BF18-4ABB-9944-C9F7BA1BACBF,spinal subependymoma,0.623591843
2D828B67-F7BC-4F2B-861C-65C370112307,Anaplastic neuroepithelial tumour with condensed nuclei,0.622817962
66B7081A-33A6-446E-BAC6-03B05D0904A8,Anaplastic neuroepithelial tumour with condensed nuclei,0.622817962
F45FA276-81F3-4D44-949A-4FADB1E47080,Anaplastic neuroepithelial tumour with condensed nuclei,0.622817962
BE8B8287-CD37-4040-B413-B6262686BABE,Dysembryoplastic neuroepithelial tumour,0.621556419
04B41155-C251-4276-8660-5C4EB862708C,Dysembryoplastic neuroepithelial tumour,0.621556419
1C5197F0-8750-4610-A8CB-E0B4995B4726,"glioblastoma, IDH-wildtype",0.618297101
38181D7F-1F88-4430-8E58-55643938237F,"glioblastoma, IDH-wildtype",0.618297101
799D6E65-9FDE-4F26-AD21-5480DA4DB0E2,"glioblastoma, IDH-wildtype",0.61725402
27A6EC99-A11A-4F2A-A7CE-5E56B833E854,Rosette-forming glioneuronal tumour,0.616772959
4728CA12-42EC-4C63-944F-196402EE2395,"meningioma, benign",0.616432543
A3ADF28C-78C4-494D-B072-AC91A4339E93,Malignant melanotic nerve sheath tumour,0.616198697
EE13F7FD-0C73-448B-A9F4-86D8A4C4F555,"Control tissue, reactive tumour microenvironment",0.613657719
CC129594-3123-4546-A585-CDCC5FDB774B,"meningioma, benign",0.61304214
8B9C791D-E082-4264-903D-64ABB04C54EE,"meningioma, intermediate",0.610767344
E7B7FDBA-217F-4D0B-8AED-C87F2177FB23,High-grade astrocytoma with piloid features,0.609735842
90007D54-157B-4DB0-B38A-102284F78033,"glioblastoma, IDH-wildtype",0.607420813
D7B2A389-A977-418F-A08D-64548C91C7D4,"glioblastoma, IDH-wildtype",0.607420813
2FB1FFA0-9CB1-4B3F-A956-D2FED8F10D35,"glioblastoma, IDH-wildtype",0.607152413
1A7014FD-6722-484D-8AC9-030567E8E522,"Astrocytoma, IDH-mutant",0.606914409
BF96B7C1-1F71-47FE-96DE-55981E16DD4C,"Astrocytoma, IDH-mutant",0.606914409
2E10AA28-A5A2-4368-A644-0C62C162AB48,"meningioma, benign",0.605842277
5896D466-32FC-48D4-8575-720675F4CDFD,"meningioma, benign",0.605842277
2A5DA728-AFAD-4929-BE8A-520322DE8AA0,"meningioma, benign",0.605842277
D081286C-1D0C-4ACF-BFB9-6C0C8FDB41AE,Pleomorphic xanthoastrocytoma,0.605069731
798984EE-80D0-4471-B57F-A6681061894E,"Astrocytoma, IDH-mutant",0.601306757
51C043B1-BD34-4765-BE67-5CCB55FD2081,"meningioma, benign",0.600760719
C57C10D8-AF2B-4041-A85A-7110BDF35844,"Diffuse hemispheric glioma, H3 G34-mutant",0.598936741
1FF1339E-6A4B-454C-9085-9322C91F8CAD,"Astrocytoma, IDH-mutant",0.597883021
7F0748EB-A264-4B6A-BBB4-5CE4F60C475E,"Astrocytoma, IDH-mutant",0.597883021
FCED3C7B-6011-4F11-8DE3-24257E9EEFEC,"Astrocytoma, IDH-mutant",0.597883021
111EB60F-84AE-4F2C-8B78-0EB885FF21B4,Ganglioglioma,0.594862343
56C332E7-45E9-4309-A387-4C2F8F93A253,"Spinal ependymoma, MYCN-amplified",0.594748045
7DF25691-0F61-408C-826A-22ABA4C0388B,Pleomorphic xanthoastrocytoma,0.593421645
1C9B83F2-F700-4D31-9D9C-EF52448A73AE,"Oligosarcoma, IDH-mutant",0.591016085
5DBEBE12-8704-4D7A-A875-E30475B6997D,"Oligosarcoma, IDH-mutant",0.591016085
CAC61759-D8F2-4E3A-926C-83203D3C0608,"Oligosarcoma, IDH-mutant",0.591016085
2E6B39B6-8580-4CD7-9C67-DFFDD4F2E96C,Inflammatory microenvironment,0.588181567
B7BFF71C-94DD-46A4-A50E-F444D89B1F4E,"meningioma, intermediate",0.587919625
E094931F-7762-472C-8BEA-A6E73BBC1ED7,pilocytic astrocytoma,0.586242032
89C61F24-4D58-4CDE-B0FE-1DA2D41E0D56,"Adult-type diffuse high grade glioma, IDH-wildtype",0.584736838
A7F7EA2B-16C1-477A-8F61-8406F403DB12,"meningioma, intermediate",0.584374139
1B817C73-845F-47D0-8213-B1B74595FA38,"Diffuse midline glioma, H3 K27-altered",0.583298066
CF83C709-F94D-42AD-9410-D71151CC35F5,"meningioma, malignant",0.581617446
3C7C9DD4-2F82-4539-A294-7907A140C807,pilocytic astrocytoma,0.58131561
C56F3B7A-7DCA-4239-9EBB-189BB8A155C5,pilocytic astrocytoma,0.58131561
EB2E79F5-29DB-46D3-B993-FD874E0C811C,Dysembryoplastic neuroepithelial tumour,0.580099828
2023F0AC-A9FB-4B1D-A17C-3042D3EBB6DC,"Astrocytoma, IDH-mutant",0.579325406
1B764BEC-053C-4BD3-B2FD-9FA845F0D0FE,Subependymal giant cell astrocytoma,0.576181465
19F4F99B-3573-4298-A20D-EEF4B4B9C045,"glioblastoma, IDH-wildtype",0.576130934
8CB3F0FD-C003-456A-BAC1-110FD5242A2C,pilocytic astrocytoma,0.574627648
7E1913A4-1488-4F3B-BF83-F3B16955FE02,"Medulloblastoma, WNT activated",0.574458974
BA509FF3-B644-45BE-8CDB-E0E7181633DF,"Medulloblastoma, WNT activated",0.574458974
74E2C677-DB15-4AE2-B230-F526BC2764A6,Diffuse paediatric-type high grade glioma,0.574006783
C8A14411-F196-43CB-ACBE-173B3891261E,"glioblastoma, IDH-wildtype",0.571892239
0E78DB56-DEB3-4F3F-B662-AFA2ABF6A075,"glioblastoma, IDH-wildtype",0.57133286
30DBDCA6-160B-4F27-9B09-DCBACD2E49FE,"glioblastoma, IDH-wildtype",0.57133286
30CE697D-6EC1-4605-B98C-F9412537DD72,"glioblastoma, IDH-wildtype",0.57133286
355791E0-838F-46FB-BA63-CA5E08A7B99E,"glioblastoma, IDH-wildtype",0.57133286
F46A2FB8-71D5-4EA2-9D74-A7270AC5488A,"glioblastoma, IDH-wildtype",0.57133286
AC5DA52D-39E2-4485-80CE-AF8EDAF6D8CC,"Diffuse midline glioma, H3 K27-altered",0.571059305
244543E3-6D6A-4D7D-993E-A5447E33183C,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.570640244
93F1933F-38CE-46A2-9A61-5691F67853C1,Pleomorphic xanthoastrocytoma,0.565128639
A12B10EF-ED9B-4A86-9677-E9E4B7E2323E,"medulloblastoma, SHH-activated",0.564767194
ED9A8F1C-AC55-4E89-9FA5-5BDB9497DCE7,spinal subependymoma,0.561319062
C9BFED91-3328-4D9C-B20A-2181223867B1,choroid plexus papilloma,0.560833783
6D389E73-3975-47C1-BD9B-9521870F0CB6,"glioblastoma, IDH-wildtype",0.560804295
0B03F93D-5014-4A66-A484-AFE521307B59,pilocytic astrocytoma,0.558590061
D813AE25-DEF8-42A3-B576-8236CC4F65C2,Diffuse paediatric-type high grade glioma,0.558459308
E9B51CB8-4D54-4D8D-B9F1-465115C344CA,High-grade astrocytoma with piloid features,0.5540411
8F213B0D-C0A4-481A-8A26-B1CE6987365F,Diffuse paediatric-type high grade glioma,0.55284349
3470673F-A3D8-4CF8-9F0D-0F5514026F16,"Astrocytoma, IDH-mutant",0.551735695
90B10CB6-54EE-4046-B518-2D17CC28C83D,"Astrocytoma, IDH-mutant",0.551735695
C3FFB575-2182-4544-95AB-A83D52C4658A,Medullomyoblastoma,0.551012273
3E50B251-0EAC-4AAE-82CB-2D86C41BC20B,pilocytic astrocytoma,0.550854337
474EE629-CDDD-43F8-BD04-AAE1DD6F39CD,Germinoma,0.548735897
CFFBDE33-0A5C-4A22-BDA9-95B6ECDE1FAD,Dysembryoplastic neuroepithelial tumour,0.547123961
6EC487E9-6903-435F-8494-7EAB5EFCD22E,"glioblastoma, IDH-wildtype",0.545737729
4E5737EE-37C4-4EDF-9AFB-AF1FABA91E52,"glioblastoma, IDH-wildtype",0.545737729
0F5A3517-D2AB-4B8C-B9D1-74EC20679208,pilocytic astrocytoma,0.543846534
2D82841A-50BC-4C32-AFC7-9F5AB64CDDDE,Plexiform neurofibroma,0.541071813
D143F925-2D14-4200-97E1-35212BB8E22D,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.538603826
6F4B8347-A87E-4165-BFB3-D875030A3600,High-grade astrocytoma with piloid features,0.538230776
C1784834-D8AD-4FB9-B518-CC8A24F467AE,"glioblastoma, IDH-wildtype",0.537116232
DA3A8F17-5C12-4532-A99A-9A9BEF37F6BF,"meningioma, benign",0.5318444
38131288-FE7D-4874-9133-AF96BA067AA4,Germinoma,0.530864376
8BEB4068-1777-45F3-A831-837F9368EFE2,Inflammatory microenvironment,0.529875646
A2DC38DA-A6C8-4D05-9684-1D1856CB7741,"glioblastoma, IDH-wildtype",0.528372001
71452212-E72E-43C6-820E-B72069E21042,"meningioma, benign",0.528295462
DE04FD31-7A9C-4936-96ED-5C79FD7D11D3,"Adult-type diffuse high grade glioma, IDH-wildtype",0.527392283
F57768F6-236B-42B5-BD42-649B7E2FD131,"Adult-type diffuse high grade glioma, IDH-wildtype",0.527392283
39EFD20E-4F22-4F14-A393-C96833176BF8,"Adult-type diffuse high grade glioma, IDH-wildtype",0.527392283
490FF913-2AE7-4536-91E7-D781AA59A75B,"Adult-type diffuse high grade glioma, IDH-wildtype",0.527392283
AA7FA50E-BE07-4CEA-B9B4-01244050C3A6,High-grade astrocytoma with piloid features,0.525591785
8252DFBA-DCD9-47CA-8290-C1DE8AD1F639,pilocytic astrocytoma,0.525359579
91A3661F-BE9D-44BD-A29B-879472432A09,Chordoma,0.525083043
6544E1FF-245A-4129-B451-0126FC0130E5,"Diffuse midline glioma, H3 K27-altered",0.524668182
D3A172EA-1B41-4ADC-AEB3-F88F8405B087,"meningioma, malignant",0.5231114
AC0963B0-F31A-4755-82AA-AE3F0E246E6B,"glioblastoma, IDH-wildtype",0.523099304
9D0F28AE-1F62-4D97-B449-CB360C0572A4,"glioblastoma, IDH-wildtype",0.523099304
C28B7A7E-E92C-44DB-B70A-2FA1ED2881CC,"glioblastoma, IDH-wildtype",0.523099304
4EAC8207-DC33-4BD1-939A-D9986819AADC,"glioblastoma, IDH-wildtype",0.523099304
4D90C43F-2248-43CD-AC5D-987B4CA1C9C4,"glioblastoma, IDH-wildtype",0.523099304
CA08AE12-1DE3-48E8-9630-C71E18432977,Primary diffuse large B cell lymphoma of the CNS,0.522248841
FAE1950D-6AA2-41D4-B927-7530EB2B481C,"meningioma, benign",0.521645567
C3A441F3-ADA5-4A9D-A8A9-4BBB606771CD,Primary diffuse large B cell lymphoma of the CNS,0.519713483
F89BBF05-263C-422B-AAC9-58DF553CA5E1,"Control tissue, reactive tumour microenvironment",0.518242248
EF9AABAC-1FC6-40FC-8A55-66F7DFA2722B,Dysembryoplastic neuroepithelial tumour,0.517899783
6743AB61-72DF-47EB-B184-CAAB6FF062E8,"glioblastoma, IDH-wildtype",0.517487348
1EA79074-9B42-403D-AECF-2C043F19ED91,Schwannoma,0.512606629
A4373054-B9DC-45BB-9587-E95BBCF4654A,Schwannoma,0.512606629
C41FE813-1235-4012-B3DC-8B565BF75756,Chordoma,0.51168471
617E7650-1B0D-4BED-931F-E48DF49BB537,"glioblastoma, IDH-wildtype",0.507857403
5B679666-6975-4BAE-A109-BE74E0D5DD3F,Ganglioglioma,0.507629322
AAA1A7DA-1C68-46F5-A60A-5E725D2797C0,Atypical teratoid rhabdoid tumour,0.507580408
21237815-5D03-4013-ACB0-647F106C4AC1,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
186F82E2-9612-4CEE-B735-6FD58FCDDDDE,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
2133F66A-074E-4440-89F7-F0C288519066,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
40A0B2B4-F433-4ED1-9C8B-E63359217CD1,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
F5D95AFA-9E08-47A9-8A48-F98FCD32DC1A,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
9E494065-EA6D-4A7E-A0A9-DE795AA5456A,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
A254DB37-CE1F-4CB2-8A9D-2DAEE6586429,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
5857A84E-D139-49C8-A2F9-2DB72D45080F,"Astroblastoma, MN1-altered, MN1:BEND2-fused",0.505783027
9EEC1D9F-5B3E-49F1-95A3-CCE19B2A2E03,"meningioma, benign",0.504563177
3AC67927-FE19-4AA0-BD8A-50A45D96326B,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.502246504
00FC4A51-32C8-48F2-AC10-B0B2D89F4EA3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.502246504
61DC2823-1C4E-4CB6-8A61-3CF3397B8B65,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.502246504
F1F8FA3B-7BA2-4AEF-87BE-08B66C400FCD,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.502246504
71617AD4-BF23-4330-8478-B6699449F7A9,Diffuse paediatric-type high grade glioma,0.501773334
F638D0CF-B71F-43D1-9606-86EC4E8BF9DA,"Neuroblastoma, subtype TMM negative",0.500098494
0F1D944D-F932-46E9-8452-C55A37A541F8,"Neuroblastoma, subtype TMM negative",0.500098494
1B6F2277-9523-4A43-AA61-D0554A9F37B2,Chordoma,0.498652571
E8668409-2B68-47D5-BF48-6248DB5CBB1D,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.49645838
7AD353C8-E0A3-4CF8-9A40-6648C01913C2,Malignant melanotic nerve sheath tumour,0.492733979
71694200-CB78-41A9-9FF1-B974E3202BA0,Malignant melanotic nerve sheath tumour,0.492733979
0C289B8A-48E7-4E31-A1B0-D8230FC8F64F,"glioblastoma, IDH-wildtype",0.492633027
BC73CF9C-20F6-46F7-961E-60A38713A932,"Astrocytoma, IDH-mutant",0.492584112
1C89CFDB-4840-4923-A2B0-C8EA663E101C,"Astrocytoma, IDH-mutant",0.492584112
B8F816C0-C41D-4C89-8557-C5FA3615722A,"Astrocytoma, IDH-mutant",0.492584112
B61A2080-7FF2-465D-8AD1-487F49374A0A,"Astrocytoma, IDH-mutant",0.492584112
3DF0A823-234F-4D03-8943-28E26E5CA712,Ganglioglioma,0.492564468
420AFA44-9636-421C-989D-4603408EABA1,Diffuse paediatric-type high grade glioma,0.492551621
AE6D2AFE-33D0-486A-8DEC-ED7F524EA02C,Diffuse paediatric-type high grade glioma,0.492551621
0FF7E077-50DC-454D-A097-C91A4BF785F8,"glioblastoma, IDH-wildtype",0.492465434
4FE45DAC-463F-41C2-B385-BBDC91CC9F55,"glioblastoma, IDH-wildtype",0.491514454
D74FC563-EE32-4DFC-8F0E-3D95CD05FF50,"glioblastoma, IDH-wildtype",0.491002877
0E947053-2CAF-46AE-9112-82164DDBB9EC,"meningioma, benign",0.490748632
177CF0B4-DAC2-4032-8C95-128B8B271B42,Chordoma,0.490373027
04BEFB0D-71C4-4717-BD3C-D48960C387C3,"CNS neuroblastoma, FOXR2-altered",0.489988184
41978B1F-E468-4489-97EF-833335D0E588,"glioblastoma, IDH-wildtype",0.489228235
17954FD1-42FA-4FBC-B808-C301C46CBA48,"Astrocytoma, IDH-mutant",0.486705215
7DF6D914-3074-42A1-AA7E-5F63FBAEC657,Malignant melanotic nerve sheath tumour,0.48616393
7BD56763-F231-4473-90C2-5FA325488538,Atypical teratoid rhabdoid tumour,0.486094209
C6ABE29A-E77A-4ABD-92AA-FDC107783854,"Primary intracranial sarcoma, DICER1-mutant",0.484007584
13D03967-7E3F-40C5-892A-3C0B87C17FFD,"Neuroblastoma, subtype TMM negative",0.483731441
64AD7682-7156-41A2-B0BD-333AFAE3C175,Melanoma [metastatic],0.483258212
CC2AC433-1D4F-420A-B7C8-644B6A68014F,High-grade astrocytoma with piloid features,0.483052674
2F343AC0-FF83-46BB-BC13-BA2962DB9FAE,"glioblastoma, IDH-wildtype",0.482904379
80C38C2D-513C-41FA-BE7F-6CC115E4C234,"Adult-type diffuse high grade glioma, IDH-wildtype",0.482785539
5E89FC6A-EFE6-44B5-BFE3-8BBCF65D22A1,"glioblastoma, IDH-wildtype",0.48231251
66679D34-4A99-40B5-BB5C-11F7B5FD564C,"Adult-type diffuse high grade glioma, IDH-wildtype",0.48085954
75007CF4-4B10-465E-8D16-34006F1DDA66,"Oligosarcoma, IDH-mutant",0.480574344
6B888A2C-5F55-48EB-80B1-904B7DB9BC49,embryonal tumour with multilayered rosettes,0.480360751
0209270D-E153-4181-A957-94DBF04BC9C3,Ganglioglioma,0.480087687
4357D4AD-DEA5-49E8-B7CC-9949C576F12F,Ganglioglioma,0.480087687
ED8BCD77-76EB-413E-8D12-D3E59B0B3E30,"Astrocytoma, IDH-mutant",0.478751793
43F99DE0-35F1-49C4-9A4C-1E18AB999468,pilocytic astrocytoma,0.478044791
B756AEB6-7CEC-4920-BF93-95D3053A88D4,pilocytic astrocytoma,0.477191318
C47DDE63-0453-40D8-8A67-28B6B3505DEF,Diffuse paediatric-type high grade glioma,0.473388824
E868124E-BA59-4383-889F-78CC901C3240,"glioblastoma, IDH-wildtype",0.471482925
C888BCFE-5D11-4CEB-A4DB-953952DB48BC,pilocytic astrocytoma,0.471261249
8206C744-931D-4A25-BD81-1A42D2D976CB,Pleomorphic xanthoastrocytoma,0.470614366
342CE9C3-ABFA-43ED-9C02-7C671C0CAA6B,pilocytic astrocytoma,0.469755739
C1C7FC67-7648-4C71-BBAE-17C2D5F5CF23,pilocytic astrocytoma,0.469755739
DFF14A0E-92D4-4D96-AC37-7EA0639AD4B0,Papillary craniopharyngioma,0.469280865
AB096215-6434-4F51-9112-5F6A1FBFEAC3,Solitary fibrous tumour / haemangiopericytoma,0.468181715
2391AE86-BF40-4374-A069-143EB82690E9,Solitary fibrous tumour / haemangiopericytoma,0.468181715
D2816FA3-F903-43DA-B913-CEFE3E9C08B9,Pleomorphic xanthoastrocytoma,0.465170279
809EA04A-FB8B-49E8-9AB7-F7779398DEA0,control tissue,0.465049015
27015AA2-AF2F-4298-9EBA-D6234095F71C,control tissue,0.465049015
59574A98-331A-4DD0-B587-426AD644C307,control tissue,0.465049015
07319198-6C82-431B-BF06-F8F58131D08A,control tissue,0.465049015
5E0009FE-2127-4BCD-B694-25A78EACD42E,control tissue,0.465049015
43E342BD-6D09-4F02-AB84-E01E9741274E,"Control tissue, reactive tumour microenvironment",0.464771197
F78D1733-7A22-4D2D-BF0B-9B21D420272F,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",0.463551857
CBCCB592-E5E4-44EC-9E4A-8CA2CD7FB5F2,Pleomorphic xanthoastrocytoma,0.463308335
E5D3F155-370B-4254-AB07-C98B2EAF82B8,"Astrocytoma, IDH-mutant",0.462241371
8E736ACF-E9A7-46BA-9EA8-7970A19DC780,"medulloblastoma, SHH-activated",0.460985606
E65F41F2-6676-42C2-AA82-A0804F3E552E,"glioblastoma, IDH-wildtype",0.460792466
3C3A6F86-F778-4E5E-A731-9763E009112D,"meningioma, benign",0.460098853
FAB58C80-C648-49FF-9375-8EA1729CCDDC,Inflammatory microenvironment,0.45935553
BA22EF6C-655C-4462-A9D8-F839C4FA7C4C,Pineal parenchymal tumour of intermediate differentiation,0.457835756
57FA1809-3077-4898-BE9B-B3388859C7AE,"glioblastoma, IDH-wildtype",0.456561839
58D877D5-2341-4DC7-A613-9F1AEB12951A,"Control tissue, reactive tumour microenvironment",0.456277131
8520C687-0589-48DA-B16C-57FAF3DF98FF,pilocytic astrocytoma,0.456230465
1622C771-C609-48E0-952F-BD42420F8DA3,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.455416862
747F0634-8D87-4408-9743-2B064F6154CA,"Myxoid glioneuronal tumour, PDGFRA-mutant",0.45483989
EF9A39C9-9173-4F2D-9462-1D41DBE358FB,"Oligosarcoma, IDH-mutant",0.454336582
9F481001-34EE-46EA-B032-4E47A1F4DAB7,"Oligosarcoma, IDH-mutant",0.454336582
5829E766-1752-45E4-B76E-F59F7E9E38E2,"Oligosarcoma, IDH-mutant",0.454336582
E437AB07-64A0-4B47-8678-01DDE6EBB62A,"Neuroblastoma, subtype TMM negative",0.453827915
7547307C-B31B-4B7B-ACBC-E2B5A3030084,"glioblastoma, IDH-wildtype",0.453545467
AEB1FCC5-C657-4659-A946-9E7917A470C3,"glioblastoma, IDH-wildtype",0.453162241
8E52522B-4BA6-4E3F-8AEF-89D97FF001F6,Extraventricular neurocytoma,0.452972525
77F52F5B-D85C-4606-A781-FEFBDC08A8CC,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.4517962
4A9A1974-5467-4390-94B4-B015BB4C01A1,Malignant melanotic nerve sheath tumour,0.451311561
B03A2CA8-815C-4A4B-A334-87A2592B58BA,"glioblastoma, IDH-wildtype",0.449411791
56677F0A-3B93-4C24-AFD7-7316D92336A6,"Myxoid glioneuronal tumour, PDGFRA-mutant",0.448931089
8FA098D2-A919-4D40-97AC-0CE3B7219D90,Pineoblastoma,0.446716086
A4A49A00-07DA-452C-B114-60A3509DE63F,pilocytic astrocytoma,0.446078318
7DCA9C83-05B5-416C-8130-916B243959EB,pilocytic astrocytoma,0.446078318
40A2F552-FEDA-425B-83C1-D46CDB8FAC00,"Astrocytoma, IDH-mutant",0.445568334
CE901EDA-E1A3-4CCF-9582-F7144E72045E,"glioblastoma, IDH-wildtype",0.444116963
F4408C23-45AC-47D8-BA9F-0654E1A145FF,"Astrocytoma, IDH-mutant",0.443459783
298D2B16-B6F7-4264-A86C-0FC3A81DD82D,Infant-type hemispheric glioma,0.443085694
61E8E37E-5DEC-4757-A20B-CC0A8AF2A306,control tissue,0.442472064
9BFA2ABE-4AE4-45F1-86FD-FF6EEFD8FB35,Neuroepithelial tumour with PATZ1 fusion,0.441795263
D4428BDE-8C8B-4FD8-9818-C797378F7393,"Adult-type diffuse high grade glioma, IDH-wildtype",0.441705538
CFA669AE-9371-4F2B-BCF1-8C2E5C11B856,Dysembryoplastic neuroepithelial tumour,0.441255963
BB99EAA6-E399-4EBC-88BC-5B961ACDB3CD,"glioblastoma, IDH-wildtype",0.44095111
077D7BD6-C5E7-4C94-AE9C-98A879376670,Liponeurocytoma,0.440525099
6B511416-243F-433A-BDD1-8407F888BF0B,Teratoma,0.438844658
ADEE4207-14AE-491B-8E81-99AE6CA854CE,"glioblastoma, IDH-wildtype",0.438458188
9C5EF654-A305-41E8-A635-A10EDC5F255B,"glioblastoma, IDH-wildtype",0.438458188
FAD1C97C-A147-4E7E-B86E-FB04A267D5AE,"glioblastoma, IDH-wildtype",0.438458188
FB2721FC-207D-4021-89F1-68DC1A853BD9,"Neuroblastoma, subtype TMM negative",0.43803944
CAA6A76B-70D7-4A5A-823A-E4B82321206F,"Astrocytoma, IDH-mutant",0.437223308
F6DDD40E-25D2-4177-9DE1-A069A1BCE0A9,Chordoma,0.436635489
C9388F5A-C09B-4CD1-88A0-487AB6FED8BF,Diffuse paediatric-type high grade glioma,0.435869542
62877E18-C807-46B2-B81D-3D09A2609749,Diffuse paediatric-type high grade glioma,0.435869542
242191E6-C3F2-46C6-A333-87BF679F8F74,Diffuse paediatric-type high grade glioma,0.43545877
FD02F83B-33DC-48BA-9628-65812AB3D287,High-grade astrocytoma with piloid features,0.435200554
1881E8E9-1969-45FC-A22B-A754D1D46A6A,pilocytic astrocytoma,0.43261184
802BA345-5710-4126-91BF-A0C03BC3C6AA,"Astrocytoma, IDH-mutant",0.431819254
AC8D5735-52DD-44D7-907B-391608F7340C,Ganglioglioma,0.427888133
A381B1B2-A1D7-47A4-96E7-E17174547F36,"glioblastoma, IDH-wildtype",0.426979553
5D7EEBC5-0541-4610-94B7-553F8EC89F0B,Dysembryoplastic neuroepithelial tumour,0.426334646
CC2D1BF6-5D56-44F3-9361-43B8C21BFC77,Ganglioglioma,0.425313317
74D4FEC3-1124-4C50-9F57-0C3C7D358D1F,"glioblastoma, IDH-wildtype",0.425184751
C743232D-A820-4C5C-951C-6BD96621BF3E,Pleomorphic xanthoastrocytoma,0.424909004
F2841D27-5B51-492F-9125-80C26975C2B1,"Control tissue, reactive tumour microenvironment",0.424143437
65865A87-F995-4010-A0C7-D3CBCA629649,"Astrocytoma, IDH-mutant",0.4211827
7B646EA8-E80C-4F98-8190-E9633D814F09,"glioblastoma, IDH-wildtype",0.420284413
F68B8BB8-75A3-4EB2-912A-08BE135DBB29,"glioblastoma, IDH-wildtype",0.41913284
9B9BC20B-02CE-4CF8-933E-03B14E9FA1F1,control tissue,0.418358942
620DA887-F54B-48F2-98AA-A2C6890FD806,"glioblastoma, IDH-wildtype",0.418242563
3904AAD4-CC69-4F6D-BD25-1A84F4AE3562,"Astrocytoma, IDH-mutant",0.416094543
8BC031B5-7D7E-40BC-866B-06301AE5A867,"glioblastoma, IDH-wildtype",0.415505209
95E23CD5-9134-45E7-A2A2-8D4B029072B0,Chordoma,0.412585837
CB407B58-24CE-4DD3-92A9-73A7B7A995AE,Chordoma,0.411626587
154A4DCC-9BD2-45AD-AD70-2660286A12C6,Chordoma,0.411518961
823779E7-3136-4EB7-9E7C-5C303289E423,pilocytic astrocytoma,0.41013268
1EA510B5-2107-46A1-A68F-18440CB2133A,medulloblastoma Group 4,0.409307691
2A819C6C-2E27-4C23-9615-B9F79E5C3F91,Papillary craniopharyngioma,0.408602488
5DB31741-4C41-41C6-8C70-FD35ED646130,Infant-type hemispheric glioma,0.407817968
CFD1847F-E2D5-4254-81D6-B312F534EE70,pilocytic astrocytoma,0.40730688
902C256C-22E5-427E-9FAF-CAA206CE46C1,"glioblastoma, IDH-wildtype",0.40705566
19A278BC-15C1-417C-91A3-1F7D9362AD1A,"glioblastoma, IDH-wildtype",0.40705566
60D557B3-69D1-434A-BB2F-FBA459463EC2,Papillary craniopharyngioma,0.406585983
F9A1F2AF-06AE-428C-AC72-9BD2DAAB0652,"glioblastoma, IDH-wildtype",0.405647112
9EDB3FCD-A946-4385-A17D-EAEB80CB3800,pilocytic astrocytoma,0.405036277
9684CFA5-26B6-474F-AD04-2BA13D66CC7E,Chordoma,0.404149778
82918C52-4DD0-4948-8440-79D42FB233DB,Diffuse paediatric-type high grade glioma,0.403600783
200A6076-7AD6-4490-B7DD-E391A6AA1693,Pleomorphic xanthoastrocytoma,0.403389154
BD5C906C-41D7-463D-B9BB-BB8A8F9601FD,"Control tissue, reactive tumour microenvironment",0.402879826
B38A64A3-DACA-439C-BCC0-5F49C3E078A4,spinal subependymoma,0.401466463
F4E97430-26AC-4D55-A4FD-83CE0803A233,"meningioma, intermediate",0.400059774
E5A05408-AC74-4EC0-AA1D-513AA4DC847B,Diffuse paediatric-type high grade glioma,0.397299974
219EFCC8-820E-418B-A63B-21E3D4B483C1,"Astrocytoma, IDH-mutant",0.396625091
FD698B37-B04E-413D-8FAD-4B910C403739,Spinal ependymoma,0.395901164
7674BA90-3960-4F75-9093-679475F7E751,"glioblastoma, IDH-wildtype",0.395540629
36ADB66F-A8B5-4CA6-A5A9-A29C531FABD3,"Oligosarcoma, IDH-mutant",0.39352957
C3087962-3A86-4C6D-BB5A-5C0589D3B14D,"glioblastoma, IDH-wildtype",0.392195356
24E3CEA1-E691-4A82-98D6-B1B0BA31784C,"Adult-type diffuse high grade glioma, IDH-wildtype",0.384626965
08642C95-338E-453B-8B5A-14CCBACB2895,"glioblastoma, IDH-wildtype",0.384397546
78569741-7CCC-4829-A279-F209E57FA4DC,Central neurocytoma,0.383743522
63EC5BB5-F755-4124-A6B9-3A0C709A1139,pilocytic astrocytoma,0.383491474
BED31F1D-2C77-476B-A695-E70C338B2773,High-grade diffuse glioma of the midline/posterior fossa; H3/IDH-wildtype,0.383143452
66B61395-41EF-4A75-9671-58A86A5387B6,Supratentorial subependymoma,0.378491409
D801042F-3075-4CBD-A28A-23E38669CACC,medulloblastoma Group 4,0.374942359
CCD5417B-828B-45BD-B54F-4958793B8CD4,"Oligosarcoma, IDH-mutant",0.37343603
F0C96F0D-EB28-4B2E-A773-8FEE96F16B1B,"Oligosarcoma, IDH-mutant",0.37343603
CA8FD0E0-F4AA-4E95-91A8-1DA425E2A747,High-grade astrocytoma with piloid features,0.373088418
53753705-3814-464F-846F-321E535B727B,High-grade astrocytoma with piloid features,0.373088418
8C1B904C-BEF7-43DA-8747-C28A9B1D3190,Plasmacytoma of the CNS,0.36769271
9423AC8F-65A7-49F6-B614-40BD9C81AFF9,Yolk sac tumour,0.365739113
9834811B-B6E3-46E7-9D35-7E12CA9D4578,Ganglioglioma,0.365516733
9AFE93C9-29EA-4FA1-A039-9F1AB982F03A,"Control tissue, reactive tumour microenvironment",0.364840932
9B308B86-4032-4C42-A3D0-E9EFB73192D6,"Adult-type diffuse high grade glioma, IDH-wildtype",0.363922186
B7E815A9-84AA-4FE0-AF55-750BAF34A948,"Adult-type diffuse high grade glioma, IDH-wildtype",0.363922186
B78BF0D9-36F4-412B-A0DA-AF95AE45BFCD,"Adult-type diffuse high grade glioma, IDH-wildtype",0.363922186
F127D006-BA8E-42B9-9311-EDFB46CBA5E9,Ganglioglioma,0.363855609
EBF7BF76-8D59-4271-9127-CD8C7BC4DCA8,"Control tissue, reactive tumour microenvironment",0.361241928
624328D5-768A-49C2-B9D8-419EDB6D1FD8,"Control tissue, reactive tumour microenvironment",0.361241928
91639F64-DB71-40FB-83BF-4C9736F17DC7,"Control tissue, reactive tumour microenvironment",0.361241928
B242F469-113D-4410-BC44-FCECE011EE05,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma,0.356462173
1E54FD39-8316-41F9-966F-11359FAC511C,"Diffuse hemispheric glioma, H3 G34-mutant",0.355265428
3FDD4C0C-A396-4E1A-85BF-E6C4505C4C16,"Pituicytoma, granular cell tumour of the sellar region, and spindle-cell oncocytoma",0.353962125
196DEE4A-8E4E-4DC1-AFA6-EDA480F9DEF5,Rosette-forming glioneuronal tumour,0.353116127
